<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/251577-novel-anthranilic-acid-derivative-or-salt-thereof by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 13:50:39 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 251577:NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>An anthranilic acid derivative represented by the general formula (X) [wherein R1 represents hydrogen or a carboxy-protecting group; R2 represents optionally substituted phenyl, a heterocyclic group, etc.; R3 represents optionally substituted phenyl, a monocyclic heterocyclic group, etc.; X1 represents carbonyl, etc.; X2 represents optionally substituted alkylene group, a bond, etc.; X3 represents oxygen, a bond, etc.; and X4 represents a group represented by the general formula -X5-X6- or -X6-X5- (wherein X5 means oxygen, a bond, etc.; and X6 means optionally substituted alkylene, a bond, etc.)] or a salt of the derivative. The derivative or salt has the inhibitory activity of MMP- 13 production and is hence useful as a therapeutic agent for articular rheumatism, osteoarthritis, cancer, etc.</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td>W3763458/8                  1<br>
DESCRIPTION<br>
NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF<br>
TECHNICAL FIELD<br>
[0001]<br>
The present invention relates to a novel<br>
anthranilic acid derivative or a salt thereof having<br>
the inhibitory activity of matrix metalloprotease 13<br>
(MMP-13) production.<br>
BACKGROUND ART<br>
[0002]<br>
Matrix metalloproteases are a family<br>
consisting of zinc-dependent proteases whose substrates<br>
are components of extracellular matrix, and they are<br>
activated by removal of a propeptide after secretion.<br>
More than 20 members of matrix metalloproteases have<br>
been identified in human, and they are classified into<br>
collagenase (MMP-1, 8, 13), gelatinase (MMP-2, 9),<br>
stromelysin (MMP-3, 10), matrilysin (MMP-7, 26),<br>
membrane-type MMP (MMP-14, 15, 16, 17, 24, 25)<br>
according to the domain structure and substrate<br>
specificity. Overexpression of these matrix<br>
metalloproteases are observed in various cancer cells,<br>
and it is considered to be involved in the<br>
proliferation and metastasis thereof. Anticancer agents<br>
that inhibit matrix metalloprotease have been developed<br>
up to now (Non-Patent Document 1).<br><br>
2<br>
[0003]<br>
Matrix metalloprotease inhibitors have been<br>
developed as a therapeutic agent for rheumatoid<br>
arthritis and osteoarthritis. The articular cartilage<br>
is composed of a cartilage type II collagen network in<br>
which cartilage proteoglycans such as aggrecan and<br>
hyaluronic acid are retained. Matrix metalloprotease<br>
participates in the maintenance of the extracellular<br>
matrix. When matrix metalloprotease and TIMP (tissue<br>
inhibitor of metalloproteinases), an endogenous<br>
inhibitor thereof, are not in balance and matrix<br>
metalloprotease becomes excessively present,<br>
destruction of the cartilages and bones may progress.<br>
Particularly when collagen fibers are damaged, the<br>
joints suffer from progressive destruction as observed<br>
in rheumatoid arthritis and osteoarthritis. Accordingly,<br>
long-term suppression of the progress of joint<br>
destruction in rheumatoid arthritis and osteoarthritis<br>
can be expected by inhibiting excessive matrix<br>
metalloprotease (Non-Patent Document 2).<br>
[0004]<br>
In osteoarthritis, the production of<br>
interleukin-1 (IL-1) and tumor necrosis factor (TNF) a<br>
also increases and extracellular matrix is degraded.<br>
The production of matrix metalloprotease is further<br>
increased by degradation products of type II collagen<br>
and fibronectin, leading to progress in degradation of<br>
matrix in the joints. When this damage of matrix<br>
exceeds a certain threshold, character of cartilage<br><br>
3<br>
cells pathological change, and joint destruction keeps<br>
progressing. It is MMP-13 that plays a dominant role in<br>
this cleavage of type II collagen (Non-Patent Document<br>
3).<br>
[0005]<br>
Non-Patent Document 1: Current Oncology Reports, Vol. 6,<br>
page 96-102, 2004<br>
Non-Patent Document 2: Annals of the Rheumatic Diseases,<br>
Vol. 60, page 62-67, 2001<br>
Non-Patent Document 3: Biochemical Society Symposia,<br>
Vol. 70, page 115-123, 2003<br>
DISCLOSURE OF THE INVENTION<br>
[0006]<br>
Drugs inhibiting the production of matrix<br>
metalloproteases, particularly MMP-13, are strongly<br>
demanded.<br>
[0007]<br>
Under the circumstances, the present<br>
inventors have conducted extensive studies, and<br>
consequently have found that an anthranilic acid<br>
derivative represented by general formula [1]<br>
[Formula 1]<br>
wherein, R1 represents a hydrogen atom or a carboxyl<br>
protecting group; R2 represents a phenyl, cycloalkyl or<br><br><br>
4<br>
heterocyclic group which may be optionally substituted;<br>
R3 represents a phenyl, cycloalkyl, cycloalkenyl,<br>
monocyclic heterocyclic or bicyclic heterocyclic group<br>
which may be optionally substituted; X1 represents a<br>
carbonyl group or sulfonyl group; X2 represents an<br>
alkylene, alkenylene or alkynylene group which may be<br>
optionally substituted or a bond; provided that when X1<br>
is a sulfonyl group and X4 is a bond, X2 represents an<br>
alkylene, alkenylene or alkynylene group which may be<br>
optionally substituted; X3 represents an oxygen atom, a<br>
sulfur atom or a bond; X4 represents a group represented<br>
by the general formula, -X5-X6- or -X6-X5-, wherein the<br>
bond on the left side of each general formula is linked<br>
to R3; and X5 represents an oxygen atom, a sulfur atom,<br>
an imino group which may be optionally protected, a<br>
sulfinyl group or a sulfonyl group or a bond; X6<br>
represents an alkylene, alkenylene or alkynylene group<br>
which may be optionally substituted or a bond, or a<br>
salt thereof has the inhibitory activity of MMP-13<br>
production and thus completed the present invention.<br>
[0008]<br>
The novel anthranilic acid derivative or a<br>
salt thereof of the present invention has the<br>
inhibitory activity of MMP-13 production and is<br>
therefore useful as, for example, a therapeutic agent<br>
for rheumatoid arthritis, osteoarthritis, cancer and<br>
the other diseases in which MMP-13 is involved.<br><br>
5<br>
BEST MODE FOR CARRYING OUT THE INVENTION<br>
[0009]<br>
Hereinbelow, compounds of the present<br>
invention are described in detail.<br>
In the present specification, unless<br>
otherwise stated in particular, a halogen atom refers<br>
to a fluorine atom, a chlorine atom, a bromine atom and<br>
an iodine atom; an alkyl group refers to, for example,<br>
a linear or branched C1-12 alkyl group such as methyl,<br>
ethyl, propyl, isopropyl, butyl, sec-butyl, isobutyl,<br>
tert-butyl, pentyl, isopentyl, hexyl, heptyl and octyl;<br>
a lower alkyl group refers to, for example, a linear or<br>
branched C1-6 alkyl group such as methyl, ethyl, propyl,<br>
isopropyl, butyl, sec-butyl, isobutyl, tert-butyl,<br>
pentyl and isopentyl; an alkenyl group refers to, for<br>
example, a linear or branched C2-12 alkenyl group such as<br>
vinyl, allyl, propenyl, isopropenyl, butenyl,<br>
isobutenyl, pentenyl, hexenyl, heptenyl and octenyl; an<br>
alkynyl group refers to, for example, a linear or<br>
branched C2-12 alkynyl group such as ethynyl, 2-propynyl<br>
and 2-butynyl; a cycloalkyl group refers to, for<br>
example, a C3-8 cycloalkyl group such as cyclopropyl,<br>
cyclobutyl, cyclopentyl and cyclohexyl; a cycloalkenyl<br>
group refers to, for example, a C3-8 cycloalkenyl group<br>
such as cyclopropenyl, cyclobutenyl, cyclopentenyl and<br>
cyclohexenyl; an alkylene group refers to, for example,<br>
a linear or branched C1-6 alkylene group such as<br>
methylene, ethylene, propylene, butylene and hexylene;<br>
an alkenylene group refers to, for example, a linear or<br><br>
6<br>
branched C2-6 alkenylene group such as vinylene,<br>
propenylene, 1-butenylene and 2-butenylene; an<br>
alkynylene group refers to, for example, a linear or<br>
branched C2-6 alkynylene group such as ethynylene,<br>
propynylene, 1-butynylene and 2-butynylene; an aryl<br>
group refers to, for example, a group such as phenyl<br>
and naphthyl; an aralkyl group refers to, for example,<br>
an ar-C1-6 alkyl group such as benzyl, diphenylmethyl,<br>
trityl, phenethyl and naphthylmethyl; an alkoxy group<br>
refers to, for example, a linear or branched C1-6<br>
alkyloxy group such as methoxy, ethoxy, propoxy,<br>
isopropoxy, butoxy, isobutoxy, sec-butoxy, tert-butoxy,<br>
pentyloxy and isopentyloxy; an aryloxy group refers to,<br>
for example, a group such as phenoxy and naphthoxy; an<br>
alkoxyalkyl group refers to, for example, a C1-6<br>
alkyloxy C1-6 alkyl group such as methoxymethyl and 1-<br>
ethoxyethyl; and an aralkyloxyalkyl group refers to,<br>
for example, an ar-C1-6 alkyloxy C1-6 alkyl group such as<br>
benzyloxymethyl and phenethyloxymethyl;<br>
[0010]<br>
an acyl group refers to, for example, a formyl group, a<br>
linear or branched C2-12 alkanoyl group such as acetyl,<br>
propionyl and isovaleryl, an ar-C1-6 alkylcarbonyl group<br>
such as benzylcarbonyl, a cyclic hydrocarbon carbonyl<br>
group such as benzoyl and naphthoyl, a heterocyclic<br>
carbonyl group such as nicotinoyl, thenoyl,<br>
pyrrolidinocarbonyl and furoyl, a succinyl group, a<br>
glutaryl group, a maleoyl group, a phthaloyl group and<br>
a linear or branched a-aminoalkanoyl group derived from<br><br>
7<br>
an amino acid (Examples of the amino acid include<br>
glycine, alanine, valine, leucine, isoleucine, serine,<br>
threonine, cysteine, methionine, aspartic acid,<br>
glutamic acid, asparagine, glutamine, arginine, lysine,<br>
histidine, hydroxylysine, phenylalanine, tyrosine,<br>
tryptophan, proline and hydroxyproline.) in which the<br>
N-terminal may be optionally protected; an<br>
alkyloxycarbonyl group refers to, for example, a linear<br>
or branched C1-12 alkyloxycarbonyl group such as<br>
methoxycarbonyl, ethoxycarbonyl, 1,1-<br>
dimethylpropoxycarbonyl, isopropoxycarbonyl, 2-<br>
ethylhexyloxycarbonyl, tert-butoxycarbonyl and tert-<br>
pentyloxycarbonyl; an aralkyloxycarbonyl group refers<br>
to, for example, an ar-C1-6 alkyloxycarbonyl group such<br>
as benzyloxycarbonyl and phenethyloxycarbonyl group; an<br>
aryloxycarbonyl group refers to, for example, a group<br>
such as phenyloxycarbonyl;<br>
[0011]<br>
an acyloxy group refers to, for example, a linear or<br>
branched C2-6 alkanoyloxy group such as acetyloxy and<br>
propionyloxy and an aroyloxy group such as benzoyloxy;<br>
an acylalkyl group refers to, for example, a group such<br>
as acetylmethyl, benzoylmethyl, p-nitrobenzoylmethyl,<br>
p-bromobenzoylmethyl, p-methoxybenzoylmethyl and 1-<br>
benzoylethyl; an acyloxyalkyl group refers to, for<br>
example, a group such as acetoxymethyl,<br>
propionyloxymethyl and pivaloyloxymethyl; an<br>
alkylthioalkyl group refers to, for example, a C1-6<br>
alkylthio C1-6 alkyl group such as methylthiomethyl,<br><br>
8<br>
ethylthiomethyl and propylthio- methyl; an arylthio<br>
group refers to, for example, a group such as<br>
phenylthio; an alkanesulfonyl group refers to, for<br>
example, a C1-6 alkanesulfonyl group such as<br>
methanesulfonyl, ethanesulfonyl and propanesulfonyl; an<br>
arylsulfonyl group refers to, for example, a group such<br>
as benzenesulfonyl, toluenesulfonyl and<br>
naphthalenesulfonyl; an alkanesulfonyloxy group refers<br>
to, for example, a C1-6 alkanesulfonyloxy group such as<br>
methanesulfonyloxy and ethanesulfonyloxy; an<br>
arylsulfonyloxy group refers to, for example, a group<br>
such as benzenesulfonyloxy and toluenesulfonyloxy; an<br>
arylthioalkyl group refers to, for example, a group<br>
such as phenylsulfenylmethyl and 2-(p-<br>
nitrophenylsulfenyl)ethyl; an arylsulfonylalkyl group<br>
refers to, for example, a group such as p-<br>
toluenesulfonylethyl; and an alkanesulfonamide group<br>
refers to, for example, a C1-6 alkanesulfonamide group<br>
such as methanesulfonamide and ethanesulfonamide.<br>
[0012]<br>
An oxygen-containing heterocyclic group<br>
refers to, for example, a group such as 2-<br>
tetrahydropyranyl and 2-tetrahydrofuranyl; a sulfur-<br>
containing heterocyclic group refers to, for example, a<br>
group such as tetrahydrothiopyranyl; a heterocyclic<br>
oxycarbonyl group refers to, for example, a group such<br>
as 2-furfuryloxycarbonyl and 8-quinolyloxycarbonyl; a<br>
nitrogen-containing heterocyclic alkyl group refers to,<br>
for example, a group such as phthalimidomethyl and<br><br>
9<br>
succinimidomethyl; a substituted silyl group refers to,<br>
for example, a group such as trimethylsilyl,<br>
triethylsilyl and tributylsilyl; and an alkylsilylalkyl<br>
group refers to, for example, a group such as 2-<br>
(trimethylsilyl)ethyl.<br>
[0013]<br>
A monocyclic heterocyclic group refers to,<br>
for example, a nitrogen-containing monocyclic<br>
heterocyclic group containing a nitrogen atom(s) as<br>
sole ring-member heteroatom such as pyrrolyl,<br>
pyrrolinyl, pyrrolidinyl, piperidyl, piperazinyl,<br>
imidazolyl, pyrazolyl, pyridyl, tetrahydropyridyl,<br>
pyridazinyl, pyrazinyl, pyrimidinyl, tetrazolyl,<br>
imidazolinyl, imidazolidinyl, pyrazolinyl and<br>
pyrazolidinyl group; an oxygen-containing monocyclic<br>
heterocyclic group containing an oxygen atom(s) as sole<br>
ring-member heteroatom such as furyl and pyranyl group;<br>
a sulfur-containing monocyclic heterocyclic group<br>
containing a sulfur atom(s) as sole ring-member<br>
heteroatom such as a thienyl group; a nitrogen-and-<br>
oxygen-containing monocyclic heterocyclic group<br>
containing nitrogen and oxygen atoms as sole ring-<br>
member heteroatoms such as oxazolyl, oxadiazolyl,<br>
isoxazolyl and morpholinyl group; a nitrogen-and-<br>
sulfur-containing monocyclic heterocyclic group<br>
containing nitrogen and sulfur atoms as sole ring-<br>
member heteroatoms such as thiazolyl, isothiazolyl,<br>
thiadiazolyl and thiomorpholinyl group; and an oxygen-<br>
and-sulfur-containing monocyclic heterocyclic group<br><br>
10<br>
containing oxygen and sulfur atoms as sole ring-member<br>
heteroatoms such as a thioxanyl group.<br>
[0014]<br>
A bicyclic heterocyclic group refers to, for<br>
example, a nitrogen-containing bicyclic heterocyclic<br>
group represented by a condensed or bridged ring<br>
containing only 1 to 3 nitrogen atom(s) as the<br>
heteroatom of the said ring such as indolyl, indolinyl,<br>
2-oxoindolinyl, isoindolyl, indolizinyl, benzimidazolyl,<br>
benzotriazolyl, indazolyl, quinolyl,<br>
tetrahydroquinolinyl, tetrahydroisoquinolinyl,<br>
quinolizinyl, isoquinolyl, phthalazinyl, naphthyridinyl,<br>
quinoxalinyl, dihydroquinoxalinyl, quinazolinyl,<br>
cinnolinyl, quinuclidinyl and 2,3-dihydrobenzopyrrolyl<br>
group; an oxygen-containing bicyclic heterocyclic group<br>
represented by a condensed or bridged ring containing<br>
only oxygen atom(s) as the heteroatom of the said ring<br>
such as benzofuranyl, isobenzofuranyl, chromenyl,<br>
chromanyl, isochromanyl, benzo-1,3-dioxolyl, benzo-1,4-<br>
dioxanyl and 2,3-dihydrobenzofuranyl group; a sulfur-<br>
containing bicyclic heterocyclic group represented by a<br>
condensed or bridged ring containing only sulfur<br>
atom(s) as the heteroatom of the said ring such as<br>
benzothienyl and 2,3-dihydrobenzothienyl group; a<br>
nitrogen-and-oxygen-containing bicyclic heterocyclic<br>
group represented by a condensed or bridged ring<br>
containing only nitrogen and oxygen atom(s) as the<br>
heteroatom of the said ring such as benzomorpholinyl<br>
and benzomorpholonyl group; and a nitrogen-and-sulfur-<br><br>
11<br>
containing bicyclic heterocyclic group represented by a<br>
condensed or bridged ring containing only nitrogen and<br>
sulfur atom(s) as the heteroatom of the said ring such<br>
as benzothiazolyl and benzothiadiazolyl group.<br>
[0015]<br>
A heterocyclic group refers to, for example,<br>
a monocyclic heterocyclic group; a bicyclic<br>
heterocyclic group; a tricyclic heterocyclic group such<br>
as thianthrenyl, xanthenyl, phenoxathiinyl, carbazolyl,<br>
P-carbolinyl, phenanthridinyl, acridinyl, perimidinyl,<br>
phenathrolinyl, phenazinyl, phenothiazinyl and<br>
phenoxazinyl.<br>
[0016]<br>
A cyclic amino group may be, for example, a<br>
saturated cyclic amino group and an unsaturated amino<br>
group, may optionally contain one or more heteroatoms<br>
such as nitrogen atom, oxygen atom and sulfur atom and<br>
carbonyl carbon in the ring, and may be monocyclic,<br>
bicyclic or tricylic; and more specifically refers to a<br>
saturated or unsaturated monocyclic 3- to 7-membered<br>
cyclic amino group having one nitrogen atom such as<br>
aziridin-1-yl, azetidin-1-yl, pyrrolidin-1-yl,<br>
pyrrolin-1-yl, pyrrol-1-yl, dihydropyridin-1-yl,<br>
tetrahydropyridin-1-yl, piperidin-1-yl, dihydroazepin-<br>
1-yl and perhydroazepin-1-yl; a saturated or<br>
unsaturated monocyclic 3- to 7-membered cyclic amino<br>
group having 2 nitrogen atoms such as imidazol-1-yl,<br>
imidazolidin-1-yl, imidazolin-1-yl, pyrazolidin-1-yl,<br>
piperazin-1-yl, 1,4-dihydropyrazin-l-yl, 1,2-<br><br>
12<br>
dihydropyrimidin-1-yl, perhydropyrazin-1-yl and<br>
homopiperazin-1-yl; a saturated or unsaturated<br>
monocyclic 3- to 7-membered cyclic amino group having 3<br>
or more nitrogen atoms such as 1,2,4-triazol-l-yl,<br>
1,2,3-triazol-l-yl, 1,2-dihydro-l,2,4-triazin-l-yl and<br>
perhydro-S-triazin-1-yl; a saturated or unsaturated<br>
monocyclic 3- to 7-membered cyclic amino group having 1<br>
to 4 heteroatoms selected from an oxygen atom and a<br>
sulfur atom in addition to a nitrogen atom(s) such as<br>
oxazolidin-3-yl, isoxazolidin-2-yl, morpholin-4-yl,<br>
thiazolidin-3-yl, thiazolidin-2-yl, thiomorpholin-4-yl,<br>
homothiomorpholin-4-yl and 1,2,4-thiaziazolin-2-yl; a<br>
saturated or unsaturated bicyclic or tricyclic cyclic<br>
amino group such as isoindolin-2-yl, indolin-1-yl, 1H-<br>
indazol-1-yl, lH-indol-1-yl, lH-benzimidazol-1-yl,<br>
purin-7-yl, tetrahydroquinolin-1-yl and<br>
tetrahydroisoquinolin-2-yl; and a saturated or<br>
unsaturated 5- to 12-membered spiro or bridged cyclic<br>
amino group such as 5-azaspiro[2.4]heptan-5-yl, 2,8-<br>
diazabicyclo[4.3.0]nonan-8-yl, 3-<br>
azabicyclo[3.1.0]hexan-3-yl, 2-oxa-5,8-<br>
diazabicyclo[4.3.0]nonan-8-yl, 2,8-<br>
diazaspiro[4.4]nonan-2-yl and 7-<br>
azabicyclo[2.2.1]heptan-7-yl.<br>
[0017]<br>
The amino protecting group includes any group<br>
which can be normally used as a protecting group of an<br>
amino group, and examples thereof include groups<br>
described in W. Greene et al., Protective Groups in<br><br>
13<br>
Organic Synthesis, third edition, pp. 494-615, 1999,<br>
John Wiley &amp; Sons, INC. Specific examples thereof<br>
include an acyl group, an alkyloxycarbonyl group, an<br>
aralkyloxycarbonyl group, an aryloxycarbonyl group, an<br>
aralkyl group, an alkoxyalkyl group, an aralkyloxyalkyl<br>
group, an arylthio group, an alkanesulfonyl group, an<br>
arylsulfonyl group and a substituted silyl group.<br>
[0018]<br>
The imino protecting group includes any group<br>
which can be normally used as a protecting group of an<br>
imino group, and examples thereof include groups<br>
described in W. Greene et al., Protective Groups in<br>
Organic Synthesis, third edition, pp. 494-615, 1999,<br>
John Wiley &amp; Sons, INC. Specific examples thereof<br>
include an acyl group, an alkyloxycarbonyl group, an<br>
aralkyloxycarbonyl group, an aryloxycarbonyl group, an<br>
aralkyl group, an alkoxyalkyl group, an arylthio group,<br>
an alkanesulfonyl group, an arylsulfonyl group and a<br>
substituted silyl group.<br>
[0019]<br>
The hydroxyl protecting group includes any<br>
group which can be normally used as a protecting group<br>
of a hydroxyl group, and examples thereof include<br>
groups described in W. Greene et al., Protective Groups<br>
in Organic Synthesis, third edition, pp. 17-245, 1999,<br>
John Wiley &amp; Sons, INC. Specific examples thereof<br>
include an acyl group, an alkyloxycarbonyl group, an<br>
aralkyloxycarbonyl group, a heterocyclic oxycarbonyl<br>
group, an alkyl group, an alkenyl group, an aralkyl<br><br>
14<br>
group, an oxygen-containing heterocyclic group, a<br>
sulfur-containing heterocyclic group, an alkoxyalkyl<br>
group, an aralkyloxyalkyl group, an alkanesulfonyl<br>
group, an arylsulfonyl group and a substituted silyl<br>
group.<br>
[0020]<br>
The carboxyl protecting group includes any<br>
group which can be normally used as a protecting group<br>
of a carboxyl group, and examples thereof include<br>
groups described in W. Greene et al., Protective Groups<br>
in Organic Synthesis, third edition, pp. 369-453, 1999,<br>
John Wiley &amp; Sons, INC. Specific examples thereof<br>
include an alkyl group, an aryl group, an aralkyl group,<br>
an acylalkyl group, an arylthioalkyl group, an<br>
arylsulfonylalkyl group, an oxygen-containing<br>
heterocyclic group, an alkyl silyl alkyl group, an<br>
acyloxyalkyl group, a nitrogen-containing heterocyclic<br>
alkyl group, a cycloalkyl group, an alkoxyalkyl group,<br>
an aralkyloxyalkyl group, an alkylthioalkyl group, an<br>
alkenyl group and a substituted silyl group.<br>
[0021]<br>
The phenolic hydroxyl protecting group<br>
includes any group which can be normally used as a<br>
protecting group of a phenolic hydroxyl group, and<br>
examples thereof include groups described in W. Greene<br>
et al., Protective Groups in Organic Synthesis, third<br>
edition, pp. 246-287, 1999, John Wiley &amp; Sons, INC.<br>
Specific examples thereof include an acyl group, an<br>
alkyl group, an alkenyl group, an aralkyl group, an<br><br>
15<br>
oxygen-containing heterocyclic group, a sulfur-<br>
containing heterocyclic group, an alkoxyalkyl group, an<br>
alkanesulfonyl group, an arylsulfonyl group and a<br>
substituted silyl group.<br>
[0022]<br>
The thiol protecting group includes any group<br>
which can be normally used as a protecting group of a<br>
thiol group, and examples thereof include groups<br>
described in W. Greene et al., Protective Groups in<br>
Organic Synthesis, third edition, pp. 454-493, 1999,<br>
John Wiley &amp; Sons, INC. Specific examples thereof<br>
include an acyl group, an alkyl group, an alkenyl group,<br>
an aralkyl group, an alkoxyalkyl group and a<br>
substituted silyl group.<br>
[0023]<br>
The acetylene protecting group includes any<br>
group which can be normally used as a protecting group<br>
of acetylene, and examples thereof include groups<br>
described in W. Greene et al., Protective Groups in<br>
Organic Synthesis, third edition, pp. 654-659, 1999,<br>
John Wiley &amp; Sons, INC. Specific examples thereof<br>
include substituted silyl group.<br>
[0024]<br>
Examples of a leaving group include a halogen<br>
atom, an alkanesulfonyloxy group, an arylsulfonyloxy<br>
group and an acyloxy group.<br>
[0025]<br>
The salt of a compound of general formula [1]<br>
includes commonly known salts formed from a basic group<br><br>
16<br>
such as an amino group or from an acidic group such as<br>
a phenolic hydroxyl group or a carboxyl group.<br>
Examples of salts formed from a basic group<br>
include salts with a mineral acid such as hydrochloric<br>
acid, hydrogen bromide and sulfuric acid; salts with an<br>
organic carboxylic acid such as tartaric acid, formic<br>
acid, acetic acid, citric acid, trichloroacetic acid<br>
and trifluoroacetic acid and salts with a sulfonic acid<br>
such as methanesulfonic acid, benzenesulfonic acid, p-<br>
toluenesulfonic acid, mesitylenesulfonic acid and<br>
naphthalenesulfonic acid.<br>
Examples of salts formed from an acidic group<br>
include salts with an alkali metal such as sodium and<br>
potassium; salts with an alkali earth metal such as<br>
calcium and magnesium; ammonium salt and salts with a<br>
nitrogen-containing organic base group such as<br>
trimethylamine, triethylamine, tributylamine, pyridine,<br>
N,N-dimethylaniline, N-methylpiperidine, N-<br>
methylmorpholine, diethylamine, dicyclohexylamine,<br>
procaine, dibenzylamine, N-benzyl-p-phenethylamine and<br>
N,N'-dibenzylethylenediamine.<br>
Furthermore, as preferable salts of a<br>
compound of general formula [1], pharmacologically<br>
acceptable salts are included.<br>
[0026]<br>
The phenyl, cycloalkyl and heterocyclic<br>
groups of R2 in the present invention may be optionally<br>
substituted with at least one group selected from a<br>
halogen atom, a cyano group, a nitro group, an acyl<br><br>
17<br>
group, an acyloxy group, a sulfo group, a phosphoryl<br>
group, an alkanesulfonyl group, an alkanesulfonamide<br>
group, an acetamide group, a carbamoyl group, carboxyl,<br>
amino and hydroxyl groups which may be optionally<br>
protected and alkyl, alkenyl, alkynyl, alkoxy, aryl,<br>
cyclic amino, aralkyl and heterocyclic groups which may<br>
be optionally substituted.<br>
The phenyl, cycloalkyl, cycloalkenyl,<br>
monocyclic heterocyclic and bicyclic heterocyclic<br>
groups in R3 may be optionally substituted with at least<br>
one group selected from a halogen atom, a cyano group,<br>
a nitro group, an acyl group, an acyloxy group, a sulfo<br>
group, a phosphoryl group, an amino group, an<br>
alkanesulfonyl group, an alkanesulfonamide group, an<br>
acetamide group, a dimethylamino group, a carbamoyl<br>
group, carboxyl and hydroxyl groups which may be<br>
optionally protected and an alkyl, alkenyl, alkynyl,<br>
alkoxy, aryl, aryloxy, cyclic amino, aralkyl and<br>
heterocyclic groups which may be optionally substituted.<br>
The alkylene, alkenylene and alkynylene<br>
groups in X2 and X6 may be optionally substituted with<br>
at least one group selected from a halogen atom, a<br>
cyano group, a nitro group, an acyl group, a sulfo<br>
group, a phosphoryl group, an alkanesulfonyl, an<br>
alkanesulfonamide group, an acetamide group, a<br>
carbamoyl group, carboxyl, amino and hydroxyl groups<br>
which may be optionally protected and alkyl, alkenyl,<br>
alkynyl, alkoxy, aryl, cyclic amino, aralkyl and<br>
heterocyclic groups which may be optionally substituted.<br><br>
18<br>
[0027]<br>
Examples of the substituent of the alkyl,<br>
alkenyl, alkynyl, alkoxy, aryl, cyclic amino, aralkyl<br>
and heterocyclic groups which may be optionally<br>
substituted shown above include a halogen atom, a cyano<br>
group, a nitro group, an acyl group, a sulfo group, a<br>
phosphoryl group, a cyclic amino group, an<br>
alkanesulfonyl group, an alkanesulfonamide group, an<br>
acetamide group, an aralkyl group, a carbamoyl group,<br>
an alkyl group, an alkenyl group, an alkynyl group, an<br>
alkoxy group, an aryl group, a heterocyclic group and<br>
carboxyl, amino and hydroxyl groups which may be<br>
optionally protected.<br>
[0028]<br>
Among the compounds of the present invention,<br>
preferable compounds include the following compounds.<br>
The compounds in which R1 is a hydrogen atom<br>
are preferable.<br>
The compounds in which R2 is a phenyl, C5-7<br>
cycloalkyl or heterocyclic group which may be<br>
optionally substituted are preferable, the compounds in<br>
which R2 is a phenyl or heterocyclic group which may be<br>
optionally substituted with a group selected from a<br>
halogen atom, a cyano group, a nitro group, a hydroxyl<br>
group which may be optionally protected, an alkyl group<br>
which may be optionally substituted, an alkenyl group<br>
which may be optionally substituted, an alkynyl group<br>
which may be optionally substituted, an alkoxy group<br>
which may be optionally substituted, an aryl group<br><br>
19<br>
Which may be optionally substituted, a cyclic amino<br>
group which may be optionally substituted, an aralkyl<br>
group which may be optionally substituted and a<br>
heterocyclic group which may be optionally substituted<br>
are more preferable, the compounds in which R2 is a<br>
phenyl or heterocyclic group which may be optionally<br>
substituted with a group selected from a halogen atom,<br>
a nitro group, a hydroxyl group, an alkyl group which<br>
may be optionally substituted, an alkenyl group which<br>
may be optionally substituted, an alkoxy group which<br>
may be optionally substituted, an aryl group which may<br>
be optionally substituted, a cyclic amino group which<br>
may be optionally substituted and a monocyclic<br>
heterocyclic group which may be optionally substituted<br>
are still more preferable, and the compounds in which R2<br>
is a phenyl group, an oxygen-containing bicyclic<br>
heterocyclic group represented by a condensed or<br>
bridged ring containing only oxygen atom(s) as the<br>
heteroatom of the said ring, a sulfur-containing<br>
bicyclic heterocyclic group represented by a condensed<br>
or bridged ring containing only sulfur atom(s) as the<br>
heteroatom of the said ring and a nitrogen-and-sulfur-<br>
containing bicyclic heterocyclic group represented by a<br>
condensed or bridged ring containing only nitrogen and<br>
sulfur atom(s) as the heteroatom of the said ring; and<br>
these groups may be optionally substituted with a group<br>
selected from a halogen atom, a hydroxyl group, an<br>
alkyl group which may be optionally substituted with a<br>
halogen atom, an aryl group which may be optionally<br><br>
20<br>
substituted with a halogen atom, a cyclic amino group<br>
and a nitrogen-containing monocyclic heterocyclic group<br>
containing a nitrogen atom(s) as sole ring-member<br>
heteroatom are still further more preferable.<br>
The compounds in which R3 is a phenyl, C5-7<br>
cycloalkyl, C5-7 cycloalkenyl or monocyclic heterocyclic<br>
or bicyclic heterocyclic group which may be optionally<br>
substituted are preferable, the compounds in which R3 is<br>
a phenyl, monocyclic heterocyclic or bicyclic<br>
heterocyclic group which may be optionally substituted<br>
with a group selected from a halogen atom, a cyano<br>
group, a nitro group, an acyl group, a hydroxyl group,<br>
an alkanesulfonyl group, an alkyl group which may be<br>
optionally substituted, an alkoxy group which may be<br>
optionally substituted, an aryl group which may be<br>
optionally substituted, an aryloxy group which may be<br>
optionally substituted and a heterocyclic group which<br>
may be optionally substituted are more preferable, the<br>
compounds in which R3 is a phenyl, monocyclic<br>
heterocyclic or bicyclic heterocyclic group which may<br>
be optionally substituted with a group selected from a<br>
halogen atom, a hydroxyl group, an alkyl group which<br>
may be optionally substituted and an alkoxy group which<br>
may be optionally substituted are still more preferable,<br>
and the compounds in which R3 is phenyl groups,<br>
nitrogen-containing bicyclic heterocyclic group<br>
represented by a condensed or bridged ring containing<br>
only 1 to 3 nitrogen atom(s) as the heteroatom of the<br>
said ring, oxygen-containing bicyclic heterocyclic<br><br>
21<br>
group represented by a condensed or bridged ring<br>
containing only oxygen atom(s) as the heteroatom of the<br>
said ring or sulfur-containing bicyclic heterocyclic<br>
group represented by a condensed or bridged ring<br>
containing only sulfur atom(s) as the heteroatom of the<br>
said ring; and these groups may be optionally<br>
substituted with a group selected from a halogen atom,<br>
a hydroxyl group, an alkyl group which may be<br>
optionally substituted with a halogen atom and an<br>
alkoxy group which may be optionally substituted with a<br>
halogen atom are still further more preferable.<br>
[0029]<br>
The compounds in which X1 is a carbonyl group<br>
are preferable.<br>
The compounds in which X2 is an alkylene,<br>
alkenylene or alkynylene group which may be optionally<br>
substituted with a group selected from an alkyl and<br>
phenyl group which may be optionally substituted or a<br>
bond are preferable, the compound in which X2 is an<br>
alkylene group, an alkenylene group, an alkynylene<br>
group or a bond are more preferable, and the compounds<br>
in which X2 is an alkylene group, an alkenylene group or<br>
a bond are still more preferable.<br>
The compounds in which X3 is an oxygen atom or<br>
a bond are preferable, and the compounds in which X3 is<br>
a bond are more preferable.<br>
When X2 is an alkylene, alkenylene or<br>
alkynylene group which may be optionally substituted,<br><br>
22<br>
the compounds in which X3 is an oxygen atom are<br>
preferable.<br>
[0030]<br>
The compounds in which X4 is the general<br>
formula -X6-X5-, wherein the bond on the left side of<br>
the general formula is linked to R3, and X5 represents<br>
an oxygen atom, a sulfur atom, an imino group which may<br>
be optionally protected, a sulfinyl group, a sulfonyl<br>
group or a bond; X6 represents an alkylene, alkenylene<br>
or alkynylene group which may be optionally substituted<br>
or a bond are preferable.<br>
The compounds in which X4 is the general<br>
formula -X6p-X5p-, wherein the bond on the left side of<br>
the general formula is linked to R3; and X5p represents<br>
an oxygen atom, a sulfur atom, an imino group or a<br>
bond; and X6p represents an alkylene, alkenylene or<br>
alkynylene group which may be optionally substituted<br>
are preferable, the compounds in which X4 is the general<br>
formula -X6p-X5q-, wherein the bond on the left side of<br>
the general formula is linked to R3; and X5q represents<br>
an oxygen atom, a sulfur atom or a bond; and X6p means<br>
the same as above are more preferable, and the<br>
compounds in which X4 is a general formula -X6q-X5r-,<br>
wherein the bond on the left side of the general<br>
formula is linked to R3; and X5r represents a bond; and<br>
X6q represents an alkylene group, an alkenylene group or<br>
an alkynylene group are further preferable.<br>
The compounds in which X4 is the general formula -X6r-<br>
X5p-, wherein the bond on the left side of the general<br><br>
23<br><br>
formula is linked to R3; and X6r represents a bond; and<br>
X5p means the same as above are preferable, and the<br>
compounds in which X4 is a general formula -X6r-X5s-,<br>
wherein the bond on the left side of the general<br>
formula is linked to R3; and X5s represents an oxygen<br>
atom or a bond; and X6r means the same as above are more<br>
preferable.<br>
[0031]<br>
Examples of typical compounds, among the<br>
compounds of the present invention, include compounds<br>
of the following Tables 1 to 6.<br>
[0032]<br>
[Table 1]<br><br><br>
R3	R3<br>
Phenyl	2-Chlorophenyl<br>
4-(tert-Butyl)phenyl	3-Chlorophenyl<br>
Thiazol-2-yl	4-Chlorophenyl<br>
Thiophen-2-yl	3,5-Dichlorophenyl<br>
Benzofuran-2-yl	3,4-Dichlorophenyl<br>
Benzofuran-5-yl	2,3-Dichlorophenyl<br>
lH-benzimidazol-1-yl	2,4-Dichlorophenyl<br>
lH-indol-1-yl	2,5-Dichlorophenyl<br>
lH-indol -5-yl	3-Chloro-2-fluorophenyl<br>
lH-indol -4-yl	5-Chloro-2-fluorophenyl<br>
4-(Methanesulfonyl)phenyl	2-Chloro-6-fluorophenyl<br>
Benzothiophen-2-yl	3-Chloro-4-fluorophenyl<br>
Benzothiophen-5-yl	4-Hydroxyphenyl<br>
3-Nitrophenyl	3-Chloro-4-hydroxyphenyl<br>
4-Nitrophenyl	3-Cyanophenyl<br>
4-Acetylphenyl	4-Cyanophenyl<br>
2-Fluorophenyl	2-Methylphenyl<br>
3-Fluorophenyl	3-Methylphenyl<br>
4-Fluorophenyl	4-Methylphenyl<br>
2,3-Difluorophenyl	2,3-Dimethylphenyl<br>
2,6-Difluorophenyl	2,6-Dimethylphenyl<br>
3,4-Difluorophenyl	3,4-Dimethylphenyl<br>
2,5-Difluorophenyl	3,5-Dimethyl-4-hydroxyphenyl<br>
3,5-Difluorophenyl	3-Fluoro-4-methylphenyl<br><br>
2,4-Difluorophenyl	244-Fluoro-2-methylphenyl<br>
2-Methoxyphenyl	3-Chloro-2-methylphenyl<br>
3-Methoxyphenyl	3-Chloro-4-methylphenyl<br>
4-Methoxyphenyl	5-Chloro-2-methylphenyl<br>
5-Chloro-2-methoxyphenyl	2-Phenoxyphenyl<br>
3-Chloro-4-methoxyphenyl	4-Phenoxypheny1<br>
2-1s opropoxyphenyl	4-Benzoylphenyl<br>
4-Isopropoxyphenyl	Indolin-1-yl<br>
2-(Trifluoromethoxy)phenyl	2,3-Dihydrobenzo[1,4]dioxin-6-yl<br>
3-(Trifluoromethoxy)phenyl	Benzo[1,3]dioxol-5-yl<br>
4-(Trifluoromethoxy)phenyl	4-(lH-pyrrol-1-yl)phenyl<br>
4-Phenylpiperidin-l-yl	1,2,3,4-tetrahydroisoquinolin-2-yl<br>
4-Benzylpiperidin-l-yl	<br><br><br>
	X4	R3	X4<br>
Phenyl	CH2	3-(Trifluoromethoxy)phenyl	0<br>
Phenyl	CH=CH	4-(Trifluoromethoxy)phenyl	0<br>
Phenyl	C=C	3-Fluoro-4-methylphenyl	0<br>
Phenyl	0	4-Fluoro-2-methylphenyl	0<br>
Phenyl	S	3-Chloro-4-fluorophenyl	0<br>
Phenyl	NH	5-Chloro-2-methylphenyl	0<br>
Phenyl	(CH2)2	3-(Trifluoromethyl)phenyl	0<br>
Phenyl	(CH2)3	4- (Trifluoromethyl)phenyl	0<br>
		2,3-	<br>
Phenyl	(CH2)4	Dihydrobenzo[1,4]dioxin-6-	0<br>
Phenyl	CH2O	Benzofuran-5-yl	0<br>
Phenyl	(CH2)2O	Benzothiophen-5-yl	0<br>
Phenyl	(CH2)3O	Cyclohexyl	(CH2)2<br>
Phenyl	CH2S	Cyclohexyl	(CH2)3<br>
Phenyl	SCH2	2-Methylphenyl	CH=CH<br>
Cyclohexyl	CH=CH	4-Fluorophenyl	CH=CH<br>
Cyclohexyl	CH2CH=CH	3-Fluoro-4-methylphenyl	CH=CH<br>
Cyclohexyl	0	3-Nitrophenyl	CH=CH<br>
2-Fluorophenyl	0	4-Acetylphenyl	CH=CH<br>
3-Fluorophenyl	0	3-Methoxyphenyl	CH=CH<br>
4-Fluorophenyl	0	4-Methoxyphenyl	CH=CH<br>
2,3-Difluorophenyl	0	3-Chlorophenyl	CH=CH<br>
2,4-Di fluorophenyl	0	2,3-Dihydrobenzo[l,4]dioxin-6-yi	CH=CH<br>
2,5-Di fluorophenyl	0	Benzofuran-5-yl	CH=CH<br>
2,6-Difluorophenyl	0	Benzothiophen-5-yl	CH=CH<br><br>
		25	<br>
3,4-Di fluorophenyl	0	Benzo[1,3]dioxol-5-yl	CH=CH<br>
3,5-Difluorophenyl2-Chlorophenyl3-Chlorophenyl4-Chlorophenyl	0000	2,1,3-Benzothiadiazol-4-yl4-(Trifluoromethyl)phenyl2,4-Difluorophenyl3,5-Difluorophenyl	CH=CHCH=CHCH=CHCH=CH<br>
2,3-Dichlorophenyl	0	3,5-Dichlorophenyl	CH=CH<br>
2,4-Dichlorophenyl	0	4-Hydroxyphenyl	CH=CH<br>
2,5-Dichlorophenyl	0	4-(Trifluoromethoxy)phenyl	CH=CH<br>
2,6-Dichlorophenyl	0	4-Nitrophenyl	CH=CH<br>
3,4-Dichlorophenyl	0	2-Methylphenyl	(CH2)2<br>
3,5-Dichlorophenyl3-Nitrophenyl4-Nitrophenyl2-Methylphenyl3-Methylphenyl4-Methylphenyl	000000	4-Fluorophenyl3-Fluoro-4-methylphenyl4-Ethylphenyl3-Methoxyphenyl4-(Trifluoromethyl)phenyl3-Chlorophenyl	(CH2)2(CH2)2(CH2)2(CH2)2(CH2)2(CH2)2<br>
2,3-Dimethylphenyl	0	Benzofuran-5-yl	(CH2)2<br>
2,6-Dimethylphenyl	0	3,5-Difluorophenyl	(CH2)2<br>
3,4-Dimethylphenyl	0	4-(Trifluoromethoxy)phenyl	(CH2)2<br><br>
X1	X2-X:	J      R2	X1	X2-X3	R2<br>
c=o	Bond	Cyclohexyl	c=o	Bond	Benzofuran-5-yl<br>
c=o	Bond	2-Fluorophenyl	c=o	Bond	Benzothiophen-2-yl<br>
c=o	Bond	3-Fluorophenyl	c=o	Bond	Benzothiophen-3-yl<br>
c=o	Bond	4-Fluorophenyl	c=o	Bond	Benzothiophen-5-yl<br>
c=o	Bond	2,4-Difluorophenyl	c=o	Bond	Benzothiazol-2-yl<br>
c=o	Bond	2,6-Difluorophenyl	c=o	Bond	Benzo[1,3]dioxol-5-yi<br>
c=o	Bond	3,4-Difluorophenyl	c=o	Bond	2,3-Dihydrobenzo[1,4]dioxin-6-yl<br>
c=o	Bond	3,5-	c=o	Bond	6-Morpholinopyridin-<br>
		Difluorophenyl			3-yl<br>
c=o	Bond	2-Chlorophenyl	c=o	Bond	1-Phenyl-lH-pyrazol-5-yl<br>
c=o	Bond	3-Chlorophenyl	c=o	Bond	6-(Piperidin-1-<br><br>
			26		<br>
					yl)pyridin-3-yl<br>
c=o	Bond	4-Chlorophenyl	c=o	Bond	6-(lH-pyrrol-l-yl)pyridin-3-yl<br>
c=o	Bond	2,4-Dichlorophenyl	c=o	Bond	5-(lH-pyrrol-l-yl)pyridin-3-yl<br>
c=o	Bond	2,6-Dichlorophenyl	c=o	Bond	2-(lH-pyrrol-l-yl)pyridin-4-yl<br>
c=o	Bond	3,4-	c=o	Bond	3-Phenylisoxazol-5-<br>
		Dichlorophenyl			yi<br>
c=o	Bond	3,5-	c=o	Bond	3-Phenyl-lH-pyrazol-<br>
		Dichlorophenyl			5-yl<br>
c=o	Bond	2-Methylphenyl	c=o	Bond	6-Phenylpyrimidin-4-yl<br>
					J2-<br>
c=o	Bond	3-Methylphenyl	c=o	Bond	(Trifluoromethyl)phe<br>
					nyl<br>
					3-<br>
c=o	Bond	4-Methylphenyl	c=o	Bond	{Tri fluoromethyl)phe<br>
					nyl<br>
c=o	Bond	2,3-Dimethylphenyl	c=o	Bond	4-(Tri fluoromethyl)phenyl<br>
c=o	Bond	3,4-Dimethylphenyl	c=o	Bond	2,4-Bis(trifluoromethyl)phenyl<br>
c=o	Bond	3,5-Dimethylphenyl	c=o	Bond	Bis(trifluoromethyl)phenyl<br>
c=o	Bond	3-Nitrophenyl	c=o	CH=CH(E)	Phenyl<br>
c=o	Bond	4-Nitrophenyl	c=o	CH=CH(E)	3,4-Dimethoxyphenyl<br>
c=o	Bond	2-Hydroxyphenyl	c=o	CH2	Phenyl<br>
c=o	Bond	4-Hydroxyphenyl	c=o	CH2O	Phenyl<br>
c=o	Bond	3-Biphenyl	c=o	CH2CH=CH(E)	Phenyl<br>
c=o	Bond	4-Biphenyl	c=o	C(CH3)=CH(E)	Phenyl<br>
c=o	Bond	Thiophen-2-yl	c=o	(CH2)2	Phenyl<br>
c=o	Bond	Benzofuran-2-yi	c=o	(CH2)3	Phenyl<br>
c=o	6	Phenyl	so2	Bond	Phenyl<br>
			so2	CH=CH	Phenyl<br><br><br>
X1	X2-X3	R2	X1	X2-X3	R2<br>
c=oc=o	BondBond	Cyclohexyl2-Fluorophenyl	c=oc=o	BondBond	2-Phenylthiazol-4-ylBenzo[l,3]dioxol-5-yi<br>
c=o	Bond	3-Fluorophenyl	c=o	Bond	2,3-Dihydrobenzo[1,4]dio<br><br>
			27		<br>
					xin-6-yl<br>
c=o	Bond	4-Fluorophenyl	c=o	Bond	1-Methyl-1H-benzotriazol-5-yl<br>
c=o	Bond	2,4-	c=o	Bond	6-Morpholinopyridin-<br>
		Di fluorophenyl			3-yl<br>
c=o	Bond	2,6-Di fluorophenyl	c=o	Bond	6-(Piperidin-1-yl)pyridin-3-yl<br>
c=o	Bond	3,4-Difluorophenyl	c=o	Bond	6-(lH-pyrrol-l-yl)pyridin-3-yl<br>
c=o	Bond	3,5-	c=o	Bond	5-(lH-pyrrol-l-<br>
		Di fluorophenyl			yl)pyridin-3-yl<br>
c=o	Bond	2-Chlorophenyl	c=o	Bond	2-(lH-pyrrol-l-yl)pyridin-4-yl<br>
c=o	Bond	3-Chlorophenyl	c=o	Bond	5-(Thiophen-2-yl)pyridin-3-yl<br>
c=o	Bond	4-Chlorophenyl	c=o	Bond	3-Phenylisoxazol-5-yi<br>
c=o	Bond	2,4-	c=o	Bond	3-Phenyl-lH-pyrazol-<br>
		Dichlorophenyl			5-yl<br>
c=o	Bond	2,6-Dichlorophenyl	c=o	Bond	3-(lH-pyrrol-l-yDphenyl<br>
c=o	Bond	3,4-Dichlorophenyl	c=o	Bond	4-(lH-pyrrol-l-yl)phenyl<br>
c=o	Bond	3,5-	c=o	Bond	3-(lH-pyrazol-l-<br>
		Dichlorophenyl			yl)phenyl<br>
c=o	Bond	3-	c=o	Bond	2-(Trifluoromethyl)<br>
		Methoxyphenyl			phenyl<br>
c=o	Bond	4-	c=o	Bond	3-(Trifluoromethyl)<br>
		Methoxyphenyl			phenyl<br>
c=o	Bond	2-Methylphenyl	c=o	Bond	4- (Trifluoromethyl)phenyl<br>
					2,4-<br>
c=o	Bond	3-Methylphenyl	c=o	Bond	Bis(trifluoromethyl)<br>
					phenyl<br>
					3,5-<br>
c=o	Bond	4-Methylphenyl	c=o	Bond	Bis(trifluoromethyl)<br>
					phenyl<br>
c=o	Bond	2,3-Dimethylphenyl	c=o	CH=CH(E)	Phenyl<br>
c=o	Bond	3,4-Dimethylphenyl	c=o	CH=CH(E)	3-Chlorophenyl<br>
c=o	Bond	3,5-Dimethylphenyl	c=o	CH=CH(E)	4-Chlorophenyl<br>
c=o	Bond	2-Biphenyl	c=o	CH=CH(E)	3,4-Dichlorophenyl<br>
c=o	Bond	3-Biphenyl	c=o	CH=CH(E)	3-Methoxyphenyl<br>
c=o	Bond	4-Biphenyl	c=o	CH=CH(E)	Thiophen-2-yl<br>
c=o	Bond	4-Morpholinophen	c=o	CH=CH(E)	Benzo[1,3]dioxol-5-yi<br>
c=o	Bond	y13-Nitrophenyl	c=o	CH=CH(E)	3,4-Dimethoxyphenyl<br>
c=o	Bond	4-Nitrophenyl	c=o	CH=CH(E)	3-Nitrophenyl<br>
c=o	Bond	2-Hydroxyphenyl	c=o	CH=CH(E)	4-Hydroxyphenyl<br>
c=o	Bond	Thiophen-2-yl	c=o	CH2CH=CH(E)	Phenyl<br>
c=o	Bond	Benzofuran-2-yl	c=o	C(CH3)=CH(E)	Phenyl<br>
c=o	Bond	Benzofuran-5-yl	c=o	(CH2)2	Phenyl<br>
c=o	Bond	Benzothiophen-2-yl	c=o	(CH2)3	Phenyl<br><br>
c=o	Bond	Benzothiophen-3-yl	28c=o	CH2O	Phenyl<br>
c=o	Bond	Benzothiophen-5-yl	so2	CH2	Phenyl<br>
c=o	Bond	Benzothiazol-2-yl	so2	CH=CH	Phenyl<br>
c=o	Bond	6-Phenylpyrimidin-4-yl			<br><br><br>
X1	X2-X	R2	X1	X2-X3	R2<br>
C=0	Bond	2-Fluorophenyl	C=0	Bond	Benzothiophen-5-yl<br>
c=o	Bond	3-Fluorophenyl	c=o	Bond	Benzothiazol-2-yl<br>
c=o	Bond	4-Fluorophenyl	c=o	Bond	Benzo[l,3]dioxol-5-yi<br>
c=o	Bond	2,4-Di fluorophenyl	c=o	Bond	2,3-Dihydrobenzo[1,4]dioxin-6-yl<br>
c=o	Bond	2,6-Difluorophenyl	c=o	Bond	4-Morpholinophenyl<br>
c=o	Bond	3,4-Di fluorophenyl	c=o	Bond	6-(Piperidin-l-yl)pyridin-3-yl<br>
c=o	Bond	3,5-Di fluorophenyl	c=o	Bond	6-(lH-pyrrol-l-yl)pyridin-3-yl<br>
c=o	Bond	2-Chlorophenyl	c=o	Bond	5-(lH-pyrrol-l-yl)pyridin-3-yl<br>
c=o	Bond	3-Chlorophenyl	c=o	Bond	2-(lH-pyrrol-l-yl)pyridin-4-yl<br>
c=o	Bond	4-Chlorophenyl	c=o	Bond	3-Phenylisoxazol-5-yi<br>
c=o	Bond	2,4-	c=o	Bond	3-Phenyl-lH-pyrazol-<br>
		Dichlorophenyl			5-yl<br>
c=o	Bond	2,6-	c=o	Bond	3-(lH-pyrrol-l-<br>
		Di chlorophenyl			yl)phenyl<br>
c=o	Bond	3,4-Dichlorophenyl	c=o	Bond	4-(lH-pyrrol-l-yl)phenyl<br>
c=o	Bond	3,5-	c=o	Bond	6-Phenylpyrimidin-4-<br>
		Dichlorophenyl			yi<br>
					2-<br>
c=o	Bond	3-Methoxyphenyl	c=o	Bond	(Trifluoromethyl)phe<br>
					nyl<br>
					3-<br>
c=o	Bond	4-Methoxyphenyl	c=o	Bond	(Trifluoromethyl)phe<br>
					nyl4-<br>
c=o	Bond	2-Methylphenyl	c=o	Bond	{Trifluoromethyl)phe<br>
					nyl<br>
c=o	Bond	3-Methylphenyl	c=o	Bond	2,4-Bis(trifluoromethyl)<br><br>
c=o	Bond	4-Methylphenyl	29c=o	Bond	phenyl3,5-Bis(trifluoromethyl)phenyl<br>
c=o	Bond	2,3-Dimethylphenyl	c=o	CH=CH(E)	Phenyl<br>
c=o	Bond	3,4-Dimethylphenyl	c=o	CH=CH(E)	3-Chlorophenyl<br>
II       II    1!    II       IIo   o o o   o	BondBondBondBondBond	3,5-Dimethylphenyl3-Nitrophenyl2-Hydroxyphenyl4-Hydroxyphenyl2-Biphenyl	c=oc=oc=oc=oc=o	CH=CH(E)CH=CH(E)CH=CH(E)CH=CH(E)CH=CH(E)	4-Chlorophenyl3,4-Dichlorophenyl3-MethoxyphenylThiophen-2-ylBenzotl,3]dioxol-5-yl<br>
II    1!    IIo o o	BondBondBond	3-Biphenyl4-BiphenylBenzofuran-2-yl	c=oc=oc=o	CH=CH(E)CH=CH(E)CH=CH(E)	3,4-Dimethoxyphenyl3-Nitrophenyl4-Hydroxyphenyl<br>
c=o	Bond	Benzofuran-5-yl	c=o	CH2CH=CH(E)	Phenyl<br>
c=o	Bond	Benzothiophen-2-yi	c=o	C(CH3)=CH(E)	Phenyl<br>
c=o	Bond	Benzothiophen-3-yi	c=o	(CH2)2	Phenyl<br>
c=o	6	Phenyl	so2	CH=CH	Phenyl<br><br><br>
R3-X4-	-X2-X3-R2<br>
3-Chlorophenyl	4-Fluorophenyl<br>
3-Chlorophenyl	4-Nitrophenyl<br>
3-Chlorophenyl	4-(Trifluoromethyl)phenyl<br>
3-Chlorophenyl	4-Hydroxyphenyl<br>
3-Chlorophenyl	2,3-Dimethylphenyl<br>
3-Chlorophenyl	Benzothiazol-2-yl<br>
3-Chlorophenyl	5-(lH-pyrrol-1-yl)pyridin-3-yl<br>
3-Chlorophenyl	Benzo[1,3]dioxol-5-yl<br>
3-Chlorophenyl	2-Phenylvinyl<br>
2,4-Difluorophenyl	4-Fluorophenyl<br>
2,4-Difluorophenyl	4- (Trifluoromethyl)phenyl<br>
2,4-Difluorophenyl	2,3-Dimethylphenyl<br>
2,4-Difluorophenyl	Benzothiazol-2-yl<br>
2,4-Difluorophenyl	5- (lH-pyrrol-1-yl)pyridin-3-yl<br>
2,4-Difluorophenyl	2-Phenylvinyl<br>
4-Hydroxyphenyl	4-Fluorophenyl<br>
4-Hydroxyphenyl	4-(Trifluoromethyl)phenyl<br>
4-Hydroxyphenyl	Benzothiazol-2-yl<br><br>
4-Hydroxyphenyl	305-(lH-pyrrol-l-yl)pyridin-3-yl<br>
4-Hydroxyphenyl	2-Phenylvinyl<br>
Benzofuran-2-yl	4-Fluorophenyl<br>
Benzofuran-2-yl	4-(Tri fluoromethyl)phenyl<br>
Benzofuran-2-yl	2,3-Dimethylphenyl<br>
Benzofuran-2-yl	Benzo[1,3]dioxol-5-yl<br>
Benzofuran-2-yl	2-Phenylvinyl<br>
Benzo[1,3]dioxol-5-yl	4-(Trifluoromethyl)phenyl<br>
Benzo[1,3]dioxol-5-yl	2,3-Dimethylphenyl<br>
Benzo[1,3]dioxol-5-yl	Benzothiazol-2-yl<br>
Benzo[1,3]dioxol-5-yl	Benzo[1,3]dioxol-5-yl<br>
Benzo[1,3]dioxol-5-yl	2-Phenylvinyl<br>
2-(3-Methoxyphenyl)vinyl	4-Fluorophenyl<br>
2-(3-Methoxyphenyl)vinyl	4-Nitrophenyl<br>
2-(3-Methoxyphenyl)vinyl	Benzothiazol-2-yl<br>
2-(3-Methoxyphenyl)vinyl	2,3-Dimethylphenyl<br>
2-(3-Methoxyphenyl)vinyl	Benzo[1,3]dioxol-5-yl<br>
2-(3-Methoxyphenyl)vinyl	5-(lH-pyrrol-l-yl)pyridin-3-yl<br>
2-(3-Methoxyphenyl)vinyl	2-Phenylvinyl<br>
[0038]<br>
In addition, when any isomer (for example,<br>
optical isomer, geometrical isomer, tautomer and the<br>
like) is present for the compounds of general formula<br>
[1] or a salt thereof, the present invention includes<br>
those isomers and, in addition, includes solvates,<br>
hydrates and crystals of various kinds.<br>
[0039]<br>
Next, production processes of the compounds<br>
of the present invention are described.<br>
The compound of the present invention can be<br>
produced by combining methods well known per se<br>
together, but, for example, can be produced following<br>
the production processes shown below.<br>
[0040]<br>
[Production Process 1]<br><br><br>
"In the formula, Rla represents a carboxyl protecting<br>
group; R3a represents a phenyl, cycloalkyl, cycloalkenyl,<br>
or monocyclic heterocyclic or bicyclic heterocyclic<br>
group linking through a ring-member carbon atom, any of<br>
which groups may be optionally substituted; R4<br>
represents a hydrogen atom or a lower alkyl group; X7<br>
represents an alkylene group which may be optionally<br>
substituted; L1 represents a leaving group; and R2, X1,<br>
X2 and X3 mean the same as above."<br>
[0041]<br>
As a compound of general formula [3a], for<br>
example, pyridine-3-boronic acid, 3-<br>
(methanesulfonamide)phenylboronic acid, thiophene-2-<br>
boronic acid, benzofuran-2-boronic acid and 3-<br>
methoxyphenyl boronic acid are known. As a compound of<br>
general formula [3b], for example, 3-(4,4,5,5-<br>
tetramethyl-1,3,2-dioxaborolan-2-yl)furan is known.  In<br>
addition, the compounds of general formulae [3a] and<br>
[3b] can be produced from corresponding halogeno<br>
compounds following a method, for example, described in<br>
JP-A-2003-206290.<br>
The compounds of general formula [la] can be<br>
produced by reacting a compound of general formula [2]<br><br>
32<br>
with a compound of general formula [3a] or [3b] in the<br>
presence of or in the absence of a base, in the<br>
presence of a palladium catalyst, and in the presence<br>
of or in the absence of a ligand.<br>
[0042]<br>
The solvent used in this reaction is not<br>
particularly limited as long as it does not adversely<br>
affect the reaction and examples thereof include water;<br>
alcohols such as methanol, ethanol, 2-propanol and 2-<br>
methyl-2-propanol; aromatic hydrocarbons such as<br>
benzene, toluene and xylene; amides such as N,N-<br>
dimethylformamide, N,N-dimethylacetamide and 1-methyl-<br>
2-pyrrolidone; halogenated hydrocarbons such as<br>
methylene chloride, chloroform and dichloroethane;<br>
ethers such as dioxane, tetrahydrofuran, anisole,<br>
ethylene glycol dimethyl ether, diethylene glycol<br>
dimethyl ether and diethylene glycol diethyl ether;<br>
ketones such as acetone and 2-butanone; nitriles such<br>
as acetonitrile; esters such as ethyl acetate and butyl<br>
acetate and sulfoxides such as dimethylsulfoxide and<br>
these may be optionally mixed for use.<br>
[0043]<br>
Examples of a base optionally used in this<br>
reaction include inorganic bases such as sodium<br>
hydrogen carbonate, sodium carbonate, potassium<br>
carbonate, cesium carbonate and tripotassium phosphate<br>
and organic bases such as triethylamine and<br>
diisopropylethylamine. The used amount of the base can<br><br>
33<br>
be 1 to 50 times mol, preferably 2 to 5 times mol for<br>
the compound of general formula [2].<br>
The palladium catalyst used in this reaction<br>
includes metal palladium such as palladium-carbon and<br>
palladium black; inorganic palladium salts such as<br>
palladium chloride; organic palladium salts such as<br>
palladium acetate; organopalladium complex such as<br>
tetrakis(triphenylphosphine)palladium (0),<br>
bis(triphenylphosphine)palladium (II) chloride, 1,1'-<br>
bis(diphenylphosphino)ferrocene palladium (II) chloride<br>
and tris(dibenzylideneacetone)dipalladium (0) and<br>
polymer immobilized organopalladium complex such as<br>
polymer supported bis(acetato)triphenylphosphine<br>
palladium (II) and polymer supported<br>
di(acetato)dicyclohexylphenylphosphine palladium (II)<br>
and these may be optionally used in combination. The<br>
used amount of the palladium catalyst can be 0.00001 to<br>
1 time mol, preferably 0.001 to 0.1 times mol for the<br>
compound of general formula [2].<br>
[0044]<br>
The ligand optionally used in this reaction<br>
includes trialkylphosphines such as trimethylphosphine<br>
and tri-tert-butylphosphine; tricycloalkylphosphines<br>
such as tricyclohexylphosphine; triarylphosphines such<br>
as triphenylphosphine and tritolylphosphine;<br>
trialkylphosphites such as trimethylphosphite,<br>
triethylphosphite and tributylphosphite;<br>
tricycloalkylphosphites such as tricyclohexylphosphite;<br>
triarylphosphite such as triphenylphosphite;<br><br>
34<br>
imidazolium salts such as 1, 3-bis(2,4, 6-<br>
trimethylphenyl)imidazolium chloride; diketones such as<br>
acetylacetone and octafluoroacetylacetone; amines such<br>
as trimethylamine, triethylamine, tripropylamine and<br>
triisopropylamine;  1,1'-bis(diphenylphosphino)ferrocene,<br>
2,2'-bis(diphenylphosphino)-1,1'-binaphthyl, 2-<br>
dicyclohexylphosphino-2',6'-dimethoxybiphenyl, 2-<br>
dicyclohexylphosphino-2',4',6'-triisopropylbiphenyl, 2-<br>
(di-tert-butylphosphino)-2',4',6'-triisopropylbiphenyl<br>
and 2-(di-tert-butylphosphino)biphenyl and these may be<br>
optionally used in combination. The used amount of the<br>
ligand can be 0.00001 to 1 time mol and preferably<br>
0.001 to 0.1 time mol for the compound of general<br>
formula [2].<br>
[0045]<br>
The used amount of the compound of general<br>
formula [3a] or [3b] can be 1 to 50 times mol and<br>
preferably 1 to 2 times mol for the compound of general<br>
formula [2].<br>
This reaction can be preferably carried out<br>
in an inert gas (for example, nitrogen, argon)<br>
atmosphere at 40 to 170C for 1 minute to 96 hours.<br>
[0046]<br>
[Production Process 2]<br><br><br>
35<br>
"In the formula, R3b represents a phenyl or monocyclic<br>
heterocyclic or bicyclic heterocyclic group linking<br>
through a ring-member carbon atom, any of which groups<br>
may be optionally substituted; and R5 represents a lower<br>
alkyl group; Rla, R2, X1, X2, X3 and L1 mean the same as<br>
above."<br>
[0047]<br>
As a compound of general formula [4], for<br>
example, 2-(tributyltin)thiazole and 2-<br>
(tributyltin)furan are known.<br>
The compounds of general formula [lb] can be<br>
produced by reacting a compound of general formula [2]<br>
with a compound of general formula [4] in the presence<br>
of or in the absence of silver oxide, in the presence<br>
of a palladium catalyst.<br>
The solvent used in this reaction is not<br>
particularly limited as long as it does not adversely<br>
affect the reaction and examples thereof include<br>
aromatic hydrocarbons such as benzene, toluene and<br>
xylene; amides such as N,N-dimethylformamide, N,N-<br>
dimethylacetamide and l-methyl-2-pyrrolidone; ethers<br>
such as dioxane, tetrahydrofuran, anisole, ethylene<br>
glycol dimethyl ether, diethylene glycol dimethyl ether<br>
and diethylene glycol diethyl ether; nitriles such as<br>
acetonitrile and sulfoxides such as dimethylsulfoxide<br>
and these may be optionally mixed for use.<br>
[0048]<br>
The palladium catalyst used in this reaction<br>
includes organopalladium complexes such as<br><br>
36<br>
tetrakis(triphenylphosphine)palladium (0),<br>
bis(triphenylphosphine)palladium (II) chloride, 1,1'-<br>
bis(diphenylphosphino)ferrocene palladium (II) chloride<br>
and tris(dibenzylideneacetone)dipalladium (0) and a<br>
polymer immobilized organopalladium complex such as a<br>
polymer supported bis(acetato)triphenylphosphine<br>
palladium (II) and a polymer supported<br>
di(acetato)dicyclohexylphenylphosphine palladium (II)<br>
and these may be optionally used in combination. The<br>
used amount of the palladium catalyst can be 0.00001 to<br>
1 time mol, preferably 0.001 to 0.1 time mol for the<br>
compound of general formula [2].<br>
The amount of silver oxide optionally used in<br>
this reaction can be 1 to 50 times mol, preferably 1 to<br>
10 times mol for the compound of general formula [2].<br>
The used amount of the compound of general<br>
formula [4] can be 1 to 50 times mol, preferably 1 to 2<br>
times mol for the compound of general formula [2].<br>
This reaction can be preferably carried out<br>
in an inert gas (for example, nitrogen, argon)<br>
atmosphere at 40 to 170C for 1 minute to 96 hours.<br>
[0049]<br>
[Production Process 3]<br><br><br>
"In the formula, R3c represents a phenyl, cycloalkyl, or<br>
monocyclic heterocyclic or bicyclic heterocyclic group<br>
linking through a ring-member carbon atom, any of which<br>
groups may be optionally substituted; X2a represents an<br>
alkynyl group which may be optionally substituted or a<br>
bond; X6a represents an alkenylene or alkynylene group<br>
which may be optionally substituted; X6b represents an<br>
alkylene group which may be optionally substituted; Rla,<br>
R2, R3a, X1, X2, X3, X5 and L1 mean the same as above."<br>
[0050]<br>
As a compound of general formula [5], for<br>
example, styrene, allylbenzene, 4-phenyl-l-butene,<br>
vinylcyclohexane and allylcyclohexane are known.  In<br>
addition, the compounds of general formula [5] can be<br>
produced by a method, for example, described in "Jikken<br>
Kagaku Kouza", 4th edition, Vol. 19, pp. 298-361, 1992,<br>
Maruzen or the like method.<br>
[0051]<br>
(3-1)<br>
When X6a is an alkenylene group which may be<br>
optionally substituted, the compound of general formula<br><br>
38<br>
[lc] can be produced by reacting a compound of general<br>
formula [2] with a compound of general formula [5] in<br>
the presence of or in the absence of a base, in the<br>
presence of or in the absence of a phase transfer<br>
catalyst, in the presence of or in the absence of a<br>
ligand, and in the presence of a palladium catalyst.<br>
The solvent used in this reaction is not<br>
particularly limited as long as it does not adversely<br>
affect the reaction and examples thereof include water;<br>
alcohols such as methanol, ethanol, 2-propanol and 2-<br>
methyl-2-propanol; aromatic hydrocarbons such as<br>
benzene, toluene and xylene; amides such as N,N-<br>
dimethylformamide, N,N-dimethylacetamide and 1-methyl-<br>
2-pyrrolidone; halogenated hydrocarbons such as<br>
methylene chloride, chloroform and dichloroethane;<br>
ethers such as dioxane, tetrahydrofuran, anisole,<br>
ethylene glycol dimethyl ether, diethylene glycol<br>
dimethyl ether and diethylene glycol diethyl ether;<br>
ketones such as acetone and 2-butanone; nitriles such<br>
as acetonitrile; esters such as ethyl acetate and butyl<br>
acetate and sulfoxides such as dimethylsulfoxide and<br>
these may be optionally mixed for use.<br>
Examples of a base optionally used in this<br>
reaction include inorganic bases such as sodium hydride,<br>
sodium hydrogen carbonate, sodium carbonate, potassium<br>
carbonate, cesium carbonate and tripotassium phosphate<br>
and organic bases such as sodium acetate, potassium<br>
acetate, sodium tert-butoxide, triethylamine,<br>
diisopropylethylamine, tributylamine and N,N-<br><br>
39<br>
dicyclohexylmethylamine. The used amount of the base<br>
can be 1 to 50 times mol, preferably 2 to 5 times mol<br>
for the compound of general formula [2] .<br>
[0052]<br>
Examples of the phase transfer catalyst<br>
optionally used in this reaction include quaternary<br>
ammonium salts such as tetramethylammonium chloride,<br>
benzyltrimethylammonium chloride,<br>
benzyltriethylammonium chloride, benzyltributylammonium<br>
chloride, tetrabutylammonium chloride,<br>
tetrabutylammonium bromide, tetrabutylammonium hydrogen<br>
sulfate and trioctylmethylammonium chloride; N-<br>
laurylpyridinium chloride, N-lauryl-4-picolinium<br>
chloride, N-laurylpicolinium chloride and N-<br>
benzylpicolinium chloride. The used amount of the phase<br>
transfer catalyst can be 0.01 to 50 times mol,<br>
preferably 0.1 to 5 times mol for the compound of<br>
general formula [2].<br>
[0053]<br>
The ligand optionally used in this reaction<br>
includes trialkylphosphines such as trimethylphosphine<br>
and tri-tert-butylphosphine; tricycloalkylphosphines<br>
such as tricyclohexylphosphine; triarylphosphines such<br>
as triphenylphosphine and tritolylphosphine;<br>
trialkylphosphites such as trimethylphosphite,<br>
triethylphosphite and tributylphosphite;<br>
tricycloalkylphosphites such as tricyclohexylphosphite,<br>
triarylphosphites such as triphenylphosphite;<br>
imidazolium salts such as 1,3-bis(2,4,6-<br><br>
40<br>
trimethylphenyl)imidazolium chloride; diketone such as<br>
acetylacetone and octafluoroacetylacetone; amines such<br>
as trimethylamine, triethylamine, tripropylamine and<br>
triisopropylamine;  1,1'-bis(diphenylphosphino)ferrocene,<br>
2,2'-bis(diphenylphosphino)-1,1'-binaphthyl, 2-<br>
dicyclohexylphosphino-2',6'-dimethoxy biphenyl, 2-<br>
dicyclohexylphosphino-2',4',6'-triisopropyl biphenyl,<br>
2-(di-tert-butylphosphino)-2',4',6'-triisopropyl<br>
biphenyl and 2-(di-tert-butylphosphino) biphenyl and<br>
these may be optionally used in combination. The used<br>
amount of the ligand can be 0.00001 to 1 time mol and<br>
preferably 0.001 to 0.1 time mol for the compound of<br>
general formula [2].<br>
[0054]<br>
Examples of the palladium catalyst used in<br>
this reaction include metal palladium such as<br>
palladium-carbon and palladium black; inorganic<br>
palladium salts such as palladium chloride; organic<br>
palladium salts such as palladium acetate;<br>
organopalladium complex such as<br>
tetrakis(triphenylphosphine)palladium (0),<br>
bis(triphenylphosphine)palladium (II) chloride, 1,1'-<br>
bis(diphenylphosphino)ferrocene palladium (II) chloride,<br>
(E)-di(^-acetato) bis(o-(di-o-<br>
tolylphosphino)benzyl)dipalladium (II) and<br>
tris(dibenzylideneacetone)dipalladium (0) and polymer<br>
immobilized organopalladium complex such as polymer<br>
supported bis(acetato) triphenylphosphine palladium<br>
(II) and polymer supported di(acetato)<br><br>
41<br>
dicyclohexylphenylphosphine palladium (II) and these<br>
may be optionally used in combination. The used amount<br>
of the palladium catalyst can be 0.00001 to 1 time mol,<br>
preferably 0.001 to 0.1 time mol for the compound of<br>
general formula [2].<br>
[0055]<br>
The used amount of the compound of general<br>
formula [5] can be 1 to 50 times mol and preferably 1<br>
to 2 times mol for the compound of general formula [2].<br>
This reaction can be preferably carried out<br>
in an inert gas (for example, nitrogen, argon)<br>
atmosphere at 40 to 170C for 1 minute to 24 hours.<br>
[0056]<br>
(3-2)<br>
When X6a is an alkynylene group which may be<br>
optionally substituted, the compound of general formula<br>
[lc] can be produced by reacting a compound of general<br>
formula [2] with a compound of general formula [5] in<br>
the presence of or in the absence of a base, in the<br>
presence of or in the absence of a copper catalyst, and<br>
in the presence of a palladium catalyst.<br>
The solvent used in this reaction is not<br>
particularly limited as long as it does not adversely<br>
affect the reaction and examples thereof include water;<br>
alcohols such as methanol, ethanol, 2-propanol and 2-<br>
methyl-2-propanol; aromatic hydrocarbons such as<br>
benzene, toluene and xylene; amides such as N,N-<br>
dimethylformamide, N,N-dimethylacetamide and 1-methyl-<br>
2-pyrrolidone; halogenated hydrocarbons such as<br><br>
42<br>
methylene chloride, chloroform and dichloroethane;<br>
ethers such as dioxane, tetrahydrofuran, anisole,<br>
ethylene glycol dimethyl ether, diethylene glycol<br>
dimethyl ether and diethylene glycol diethyl ether;<br>
ketones such as acetone and 2-butanone; nitriles such<br>
as acetonitrile; esters such as ethyl acetate and butyl<br>
acetate and sulfoxides such as dimethylsulfoxide and<br>
these may be optionally mixed for use.<br>
[0057]<br>
Examples of a base optionally used in this<br>
reaction include inorganic bases such as sodium<br>
hydrogen carbonate, sodium carbonate, potassium<br>
carbonate, cesium carbonate and tripotassium phosphate<br>
and organic bases such as triethylamine and<br>
diisopropylethylamine. The used amount of the base can<br>
be 1 to 50 times mol, preferably 2 to 5 times mol for<br>
the compound of general formula [2].<br>
Examples of the copper catalyst optionally<br>
used in this reaction include copper bromide and copper<br>
iodide. The used amount of the copper catalyst can be<br>
0.01 to 50 times mol, preferably 0.1 to 5 times mol for<br>
the compound of general formula [2].<br>
Examples of the palladium catalyst used in<br>
this reaction include metal palladium such as<br>
palladium-carbon and palladium black; inorganic<br>
palladium salts such as palladium chloride; organic<br>
palladium salts such as palladium acetate;<br>
organopalladium complex such as<br>
tetrakis(triphenylphosphine)palladium (0),<br><br>
43<br>
bis(triphenylphosphine)palladium (II) chloride, 1,1'-<br>
bis(diphenylphosphino)ferrocene palladium (II) chloride<br>
and tris(dibenzylideneacetone)dipalladium (0) and<br>
polymer immobilized organopalladium complex such as<br>
polymer supported bis(acetato) triphenylphosphine<br>
palladium (II) and polymer supported di(acetato)<br>
dicyclohexylphenylphosphine palladium (II) and these<br>
may be optionally used in combination. The used amount<br>
of the palladium catalyst can be 0.00001 to 1 time mol,<br>
preferably 0.001 to 0.1 time mol for the compound of<br>
general formula [2].<br>
The used amount of the compound of general<br>
formula [5] can be 1 to 50 times mol and preferably 1<br>
to 2 times mol for the compound of general formula [2].<br>
This reaction can be preferably carried out<br>
in an inert gas (for example, nitrogen, argon)<br>
atmosphere at 10 to 170C for 1 minute to 24 hours.<br>
[0058]<br>
(3-3)<br>
The compounds of general formula [Id] can be<br>
produced by reducing a compound of general formula [lc].<br>
Examples of the reducing reaction include<br>
catalytic hydrogenation reaction using a metal catalyst.<br>
The solvent used in this reaction is not<br>
particularly limited as long as it does not adversely<br>
affect the reaction and examples thereof include water;<br>
alcohols such as methanol, ethanol, 2-propanol and 2-<br>
methyl-2-propanol; amides such as N,N-dimethylformamide,<br>
N,N-dimethylacetamide and l-methyl-2-pyrrolidone;<br><br>
44<br>
halogenated hydrocarbons such as methylene chloride,<br>
chloroform and dichloroethane; aromatic hydrocarbons<br>
such as benzene, toluene and xylene; ethers such as<br>
dioxane, tetrahydrofuran, anisole, ethylene glycol<br>
dimethyl ether, diethylene glycol dimethyl ether and<br>
diethylene glycol diethyl ether; nitriles such as<br>
acetonitrile; ketones such as acetone and 2-butanone;<br>
esters such as ethyl acetate and butyl acetate; and<br>
carboxylic acids such as acetic acid and<br>
heteroaromatics such as pyridine and these may be<br>
optionally mixed for use.<br>
Examples of the metal catalyst used in this<br>
reaction include metal palladium such as palladium-<br>
carbon and palladium black; palladium salts such as<br>
palladium oxide and palladium hydroxide, nickel metal<br>
such as Raney nickel and platinum salts such as<br>
platinum oxide. The used amount of the metal catalyst<br>
can be 0.001 to 5 times amount (W/W), preferably 0.1 to<br>
1 time amount (W/W) for the compound of general formula<br>
[lc].<br>
Examples of the reducing agent used in this<br>
reaction include hydrogen; formic acid; formates such<br>
as sodium formate, ammonium formate and<br>
triethylammonium formate; cyclohexene and<br>
cyclohexadiene. The used amount of the reducing agent<br>
can be 2 to 100 times mol, preferably 2 to 10 times mol<br>
for the compound of general formula [lc].<br>
This reaction can be carried out at 0 to 200C,<br>
preferably at 0 to 100C for 1 minute to 24 hours.<br><br>
45<br>
[0059]<br>
[Production Process 4]<br><br>
"In the formula, X5a represents an oxygen atom, a sulfur<br>
atom or an imino group which may be optionally<br>
protected; Rla, R2, R3a, X1, X2, X3, X6 and L1 mean the<br>
same as above."<br>
[0060]<br>
As a compound of general formula [6], for<br>
example, aniline, benzylamine, phenol, thiophenol and<br>
benzylmercaptan are known. In addition, for example,<br>
the compounds of general formula [6] can be produced by<br>
an ordinary method from a corresponding halogeno<br>
compound.<br>
[0061]<br>
(4-1)<br>
The compound of general formula [le] can be<br>
produced by reacting a compound of general formula [2]<br>
with a compound of general formula [6] following<br>
production process (3-1).<br>
[0062]<br>
(4-2)<br>
When X5a is an oxygen atom, the compound of<br>
general formula [le] can be produced by reacting a<br>
compound of general formula [2] with a compound of<br><br>
46<br>
general formula [6] in the presence of or in the<br>
absence of a base, and in the presence of a copper<br>
catalyst.<br>
The solvent used in this reaction is not<br>
particularly limited as long as it does not adversely<br>
affect the reaction and examples thereof include<br>
aromatic hydrocarbons such as benzene, toluene and<br>
xylene; amides such as N,N-dimethylformamide, N,N-<br>
dimethylacetamide and l-methyl-2-pyrrolidone;<br>
halogenated hydrocarbons such as methylene chloride,<br>
chloroform and dichloroethane; ethers such as dioxane,<br>
tetrahydrofuran, anisole, ethylene glycol dimethyl<br>
ether, diethylene glycol dimethyl ether and diethylene<br>
glycol diethyl ether; ketones such as acetone and 2-<br>
butanone; nitriles such as acetonitrile; esters such as<br>
ethyl acetate and butyl acetate and sulfoxides such as<br>
dimethylsulfoxide and these may be optionally mixed for<br>
use.<br>
Examples of a base optionally used in this<br>
reaction include sodium hydride and sodium. The used<br>
amount of the base can be 1 to 50 times mol, preferably<br>
1 to 5 times mol for the compound of general formula<br>
[2].<br>
Examples of the copper catalyst used in this<br>
reaction include copper powder and copper iodide. The<br>
used amount of the copper catalyst can be 0.00001 to 1<br>
time mol, preferably 0.01 to 1 time mol for the<br>
compound of general formula [2].<br><br>
-47<br>
The used amount of the compound of general<br>
formula [6] can be 1 to 50 times mol and preferably 1<br>
to 5 times mol for the compound of general formula [2].<br>
This reaction can be preferably carried out<br>
at 40 to 200C for 30 minutes to 72 hours.<br>
[0063]<br>
[Production Process 5]<br><br>
"In the formula, L2 represents a leaving group; Rla, R2,<br>
R3b, X1, X2, X3 and X6a mean the same as above."<br>
[0064]<br>
As a compound of general formula [8a], for<br>
example, 2-iodotoluene, 3-iodoanisole, 3-<br>
iodonitrobenzene and 6-iodo-2,3-dihydrobenzo[l,4]dioxin<br>
are known.<br>
[0065]<br>
The compound of general formula [If] can be<br>
produced by reacting a compound of general formula [7]<br>
with a compound of general formula [8a] following<br>
production process (3-1) or (3-2).<br>
[0066]<br>
[Production Process 6]<br><br><br>
"In the formula, Rla, R2, R3, X1, X2, X3 and X4 mean the<br>
same as above."<br>
[0067]<br>
(6-1)<br>
When X1 is a carbonyl group, the compound of<br>
general formula [lg] can be produced by amidating a<br>
compound of general formula [9]. Specifically, a method<br>
using an acid halide in the presence of or in the<br>
absence of the base, a method using an acid anhydride<br>
in the presence of or in the absence of the base and<br>
the like are included.<br>
The solvent used in this reaction is not<br>
particularly limited as long as it does not adversely<br>
affect the reaction and examples thereof include amides<br>
such as N,N-dimethylformamide, N,N-dimethylacetamide<br>
and l-methyl-2-pyrrolidone; halogenated hydrocarbons<br>
such as methylene chloride, chloroform and<br>
dichloroethane; aromatic hydrocarbons such as benzene,<br>
toluene and xylene; ethers such as dioxane,<br>
tetrahydrofuran, anisole, ethylene glycol dimethyl<br>
ether, diethylene glycol dimethyl ether and diethylene<br>
glycol diethyl ether; nitriles such as acetonitrile;<br>
ketones such as acetone and 2-butanone; esters such as<br>
ethyl acetate and butyl acetate and sulfoxides such as<br><br>
49<br>
dimethylsulfoxide and these may be optionally mixed for<br>
use.<br>
[0068]<br>
Examples of the acid halide used in this<br>
reaction include benzoyl chloride, benzoyl bromide,<br>
2,4-difluorobenzoyl chloride, 2-naphthoyl chloride,<br>
diphenylacetyl chloride, 2,3-dihydrobenzo[l,4]dioxin-6-<br>
carbonyl chloride, cyclohexane carbonyl chloride,<br>
cyclopentylcarbonyl chloride (E)-3-phenylacryloyl<br>
chloride, phenoxyacetyl chloride, 2-furoyl chloride, 1-<br>
benzofuran-2-carbonyl chloride, 2-thenoyl chloride,<br>
nicotinoyl chloride and picolinoyl chloride. In<br>
addition, the acid halide can be produced by reacting a<br>
compound represented by general formula [38]<br>
[Formula 2]<br>
R2X3X2-CO2H<br>
[38]<br>
"In the formula, R2, X2 and X3 mean the same as above."<br>
with thionyl chloride, oxalyl chloride or the like. The<br>
used amount of the acid halide can be 1 to 50 times mol<br>
and preferably 1 to 5 times mol for the compound of<br>
general formula [9].<br>
Examples of the acid anhydride used in this<br>
reaction include benzoic anhydride.  In addition, acid<br>
halides can be produced from a corresponding carboxylic<br>
acid by a method, for example, described in "Shin<br>
Jikken Kagaku Kouza", Vol. 14, pp. 1120-1133, 1977,<br>
Maruzen or the like method. The used amount of the acid<br><br>
50<br>
anhydride can be 1 to 50 times mol and preferably 1 to<br>
5 times mol for the compound of general formula [9].<br>
Examples of the base optionally used in this<br>
reaction include inorganic bases such as sodium<br>
hydrogen carbonate, sodium carbonate, potassium<br>
carbonate and cesium carbonate and organic bases such<br>
as triethylamine and diisopropylethylamine. The used<br>
amount of the base can be 1 to 50 times mol and<br>
preferably 1 to 5 times mol for the compound of general<br>
formula [9].<br>
This reaction can be carried out ordinarily<br>
at -78 to 100C, preferably at 0 to 80C for 10 minutes<br>
to 24 hours.<br>
[0069]<br>
(6-2)<br>
When X1 is a sulfonyl group, the compound of<br>
general formula [lg] can be produced by sulfonamidating<br>
a compound of general formula [9]. Specifically, a<br>
method using a sulfonyl halide in the presence of or in<br>
the absence of the base is included.<br>
The solvent used in this reaction is not<br>
particularly limited as long as it does not adversely<br>
affect the reaction and examples thereof include amides<br>
such as N,N-dimethylformamide, N,N-dimethylacetamide<br>
and l-methyl-2-pyrrolidone; halogenated hydrocarbons<br>
such as methylene chloride, chloroform and<br>
dichloroethane; aromatic hydrocarbons such as benzene,<br>
toluene and xylene; ethers such as dioxane,<br>
tetrahydrofuran, anisole, ethylene glycol dimethyl<br><br>
51<br>
ether, diethylene glycol dimethyl ether and diethylene<br>
glycol diethyl ether; nitriles such as acetonitrile;<br>
ketones such as acetone and 2-butanone; esters such as<br>
ethyl acetate and butyl acetate, sulfones such as<br>
sulfolane and sulfoxides such as dimethylsulfoxide and<br>
these may be optionally mixed for use.<br>
Examples of the sulfonyl halide used in this<br>
reaction include benzenesulfonyl chloride and cc-<br>
toluenesulfonyl chloride.  In addition, a sulfonyl<br>
halide can be produced from a corresponding sulfonic<br>
acid by a method, for example, described in "Shin<br>
Jikken Kagaku Kouza", Vol. 14, pp. 1784-1792, 1978,<br>
Maruzen or the like method. The used amount of the<br>
sulfonyl halide can be 1 to 50 times mol and preferably<br>
1 to 5 times mol for the compound of general formula<br>
[9].<br>
Examples of the base optionally used in this<br>
reaction include inorganic bases such as sodium<br>
hydrogen carbonate, sodium carbonate, potassium<br>
carbonate and cesium carbonate and organic bases such<br>
as triethylamine and diisopropylethylamine. The used<br>
amount of the base can be 1 to 50 times mol and<br>
preferably 1 to 5 times mol for the compound of general<br>
formula [9].<br>
This reaction can be carried out ordinarily<br>
at -78 to 100C, preferably at 0 to 80C for 10 minutes<br>
to 24 hours.<br>
[0070]<br>
[Production Process 7]<br><br><br>
"In the formula, X6c represents an alkylene group which<br>
may be optionally substituted or a bond; L3 represents a<br>
leaving group; Rla, R2, R3a, X1, X2, X3, X5a and X6b mean<br>
the same as above provided that if X6c represents a bond,<br>
R3a represents a cycloalkyl group which may be<br>
optionally substituted."<br>
[0071]<br>
As a compound of general formula [lla], for<br>
example, benzyl bromide and (2-bromoethyl)benzene are<br>
known. As a compound of general formula [lib], for<br>
example, 3-phenyl-l-propanol and cyclohexanol are known.<br>
[0072]<br>
(7-1)<br>
The compounds of general formula [lh] can be<br>
produced by reacting a compound of general formula [10]<br>
with a compound of general formula [lla] in the<br>
presence of the base.<br>
The solvent used in this reaction is not<br>
particularly limited as long as it does not adversely<br>
affect the reaction and examples thereof include amides<br>
such as N,N-dimethylformamide, N,N-dimethylacetamide<br>
and l-methyl-2-pyrrolidone; halogenated hydrocarbons<br>
such as methylene chloride, chloroform and<br>
dichloroethane; aromatic hydrocarbons such as benzene,<br><br>
53<br>
toluene and xylene; ethers such as dioxane,<br>
tetrahydrofuran, anisole, ethylene glycol dimethyl<br>
ether, diethylene glycol dimethyl ether and diethylene<br>
glycol diethyl ether; nitriles such as acetonitrile;<br>
ketones such as acetone and 2-butanone; esters such as<br>
ethyl acetate and butyl acetate, sulfones such as<br>
sulfolane and sulfoxides such as dimethylsulfoxide and<br>
these may be optionally mixed for use.<br>
The used amount of the compound of general<br>
formula [lla] can be 1 to 20 times mol and preferably 1<br>
to 5 times mol for the compound of general formula [10].<br>
Examples of the base used in this reaction<br>
include organic amines such as dimethylaminopyridine,<br>
triethylamine, and pyridine; alkali metal hydrides such<br>
as sodium hydride and alkali metal carbonates such as<br>
potassium carbonate and sodium carbonate.<br>
The used amount of the base can be 1 to 20<br>
times mol and preferably 1 to 5 times mol for the<br>
compound of general formula [10].<br>
This reaction can be carried out ordinarily<br>
at 0 to 200C, preferably at 25 to 150C for 10 minutes<br>
to 24 hours.<br>
[0073]<br>
(7-2)<br>
When X5a is an oxygen atom or a sulfur atom,<br>
the compound of general formula [lh] can be produced by<br>
subjecting a compound of general formula [10] and a<br>
compound of general formula [lib] to Mitsunobu reaction<br><br>
54<br>
in the presence of an azodicarbonyl compound and a<br>
phosphine.<br>
The solvent used in this reaction is not<br>
particularly limited as long as it does not adversely<br>
affect the reaction and examples thereof include<br>
aromatic hydrocarbons such as benzene, toluene and<br>
xylene; ethers such as dioxane, tetrahydrofuran,<br>
anisole, diethylene glycol dimethyl ether, ethylene<br>
glycol monomethyl ether and ethylene glycol dimethyl<br>
ether; esters such as methyl acetate, ethyl acetate and<br>
butyl acetate; nitriles such as acetonitrile; amides<br>
such as N,N-dimethylformamide and N,N-<br>
dimethylacetamide; halogenated hydrocarbons such as<br>
chloroform, methylene chloride and these may be<br>
optionally mixed for use.<br>
Examples of the azodicarbonyl compound used<br>
in this reaction include diethyl azodicarboxylate,<br>
diisopropyl azodicarboxylate and<br>
azodicarbonyldipiperidine. The used amount of the<br>
azodicarbonyl compound can be 1 to 5 times mol and<br>
preferably 1 to 3 times mol for the compound of general<br>
formula [10].<br>
Examples of the phosphines used in this<br>
reaction include triarylphosphines such as<br>
triphenylphosphine and trialkylphosphines such as<br>
tributylphosphine. The used amount of the phosphines<br>
can be 1 to 5 times mol and preferably 1 to 3 times mol<br>
for the compound of general formula [10].<br><br>
55<br>
The used amount of the compound of general<br>
formula [lib] can be 1 to 5 times mol and preferably 1<br>
to 3 times mol for the compound of general formula [10].<br>
This reaction can be carried out ordinarily<br>
at -20 to 120C, preferably at 0 to 50C for 30 minutes<br>
to 24 hours.<br>
[0074]<br>
[Production Process 8]<br><br>
"In the formula, X2b represents a bond; X3a represents an<br>
oxygen atom or a bond; X5b represents an oxygen atom, a<br>
sulfonyl group or a bond; R2, R3a and X1 mean the same as<br>
above."<br>
[0075]<br>
The compound of the general formula [li] can<br>
be produced by reacting a compound of general formula<br>
[12] with an oxidizing agent in the presence of or in<br>
the absence of an acid or a base, in the presence of or<br>
in the absence of a salt.<br>
The solvent used in this reaction is not<br>
particularly limited as long as it does not adversely<br>
affect the reaction and examples thereof include water;<br>
halogenated hydrocarbons such as methylene chloride,<br>
chloroform and dichloroethane; aliphatic hydrocarbons<br><br>
56<br>
such as hexane and cyclohexane, and pyridine and these<br>
may be optionally mixed for use.<br>
Examples of the acid optionally used in this<br>
reaction include mineral acids such as hydrochloric<br>
acid and sulfuric acid and organic acids such as acetic<br>
acid. The used amount of the acid can be 1 to 1000<br>
times mol for the compound of general formula [12].<br>
Examples of the base optionally used in this<br>
reaction include, inorganic bases such as sodium<br>
hydroxide and potassium hydroxides, and organic base<br>
such as pyridine. The used amount of the base can be 1<br>
to 1000 times mol for the compound of general formula<br>
[12].<br>
Examples of the salt optionally used in this<br>
reaction include magnesium sulfate, ammonium sulfate<br>
and magnesium chloride. The used amount of the salt can<br>
be 1 to 50 times mol, preferably 1 to 10 times mol for<br>
the compound of general formula [12].<br>
Examples of the oxidizing agent used in this<br>
reaction include chromate such as chromium oxide (VI)<br>
and sodium dichromate, and permanganate such as<br>
potassium permanganate, barium permanganate, calcium<br>
permanganate and magnesium permanganate. The used<br>
amount of the oxidizing agent can be 1 to 50 times mol,<br>
preferably 1 to 10 times mol for the compound of<br>
general formula [12].<br>
This reaction can be carried out ordinarily<br>
at 0 to 150C, preferably at 40 to 130C for 30 minutes<br>
to 48 hours.<br><br><br>
57<br>
[0076]<br>
[Production Process 9]<br>
"R3d represents a monocyclic heterocyclic or bicyclic<br>
heterocyclic group linking through a nitrogen atom<br>
which forms the ring and which group may be optionally<br>
substituted; Rla, R2, X1, X2, X3 and L1 mean the same as<br>
above."<br>
[0077]<br>
As a compound of general formula [13], for<br>
example, pyrrolidine, piperidine, morpholine, pyrrole,<br>
indoline, isoindoline, benzimidazole and indole are<br>
known.<br>
[0078]<br>
The compound of general formula [lj] can be<br>
produced by reacting a compound of general formula [2]<br>
with a compound of general formula [13] following<br>
production process 1.<br>
[0079]<br>
[Production Process 10]<br><br><br>
"In the formula, R3e represents a cycloalkenyl group<br>
which may be optionally substituted; R3f represents a<br>
cycloalkyl group which may be optionally substituted;<br>
Rla, R2, X1, X2, X2a, X3 and L1 mean the same as above."<br>
[0080]<br>
As a compound of general formula [14] , for<br>
example, cyclopentene and cyclohexene are known. In<br>
addition, the compound of general formula [14] can be<br>
produced by a method, for example, described in "Jikken<br>
Kagaku Kouza", 4th edition, Vol. 19, pp. 53-298, 1992,<br>
Maruzen or the like method.<br>
[0081]<br>
(10-1)<br>
The compound of general formula [Ik] can be<br>
produced by reacting a compound of general formula [2]<br>
with a compound of general formula [14] following<br>
production process (3-1).<br>
[0082]<br>
(10-2)<br><br>
59<br>
The compound of general formula [11] can be<br>
produced by reducing a compound of general formula [Ik]<br>
following production process (3-3).<br>
[0083]<br>
[Production Process 11]<br><br><br>
"In the formula, L2a represents a chlorine atom, a<br>
bromine atom or an iodine atom; Rla, R2, R3b, X1, X2, X3<br>
and X7 mean the same as above."<br>
[0084]<br>
As a compound of general formula [8b], for<br>
example, 2-iodotoluene, 3-iodoanisole, 3-<br>
iodonitrobenzene and 6-iodo-2,3-dihydrobenzo[1,4]dioxin<br>
are known.<br>
[0085]<br>
The compound of general formula [lb] can be<br>
produced by reacting a compound of general formula [15]<br>
with a compound of general formula [8b] following<br>
production process 1.<br>
[0086]<br><br>
[Production Process 12]<br><br>
60<br>
"In the formula, R2, R3, X1, X2, X3, X6 and X6c mean the<br>
same as above."<br>
[0087]<br>
The compound of general formula [In] can be<br>
produced by reducing a compound of general formula [lm]<br>
following production process (3-3).<br>
[0088]<br>
[Production Process 13]<br><br><br><br>
"In the formula, R2, R3, X1, X2, X3, X6a and X6b mean the<br>
same as above."<br>
[0089]<br>
The compound of general formula [lp] can be<br>
produced by reducing a compound of general formula [lo]<br>
following production process (3-3).<br>
[0090]<br>
[Production Process 14]<br><br>
"In the formula, Rla, R2, R3, X1, X2, X3 and X4 mean the<br>
same as above."<br><br>
61<br>
[0091]<br>
The compound of general formula [lq] can be<br>
produced by deprotecting a compound of general formula<br>
tig].<br>
Examples of deprotection reaction include<br>
hydrolysis reaction using an acid or a base,<br>
dealkylation reaction using a salt and reductive<br>
dealkylation reaction including metal catalyst<br>
hydrogenation reaction.<br>
[0092]<br>
Examples of the acid in hydrolysis reaction<br>
using an acid include formic acid, hydrochloric acid,<br>
sulfuric acid, hydrobromic acid, trifluoroacetic acid,<br>
aluminum chloride and iodinated trimethylsilane. The<br>
used amount of the acid can be 1 to 100000 times mol<br>
and preferably 1 to 1000 times mol for the compound of<br>
general formula [lg].<br>
Examples of the base in hydrolysis reaction<br>
using a base include inorganic bases such as sodium<br>
hydroxide, potassium hydroxide and lithium hydroxide;<br>
organic bases such as sodium methoxide, sodium ethoxide<br>
and potassium tert-butoxide; carbonates such as<br>
potassium carbonate and sodium carbonate and<br>
tetrabutylammonium fluoride. The used amount of the<br>
base can be 1 to 1000 times mol and preferably 1 to 50<br>
times mol for the compound of general formula [lg].<br>
Examples of the salt in dealkylation reaction<br>
using a salt include lithium iodide and sodium chloride.<br>
The used amount of the salt can be 1 to 100 times mol<br><br>
62<br>
and preferably 1 to 10 times mol for the compound of<br>
general formula [lg].<br>
The reductive dealkylation reaction including<br>
metal catalyst hydrogenation reaction can be conducted<br>
following production process (3-3).<br>
The solvent used in this reaction is not<br>
particularly limited as long as it does not adversely<br>
affect the reaction and examples thereof include water;<br>
alcohols such as methanol, ethanol, 2-propanol and 2-<br>
methyl-2-propanol; ethers such as dioxane,<br>
tetrahydrofuran, anisole, ethylene glycol dimethyl<br>
ether, diethylene glycol dimethyl ether and diethylene<br>
glycol diethyl ether; halogenated hydrocarbons such as<br>
methylene chloride, chloroform and dichloroethane;<br>
nitriles such as acetonitrile; aliphatic hydrocarbons<br>
such as hexane and cyclohexane; aromatic hydrocarbons<br>
such as benzene, toluene and xylene; sulfoxides such as<br>
dimethylsulfoxide; amides such as N,N-<br>
dimethylformamide; nitromethane and pyridine and these<br>
may be optionally mixed for use.<br>
This reaction can be carried out ordinarily<br>
at -78 to 100C, preferably at 0 to 80C for 10 minutes<br>
to 24 hours.<br>
[0093]<br>
[Production Process 15]<br><br><br>
63<br>
"In the formula, X5c represents a sulfinyl group or a<br>
sulfonyl group; R1, R2, R3, X1, X2, X3 and X6 mean the<br>
same as above."<br>
[0094]<br>
The compound of general formula [Is] can be<br>
produced by reacting a compound of general formula [lr]<br>
with an oxidizing agent.<br>
The solvent used in this reaction is not<br>
particularly limited as long as it does not adversely<br>
affect the reaction and examples thereof include water;<br>
halogenated hydrocarbons such as methylene chloride,<br>
chloroform and dichloroethane; aliphatic hydrocarbons<br>
such as hexane and cyclohexane and pyridine and these<br>
may be optionally mixed for use.<br>
Examples of the oxidizing agent used in this<br>
reaction include hydrogen peroxide; hyperacids such as<br>
a peroxyacetic acid, perbenzoic acid and m-<br>
chloroperbenzoic acid; peroxides such as tert-butyl<br>
peroxide and sodium metaperiodate. The used amount of<br>
the oxidizing agent can be 1 to 50 times mol,<br>
preferably 1 to 10 times mol for the compound of<br>
general formula [lr].<br>
This reaction can be carried out ordinarily<br>
at 0 to 150C, preferably at 10 to 100C for 30 minutes<br>
to 4 8 hours.<br>
[0095]<br>
[Production Process 16]<br><br><br>
"In the formula, R1, R2, R3a, X1, X2, X3, X5c and X6 mean<br>
the same as above."<br>
[0096]<br>
The compound of general formula [lu] can be<br>
produced by reacting a compound of general formula [It]<br>
with an oxidizing agent following production process 15.<br>
[0097]<br>
The thus obtained compounds of general<br>
formulae [la], [lb], [lc], [Id], [le], [If], [lg], [lh],<br>
[li], [lj], [Ik], [11], [In], [lo], [lp], [lq], [lr],<br>
[Is], [It] and [lu] or the salts thereof can be<br>
converted to the other compounds of general formula [1]<br>
or the salts thereof by subjecting them to reactions<br>
known per se such as condensation, addition, oxidation,<br>
reduction, rearrangement, substitution, halogenation,<br>
dehydration and hydrolysis or by combining these<br>
reactions appropriately.<br>
In addition, when there is any isomer (for<br>
example, optical isomer, geometrical isomer, tautomer<br>
and the like) for the compounds in the production<br>
processes mentioned above, these isomers can also be<br>
used, and solvates, hydrates and crystals of various<br>
kinds can be also used.<br><br>
65<br>
[0098]<br>
Next, production processes of the compounds<br>
of general formulae [2], [7], [9], [10], [12], [15] and<br>
[38], which are raw materials in the production of the<br>
compounds of the present invention, are described.<br>
[0099]<br>
[Production Process A]<br><br>
"In the formula, Rla, R2, X1, X2, X3 and L1 mean the same<br>
as above".<br>
[0100]<br>
As a compound of general formula [16], for<br>
example, 4-chloro-2-nitrobenzoic acid and 4-bromo-2-<br>
nitrobenzoic acid are known.<br>
[0101]<br>
(A-l)<br>
The compound of general formula [17] can be<br>
produced by esterifying a compound of general formula<br>
[16] . This reaction can be performed by a method<br>
described in W. Greene et al., Protective Groups in<br>
Organic Synthesis, third edition, pp. 369-453, 1999,<br><br>
66<br>
John Wiley &amp; Sons, INC. or the like method.<br>
Specifically, methods using an alkylating agent in the<br>
presence of or in the absence of a phase transfer<br>
catalyst, in the presence of the base, a method via an<br>
acid halide of the compound of general formula [16] are<br>
included.<br>
[0102]<br>
The solvent used in the reaction using an<br>
alkylating agent is not particularly limited as long as<br>
it does not adversely affect the reaction and examples<br>
thereof include aromatic hydrocarbons such as benzene,<br>
toluene and xylene; amides such as N,N-<br>
dimethylformamide, N,N-dimethylacetamide and 1-methyl-<br>
2-pyrrolidone; halogenated hydrocarbons such as<br>
methylene chloride, chloroform and dichloroethane;<br>
ethers such as dioxane, tetrahydrofuran, anisole,<br>
ethylene glycol dimethyl ether, diethylene glycol<br>
dimethyl ether and diethylene glycol diethyl ether;<br>
ketones such as acetone and 2-butanone; nitriles such<br>
as acetonitrile; esters such as ethyl acetate and butyl<br>
acetate and sulfoxides such as dimethylsulfoxide and<br>
these may be optionally mixed for use.<br>
Examples of the phase transfer catalyst<br>
optionally used in this reaction include quaternary<br>
ammonium salts such as tetramethyl ammonium chloride,<br>
benzyltrimethylammonium chloride,<br>
benzyltriethylammonium chloride, benzyltributylammonium<br>
chloride and tetrabutylammonium bromide. The used<br>
amount of the phase transfer catalyst can be 0.01 mol<br><br>
67<br>
or more, preferably 0.1 to 5 times mol for the compound<br>
of general formula [16].<br>
Examples of the base used in this reaction<br>
include inorganic bases such as sodium carbonate,<br>
potassium carbonate and cesium carbonate and organic<br>
bases such as triethylamine, pyridine,<br>
dimethylaminopyridine and N-methylmorpholine. The used<br>
amount of the base can be 1 to 50 times mol, preferably<br>
1 to 5 times mol for the compound of general formula<br>
[16].<br>
Examples of the alkylating agent used in this<br>
reaction include methyl iodide, ethyl iodide, dimethyl<br>
sulfate, 2-bromo-2-methylpropane, benzyl chloride and<br>
benzyl bromide. The used amount of the alkylating agent<br>
can be 1 to 50 times mol, preferably 1 to 5 times mol<br>
for the compound of general formula [16].<br>
This reaction can be carried out ordinarily<br>
at 0 to 170C for 1 minute to 24 hours.<br>
[0103]<br>
For example, in a method via an acid halide,<br>
a compound of general formula [16] can be reacted with<br>
thionyl chloride, oxalyl chloride or the like to<br>
converted it to an acid halide and then reacted with<br>
alcohols such as methanol, ethanol, benzyl alcohol in<br>
the presence of or in the absence of a base.<br>
The solvent used in this reaction is not<br>
particularly limited as long as it does not adversely<br>
affect the reaction and examples thereof include<br>
aromatic hydrocarbons such as benzene, toluene and<br><br>
68<br>
xylene; halogenated hydrocarbons such as methylene<br>
chloride, chloroform and dichloroethane; ethers such as<br>
dioxane, tetrahydrofuran, anisole, ethylene glycol<br>
dimethyl ether, diethylene glycol dimethyl ether and<br>
diethylene glycol diethyl ether; ketones such as<br>
acetone and 2-butanone; nitriles such as acetonitrile;<br>
esters such as ethyl acetate and butyl acetate and<br>
sulfoxides such as dimethylsulfoxide and these may be<br>
optionally mixed for use.<br>
Examples of the base optionally used in this<br>
reaction include inorganic bases such as sodium<br>
carbonate, potassium carbonate and cesium carbonate and<br>
organic bases such as triethylamine, pyridine,<br>
dimethylaminopyridine and N-methylmorpholine. The used<br>
amount of the base can be 1 to 50 times mol, preferably<br>
1 to 5 times mol for the compound of general formula<br>
[16].<br>
This reaction can be carried out ordinarily<br>
at 0 to 170C for 1 minute to 24 hours.<br>
[0104]<br>
(A-2)<br>
The compound of general formula [18] can be<br>
produced by reducing a compound of general formula [17] .<br>
This reaction can be performed by a method described in<br>
Richard C. Larock et al., Comprehensive Organic<br>
Transformations, second edition, pp. 823-827, 1999,<br>
John Wiley &amp; Sons, INC. or the like method.<br>
Specifically, catalytic hydrogenation reaction using a<br><br>
69<br>
metal catalyst and reductive reaction using a metal<br>
such as iron or zinc are included.<br>
[0105]<br>
When the compound of general formula [17] is<br>
subjected to catalytic hydrogenation reaction, it can<br>
be performed following production process (3-3).<br>
The solvent used for subjecting a compound of<br>
general formula [17] to reduction using a metal is not<br>
particularly limited as long as it does not adversely<br>
affect the reaction and examples thereof include water;<br>
alcohols such as methanol, ethanol, 2-propanol and 2-<br>
methyl-2-propanol; amides such as N,N-dimethylformamide,<br>
N,N-dimethylacetamide and l-methyl-2-pyrrolidone;<br>
halogenated hydrocarbons such as methylene chloride,<br>
chloroform and dichloroethane; aromatic hydrocarbons<br>
such as benzene, toluene and xylene; ethers such as<br>
dioxane, tetrahydrofuran, anisole, ethylene glycol<br>
dimethyl ether, diethylene glycol dimethyl ether and<br>
diethylene glycol diethyl ether; nitriles such as<br>
acetonitrile; ketones such as acetone and 2-butanone;<br>
esters such as ethyl acetate and butyl acetate and<br>
these may be optionally mixed for use.<br>
Examples of the metal used in this reaction<br>
include iron, zinc, tin and tin (II) chloride. The used<br>
amount of the metal can be 1 to 50 times mol,<br>
preferably 1 to 10 times mol for the compound of<br>
general formula [17].<br>
Examples of the acid optionally used in this<br>
reaction include hydrogen chloride, hydrogen bromide<br><br>
70<br>
and acetic acid. The used amount of the acid can be<br>
0.001 to 100 times amount (W/V), preferably 0.01 to 20<br>
times amount (W/V) for the compound of general formula<br>
[17].<br>
This reaction can be carried out at 0 to 200C,<br>
preferably 0 to 100C for 1 minute to 24 hours.<br>
[0106]<br>
(A-3)<br>
The compound of general formula [2] can be<br>
produced by amidating or sulfonamidating a compound of<br>
general formula [18] following production process 6.<br>
[0107]<br>
[Production Process B]<br><br>
"In the formula, Rla, R2, X1, X2b, X3a and L1 mean the<br>
same as above."<br>
[0108]<br>
As a compound of general formula [19], for<br>
example, 5-iodo-2-methylaniline is known.<br><br>
71<br>
[0109]<br>
(B-l)<br>
The compound of general formula [20] can be<br>
produced by amidating or sulfonamidating a compound of<br>
general formula [19] following production process 6.<br>
[0110]<br>
(B-2)<br>
The compound of general formula [21] can be<br>
produced by reacting a compound of general formula [20]<br>
with an oxidizing agent following production process 8.<br>
[0111]<br>
(B-3)<br>
The compound of general formula [2a] can be<br>
produced by esterifying a compound of general formula<br>
[21] following production process (A-l).<br>
[0112]<br>
[Production Process C]<br><br>
"In the formula, Rla, R2, R4, R5, X1, X2, X3, X6a, X7 and<br>
L1 mean the same as above."<br>
[0113]<br>
The compound of general formula [7] can be<br>
produced by subjecting a compound of general formula<br><br>
72<br>
[2] to coupling reaction with a compound of general<br>
formula [22a] following production process 2.  In<br>
addition, it can also be produced by reacting a<br>
compound of general formula [2] with a compound of<br>
general formula [22b1] or general formula [22b2]<br>
following production process 1.<br>
[0114]<br>
[Production Process D]<br><br>
"In the formula, R6 represents an acetylene protecting<br>
group; Rla, R2, X1, X2, X3 and L1 mean the same as above."<br>
[0115]<br>
The compound of general formula [7a] can be<br>
produced by reacted a compound of general formula [2]<br>
with a compound of general formula [22c] and then by<br>
performing deprotection following production process<br>
(3-2) .<br>
Deprotection can be performed by a method<br>
described in W. Greene et al., Protective Groups in<br>
Organic Synthesis, third edition, pp. 654-659, 1999,<br>
John Wiley &amp; Sons, INC. or the like method.<br>
[0116]<br>
[Production Process E]<br><br><br>
"In the formula, Rla, R3 and X5 mean the same as above."<br>
[0117]<br>
As a compound of general formula [23], for<br>
example, 2-nitro-4-phenoxybenzoic acid [WO03/033480] is<br>
known.<br>
[0118]<br>
(E-l)<br>
The compound of general formula [24] can be<br>
produced by esterifying a compound of general formula<br>
[23] following production process (A-l).<br>
[0119]<br>
(E-2)<br>
The compound of general formula [9a] can be<br>
produced by reducing a compound of general formula [24]<br>
following production process (3-3) or (A-2).<br>
[0120]<br>
[Production Process F]<br><br><br>
74<br>
"In the formula, Rla, R3a, R4, X7 and L1 mean the same as<br>
above."<br>
[0121]<br>
(F-l)<br>
The compound of general formula [25] can be<br>
produced by reacting a compound of general formula [17]<br>
with a compound of general formula [3a] or general<br>
formula [3b] following production process 1.<br>
[0122]<br>
(F-2)<br>
The compound of general formula [9b] can be<br>
produced by reducing a compound of general formula [25]<br>
following production process (3-3) or (A-2).<br>
[0123]<br>
[Production Process G]<br><br>
"In the formula, Rla, R3b, R5 and L1 mean the same as<br>
above."<br>
[0124]<br>
(G-l)<br>
The compound of general formula [26] can be<br>
produced by reacting a compound of general formula [17]<br>
with a compound of general formula [4] following<br>
production process 2.<br><br>
75<br>
[0125]<br>
(G-2)<br>
The compound of general formula [9c] can be<br>
produced by reducing a compound of general formula [26]<br>
following production process (3-3) or (A-2).<br>
[0126]<br>
[Production Process H]<br><br>
"In the formula, R6d represents an alkenylene group<br>
which may be optionally substituted; Rla, R3a, R3c, X6b<br>
and L1 mean the same as above."<br>
[0127]<br>
(H-l)<br>
The compound of general formula [28] can be<br>
produced by reacting a compound of general formula [17]<br>
with a compound of general formula [27] following<br>
production process (3-1).<br>
[0128]<br>
(H-2)<br>
The compound of general formula [9d] can be<br>
produced by reducing a compound of general formula [28]<br>
following production process (3-3).<br>
[0129]<br>
[Production Process I]<br><br><br>
"In the formula, L4 represents a leaving group; Rla, R3a,<br>
R3c, X5a and X6b mean the same as above."<br>
[0130]<br>
As a compound of general formula [29], for<br>
example, methyl 4-(bromomethyl)-2-nitrobenzoate is<br>
known. In addition, methyl 4-(bromomethyl)-2-<br>
nitrobenzoate can be produced by esterifying 4-<br>
(bromomethyl)-2-nitrobenzoic acid according to an<br>
ordinary method described in Journal of Medicinal<br>
Chemistry, Vol. 29, pp. 589-591, 1986.<br>
[0131]<br>
(I-D<br>
The compound of general formula [31] can be<br>
produced by reacting a compound of general formula [29]<br>
with a compound of general formula [30] following<br>
production process (7-1).<br>
[0132]<br>
(1-2)<br>
The compound of general formula [9e] can be<br>
produced by reducing a compound of general formula [31]<br>
following production process (3-3) or (A-2).<br>
[0133]<br>
[Production Process J]<br><br><br>
"In the formula, R7 represents a phenolic hydroxyl<br>
protecting group or a thiol protecting group; Rla, R2, X1,<br>
X2, X3 and X5a mean the same as above."<br>
[0134]<br>
As a compound of general formula [32], for<br>
example, methyl 2-amino-4-methoxybenzoate [Journal of<br>
the Chemical Society, Perkin Transactions 1, Vol. 21,<br>
pp. 3261-3274, 1997] is known.<br>
[0135]<br>
(J-D<br>
The compound of general formula [33] can be<br>
produced by amidating or sulfonamidating a compound of<br>
general formula [32] following production process 6.<br>
[0136]<br>
(J-2)<br>
The compound of general formula [10] can be<br>
produced by deprotecting a compound of general formula<br>
[33] . Deprotection of phenolic hydroxyl protecting<br>
group can be performed, for example, by a method<br><br>
78<br>
described in W. Greene et al., Protective Groups in<br>
Organic Synthesis, third edition, pp. 249-287, 1999,<br>
John Wiley &amp; Sons, INC. or the like method;<br>
deprotection of thiol protecting group can be performed,<br>
for example, by a method described in W. Greene et al.,<br>
Protective Groups in Organic Synthesis, third edition,<br>
pp. 454-493, 1999, John Wiley &amp; Sons, INC. or the like<br>
method.<br>
[0137]<br>
[Production Process K]<br><br>
"In the formula, R2, R3, X1, X2b, X3a and X5b mean the<br>
same as above."<br>
[0138]<br>
As a compound of general formula [34], for<br>
example, l-methyl-2-nitro-4-phenoxybenzene<br>
[International Patent Publication WO02/078693] is known.<br>
[0139]<br>
(K-l)<br>
The compound of general formula [35] can be<br>
produced by reducing a compound of general formula [34]<br>
following production process (3-3) or (A-2).<br>
[0140]<br>
(K-2)<br><br>
79<br>
The compound of general formula [12] can be<br>
produced by amidating or sulfonamidating a compound of<br>
general formula [35] following production process 6.<br>
[0141]<br>
[Production Process L]<br><br><br><br>
"In the formula, Rla, R2, X1, X2, X3, X7 and L1 mean the<br>
same as above."<br>
[0142]<br>
As a compound of general formula [36], for<br>
example, bis(pinacolato)diboron,<br>
bis(neopentylglylato)diboron and<br>
bis(hexyleneglycolato)diboron are known.<br>
[0143]<br>
The compound of general formula [15] can be<br>
produced by reacting a compound of general formula [2]<br>
with a compound of general formula [36] following<br>
production process 1.<br>
[0144]<br>
[Production Process M]<br><br><br>
80<br>
"In the formula, Rlb represents a carboxyl protecting<br>
group; R2, X2 and X3 mean the same as above."<br>
[0145]<br>
As a compound of general formula [37], for<br>
example, methyl 2-(lH-pyrrol-l-yl)pyridine-4-<br>
carboxylate [International Patent Publication<br>
WO9426709] is known.<br>
[0146]<br>
The compound of general formula [38] can be<br>
produced by deprotecting a compound of general formula<br>
[37] following production process 14.<br>
[0147]<br>
In the compounds used in the production<br>
processes mentioned above, compounds which can be in<br>
the form of a salt can be used as a salt. Examples of<br>
those salts include salts which are similar to the<br>
salts of the compound of general formula [1].<br>
[0148]<br>
When there is any isomer (for example,<br>
optical isomer, geometrical isomer, tautomer and the<br>
like) for the compounds in the production processes<br>
mentioned above, these isomers can be also used. In<br>
addition, when there are solvates, hydrates and various<br>
kinds of crystals, these solvates, hydrates and various<br>
kinds of crystals can be used. Further, when the<br>
compounds used in the production process mentioned<br>
above have a protectable group, for example, an amino<br>
group, a hydroxyl group or a carboxyl group, these<br>
groups can be protected with ordinary protecting groups<br><br>
81<br>
beforehand, and these protecting groups can be detached<br>
by methods well known per se after the reaction.<br>
[0149]<br>
When the compounds of the present invention<br>
are used as a drug, drug adjuvants usually used for<br>
preparation such as excipient, carrier and diluent may<br>
be mixed appropriately. They can be administered orally<br>
or parenterally in the forms such as tablet, capsule,<br>
powder, syrup, granule, pill, suspension, emulsion,<br>
solution, powder preparations, suppository, eyedrop,<br>
nose drop, eardrop, patch, ointment or injection. The<br>
administration method, dosage and times of<br>
administration can be selected appropriately according<br>
to the age, weight and conditions of the patient.<br>
Ordinarily, 0.01 to 1000 mg/kg per day can be<br>
administered to an adult orally or parenterally (for<br>
example, injection, intravenous feeding and<br>
administration to a rectal part) at a time or divided<br>
to several times.<br>
[0150]<br>
Usefulness of some representative compounds<br>
of the present invention is described in the following<br>
Test Examples.<br>
[0151]<br>
Test Example 1: MMP-13 production inhibition test<br>
6.8xlO3 human cartilage derived cell line<br>
SW1353 cells were suspended in 100 \iL of Dulbecco<br>
modified Eagle's medium supplemented with 10% fetal<br>
calf serum, plated on 96-well plates and cultured for 3<br><br>
82<br>
days. After the culture medium was changed to Dulbecco<br>
modified Eagle's medium containing 0.2% lactalbumin<br>
hydrolysate and the cells were cultured for 6 hours,<br>
test compounds were added and then IL-ip was added to<br>
obtain the final concentration of 10 ng/mL 1 hour later.<br>
16 hours after the stimulation, supernatant was<br>
collected and the amount of MMP-13 in the culture<br>
supernatant was determined with an ELISA kit (Amersham).<br>
The inhibition rate was calculated from the amount of<br>
MMP-13 in the presence of a test compound assuming that<br>
the amount of MMP-13 was 100% in the absence of the<br>
test compound.<br>
The results are shown in Table 7.<br>
[0152]<br>
[Table 7]<br><br>
	83<br>
Example No.	inhibition rate (%) at 30 pmol/l,<br>
4	80<br>
7	91<br>
8	95<br>
11	92<br>
15	88<br>
19	94<br>
22	81<br>
24	92<br>
25	86<br>
33	97<br>
80	92<br>
83	93<br>
85	60<br>
88	80<br>
89	94<br>
91	95<br>
96	96<br>
97	97<br>
99	71<br>
105	64<br>
130	96<br>
134	99<br>
138	95<br>
141	95<br>
146	97<br>
150	96<br>
157	98<br>
163	98<br>
176	98<br>
189	96<br>
196	97<br>
212	95<br>
217	68<br>
222	98<br>
230	95<br>
234	99<br>
240	94<br>
243	96<br>
251	83<br>
255	91<br><br>
	84<br>
Example No.	Inhibition rate (%) at 30 jimol/L<br>
261	94<br>
262	93<br>
264	94<br>
276	86<br>
282	75<br>
301	80<br>
316	96<br>
318	95<br>
325	91<br>
330	68<br>
349	95<br>
358	99<br>
382	98<br>
399	79<br>
411	81<br>
415	97<br>
423	98<br>
425	99<br>
426	98<br>
431	98<br>
433	98<br>
442	99<br>
450	98<br>
467	90<br>
495	99<br>
499	99<br>
503	99<br>
505	82<br>
509	77<br>
512	99<br>
514	91<br>
525	87<br>
539	97<br>
541	97<br>
543	85<br>
551	96<br>
560	85<br>
564	97<br>
570	98<br><br>
85<br>
[0153]<br>
Test Example 2: type II collagen-induced arthritis in<br>
Mice<br>
Eight-week old male DBA/1J mice were used<br>
(Charles River Laboratories Japan Inc.). 4 mg/mL bovine<br>
type II collagen (Collagen Gijutsu Kenshukai) dissolved<br>
in 0.01 mol/L of acetic acid aqueous solution and an<br>
equal amount of Freund's complete adjuvant (Chondorex)<br>
containing 1 mg/mL of killed tuberculosis bacillus were<br>
added to prepare an emulsion, and 0.1 mL thereof was<br>
intradermally injected at the base of tail. Similar<br>
treatment was conducted on the 21st day to cause<br>
arthritis. The test compound was suspended in 0.5%<br>
methylcellulose aqueous solution, and 30 mg/kg was<br>
orally administered once a day from the 21st day to the<br>
35th day. In the control group, 0.5% methylcellulose<br>
aqueous solution was administered in the same manner.<br>
The severity of arthritis was estimated by scoring at<br>
zero point for an animal without change; one point for<br>
an animal with swelling at the one or two finger joint<br>
or light swelling only at the carpal or tarsal joint;<br>
two points for an animal with severe swelling at the<br>
carpal or tarsal joint or with swelling at three or<br>
more finger joints; three points for an animal with<br>
severe swelling along the whole foreleg or hindleg and<br>
thus counting 12 points at the maximum for the four<br>
limbs as arthritis score. Degree of bone destruction<br>
was estimated by X-ray photographs of the four limbs on<br>
the 36th day observing the interphalangeal joints of<br><br>
86<br>
the second to fifth fingers, the metacarpophalangeal<br>
and metatarsophalangeal joints of the first to fifth<br>
fingers, carpal or tarsal parts, calcaneal bone and<br>
scoring at 0 or 0.5 point according to the absence or<br>
presence of osteoporotic image in the joint and their<br>
vicinity, 0 point for the bone image without change,<br>
one point for the partially destroyed bone image and, 2<br>
points for the completely destroyed bone image and thus<br>
counting 105 points at the maximum for the four limbs<br>
as bone destruction score. The inhibitory rate was<br>
determined by the following expression.<br>
Inhibitory ratio (%) = 100 - (score of a test compound<br>
treated group/score of the control group)xlOO<br>
The compound shown in Example 25 exhibited<br>
inhibitory action on arthritis and bone destruction.<br>
[Examples]<br>
[0154]<br>
Hereinbelow, the present invention is<br>
described by way of Referential Examples and Examples,<br>
but the present invention is not limited thereto.<br>
The mixing ratio in the eluent is a volume<br>
ratio. Unless indicated otherwise, the carrier in the<br>
silica gel column chromatography is B.W.Silica gel, BW-<br>
127ZH, manufactured by Fuji Silysia Chemical Ltd., and<br>
the carrier in the reversed-phase silica gel column<br>
chromatography is ODS-AM12S05-2520WT of YMC Co., Ltd.<br>
Each of the symbols used in each Example has<br>
the following meaning.<br><br>
87<br>
Ac: acetyl, Boc: tert-butoxycarbonyl, tBu: tert-butyl,<br>
Bz: benzoyl, Et: ethyl, Me: methyl<br>
DMSO-cU: deuterated dimethylsulfoxide<br>
[0155]<br>
Referential Example 1<br><br>
To 40 mL of acetone solution containing 4.0 g<br>
of 4-bromo-2-nitrobenzoic acid, 3.4 g of potassium<br>
carbonate and 2.3 mL of dimethyl sulfate were added at<br>
room temperature and stirred at 50C for 1 hour. After<br>
the reaction mixture was cooled to room temperature,<br>
the solvent was evaporated under reduced pressure.<br>
Water and ethyl acetate were added to the obtained<br>
residue. The organic layer was separated and dried over<br>
anhydrous magnesium sulfate after washed with a<br>
saturated sodium hydrogen carbonate aqueous solution,<br>
1.0 mol/L hydrochloric acid and a saturated sodium<br>
chloride aqueous solution sequentially, and the solvent<br>
was evaporated under reduced pressure to obtain 4.1 g<br>
of methyl 4-bromo-2-nitrobenzoate as white solid.<br>
XH-NMR (CDC13) S: 3.97 (3H, s) , 7.85 (1H, d, J = 8.3 Hz),<br>
8.07 (1H, dd, J = 8.3, 2.0 Hz), 8.47 (1H, d, J = 2.0<br>
Hz) .<br>
[0156]<br>
Referential Example 2<br><br><br>
To 50 mL of N,N-dimethylacetamide solution<br>
containing 5.0 g of 4-bromo-2-nitrobenzoic acid, 41 g<br>
of potassium carbonate, 4.6 g of benzyltriethylammonium<br>
chloride and 69 mL of 2-bromo-2-methylpropane were<br>
added at room temperature and stirred at 55C for 10<br>
hours. After the reaction mixture was cooled to room<br>
temperature, 12 mL of 2-bromo-2-methylpropane was added<br>
and stirred at 55C for 4 hours. After the reaction<br>
mixture was cooled to room temperature, water and ethyl<br>
acetate were added. The organic layer was separated and<br>
dried over anhydrous magnesium sulfate after washed<br>
with 10% citric acid aqueous solution and a saturated<br>
sodium chloride aqueous solution sequentially, and the<br>
solvent was evaporated under reduced pressure. Methanol<br>
was added to the obtained residue and solid substances<br>
were separated by filtration to obtain 3.0 g of tert-<br>
butyl 4-bromo-2-nitrobenzoate as white solid.<br>
1H-NMR (CDC13) 8: 1.55 (9H, s) , 7.63 (1H, d, J = 8.3 Hz),<br>
7.77 (1H, dd, J = 8.3, 1.9 Hz), 7.95 (1H, d, J = 1.9<br>
Hz) .<br>
[0157]<br>
Referential Example 3<br><br><br>
89<br>
2.6 g of iron powder was added to a mixed<br>
solution of 20 mL of methanol and 20 mL of acetic acid<br>
containing 4.0 g of methyl 4-bromo-2-nitrobenzoate, and<br>
the resulting mixture was heated to reflux for 3 hours.<br>
After the reaction mixture was cooled to room<br>
temperature, a saturated sodium hydrogen carbonate<br>
aqueous solution and ethyl acetate were added and<br>
insoluble were removed by filtration. The organic layer<br>
was separated and dried over anhydrous magnesium<br>
sulfate after washed with a saturated sodium hydrogen<br>
carbonate aqueous solution and a saturated sodium<br>
chloride aqueous solution sequentially, and the solvent<br>
was evaporated under reduced pressure. Hexane was added<br>
to the obtained residue and a solid substance was<br>
separated by filtration to obtain 2.0 g of methyl 2-<br>
amino-4-bromobenzoate as white solid.<br>
1H-NMR (CDC13) 8: 3.89 (3H, s) , 4.20 (2H, s) , 7.26 (1H,<br>
dd, J = 8.3, 2.1 Hz), 7.43 (1H, d, J = 2.1 Hz), 7.47<br>
(1H, d, J = 8.3 Hz).<br>
[0158]<br>
Referential Example 4<br><br>
3.0 g of iron powder was added to a mixed<br>
solution of 28 mL of methanol and 28 mL of acetic acid<br>
containing 5.5 g of tert-butyl 4-bromo-2-nitrobenzoate,<br>
and the resulting mixture was heated to reflux for 1<br><br>
90<br>
hour. After the reaction mixture was cooled to room<br>
temperature, a saturated sodium hydrogen carbonate<br>
aqueous solution and ethyl acetate were added and<br>
insoluble were removed by filtration. The organic layer<br>
was separated and dried over anhydrous magnesium<br>
sulfate after washed with a saturated sodium hydrogen<br>
carbonate aqueous solution and a saturated sodium<br>
chloride aqueous solution sequentially, and the solvent<br>
was evaporated under reduced pressure to obtain 4.3 g<br>
of tert-butyl 2-amino-4-bromobenzoate as pale yellow<br>
oil.<br>
1H-NMR (DMSO-d6) 5: 1.52 (9H, s) , 6.65 (1H, dd, J = 8.5,<br>
2.0 Hz), 6.78 (2H, s), 6.98 (1H, d, J = 2.0 Hz), 7.55<br>
(1H, d, J = 8.5 Hz).<br>
[0159]<br>
Referential Example 5<br><br>
0.55 mL of benzoyl chloride was added to 10<br>
mL of a methylene chloride solution containing 1.0 g of<br>
methyl 2-amino-4-bromobenzoate and 0.73 mL of<br>
triethylamine while ice-cooled and stirred at room<br>
temperature for 1 hour. The solvent was evaporated<br>
under reduced pressure and a saturated sodium hydrogen<br>
carbonate aqueous solution and ethyl acetate were added<br>
to the residue. The organic layer was separated and<br>
dried over anhydrous magnesium sulfate after washed<br><br>
91<br>
with 1.0 mol/L hydrochloric acid and a saturated sodium<br>
chloride aqueous solution sequentially, and the solvent<br>
was evaporated under reduced pressure. Diisopropyl<br>
ether was added to the obtained residue and a solid<br>
substance was separated by filtration to obtain 0.9 g<br>
of methyl 2-(benzamido)-4-bromobenzoate as white solid.<br>
XH-NMR (DMSO-d6) 8: 3.88 (3H, s), 7.54-7.58 (2H, m),<br>
7.61-7.66 (1H, m), 7.77 (1H, dd, J = 8.4, 2.2 Hz), 7.90<br>
(1H, d, J = 8.4 Hz), 8.00-8.02 (2H, m), 8.14 (1H, d, J<br>
i  = 2.2 Hz), 10.18 (1H, s).<br>
[0160]<br>
Referential Example 6<br><br>
1.9 mL of benzoyl chloride was added to 42 mL<br>
of a methylene chloride solution containing 4.2 g of<br>
tert-butyl 2-amino-4-bromobenzoate and 2.6 mL of<br>
triethylamine while ice-cooled and stirred at room<br>
temperature for 2 hours. The solvent was evaporated<br>
under reduced pressure and water and ethyl acetate were<br>
added to the residue. The organic layer was separated<br>
and dried over anhydrous magnesium sulfate after washed<br>
with 10% citric acid aqueous solution and a saturated<br>
sodium chloride aqueous solution sequentially, and the<br>
solvent was evaporated under reduced pressure. Hexane<br>
and diisopropyl ether were added to the obtained<br>
residue and a solid substance was separated by<br><br>
92<br>
filtration to obtain 4.4 g tert-butyl 2-(benzamido)-4-<br>
bromobenzoate as white solid.<br>
Hi-NMR (DMSO-de) 8: 1.55 (9H, s) , 7.45 (1H, dd, J = 8.5,<br>
2.1 Hz), 7.60-7.69 (3H, m), 7.89 (1H, d, J = 8.5 Hz),<br>
5  7.95-7.97 (2H, m), 8.78 (1H, d, J = 2.1 Hz), 11.68 (1H,<br>
s) .<br>
[0161]<br>
Referential Example 7<br><br>
To a mixed solution of 42 mL of toluene, 16<br>
mL of ethanol and 7.8 mL of water containing 5.2 g of<br>
methyl 4-bromo-2-nitrobenzoate, 2.9 g of<br>
dihydroxyphenyl borane, 4.2 g of sodium hydrogen<br>
carbonate and 1.1 g of tetrakis(triphenylphosphine)-<br>
palladium (0) were added sequentially and the resulting<br>
mixture was heated to reflux under nitrogen atmosphere<br>
for 2 hours. After the reaction mixture was cooled to<br>
room temperature, 1.1 g of tetrakis(triphenyl-<br>
phosphine) palladium (0) was added to the reaction<br>
mixture and the resulting mixture was heated to reflux<br>
under nitrogen atmosphere for 2 hours. After the<br>
reaction mixture was cooled to room temperature, 1.1 g<br>
of tetrakis(triphenylphosphine)palladium (0) was added<br>
to the reaction mixture and the resulting mixture was<br>
heated to reflux under nitrogen atmosphere for 2 hours.<br>
After the reaction mixture was cooled to room<br><br>
93<br>
temperature, water was added. The organic layer was<br>
separated and dried over anhydrous magnesium sulfate<br>
after washed with 1.0 mol/L hydrochloric acid and a<br>
saturated sodium chloride aqueous solution sequentially,<br>
and the solvent was evaporated under reduced pressure.<br>
The obtained residue was purified with silica gel<br>
column chromatography [eluent; hexane:ethyl acetate =<br>
20:1] to obtain 4.8 g of methyl 2-nitro-4-<br>
phenylbenzoate as pale yellow oil.<br>
1H-NMR (CDC13) 8: 3.94 (3H, s) , 7.44-7.53 (3H, m) , 7.60-<br>
7.63 (2H, m), 7.85-7.86 (2H, m), 8.07 (1H, d, J = 1.4<br>
Hz) .<br>
[0162]<br>
Referential Example 8<br><br>
3.1 g of iron powder was added to a mixed<br>
solution of 24 mL of methanol and 24 mL of acetic acid<br>
containing 4.8 g of methyl 2-nitro-4-phenylbenzoate,<br>
and the resulting mixture was heated to reflux for 2<br>
hours. After the reaction mixture was cooled to room<br>
temperature, insoluble were removed by filtration and a<br>
saturated sodium hydrogen carbonate aqueous solution<br>
and ethyl acetate added to the filtrate. The organic<br>
layer was separated and dried over anhydrous magnesium<br>
sulfate after washed with a saturated sodium hydrogen<br>
carbonate aqueous solution and a saturated sodium<br><br>
94<br>
chloride aqueous solution sequentially, and the solvent<br>
was evaporated under reduced pressure. Hexane was added<br>
to the obtained residue and a solid substance was<br>
separated by filtration to obtain 1.8 g of methyl 2-<br>
amino-4-phenylbenzoate as white solid.<br>
1H-NMR (CDC13) 5: 3.89 (3H, s), 5.79 (2H, s) , 6.87-6.91<br>
(2H, m) , 7.35-7.45 (3H, m) , 7.57-7.61 (2H, m), 7.92 (1H,<br>
d, J = 8.0 Hz).<br>
[0163]<br>
Referential Example 9<br><br>
2.1 mL of benzoyl chloride was added to 70 mL<br>
of a methylene chloride solution containing 3.5 g of 5-<br>
iodo-2-methylaniline and 2.5 mL of triethylamine at<br>
room temperature and stirred at the same temperature<br>
for 30 minutes. 1.0 mol/L hydrochloric acid was added<br>
to the reaction mixture. The organic layer was<br>
separated and dried over anhydrous magnesium sulfate<br>
after washed with a saturated sodium hydrogen carbonate<br>
aqueous solution, and the solvent was evaporated under<br>
reduced pressure. Diisopropyl ether and hexane were<br>
added to the obtained residue and a solid substance was<br>
separated by filtration to obtain 4.2 g of N-(5-iodo-2-<br>
methylphenyl)benzamide as pale yellow solid.<br><br>
95<br>
XH-NMR (CDCI3) 8: 2.29 (3H, s) , 6.96 (1H, d, J = 8.0 Hz),<br>
7.44 (1H, dd, J = 1.6, 8.0 Hz), 7.49-7.63 (4H, m) ,<br>
7.86-7.88 (2H, m), 8.39 (1H, d, J = 1.6 Hz).<br>
[0164]<br>
Referential Example 10<br><br>
2.4 g of potassium permanganate and 1.8 g of<br>
anhydrous magnesium sulfate were added to a suspension<br>
of 40 mL of tert-butyl alcohol and 80 mL of water<br>
containing 4.2 g of N-(5-iodo-2-methylphenyl)benzamide<br>
at room temperature, and the resulting mixture was<br>
heated to reflux for 4 hours. After the reaction<br>
mixture was cooled to room temperature, 2.0 g of<br>
potassium permanganate and 1.5 g of anhydrous magnesium<br>
sulfate were added and the resulting mixture was heated<br>
to reflux for 2 hours. After the reaction mixture was<br>
cooled to room temperature, 2.0 g of potassium<br>
permanganate and 1.5 g of anhydrous magnesium sulfate<br>
were added and the resulting mixture was heated to<br>
reflux for 2 hours. After the reaction mixture was<br>
cooled to room temperature, 20 mL of ethanol was added<br>
and insoluble were removed by filtration. The solvent<br>
was evaporated under reduced pressure and 1.0 mol/L<br>
hydrochloric acid and ethyl acetate were added. The<br>
organic layer was separated and dried over anhydrous<br>
magnesium sulfate, and the solvent was evaporated under<br><br>
96<br>
reduced pressure. Diisopropyl ether and hexane were<br>
added to the obtained residue and a solid substance was<br>
separated by filtration to obtain 3.3 g of 2-<br>
(benzamido)-4-iodobenzoic acid as pale yellow solid.<br>
XH-NMR (DMSO-de) 5: 7.58-7.69 (4H, m), 7.79 (1H, d, J =<br>
8.3 Hz), 7.94-7.96 (2H, m), 9.17 (1H, d, J = 1.7 Hz),<br>
12.17 (1H, s).<br>
[0165]<br>
Referential Example 11<br><br>
0.62 g of potassium carbonate and 0.43 mL of<br>
dimethyl sulfate were added to 15 mL of N,N-<br>
dimethylformamide solution containing 1.5 g of 2-<br>
(benzamido)-4-iodobenzoic acid at room temperature and<br>
stirred at the same temperature for 1 hour. Ethyl<br>
acetate and 1.0 mol/L hydrochloric acid were added to<br>
the reaction mixture. The organic layer was separated<br>
and dried over anhydrous magnesium sulfate, and the<br>
solvent was evaporated under reduced pressure. The<br>
obtained residual was purified with silica gel column<br>
chromatography [eluent; hexane:ethyl acetate =5:1] to<br>
obtain 1.3 g of methyl 2-(benzamido)-4-iodobenzoate as<br>
white solid.<br>
XH-NMR (DMSO-d6) 8: 3.89 (3H, s), 7.59-7.69 (4H, m),<br>
7.75 (1H, d, J = 8.3 Hz), 7.95-7.98 (2H, m) , 9.04 (1H,<br>
d, J = 1.5 Hz), 11.61 (1H, s).<br><br><br>
97<br>
[0166]<br>
Referential Example 12<br>
To 48 mL of N,N-dimethylacetamide solution<br>
containing 6.0 g of tert-butyl 4-bromo-2-nitrobenzoate,<br>
2.7 mL of styrene, 2.5 g of sodium acetate, 3.2 g of<br>
tetrabutylammonium bromide and 0.22 g of palladium<br>
acetate (II) were added sequentially, and heated and<br>
stirred under nitrogen atmosphere at 90C for 3 hours.<br>
After the reaction mixture was cooled to room<br>
temperature, 0.45 mL of styrene and 0.22 g of palladium<br>
acetate (II) were added and heated and stirred at 110C<br>
for 3 hours. After the reaction mixture was cooled to<br>
room temperature, water and ethyl acetate were added.<br>
The organic layer was separated and dried over<br>
anhydrous magnesium sulfate after washed with 10%<br>
citric acid aqueous solution and a saturated sodium<br>
chloride aqueous solution sequentially, and the solvent<br>
was evaporated under reduced pressure. The obtained<br>
residue was purified with silica gel column<br>
chromatography [eluent; hexane:ethyl acetate =20:1] to<br>
obtain 3.8 g of tert-butyl 2-nitro-4-((E)-2-<br>
phenylvinyl)benzoate as white solid.<br>
1H-NMR (DMSO-d6) 8: 1.51 (9H, s), 7.32-7.45 (4H, m) ,<br>
7.59 (1H, d, J = 16.6 Hz), 7.66 (2H, d, J = 7.4 Hz),<br><br>
98<br>
7.84 (1H, d, J = 8.1 Hz), 7.98 (1H, dd, J = 8.1, 1.5<br>
Hz), 8.23 (1H, d, J = 1.5 Hz).<br>
[0167]<br>
Referential Example 13<br><br>
0.74 g of 5% palladium-carbon was added to a<br>
mixed solution of 56 mL of methanol and 56 mL of ethyl<br>
acetate containing 3.7 g of tert-butyl 2-nitro-4- ( (E)-<br>
2-phenylvinyl)benzoate and stirred under hydrogen<br>
atmosphere at room temperature for 2 hours. Insoluble<br>
were removed by filtration, and the solvent was<br>
evaporated under reduced pressure to obtain 3.4 g of<br>
tert-butyl 2-amino-4-phenethylbenzoate as white solid.<br>
1H-NMR (CDC13) 6: 1.58 (9H, s) , 2.79-2.91 (4H, m) , 5.63<br>
(2H, s), 6.44-6.49 (2H, m), 7.17-7.21 (3H, m), 7.26-<br>
7.30 (2H, m), 7.72 (1H, d, J = 8.4 Hz) .<br>
[0168]<br>
Referential Example 14<br><br>
19 mg of palladium acetate (II) was added to<br>
5 mL of toluene solution containing 0.50 g of tert-<br>
butyl 4-bromo-2-nitrobenzoate, 50 mg of tri(o-<br>
tolyl)phosphine, 0.44 mL of allylbenzene and 0.46 mL of<br><br>
99<br>
triethylamine, and the resulting mixture was heated to<br>
reflux under nitrogen atmosphere for 2 hours. After the<br>
reaction mixture was cooled to room temperature, 20 mg<br>
of palladium acetate (II) was added and the resulting<br>
mixture was heated to reflux for 7 hours. After the<br>
reaction mixture was cooled to room temperature,<br>
insoluble were removed by filtration, and the solvent<br>
was evaporated under reduced pressure. The obtained<br>
residue was purified with silica gel column<br>
chromatography [eluent; hexane:ethyl acetate = 30:1] to<br>
obtain 0.31 g of tert-butyl 2-nitro-4-(3-phenyl-l-<br>
propenyl)benzoate.<br>
62 mg of 5% palladium-carbon was added to 3<br>
mL of ethyl acetate solution containing 0.31 g of tert-<br>
butyl 2-nitro-4-(3-phenyl-l-propenyl)benzoate at room<br>
temperature and stirred under hydrogen atmosphere at<br>
the same temperature for 5 hours and 30 minutes.<br>
Insoluble were removed by filtration, and the solvent<br>
was evaporated under reduced pressure to obtain 0.31 g<br>
of tert-butyl 2-amino-4-(3-phenylpropyl)benzoate as<br>
yellow oil.<br>
1H-NMR (CDC13) 8: 1.57 (9H, s) , 1.88-1.97 (2H, m) , 2.55<br>
(2H, t, J = 7.6 Hz), 2.63 (2H, t, J = 7.6 Hz), 5.64 (2H,<br>
s), 6.44-6.48 (2H, m) , 7.16-7.21 (3H, m) , 7.26-7.30 (2H,<br>
m) , 7.72 (1H, d, J = 8.0 Hz).<br>
[0169]<br>
Referential Example 15<br><br><br>
19 mg of palladium acetate (II) was added to<br>
5 mL of toluene solution containing 0.50 g of tert-<br>
butyl 4-bromo-2-nitrobenzoate, 50 mg of tri(o-<br>
tolyl)phosphine, 0.50 mL of 4-phenyl-l-butene and 0.46<br>
mL of triethylamine, and the resulting mixture was<br>
heated to reflux under nitrogen atmosphere for 4 hours<br>
and 30 minutes. After the reaction mixture was cooled<br>
to room temperature, 20 mg of palladium acetate (II)<br>
was added and the resulting mixture was heated to<br>
reflux for 5 hours and 30 minutes. After cooled to room<br>
temperature, the reaction mixture was purified with<br>
silica gel column chromatography [eluent; hexane:ethyl<br>
acetate = 30:1] to obtain 0.35 g of tert-butyl 2-nitro-<br>
4-(4-phenyl-l-butenyl)benzoate.<br>
70 mg of 5% palladium-carbon was added to 4<br>
mL of ethyl acetate solution containing 0.35 g of 2-<br>
nitro-4-(4-phenyl-l-butenyl)benzoate and stirred under<br>
hydrogen atmosphere at room temperature for 8 hours.<br>
Insoluble were removed by filtration, and the solvent<br>
was evaporated under reduced pressure to obtain 0.40 g<br>
of tert-butyl 2-amino-4-(4-phenylbutyl)benzoate as<br>
yellow oil.<br>
1H-NMR (CDC13) 8: 1.57 (9H, s), 1.61-1.67 (4H, m), 2.50-<br>
2.54 (2H, m), 2.60-2.63 (2H, m), 5.63 (2H, s), 6.42-<br><br>
101<br>
6.47 (2H, m), 7.15-7.19 (3H, m), 7.25-7.29 (2H, m) ,<br>
7.70 (1H, d, J = 8.0 Hz).<br>
[0170]<br>
Referential Example 16<br><br>
0.54 g of tetrakis(triphenylphosphine)-<br>
palladium (0) was added to 35 mL of toluene solution<br>
containing 3.5 g of tert-butyl 2-(benzamido)-4-<br>
bromobenzoate and 5.0 g of tributylvinyl tin, and the<br>
resulting mixture was heated to reflux under nitrogen<br>
atmosphere for 2 hours. After the reaction mixture was<br>
cooled to room temperature, insoluble were removed by<br>
filtration, and the solvent was evaporated under<br>
reduced pressure. The obtained residue was purified<br>
with silica gel column chromatography [eluent; hexane:<br>
ethyl acetate = 20:1] to obtain 1.4 g of tert-butyl 2-<br>
(benzamido)-4-vinylbenzoate as white solid.<br>
1H-NMR (CDC13) 8: 1.63 (9H, s) , 5.42 (1H, d, J = 11.0<br>
Hz), 5.95 (1H, d, J - 17.7 Hz), 6.77 (1H, dd, J = 17.7,<br>
11.0 Hz), 7.15 (1H, dd, J = 8.2, 1.7 Hz), 7.50-7.60 (3H,<br>
m), 7.97 (1H, d, J = 8.2 Hz), 8.05-8.10 (2H, m), 9.01<br>
(1H, d, J = 1.7 Hz), 12.23 (1H, s) .<br>
[0171]<br>
Referential Example 17<br><br><br>
0.67 mL of triethylamine and 0.34 mL of<br>
benzoyl chloride was added to 5 mL of methylene<br>
chloride solution containing 0.51 g of 3-amino-4-<br>
methylbenzophenone while ice-cooled and stirred at room<br>
temperature for 2 hours. The solvent of the reaction<br>
mixture was evaporated under reduced pressure and ethyl<br>
acetate and 1.0 mol/L hydrochloric acid were added. The<br>
organic layer was separated and dried over anhydrous<br>
magnesium sulfate after washed with a saturated sodium<br>
hydrogen carbonate aqueous solution and a saturated<br>
sodium chloride aqueous solution sequentially, and the<br>
solvent was evaporated under reduced pressure. Hexane<br>
and diisopropyl ether were added to the obtained<br>
residue and a solid substance was separated by<br>
filtration to obtain 0.71 g of N-(5-benzoyl-2-<br>
methylphenyl)benzamide as white solid.<br>
1H-NMR (CDC13) 8: 2.43 (3H, s) , 7.37 (1H, d, J = 7.8 Hz),<br>
7.47-7.52 (4H, m) , 7.56-7.63 (3H, m), 7.74 (1H, s),<br>
7.82-7.86 (2H, m), 7.87-7.91 (2H, m), 8.29 (1H, s).<br>
[0172]<br>
Referential Example 18<br><br><br>
103<br>
2.7 mL of (trimethylsilyl)acetylene was added<br>
to 30 mL of toluene suspension containing 3.2 g of<br>
methyl 2-(benzamido)-4-bromobenzoate, 92 mg of copper<br>
(I)	iodide, 0.34 g of bis(triphenylphosphine)palladium<br>
(II)	chloride and 2.7 mL of triethylamine at room<br>
temperature and stirred under nitrogen atmosphere at 70<br>
to 80C for 2 hours. After the reaction mixture was<br>
cooled to room temperature, ethyl acetate and 1.0 mol/L<br>
hydrochloric acid were added and insoluble were removed<br>
by filtration. The organic layer was separated and<br>
dried over anhydrous magnesium sulfate after washed<br>
with 1.0 mol/L hydrochloric acid and a saturated sodium<br>
chloride aqueous solution sequentially, and the solvent<br>
was evaporated under reduced pressure. Hexane and<br>
diisopropyl ether were added to the obtained residue<br>
and a solid substance was separated by filtration to<br>
obtain 3.5 g of methyl 2-(benzamido)-4-(2-<br>
(trimethylsilyl)ethynyl)benzoate as pale yellow solid.<br>
0.68 g of potassium carbonate was added to a<br>
solution of 17 mL of methanol and 17 mL of<br>
tetrahydrofuran containing 3.5 g of methyl 2-<br>
(benzamido)-4-(2-(trimethylsilyl)ethynyl)benzoate and<br>
stirred at room temperature for 1 hour. The solvent was<br>
evaporated under reduced pressure and ethyl acetate and<br>
1.0 mol/L hydrochloric acid were added and insoluble<br>
were removed by filtration. The organic layer was<br>
separated and dried over anhydrous magnesium sulfate<br>
after washed with 1.0 mol/L hydrochloric acid, and the<br>
solvent was evaporated under reduced pressure. The<br><br>
104<br>
obtained residue was purified with silica gel column<br>
chromatography [eluent; hexane: ethyl acetate =8:1] to<br>
obtain 1.6 g of methyl 2-(benzamido)-4-ethynylbenzoate<br>
as white solid.<br>
1H-NMR (CDC13) 8: 3.25 (1H, s) , 3.97 (3H, s), 7.22 (1H,<br>
dd, J= 8.3, 1.5 Hz), 7.51-7.58 (3H, m) , 8.02-8.06 (3H,<br>
m) , 9.12 (1H, d, J = 1.5 Hz), 12.02 (1H, s) .<br>
[0173]<br>
Referential Example 19<br><br>
4.2 g of iron powder was added to a solution<br>
of 57 mL of methanol and 17 mL of acetic acid<br>
containing 5.7 g of l-methyl-2-nitro-4-phenoxybenzene,<br>
and the resulting mixture was heated to reflux for 5<br>
hours. After the reaction mixture was cooled to room<br>
temperature, ethyl acetate and a saturated sodium<br>
hydrogen carbonate aqueous solution were added and<br>
insoluble were removed by filtration. The organic layer<br>
was separated and dried over anhydrous magnesium<br>
sulfate after washed with a saturated sodium hydrogen<br>
carbonate aqueous solution and a saturated sodium<br>
chloride aqueous solution sequentially, and the solvent<br>
was evaporated under reduced pressure. The obtained<br>
residue was dissolved in 60 mL of diethyl ether and 2.1<br>
mL of hydrochloric acid was added while ice-cooled.<br>
Solid substance was separated by filtration to obtain<br><br>
105<br>
4.7 g of 2-methyl-5-phenoxyaniline hydrochloride as<br>
white solid.<br>
XH-NMR (DMSO-de) 5: 2.27 (3H, s), 6.82 (1H, dd, J = 8.3,<br>
2.4 Hz), 6.96 (1H, d, J = 2.4 Hz), 7.03 (2H, d, J = 7.5<br>
Hz), 7.17 (1H, t, J = 7.5 Hz), 7.26 (1H, d, J = 8.3 Hz),<br>
7.39-7.43 (2H, m).<br>
[0174]<br>
Referential Example 20<br><br>
To a solution of 5 mL of N,N-<br>
dimethylformamide containing 0.50 g of 2-methyl-5-<br>
phenoxyaniline hydrochloride, 0.91 mL of triethylamine<br>
and 0.27 mL of benzoyl chloride were added sequentially<br>
while ice-cooled sequentially and stirred at room<br>
temperature for 3 hours. Ethyl acetate and 1.0 mol/L<br>
hydrochloric acid were added to the reaction mixture.<br>
The organic layer was separated and dried over<br>
anhydrous magnesium sulfate after washed with 1.0 mol/L<br>
hydrochloric acid, a saturated sodium hydrogen<br>
carbonate aqueous solution and a saturated sodium<br>
chloride aqueous solution sequentially, and the solvent<br>
was evaporated under reduced pressure. Hexane and<br>
diisopropyl ether were added to the obtained residue<br>
and a solid substance was separated by filtration to<br>
obtain 0.42 g of N-(2-methyl-5-phenoxyphenyl)benzamide<br>
as white solid.<br><br>
106<br>
1H-NMR (CDCI3) 8: 2.31 (3H, s) , 6.78 (1H, dd, J = 8.3,<br>
2.4 Hz), 7.03 (2H, d, J = 7.8 Hz), 7.08 (1H, t, J = 7.5<br>
Hz), 7.17 (1H, d, J = 8.3 Hz), 7.30-7.34 (2H, m), 7.47-<br>
7.51 (2H, m) , 7.54-7.58 (1H, m) , 7.67 (1H, s) , 7.78 (1H,<br>
s), 7.86 (2H, d, J = 7.1 Hz).<br>
[0175]<br>
Referential Example 21<br><br>
9.9 g of potassium carbonate, 0.82 g of<br>
benzyltriethyl-ammonium chloride and 21 mL of 2-bromo-<br>
2-methylpropane were added to 14 mL of N,N-<br>
dimethylacetamide solution containing 0.93 g of 2-<br>
nitro-4-phenoxybenzoic acid at room temperature and<br>
stirred at 55C for 18 hours. After the reaction<br>
mixture was cooled to room temperature, water and ethyl<br>
acetate were added. The organic layer was separated and<br>
dried over anhydrous magnesium sulfate after washed<br>
with a saturated sodium hydrogen carbonate aqueous<br>
solution, 10% citric acid aqueous solution and a<br>
saturated sodium chloride aqueous solution sequentially,<br>
and the solvent was evaporated under reduced pressure<br>
to obtain 0.86 g of tert-butyl 2-nitro-4-<br>
phenoxybenzoate as white solid.<br>
1H-NMR (DMSO-de) 8: 1.48 (9H, s), 7.18-7.23 (2H, m),<br>
7.26-7.32 (2H, m), 7.47-7.53 (2H, m), 7.54 (1H, d, J =<br>
2.4 Hz), 7.85 (1H, d, J = 8.5 Hz).<br><br>
107<br>
[0176]<br>
Referential Example 22<br><br>
0.17 g of 5% palladium-carbon was added to a<br>
mixed solution of 8 mL of methanol and 8 mL of ethyl<br>
acetate containing 0.82 g of tert-butyl 2-nitro-4-<br>
phenoxybenzoate and stirred under hydrogen atmosphere<br>
at room temperature for 4 hours and 30 minutes.<br>
Insoluble were removed by filtration and the solvent<br>
was evaporated under reduced pressure. The obtained<br>
residue was purified with silica gel column<br>
chromatography [eluent; hexane: ethyl acetate = 10:1]<br>
to obtain 0.63 g of tert-butyl 2-amino-4-<br>
phenoxybenzoate as colorless oil.<br>
1H-NMR (CDC13) 8: 1.57 (9H, s) , 6.16 (1H, d, J = 2.3 Hz),<br>
6.27 (1H, dd, J = 9.0, 2.3 Hz), 7.04-7.06 (2H, m),<br>
7.14-7.18 (1H, m) , 7.34-7.38 (2H, m), 7.78 (1H, d, J =<br>
9.0 Hz).<br>
[0177]<br>
Referential Example 23<br><br>
3.1 mL of triethylamine and 1.3 mL of benzoyl<br>
chloride were added to 19 mL of methylene chloride<br>
solution containing 1.9 g of methyl 2-amino-4-<br><br>
108<br>
methoxybenzoate while ice-cooled sequentially and<br>
stirred at room temperature for 3 hours. The solvent<br>
was evaporated under reduced pressure and chloroform<br>
and 1.0 mol/L hydrochloric acid were added to the<br>
obtained residue. The organic layer was separated and<br>
dried over anhydrous magnesium sulfate after washed<br>
with a saturated sodium hydrogen carbonate aqueous<br>
solution and a saturated sodium chloride aqueous<br>
solution sequentially, and the solvent was evaporated<br>
under reduced pressure. Hexane and diisopropyl ether<br>
were added to the obtained residue and a solid<br>
substance was separated by filtration to obtain 2.6 g<br>
of methyl 2-(benzamido)-4-methoxybenzoate as white<br>
solid.<br>
1H-NMR (CDC13) 5: 3.92 (3H, s) , 3.93 (3H, s) , 6.65 (1H,<br>
dd, J = 9.0, 2.7 Hz), 7.51-7.59 (3H, m), 8.00 (1H, d, H<br>
= 9.0 Hz), 8.05-8.07 (2H, m), 8.63 (1H, d, J = 2.7 Hz).<br>
[0178]<br>
Referential Example 24<br><br>
0.94 g of aluminum chloride was added to 7 mL<br>
of toluene solution containing 0.67 g of methyl 2-<br>
(benzamido)-4-methoxybenzoate at room temperature and<br>
stirred at 80C for 2 hours and 30 minutes. After the<br>
reaction mixture was cooled to room temperature, ethyl<br>
acetate and 1.0 mol/L hydrochloric acid were added and<br><br>
109<br>
a solid substance was separated by filtration to obtain<br>
0.23 g of methyl 2-(benzamido)-4-hydroxybenzoate as<br>
white solid.<br>
1H-NMR (CDC13) 8: 3.93 (3H, s) , 6.68 (1H, dd, J = 8.9,<br>
2.5 Hz), 7.54-7.62 (3H, m) , 8.02-8.05 (3H, m), 8.84 (1H,<br>
d, J = 2.5 Hz), 9.30-9.40 (1H, broad), 12.46 (1H, s).<br>
[0179]<br>
Referential Example 25<br><br>
0.50 g of potassium carbonate and 0.50 g of<br>
methyl 4-(bromomethyl)-2-nitrobenzoate were added to 5<br>
mL of N,N-dimethylformamide solution containing 0.18 g<br>
of phenol at room temperature and stirred at the same<br>
temperature for 10 hours. Ethyl acetate and 1.0 mol/L<br>
hydrochloric acid were added to the reaction mixture.<br>
The organic layer was separated and dried over<br>
anhydrous magnesium sulfate after washed with a<br>
saturated sodium chloride aqueous solution, and the<br>
solvent was evaporated under reduced pressure. The<br>
obtained residue was purified with silica gel column<br>
chromatography [eluent; hexane: ethyl acetate = 6:1] to<br>
obtain 0.53 g of methyl 2-nitro-4-<br>
(phenoxymethyl)benzoate as colorless oil.<br>
1H-NMR (CDCI3) 8: 3.93 (3H, s), 5.17 (2H, s), 6.95-7.03<br>
(3H, m) , 7.30-7.34 (2H, m), 7.72-7.79 (2H, m), 7.95-<br>
8.00 (1H, m).<br><br><br>
110<br>
[0180]<br>
Referential Example 26<br>
1.01 g of potassium carbonate and 0.39 mL of<br>
thiophenol were added to 10 mL of N,N-dimethylformamide<br>
solution containing 1.00 g of methyl 4-(bromomethyl)-2-<br>
nitrobenzoate at room temperature and stirred at the<br>
same temperature for 7 hours. Ethyl acetate was added<br>
to the reaction mixture and insoluble were removed by<br>
filtration and water was added. The organic layer was<br>
separated and dried over anhydrous magnesium sulfate<br>
after washed with a saturated sodium hydrogen carbonate<br>
aqueous solution and a saturated sodium chloride<br>
aqueous solution sequentially, and the solvent was<br>
evaporated under reduced pressure. The obtained residue<br>
was purified with silica gel column chromatography<br>
[eluent; hexane: ethyl acetate = 4:1] to obtain 0.70 g<br>
of methyl 2-nitro-4-((phenylthio)methyl)benzoate as<br>
pale yellow oil.<br>
1H-NMR (CDC13) 8: 3.86 (3H, s) , 4.27 (2H, s) , 6.60-6.74<br>
(5H, m), 7.15-7.19 (2H, m) , 7.82 (1H, d, J = 8.3 Hz).<br>
[0181]<br>
Referential Example 27<br><br>
1ll<br><br>
0.39 g of iron powder was added to a mixed<br>
solution of 7 mL of methanol and 2.1 mL of acetic acid<br>
containing 0.70 g of methyl 2-nitro-4-<br>
((phenylthio)methyl)benzoate, and the resulting mixture<br>
was heated to reflux for 3 hours. After the reaction<br>
mixture was cooled to room temperature, ethyl acetate<br>
and a saturated sodium hydrogen carbonate aqueous<br>
solution were added and insoluble were removed by<br>
filtration. The organic layer was separated and dried<br>
over anhydrous magnesium sulfate after washed with a<br>
saturated sodium hydrogen carbonate aqueous solution<br>
and a saturated sodium chloride aqueous solution<br>
sequentially, and the solvent was evaporated under<br>
reduced pressure. The obtained residue was dissolved in<br>
10 mL of diethyl ether and 1.2 mL of 1.9 mol/L hydrogen<br>
chloride / ethyl acetate were added while ice-cooled<br>
and a solid substance was separated by filtration to<br>
obtain 0.39 g of methyl 2-amino-4-<br>
((phenylthio)methyl)benzoate hydrochloride as white<br>
solid.<br>
1H-NMR (DMSO-de) 8: 3.76 (3H, s) , 4.13 (2H, s) , 4.30-<br>
4.70 (2H, broad), 6.55 (1H, dd, J = 8.2, 1.7 Hz), 6.79<br>
(1H, d, 1.7 Hz), 7.15-7.19 (1H, m), 7.26-7.33 (4H, m) ,<br>
7.62 (1H, d, J = 8.2 Hz).<br><br><br>
112<br>
[0182]<br>
Referential Example 28<br>
The following compound was obtained in the<br>
same manner as in Referential Example 2.<br>
tert-Butyl 4-chloro-2-nitrobenzoate<br>
1H-NMR (CDC13) 8: 1.55 (9H, s) , 7.59-7.62 (1H, m) , 7.70-<br>
7.73 (1H, m), 7.79 (1H, d, J = 2.0 Hz).<br>
[0183]<br>
Referential Example 29<br><br>
The following compound was obtained in the<br>
same manner as in Referential Example 2.<br>
tert-Butyl 2-(benzamido)-4-iodobenzoate<br>
1H-NMR (CDCI3) 8: 1.62 (9H, a), 7.45 (1H, dd, J= 8.5,<br>
1.7 Hz), 7.51-7.60 (3H, m), 7.68 (1H, d, J = 8.5 Hz),<br>
8.02-8.07 (2H, m), 9.38 (1H, d, J = 1.7 Hz), 12.13-<br>
12.20 (1H, broad).<br>
[0184]<br>
Referential Example 30<br><br>
113<br><br>
To 20 mL of toluene solution containing 2.0 g<br>
of tert-butyl 4-bromo-2-nitrobenzoate, 6.0 mL of<br>
ethanol, 3.0 mL of water, 1.2 g of 3-<br>
chlorophenylboronic acid, 1.7 g of sodium carbonate and<br>
0.23 g of tetrakis(triphenylphosphine)palladium (0)<br>
were added sequentially, and the resulting mixture was<br>
heated to reflux under nitrogen atmosphere for 3 hours.<br>
Water was added after the reaction mixture was cooled<br>
to room temperature. The organic layer was separated<br>
and dried over anhydrous magnesium sulfate after washed<br>
with a saturated sodium chloride aqueous solution, and<br>
the solvent was evaporated under reduced pressure. The<br>
obtained residue was purified with silica gel column<br>
chromatography [PSQ100B (spherical) manufactured by<br>
Fuji Silysia Chemical Ltd., eluent; hexane: ethyl<br>
acetate = 10:1] to obtain 0.70 g of tert-butyl 4-(3-<br>
chlorophenyl)-2-nitrobenzoate as white solid.<br>
1H-NMR (DMSO-de) 8: 1.52 (9H, s) , 7.53-7.59 (2H, m) ,<br>
7.77-7.82 (1H, m), 7.89-7.95 (2H, m), 8.15 (1H, dd, J=<br>
8.1, 1.6 Hz), 8.34 (1H, d, J = 1.6 Hz).<br>
[0185]<br>
Referential Example 31<br><br>
114<br><br>
The following compound was obtained in the<br>
same manner as in Referential Example 30.<br>
tert-Butyl 4- (4-(tert-butoxycarbonyl)oxyphenyl)-2-<br>
nitrobenzoate<br>
1H-NMR (DMSO-d6) 5: 1.51 (9H, s) , 1.52 (9H, s) , 7.36 (2H,<br>
d, J = 8.8 Hz), 7.87 (2H, d, J = 8.8 Hz), 7.91 (1H, d,<br>
J = 8.1 Hz), 8.11 (1H, dd, J = 8.1, 1.8 Hz), 8.29 (1H,<br>
d, J = 1.8 Hz).<br>
[0186]<br>
Referential Example 32<br><br>
To 15 mL of toluene solution containing 1.5 g<br>
of tert-butyl 4-chloro-2-nitrobenzoate, 1.1 g of 2,4-<br>
difluorophenylboronic acid, 2.8 g of cesium carbonate,<br>
27 mg of palladium acetate and 25 mg of 2-<br>
dicyclohexylphosphino-2',6'-dimethoxybiphenyl were<br>
added sequentially, and the resulting mixture was<br>
heated to reflux under nitrogen atmosphere for 8 hours.<br>
After the reaction mixture was cooled to room<br>
temperature, insoluble were removed by filtration and<br><br>
115<br>
added a saturated sodium hydrogen carbonate aqueous<br>
solution. The organic layer was separated and dried<br>
over anhydrous magnesium sulfate after washed with 10%<br>
citric acid aqueous solution and a saturated sodium<br>
chloride aqueous solution sequentially, and the solvent<br>
was evaporated under reduced pressure. Hexane and<br>
diisopropyl ether were added to the obtained residue<br>
and a solid substance was separated by filtration to<br>
obtain 0.95 g of tert-butyl 4-(2,4-difluorophenyl)-2-<br>
nitrobenzoate as white solid.<br>
1H-NMR (DMSO-d6) 8: 1.52 (9H, s), 7.26-7.31 (1H, m) ,<br>
7.44-7.51 (1H, m) , 7.72-7.79 (1H, m) , 7.93 (1H, d, J =<br>
7.9 Hz), 7.98 (1H, d, J = 7.9 Hz), 8.17 (1H, s).<br>
[0187]<br>
Referential Example 33<br><br>
The following compound was obtained in the<br>
same manner as in Referential Example 32.<br>
tert-Butyl 4-(benzo[1,3]dioxol-5-yl)-2-nitrobenzoate<br>
1H-NMR (DMSO-d6) 5: 1.51 (9H, s) , 6.11 (2H, s) , 7.06 (1H,<br>
d, J = 8.1 Hz), 7.34 (1H, dd, J = 8.1, 1.9 Hz), 7.45<br>
(1H, d, J = 1.9 Hz), 7.85 (1H, d, J = 8.1 Hz), 8.04 (1H,<br>
dd, J = 8.1, 1.9 Hz), 8.20 (1H, d, J = 1.9 Hz).<br>
[0188]<br>
Referential Example 34<br><br><br>
116<br>
The following compound was obtained in the<br>
same manner as in Referential Example 30.<br>
tert-Butyl 4-(benzofuran-2-yl)-2-nitrobenzoate<br>
1H-NMR (DMSO-d6) 5: 1.53 (9H, s) , 7.30-7.36 (1H, m) ,<br>
7.40-7.45 (1H, m), 7.68-7.76 (1H, m), 7.75 (1H, d, J =<br>
7.3 Hz), 7.82 (1H, d, J = 0.7 Hz), 7.96 (1H, d, J = 8.1<br>
Hz), 8.29 (1H, dd, J = 8.1, 1.6 Hz), 8.49 (1H, d, J =<br>
1.6 Hz).<br>
[0189]<br>
Referential Example 35<br><br>
0.33 g of 10% palladium-carbon was added to a<br>
mixed solution of 11 mL of methanol and 11 mL of ethyl<br>
acetate containing 1.1 g of tert-butyl 4-(3-<br>
chlorophenyl)-2-nitrobenzoate and stirred under<br>
hydrogen atmosphere at room temperature for 3 hours.<br>
After insoluble were removed by filtration, the solvent<br>
was evaporated under reduced pressure. 11 mL of acetic<br>
acid, 11 mL of methanol and 0.33 g of 10% palladium-<br>
carbon were added to the obtained residue sequentially<br>
and stirred under hydrogen atmosphere at room<br>
temperature for 2 hours. After insoluble were removed<br><br>
117<br>
by filtration, the solvent was evaporated under reduced<br>
pressure to obtain 0.70 g of tert-butyl 2-amino-4-(3-<br>
chlorophenyl)benzoate as white solid.<br>
1H-NMR (DMSO-de) 5: 1.55 (9H, s), 6.63-6.69 (2H, broad),<br>
6.83 (1H, dd, J = 8.5, 1.9 Hz),	7.06 (1H, d, J = 1.9<br>
Hz), 7.46 (1H, dt, J = 7.8, 1.6	Hz), 7.50 (1H, t, J =<br>
7.8 Hz), 7.57 (1H, dt, J = 7.8,	1.6 Hz), 7.63 (1H, t, J<br>
= 1.6 Hz), 7.73 (1H, d, J = 8.5	Hz).<br>
[0190]<br>
Referential Example 36<br><br>
The following compound was obtained in the<br>
same manner as in Referential Example 35.<br>
tert-Butyl 2-amino-4-(4-((tert-<br>
butoxycarbonyl)oxy)phenyl)benzoate<br>
1H-NMR (DMSO-de) 8: 1.51 (9H, s), 1.55 (9H, s) , 6.66-<br>
6.70 (2H, broad), 6.80 (1H, dd, J = 8.5, 1.8 Hz), 7.02<br>
(1H, d, J = 1.8 Hz), 7.27-7.32 (2H, m) , 7.61-7.65 (2H,<br>
m), 7.73 (1H, d, J = 8.5 Hz).<br>
[0191]<br>
Referential Example 37<br><br><br>
118<br>
0.27 g of 10% palladium-carbon was added to a<br>
mixed solution of 9.0 mL of methanol and 9.0 mL of<br>
ethyl acetate containing 0.90 g of tert-butyl 4-(2,4-<br>
difluorophenyl)-2-nitrobenzoate and stirred under<br>
hydrogen atmosphere at room temperature for 30 minutes.<br>
After insoluble were removed by filtration, the solvent<br>
was evaporated under reduced pressure to obtain 0.80 g<br>
of tert-butyl 2-amino-4-(2,4-difluorophenyl)benzoate as<br>
white solid.<br>
1H-NMR (DMSO-de) 8: 1.55 (9H, s) , 6.65 (1H, d, J = 8.3<br>
Hz), 6.66-6.73 (2H, broad), 6.91 (1H, s), 7.17-7.22 (1H,<br>
m), 7.33-7.39 (1H, m), 7.50-7.56 (1H, m), 7.72 (1H, d,<br>
J = 8.3 Hz).<br>
[0192]<br>
Referential Example 38<br><br>
0.42 g of 10% palladium-carbon was added to a<br>
mixed solution of 14 mL of methanol and 14 mL of ethyl<br>
acetate containing 1.4 g of tert-butyl 4-<br>
(benzo[l,3]dioxol-5-yl)-2-nitrobenzoate and stirred<br>
under hydrogen atmosphere at room temperature for 2<br>
hours. After insoluble were removed by filtration, the<br>
solvent was evaporated under reduced pressure. The<br>
obtained residue was purified with silica gel column<br>
chromatography [PSQ100B (spherical) manufactured by<br><br>
119<br>
Fuji Silysia Chemical Ltd., eluent; hexane: ethyl<br>
acetate = 20:1] to obtain 0.52 g of tert-butyl 2-amino-<br>
4-(benzo[l,3]dioxol-5-yl)benzoate as pale red solid.<br>
1H-NMR (DMSO-d6) 8: 1.54 (9H, s) , 6.07 (2H, s), 6.57-<br>
6.65 (2H, broad), 6.75 (1H, d, J = 8.5 Hz), 6.96 (1H,<br>
s), 7.00 (1H, d, J = 8.6 Hz), 7.10 (1H, d, J = 8.6 Hz),<br>
7.15 (1H, s), 7.68 (1H, d, J = 8.5 Hz).<br>
[0193]<br>
Referential Example 39<br><br>
0.69 g of iron powder was added to a<br>
suspension of 7.0 mL of methanol and 7.0 mL of acetic<br>
acid containing 1.4 g of tert-butyl 4-(benzofuran-2-<br>
yl)-2-nitrobenzoate and the resulting mixture was<br>
heated to reflux for 2 hours. After the reaction<br>
mixture was cooled to room temperature, the solvent was<br>
evaporated under reduced pressure. A saturated sodium<br>
hydrogen carbonate aqueous solution and ethyl acetate<br>
were added to the obtained residue and insoluble were<br>
removed by filtration. The organic layer was separated<br>
and dried over anhydrous magnesium sulfate after washed<br>
with a saturated sodium hydrogen carbonate aqueous<br>
solution and a saturated sodium chloride aqueous<br>
solution sequentially, and the solvent was evaporated<br>
under reduced pressure. Hexane was added to the<br><br>
120<br>
obtained residue and a solid substance was separated by<br>
filtration to obtain 0.88 g of tert-butyl 2-amino-4-<br>
(benzofuran-2-yl)benzoate as white solid.<br>
1H-NMR (DMSO-d6) 5: 1.56 (9H, s), 6.76-6.84 (2H, broad),<br>
7.07 (1H, dd, J = 8.5, 1.6 Hz), 7.26-7.39 (3H, m) , 7.43<br>
(1H, s), 7.64 (1H, d, J = 8.1 Hz), 7.69 (1H, d, J = 8.1<br>
Hz), 7.75 (1H, d, J = 8.5 Hz).<br>
[0194]<br>
Referential Example 40<br><br>
To 5 mL of N,N-dimethylacetamide solution<br>
containing 0.50 g of tert-butyl 4-bromo-2-nitrobenzoate,<br>
0.37 mL of 3-vinylanisole, 0.47 mL of triethylamine and<br>
0.11 g of palladium acetate were added at room<br>
temperature and stirred under nitrogen atmosphere at<br>
110C for 4 hours. Ethyl acetate and water were added<br>
after the reaction mixture was cooled to room<br>
temperature. The organic layer was separated and dried<br>
over anhydrous magnesium sulfate after washed with 10%<br>
citric acid aqueous solution and a saturated sodium<br>
chloride aqueous solution sequentially, and the solvent<br>
was evaporated under reduced pressure. The obtained<br>
residue was purified with silica gel column<br>
chromatography [PSQ100B (spherical) manufactured by<br>
Fuji Silysia Chemical Ltd., eluent; hexane: ethyl<br>
acetate = 10:1] to obtain 0.20 g of tert-butyl 4-((E)-<br><br>
121<br>
2-(3-methoxyphenyl)vinyl)-2-nitrobenzoate a pale yellow<br>
solid.<br>
1H-NMR (DMSO-de) 5: 1.51 (9H, s), 3.81 (3H, s) , 6.90-<br>
6.94 (1H, m) , 7.20-7.27 (2H, m), 7.34 (1H, t, J = 7.9<br>
Hz), 7.43 (1H, d, J = 16.6 Hz), 7.55 (1H, d, J = 16.6<br>
Hz), 7.84 (1H, d, J = 8.0 Hz), 7.97 (1H, d, J = 7.8 Hz),<br>
8.21 (1H, s).<br>
[0195]<br>
Referential Example 41<br><br>
0.70 g of iron powder was added to a<br>
suspension of 7.5 inL of methanol and 7.5 mL of acetic<br>
acid containing 1.5 g of tert-butyl 4-((E)-2-(3-<br>
methoxyphenyl)vinyl)-2-nitrobenzoate, and the resulting<br>
mixture was heated to reflux for 2 hours. After the<br>
reaction mixture was cooled to room temperature, the<br>
solvent was evaporated under reduced pressure. A<br>
saturated sodium hydrogen carbonate aqueous solution<br>
and ethyl acetate were added to the obtained residue<br>
and insoluble were removed by filtration. The organic<br>
layer was separated and dried over anhydrous magnesium<br>
sulfate after washed with a saturated sodium hydrogen<br>
carbonate aqueous solution and a saturated sodium<br>
chloride aqueous solution sequentially, and the solvent<br>
was evaporated under reduced pressure. The obtained<br>
residue was purified with silica gel column<br><br>
122<br>
chromatography [PSQ100B (spherical) manufactured by-<br>
Fuji Silysia Chemical Ltd., eluent; hexane: ethyl<br>
acetate =4:1] to obtain 0.44 g of tert-butyl 2-amino-<br>
4-((E)-2-(3-methoxyphenyl)vinyl)benzoate as white solid.<br>
1H-NMR (DMSO-d6) 8: 1.54 (9H, s) , 3.80 (3H, s) , 6.57-<br>
6.65 (2H, broad), 6.80-6.92 (3H, m), 7.15-7.23 (4H, m) ,<br>
7.29 (1H, t, J = 8.1 Hz), 7.64 (1H, d, J = 8.3 Hz).<br>
[0196]<br>
Referential Example 42<br><br>
To 40 mL of dioxane solution containing 4.0 g<br>
of tert-butyl 2-(benzamido)-4-bromobenzoate, 3.1 g of<br>
potassium acetate, 5.9 g of bis(pinacolato)diboron and<br>
0.43 g of (1,1'-bis(diphenylphosphino)ferrocene)-<br>
palladium (II) dichloride - methylene chloride complex<br>
were added at room temperature sequentially, and the<br>
resulting mixture was heated to reflux for 3 hours.<br>
After the reaction mixture was cooled to room<br>
temperature, insoluble were removed by filtration, and<br>
the solvent was evaporated under reduced pressure. The<br>
obtained residue was purified with silica gel column<br>
chromatography [PSQ100B (spherical) manufactured by<br>
Fuji Silysia Chemical Ltd., eluent; hexane: ethyl<br>
acetate =4:1] to obtain 3.6 g of tert-butyl 2-<br><br>
123<br>
(benzamido)-4-(4,4,5,5-tetramethyl-l,3,2-dioxaborolan-<br>
2-yl)benzoate as white solid.<br>
1H-NMR (DMSO-de) 8: 1.33 (12H, s) , 1.54 (9H, s) , 7.50<br>
(1H, dd, J = 7.8, 1.0 Hz), 7.58-7.68 (3H, m) , 7.92 (1H,<br>
d, J = 7.8 Hz), 7.96-8.00 (2H, m), 8.72 (1H, d, J = 1.0<br>
Hz), 11.43 (1H, s).<br>
[0197]<br>
Referential Example 43<br><br>
2.0 mL of 2.0 mol/L aqueous sodium hydroxide<br>
was added to a mixed solution of 4.0 mL of methanol and<br>
4.0 mL of tetrahydrofuran containing 0.47 g of methyl<br>
2-(lH-pyrrol-1-yl)pyridine-4-carboxylate and stirred at<br>
room temperature for 1 hour. 5.0 mL of 1.0 mol/L<br>
hydrochloric acid and ethyl acetate were added to the<br>
reaction mixture sequentially. The organic layer was<br>
separated and dried over anhydrous magnesium sulfate<br>
after washed with a saturated sodium chloride aqueous<br>
solution, and the solvent was evaporated under reduced<br>
pressure. Diisopropyl ether was added to the obtained<br>
residue and a solid substance was removed by filtration<br>
to obtain 0.39 g of 2-(lH-pyrrol-l-yl)pyridine-4-<br>
carboxylic acid as white solid.<br>
1H-NMR (DMSO-de) 8: 6.32 (2H, t, J = 2.3 Hz), 7.64 (1H,<br>
dd, J = 5.1, 1.3 Hz), 7.76 (2H, t, J = 2.3 Hz), 8.02<br><br>
124<br>
(1H, t, J = 0.9 Hz), 8.60 (1H, dd, J = 5.1, 0.9 Hz),<br>
13.70-13.95 (1H, broad).<br>
[0198]<br>
Example 1<br><br>
0.56 g of 2-(tributyltin)thiazole and 0.090 g<br>
of tetrakis(triphenylphosphine)palladium(0) were added<br>
to 5 mL of toluene solution containing 0.50 g of methyl<br>
2-(benzamido)-4-bromobenzoate, and the resulting<br>
mixture was heated to reflux under nitrogen atmosphere<br>
for 6 hours. After the reaction mixture was cooled to<br>
room temperature, the solvent was evaporated under<br>
reduced pressure. The obtained residue was purified<br>
with silica gel column chromatography [eluent; hexane:<br>
ethyl acetate =3:1] to obtain 0.25 g of methyl 2-<br>
(benzamido)-4-(thiazol-2-yl)benzoate as white solid.<br>
1H-NMR (DMSO-d6) 8: 3.93 (3H, s), 7.61-7.70 (3H, m) ,<br>
7.82 (1H, dd, J = 8.5, 1.8 Hz), 7.95 (1H, d, J = 3.2<br>
Hz), 7.99-8.01 (2H, m), 8.05 (1H, d, J = 3.2 Hz), 8.13<br>
(1H, d, J = 8.5 Hz), 9.29 (1H, d, J = 1.8 Hz), 11.73<br>
(1H, s).<br>
[0199]<br><br><br>
125<br>
0.35 mL of 10% aqueous sodium hydroxide was<br>
added to 5 mL of ethanol suspension containing 0.25 g<br>
of methyl 2-(benzamido)-4-(thiazol-2-yl)benzoate at<br>
room temperature, and the resulting mixture was heated<br>
to reflux for 2 hours. After the reaction mixture was<br>
cooled to room temperature, 1.0 mol/L hydrochloric acid<br>
and ethyl acetate were added. The organic layer was<br>
separated and dried over anhydrous magnesium sulfate,<br>
and the solvent was evaporated under reduced pressure.<br>
Hexane and diisopropyl ether were added to the obtained<br>
residue and a solid substance was separated by<br>
filtration to obtain 0.23 g of 2-(benzamido)-4-<br>
(thiazol-2-yl)benzoic acid as white solid.<br>
1H-NMR (DMSO-de) 8: 7.61-7.70 (3H, m) , 7.80 (1H, dd, J =<br>
8.3, 1.7 Hz), 7.94 (1H, d, J = 3.2 Hz), 7.98-8.00 (2H,<br>
m), 8.05 (1H, d, J = 3.2 Hz), 8.17 (1H, d, J = 8.3 Hz),<br>
9.43 (1H, d, J = 1.7 Hz), 12.28 (1H, s) .<br>
[0200]<br>
Example 3<br><br>
0.28 mL of benzoyl chloride was added to 10<br>
mL of methylene chloride solution containing 0.50 g of<br>
methyl 2-amino-4-phenylbenzoate and 0.36 mL of<br>
triethylamine and stirred at room temperature overnight.<br>
The solvent was evaporated under reduced pressure and<br>
water and ethyl acetate were added. The organic layer<br><br>
126<br>
was separated and dried over anhydrous magnesium<br>
sulfate after washed with 1.0 mol/L hydrochloric acid<br>
and a saturated sodium chloride aqueous solution<br>
sequentially, and the solvent was evaporated under<br>
reduced pressure. Hexane and diisopropyl ether were<br>
added to the obtained residue and a solid substance was<br>
separated by filtration to obtain 0.52 g of methyl 2-<br>
(benzamido)-4-phenylbenzoate as white solid.<br>
1H-NMR (CDC13) 5: 3.99 (3H, s) , 7.37-7.60 (7H, m) , 7.73-<br>
7.75 (2H, m), 8.07-8.10 (2H, m), 8.15 (1H, d, J = 8.3<br>
Hz), 9.29 (1H, d, J = 1.7 Hz), 12.13 (1H, s) .<br>
[0201]<br>
Example 4<br><br>
1.2 mL of 2.0 mol/L aqueous sodium hydroxide<br>
was added to a suspension of 5 mL of methanol and 2.5<br>
mL of dioxane containing 0.50 g of methyl 2-<br>
(benzamido)-4-phenylbenzoate at room temperature and<br>
stirred at 50C for 30 minutes. After the reaction<br>
mixture was cooled to room temperature, 1.0 mol/L<br>
hydrochloric acid was added to adjust to pH 3 and water<br>
and ethyl acetate were added. The organic layer was<br>
separated and dried over anhydrous magnesium sulfate<br>
after washed with a saturated sodium chloride aqueous<br>
solution, and the solvent was evaporated under reduced<br>
pressure. Hexane was added to the obtained residue and<br><br>
127<br>
a solid substance was separated by filtration to obtain<br>
0.36 g of 2-(benzamido)-4-phenylbenzoic acid as white<br>
solid.<br>
1H-NMR (DMSO-d6) 5: 7.45-7.69 (7H, m) , 7.73-7.75 (2H, m) ,<br>
7.98-8.00 (2H, m), 8.15 (1H, d, J = 8.1 Hz), 9.09 (1H,<br>
d, J = 2.0 Hz), 12.29 (1H, s), 13.70-14.00 (1H, broad).<br>
[0202]<br>
Example 5<br><br>
55 mg of pyridine-3-boronic acid, 88 mg of<br>
sodium hydrogen carbonate and 17 mg of<br>
tetrakis(triphenylphosphine)palladium(O) were added to<br>
a mixed solution of 2.0 mL of toluene, 0.5 mL of<br>
ethanol and 0.2 mL of water containing 100 mg of methyl<br>
2-(benzamido)-4-bromobenzoate, and heated to reflux<br>
with stirring for 2 hours. After the reaction mixture<br>
was cooled to room temperature, 17 mg of<br>
tetrakis(triphenylphosphine)palladium(O) was added and<br>
heated to reflux with stirring for 2 hours. After the<br>
reaction mixture was cooled to room temperature,<br>
toluene and water were added. The organic layer was<br>
separated and dried over anhydrous magnesium sulfate<br>
after washed with a saturated sodium hydrogen carbonate<br>
aqueous solution and a saturated sodium chloride<br>
aqueous solution sequentially, and the solvent was<br>
evaporated under reduced pressure. 3.0 mL of ethanol<br><br>
128<br>
and 0.5 mL of 2.0 mol/L aqueous sodium hydroxide<br>
solution were added to the obtained residue and stirred<br>
at room temperature for 2 hours. The reaction mixture<br>
was purified with reversed-phase silica gel column<br>
chromatography [eluent; 30-100% acetonitrile/0.1%<br>
trifluoroacetic acid aqueous solution] to obtain 25 mg<br>
of 2-(benzamido)-4-(pyridin-3-yl)benzoic acid<br>
trifluoroacetate as white solid.<br>
1H-NMR (DMSO-de) 6: 7.45-7.49 (2H, m) , 7.56 (1H, t, J =<br>
7.0 Hz), 7.63-7.69 (2H, m), 7.77 (2H, d, J = 7.1 Hz),<br>
7.97 (1H, dd, J = 8.1 Hz, J = 1.2 Hz), 8.09 (1H, s),<br>
8.17 (1H, d, J = 7.6 Hz), 8.65 (1H, d, J = 5.1 Hz),<br>
8.83 (1H, s), 10.25 (1H, s).<br>
[0203]<br>
Example 6<br><br>
56 mg of 4-(acetamido)phenylboronic acid, 55<br>
mg of sodium carbonate and 30 mg of polymer supported<br>
bis(acetato)triphenylphosphine palladium(II) were added<br>
to 2.5 mL of N,N-dimethylacetamide solution containing<br>
70 mg of methyl 2-(benzamido)-4-bromobenzoate, and<br>
stirred at 90C for 11 hours. After the reaction<br>
mixture was cooled to room temperature, 19 mg of 4-<br>
(acetamido)phenylboronic acid was added and the mixture<br>
was stirred at 90C for 12 hours. After the reaction<br><br>
129<br>
mixture was cooled to room temperature, 11 mg of sodium<br>
carbonate and 30 mg of polymer supported<br>
bis(acetato)triphenylphosphine palladium(II) were added<br>
and stirred at 90C for 14 hours. After the reaction<br>
mixture was cooled to room temperature, insoluble were<br>
removed by filtration and ethyl acetate and 1.2 mol/L<br>
hydrochloric acid were added. The organic layer was<br>
separated and dried over anhydrous magnesium sulfate<br>
after washed with 1.0 mol/L hydrochloric acid, a<br>
saturated sodium hydrogen carbonate aqueous solution<br>
and a saturated sodium chloride aqueous solution<br>
sequentially, and the solvent was evaporated under<br>
reduced pressure. 1 mL of 1.0 mol/L aqueous sodium<br>
hydroxide and 2 mL of ethanol were added to the<br>
obtained residue and stirred at room temperature for 1<br>
hour. 0.6 mol/L hydrochloric acid was added, and solid<br>
substances were separated by filtration and purified<br>
with reversed-phase silica gel column chromatography<br>
[eluent; 40-100% acetonitrile /0.1% trifluoroacetic<br>
acid aqueous solution] to obtain 5.9 mg of 4-(4-<br>
(acetamido)phenyl)-2-(benzamido)benzoic acid as white<br>
solid.<br>
1H-NMR (DMSO-de) 5: 2.08 (3H, s) , 7.49-7.52 (1H, m) ,<br>
7.60-7.76 (7H, m), 7.99 (2H, d, J = 7.6 Hz), 8.11 (1H,<br>
d, J = 8.1 Hz), 9.06 (1H, d, J = 1.7 Hz), 10.14 (1H, s) .<br>
[0204]<br>
Example 7<br><br><br>
The following compound was obtained in the<br>
same manner as in Example 6.<br>
2-(Benzamido)-4-(thiophen-2-yl)benzoic acid<br>
1H-NMR (DMSO-de) 8: 7.22 (1H, t, J = 4.5 Hz), 7.54-7.67<br>
(5H, m), 7.71 (1H, d, J = 4.5 Hz), 7.99 (2H, d, J = 6.8<br>
Hz), 8.08 (1H, d, J = 8.6 Hz), 9.11 (1H, s).<br>
[0205]<br>
Example 8<br><br>
51 mg of benzofuran-2-boronic acid, 55 mg of<br>
sodium carbonate and 30 mg of polymer supported<br>
bis(acetato)triphenylphosphine palladium(II) were added<br>
to 2.5 mL of N,N-dimethylacetamide solution containing<br>
70 mg of methyl 2-(benzamido)-4-bromobenzoate, and<br>
stirred at 90C for 22 hours. After the reaction<br>
mixture was cooled to room temperature, insoluble were<br>
removed by filtration and ethyl acetate and 1.2 mol/L<br>
hydrochloric acid were added. The organic layer was<br>
separated and dried over anhydrous magnesium sulfate<br>
after washed with 1.0 mol/L hydrochloric acid and a<br>
saturated sodium chloride aqueous solution sequentially,<br><br>
131<br>
and the solvent was evaporated under reduced pressure.<br>
1.0 mL of 1.0 mol/L aqueous sodium hydroxide and 2.0 mL<br>
of ethanol were added to the obtained residue and<br>
stirred at room temperature for 1 hour. 0.6 mol/L<br>
hydrochloric acid was added to the reaction mixture and<br>
a solid substance was separated by filtration to obtain<br>
11 mg of 2-(benzamido)-4-(benzofuran-2-yl)benzoic acid<br>
as white solid.<br>
1H-NMR (DMSO-d6) 8: 7.32 (1H, td, J = 7.3, 0.7 Hz), 7.40<br>
(1H, td, J - 7.7, 1.1 Hz), 7.62-7.79 (7H, m), 8.01-8.03<br>
(2H, m), 8.16 (1H, d, J = 8.6 Hz), 9.33 (1H, s).<br>
[0206]<br>
Example 9<br><br>
36 mg of 3-methoxyphenylboronic acid, 55 mg<br>
of sodium carbonate and 30 mg polymer supported<br>
bis(acetato)triphenylphosphine palladium(II) were added<br>
to 2.5 mL of N,N-dimethylacetamide solution containing<br>
70 mg of methyl 2-(benzamido)-4-bromobenzoate, and<br>
stirred at 90C for 11 hours. After the reaction<br>
mixture was cooled to room temperature, insoluble were<br>
removed by filtration and ethyl acetate and 1.2 mol/L<br>
hydrochloric acid were added. The organic layer was<br>
separated and dried over anhydrous magnesium sulfate<br>
after washed with 1.0 mol/L hydrochloric acid, a<br>
saturated sodium hydrogen carbonate aqueous solution<br><br>
132<br>
and a saturated sodium chloride aqueous solution<br>
sequentially, and the solvent was evaporated under<br>
reduced pressure.  1.0 mL of 1.0 mol/L aqueous sodium<br>
hydroxide and 2.0 mL of ethanol were added to the<br>
obtained residue and stirred at room temperature for 1<br>
hour. 0.6 mol/L hydrochloric acid was added to the<br>
reaction mixture and a solid substance was separated by<br>
filtration to obtain 18 mg of 2-(benzamido)-4-(3-<br>
methoxyphenyl)benzoic acid as white solid.<br>
1H-NMR (DMSO-d6) 8: 3.85 (3H, s) , 7.05 (1H, dd, J = 8.2,<br>
2.6 Hz), 7.24 (1H, s), 7.30 (1H, d, J = 8.1 Hz), 7.47<br>
(1H, t, J = 7.9 Hz), 7.53 (1H, dd, J = 8.3, 1.5 Hz),<br>
7.60-7.69 (3H, m), 7.99 (2H, d, J = 7.1 Hz), 8.13 (1H,<br>
d, J = 8.3 Hz), 9.06 (1H, s), 12.30 (1H, s).<br>
[0207]<br>
Example 10<br><br>
The following compound was obtained in the<br>
same manner as in Example 9.<br>
2-(Benzamido)-4-(4-carboxyphenyl)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 7.57-7.69 (4H, m), 7.87 (2H, d, J =<br>
8.0 Hz), 7.99-8.01 (2H, m), 8.10 (2H, d, J = 8.3 Hz),<br>
8.17 (1H, d, J = 8.6 Hz), 9.13 (1H, s).<br>
[0208]<br>
Example 11<br><br><br>
52 mg of 3,4-methylenedioxyphenylboronic acid,<br>
55 mg of sodium carbonate and 30 mg of polymer<br>
supported bis(acetato)triphenylphosphine palladium(II)<br>
were added to 2.5 mL of N,N-dimethylacetamide solution<br>
containing 70 mg of methyl 2-(benzamido)-4-<br>
bromobenzoate, and stirred at 90C for 22 hours. After<br>
the reaction mixture was cooled to room temperature,<br>
insoluble were removed by filtration and ethyl acetate<br>
and 1.2 mol/L hydrochloric acid were added. The organic<br>
layer was separated and dried over anhydrous magnesium<br>
sulfate after washed with 1.0 mol/L hydrochloric acid<br>
and a saturated sodium chloride aqueous solution<br>
sequentially, and the solvent was evaporated under<br>
reduced pressure. 1.0 mL of 1.0 mol/L aqueous sodium<br>
hydroxide and 2.0 mL of ethanol were added to the<br>
obtained residue and stirred at room temperature for 1<br>
hour.  0.6 mol/L hydrochloric acid was added to the<br>
reaction mixture and a solid substance was separated by<br>
filtration to obtain 43 mg of 2-(benzamido)-4-<br>
(benzo[l,3]dioxol-5-yl)benzoic acid as white solid.<br>
1H-NMR (DMSO-d6) 8: 6.11 (2H, s), 7.08 (1H, d, J = 8.1<br>
Hz), 7.24 (1H, dd, J = 8.2, 1.8 Hz), 7.30 (1H, d, J =<br>
1.7 Hz), 7.45-7.47 (1H, m) , 7.59-7.69 (3H, m), 7.98-<br>
8.00 (2H, m), 8.09 (1H, d, J = 8.1 Hz), 9.01 (1H, s).<br><br>
134<br>
[0209]<br>
Examples 12, 13<br>
The compounds shown in Table 8 were obtained<br>
in the same manner as in Example 11.<br>
[0210]<br><br>
[Table 8]<br><br>
[0211]<br>
2-(Benzamido)-4-(lH-indol-5-yl)benzoic acid<br>
1H-NMR (DMSO-de) 8: 6.56 (1H, s), 7.43 (1H, t, J= 2.7<br>
Hz), 7.47-7.69 (6H, m), 7.94 (1H, s) , 8.01 (2H, d, J =<br>
7.1 Hz), 8.12 (1H, d, J = 8.3 Hz), 9.14 (1H, d, J = 1.5<br>
Hz), 11.26 (1H, s).<br>
[0212]<br>
2-(Benzamido)-4-(4-(methanesulfonyl)phenyl)benzoic acid<br>
Hl-NMR (DMSO-de) 8: 3.33 (3H, s) , 7.57-7.70 (4H, m) ,<br>
7.99-8.01 (4H, m), 8.09 (2H, d, J = 8.6 Hz), 8.19 (1H,<br>
d, J = 8.3 Hz), 9.13 (1H, d, J = 1.7 Hz), 12.28 (1H, s) .<br>
[0213]<br>
Example 14<br><br><br>
61 mg of 3-(4,4,5,5-tetramethyl-l,3,2-<br>
dioxaborolan-2-yl)furan, 55 mg of sodium carbonate and<br>
30 mg of polymer supported<br>
bis(acetato)triphenylphosphine palladium(II) were added<br>
to 2.5 mL of N,N-dimethylacetamide solution containing<br>
70 mg of methyl 2-(benzamido)-4-bromobenzoate, and<br>
stirred at 90C for 12 hours. After the reaction<br>
mixture was cooled to room temperature, 41 mg of 3-<br>
(4,4,5,5-tetramethyl-l,3,2-dioxaborolan-2-yl)furan and<br>
22 mg of sodium carbonate were added and stirred at 90C<br>
for 12 hours. After the reaction mixture was cooled to<br>
room temperature, insoluble were removed by filtration<br>
and ethyl acetate and 1.0 mol/L hydrochloric acid were<br>
added. The organic layer was separated and dried over<br>
anhydrous magnesium sulfate after washed with 1.0 mol/L<br>
hydrochloric acid and a saturated sodium chloride<br>
aqueous solution sequentially, and the solvent was<br>
evaporated under reduced pressure. 1.0 mL of 2.0 mol/L<br>
aqueous sodium hydroxide and 2.0 mL of ethanol were<br>
added to the obtained residue and stirred at room<br>
temperature for 1 hour. 0.6 mol/L hydrochloric acid was<br>
added to the reaction mixture, and solid substances<br>
were separated by filtration and purified with<br>
reversed-phase silica gel column chromatography<br>
[eluent; 50-100% acetonitrile /0.1% trifluoroacetic<br><br>
136<br>
acid aqueous solution] to obtain 6.2 mg of 2-<br>
(benzamido)-4-(furan-3-yl)benzoic acid as white solid.<br>
1H-NMR (DMSO-d6) 8: 6.97 (1H, d, J = 1.7 Hz), 7.47 (1H,<br>
dd, J= 8.3, 1.7 Hz), 7.59-7.69 (3H, m), 7.83 (1H, t, J<br>
= 1.6 Hz), 7.98-8.00 (2H, m), 8.06 (1H, d, J = 8.3 Hz),<br>
8.32 (1H, s), 8.94 (1H, d, J = 1.7 Hz), 12.29 (1H, s).<br>
[0214]<br>
Example 15<br><br>
The following compound was obtained in the<br>
same manner as in Example 14.<br>
2-(Benzamido)-4-(2,3-dihydrobenzo[1,4]dioxin-6-<br>
yl)benzoic acid<br>
1H-NMR (DMSO-d6) 5: 4.31 (4H, s), 7.02 (1H, d, J = 8.8<br>
Hz), 7.21-7.24 (2H, m), 7.46 (1H, dd, J = 8.3, 2.0 Hz),<br>
7.60-7.69 (3H, m), 7.97-7.99 (2H, m), 8.09 (1H, d, J =<br>
8.5 Hz), 9.02 (1H, d, J = 1.7 Hz).<br>
[0215]<br>
Example 16<br><br>
56 mg of (4-(tert-butyl)phenyl)boronic acid,<br>
55 mg of sodium carbonate and 30 mg of polymer<br><br>
137<br>
supported bis(acetato)triphenylphosphine palladium(II)<br>
were added to 2.5 mL of N,N-dimethylacetamide solution<br>
containing 70 mg of methyl 2-(benzamido)-4-<br>
bromobenzoate, and stirred at 90C for 21 hours. After<br>
the reaction mixture was cooled to room temperature,<br>
insoluble were removed by filtration and ethyl acetate<br>
and 1.0 mol/L hydrochloric acid were added. The organic<br>
layer was separated and dried over anhydrous magnesium<br>
sulfate after washed with 1.0 mol/L hydrochloric acid<br>
and a saturated sodium chloride aqueous solution<br>
sequentially, and the solvent was evaporated under<br>
reduced pressure. 1.0 mL of 2.0 mol/L aqueous sodium<br>
hydroxide and 5.0 mL of ethanol were added to the<br>
obtained residue and stirred at room temperature for 1<br>
hour and 30 minutes. 0.5 mol/L hydrochloric acid and<br>
ethyl acetate were added to the reaction mixture. The<br>
organic layer was separated and the solvent was<br>
evaporated under reduced pressure to obtain 9.3 mg of<br>
2-(benzamido)-4-(4-(tert-butyl)phenyl)benzoic acid as<br>
white solid.<br>
1H-NMR (DMSO-d6) 8: 1.28 (9H, s) , 7.41-7.57 (8H, m) ,<br>
7.78-7.80 (2H, m), 7.90 (1H, dd, J = 8.1, 1.7 Hz), 8.06<br>
(1H, d, J = 1.7 Hz), 9.93 (1H, s), 13.09 (1H, s).<br>
[0216]<br>
Example 17<br><br><br>
138<br>
56 mg of benzothiophene-2-boronic acid, 55 mg<br>
of sodium carbonate and 30 mg of polymer supported<br>
bis(acetato)triphenylphosphine palladium(II) were added<br>
to 2.5 mL of N,N-dimethylacetamide solution containing<br>
70 mg of methyl 2-(benzamido)-4-bromobenzoate, and<br>
stirred at 90C for 12 hours. After cooled to room<br>
temperature 37 mg of benzothiophene-2-boronic acid and<br>
22 mg of sodium carbonate were added and stirred at 90C<br>
for 12 hours. After the reaction mixture was cooled to<br>
room temperature, insoluble were removed by filtration<br>
and ethyl acetate and 1.0 mol/L hydrochloric acid were<br>
added. The organic layer was separated and dried over<br>
anhydrous magnesium sulfate after washed with 1.0 mol/L<br>
hydrochloric acid and a saturated sodium chloride<br>
aqueous solution sequentially, and the solvent was<br>
evaporated under reduced pressure. 1.0 mL of 2.0 mol/L<br>
aqueous sodium hydroxide and 2.0 mL of ethanol were<br>
added to the obtained residue and stirred at room<br>
temperature for 1 hour.  0.6 mol/L hydrochloric acid was<br>
added to the reaction mixture and a solid substance was<br>
separated by filtration to obtain 2.5 mg of 2-<br>
(benzamido)-4-(benzothiophen-2-yl)benzoic acid as white<br>
solid.<br>
1HV-NMR (DMSO-de) 5: 7.41-7.46 (2H, m) , 7.61-7.70 (4H, m) ,<br>
7.94-8.06 (5H, m), 8.15 (1H, d, J = 8.3 Hz), 9.24 (1H,<br>
s), 12.30-12.50 (1H, broad).<br>
[0217]<br>
Example 18<br><br><br>
51 mg of 4-acetylphenylboronic acid, 61 mg of<br>
sodium hydrogen carbonate and 12 mg of<br>
tetrakis(triphenylphosphine)palladium(O) were added to<br>
a mixed solution of 2.0 mL of toluene, 0.6 mL jof<br>
ethanol and 0.4 mL of water containing 70 mg o|f methyl<br>
2-(benzamido)-4-bromobenzoate, and stirred un4er<br>
pressure at 160C for 5 minutes. After the reaction<br>
mixture was cooled to room temperature, insoluble were<br>
removed by filtration, ethyl acetate and 0.5 riiol/L<br>
hydrochloric acid were added and a solid substance was<br>
separated by filtration. The obtained solid sjubstance<br>
was added to a mixed solution of 1.0 mL of 2.0 mol/L<br>
aqueous sodium hydroxide and 5.0 mL of ethanoj. and<br>
stirred at room temperature for 1 hour and 30jminutes.<br>
0.6 mol/L hydrochloric acid and ethyl acetate were<br>
added to the reaction mixture. The organic l^yer was<br>
separated, and the solvent was evaporated undfer reduced<br>
pressure to obtain 50 mg of 4-(4-acetylphenyl^-2-<br>
(benzamido)benzoic acid as white solid.<br>
1H-NMR (DMSO-de) 8: 2.64 (3H, s) , 7.59-7.70 (4JH, m) ,<br>
7.89 (2H, d, J = 8.3 Hz), 7.99-8.01 (2H, m) , J8.12 (2H,<br>
d, J = 8.3 Hz), 8.17 (1H, d, J = 8.3 Hz), 9.14 (1H, d,<br>
J = 1.7 Hz), 12.28 (1H, s), 13.80-14.10 (1H, broad).<br>
[0218]	j<br>
Example 19<br><br><br>
56 mg of 2,4-difluorophenylboronic acid, 63<br>
mg of sodium carbonate and 34 mg of polymer supported<br>
bis(acetato)triphenylphosphine palladium(II) were added<br>
to 2.5 mL of N,N-dimethylacetamide solution containing<br>
80 mg of methyl 2-(benzamido)-4-bromobenzoate, and<br>
stirred at 90C for 20 hours. After the reaction<br>
mixture was cooled to room temperature, insoluble were<br>
removed by filtration and ethyl acetate and 1.2 mol/L<br>
hydrochloric acid were added. The organic layer was<br>
separated and dried over anhydrous magnesium sulfate<br>
after washed with 1.0 mol/L hydrochloric acid and a<br>
saturated sodium chloride aqueous solution sequentially,<br>
and the solvent was evaporated under reduced pressure.<br>
1.0	mL of 1.0 mol/L aqueous sodium hydroxide and 4.0 mL<br>
of ethanol were added to the obtained residue and<br>
stirred at room temperature for 1 hour. 0.6 mol/L<br>
hydrochloric acid was added to the reaction mixture and<br>
a solid substance was separated by filtration to obtain<br>
24 mg of 2-(benzamido)-4-(2,4-difluorophenyl)benzoic<br>
acid.<br>
1H-NMR (DMSO-de) 5: 7.28 (1H, td, J = 8.2 Hz, J = 2.2<br>
Hz), 7.39 (1H, dt, J = 8.4, 1.6 Hz), 7.42-7.48 (1H, m) ,<br>
7.59-7.70 (4H, m), 7.96-7.99 (2H, m), 8.15 (1H, d, J =<br>
8.1	Hz), 8.95 (1H, d, J = 1.4 Hz), 12.24 (1H, s).<br><br>
141<br>
[0219]<br>
Examples 20 to 22<br>
The compounds shown in Table 9 were obtained<br>
in the same manner as in Example 19.<br>
[0220]<br>
[Table 9]<br><br>
[0221]<br>
2-(Benzamido)-4-(4-fluorophenyl)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 7.36-7.40 (2H, m), 7.51 (1H, dd, J =<br>
8.1, 2.0 Hz), 7.60-7.69 (3H, m), 7.77-7.81 (2H, m),<br>
7.98-8.00 (2H, m), 8.13 (1H, d, J = 8.3 Hz), 9.06 (1H,<br>
s) .<br>
[0222]<br>
2-(Benzamido)-4-(2-methoxyphenyl)benzoic acid<br>
1H-NMR (DMSO-d6) 6: 3.80 (3H, s), 7.09 (1H, td, J = 7.4,<br>
1.0 Hz), 7.17 (1H, d, J = 7.8 Hz), 7.32-7.37 (2H, m),<br>
7.41-7.45 (1H, m), 7.59-7.68 (3H, m) , 7.96-7.98 (2H, m) ,<br>
8.08 (1H, d, J = 8.3 Hz), 8.88 (1H, t, J = 1.6 Hz).<br>
[0223]<br>
2-(Benzamido)-4-(4-methoxyphenyl)benzoic acid<br><br>
142<br>
1H-NMR (DMSO-de) 8: 3.83 (3H, s) , 7.09-7.12 (2H, m) ,<br>
7.49 (1H, dd, J= 8.3, 1.7 Hz), 7.59-7.72 (5H, m),<br>
7.98-8.00 (2H, m), 8.10 (1H, d, J = 8.3 Hz), 9.06 (1H,<br>
s), 12.20-12.40 (1H, broad).<br>
[0224]<br>
Example 23<br><br>
0.83 mL of triethylamine, 34 mg of palladium<br>
acetate and 0.69 mL of styrene were added to 10 mL of<br>
N,N-dimethylacetamide solution containing 1.0 g of<br>
 methyl 2-(benzamido)-4-bromobenzoate and 91 mg of<br>
tri(o-tolyl)phosphine, and stirred under nitrogen<br>
atmosphere at 120C for 1 hour and 30 minutes. After<br>
the reaction mixture was cooled to room temperature,<br>
0.35 mL of styrene and 5 mg of palladium acetate were<br>
  added and stirred at 120C for 2 hours. After the<br>
reaction mixture was cooled to room temperature, ethyl<br>
acetate and 1.0 mol/L hydrochloric acid were added. The<br>
organic layer was separated and dried over anhydrous<br>
magnesium sulfate after washed with a saturated sodium<br>
  chloride aqueous solution, and the solvent was<br>
evaporated under reduced pressure. The obtained residue<br>
was purified with silica gel column chromatography<br>
[eluent; hexane: ethyl acetate =8:1] to obtain 0.18 g<br>
of methyl 2-(benzamido)-4-((E)-2-phenylvinyl)benzoate<br>
 as white solid.<br><br>
143<br>
1H-NMR (CDCI3) 8: 3.97 (3H, s) , 7.16 (1H, d, J= 16.4<br>
Hz), 7.26-7.41 (5H, m) , 7.52-7.59 (5H, m) , 8.06-8.10<br>
(3H, m), 9.17 (1H, d, J = 1.4 Hz), 12.12 (1H, s) .<br>
[0225]<br>
Example 24<br><br>
0.37 mL of 2.0 mol/L aqueous sodium hydroxide<br>
was added dropwise to a mixed solution of 2 mL of<br>
methanol and 2 mL of tetrahydrofuran containing 0.18 g<br>
of methyl 2-(benzamido)-4-((E)-2-phenylvinyl)benzoate<br>
at room temperature, and stirred at the same<br>
temperature for 7 hours. The solvent was evaporated<br>
under reduced pressure and water was added and pH was<br>
adjusted to pH 4.0 with 1.0 mol/L hydrochloric acid.<br>
Solid substances were separated by filtration and<br>
purified with silica gel column chromatography [eluent;<br>
hexane: ethyl acetate =2:1] to obtain 65 mg of 2-<br>
(benzamido)-4-((E)-2-phenylvinyl)benzoic acid as white<br>
solid.<br>
1H-NMR (DMSO-d6) 8: 7.31-7.44 (5H, m) , 7.49 (1H, dd, J =<br>
8.4, 1.3 Hz), 7.60-7.67 (3H, m), 7.71 (2H, d, J = 7.6<br>
Hz), 7.99 (2H, d, J = 7.1 Hz), 8.06 (1H, d, J = 8.4 Hz),<br>
8.94 (1H, d, J = 1.3 Hz), 12.27 (1H, s), 13.65-13.85<br>
(1H, broad).<br>
[0226]<br>
Example 25<br><br><br>
20 mg of 5% palladium-carbon was added to a<br>
mixed solution of 1 mL of methanol and 2 mL of ethyl<br>
acetate containing 0.10 g of 2-(benzamido)-4-((E)-2-<br>
phenylvinyl)benzoic acid and stirred under hydrogen<br>
atmosphere at room temperature for 5 hours.  Insoluble<br>
were removed by filtration and the solvent was<br>
evaporated under reduced pressure. Hexane and<br>
diisopropyl ether were added to the obtained residue<br>
and a solid substance was separated by filtration to<br>
obtain 69 mg of 2-(benzamido)-4-phenethylbenzoic acid<br>
as white solid.<br>
1H-NMR (DMSO-de) 8: 2.91-2.99 (4H, m) , 7.07 (1H, dd, J =<br>
8.1, 1.4 Hz), 7.17-7.20 (1H, m) , 7.26-7.31 (4H, m) ,<br>
7.58-7.67 (3H, m), 7.95-7.98 (3H, m), 8.67 (1H, d, J =<br>
1.4 Hz), 12.40-12.50 (1H, broad).<br>
[0227]<br>
Example 2 6<br><br>
0.037 mL of vinylcyclohexane, 87 mg of cesium<br>
carbonate, 13 mg of tetrabutylammonium bromide and 21<br>
mg of polymer supported<br>
di(acetato)dicyclohexylphosphino palladium(II) were<br><br>
145<br>
added to 1.0 mL of toluene solution containing 50 mg of<br>
tert-butyl 2-(benzamido)-4-bromobenzoate at room<br>
temperature and stirred at 110C for 48 hours. After<br>
the reaction mixture was cooled to room temperature,<br>
ethyl acetate and 10% citric acid aqueous solution were<br>
added. The organic layer was separated, and the solvent<br>
was evaporated under reduced pressure after washed with<br>
10% citric acid aqueous solution.  5 mL of<br>
trifluoroacetic acid was added to the obtained residue<br>
i  and stirred at room temperature for 1 hour. The solvent<br>
was evaporated under reduced pressure, and the obtained<br>
residue was purified with reversed-phase silica gel<br>
column chromatography [eluent; 55-100% acetonitrile<br>
/0.1% trifluoroacetic acid aqueous solution] to obtain<br>
i  2.9 mg of 2-(benzamido)-4-((E)-2-<br>
cyclohexylvinyl)benzoic acid as white solid.<br>
The following compound was obtained in the<br>
same manner as in Example 26.<br>
1H-NMR (DMSO-de) 5: 1.16-1.36 (5H, m) , 1.64-1.81 (5H, m) ,<br>
2.16-2.24 (1H, m) , 6.42-6.44 (2H, m), 7.24 (1H, dd, J =<br>
8.3, 1.7 Hz), 7.58-7.67 (3H, m) , 7.95-7.99 (3H, m) ,<br>
i  8.76 (1H, s), 12.20-12.40 (1H, broad).<br>
[0228]<br>
Example 27<br><br><br>
146<br>
2-(Benzamido)-4-((E)-3-cyclohexyl-l-propenyl)benzoic<br>
acid<br>
1H-NMR (DMSO-d6) 8: 0.92-1.28 (5H, m) , 1.39-1.49 (1H, m) ,<br>
1.61-1.74 (5H, m), 2.12-2.18 (2H, m), 6.45-6.47 (2H, m),<br>
7.25 (1H, dd, J = 8.3, 1.5 Hz), 7.58-7.67 (3H, m),<br>
7.95-7.99 (3H, m), 8.75 (1H, d, J = 1.5 Hz), 12.20-<br>
12.35 (1H, broad).<br>
[0229]<br>
Example 28<br><br>
0.074 mL of vinylcyclohexane, 0.17 g cesium<br>
carbonate, 26 mg of tetrabutylammonium bromide and 42<br>
mg of polymer supported<br>
di(acetato)dicyclohexylphosphino palladium(II) were<br>
added to 2.0 mL of toluene solution containing 0.10 g<br>
of tert-butyl 2-(benzamido)-4-bromobenzoate at room<br>
temperature and stirred at 110C for 48 hours. After<br>
the reaction mixture was cooled to room temperature,<br>
ethyl acetate and 10% citric acid aqueous solution were<br>
added. The organic layer was separated, and the solvent<br>
was evaporated under reduced pressure after washed with<br>
10% citric acid aqueous solution. 2.4 mL of<br>
tetrahydrofuran, 0.6 mL of water, 0.42 g sodium formate,<br>
0.44 mL of acetic acid and 50 mg of 3.9% palladium-<br>
carbon (ethylenediamine complex) were added to the<br>
obtained residue and stirred at 50C for 12 hours.<br><br>
147<br>
After the reaction mixture was cooled to room<br>
temperature, ethyl acetate and 10% citric acid aqueous<br>
solution were added. The organic layer was separated<br>
and the solvent was evaporated under reduced pressure.<br>
10 mL of trifluoroacetic acid was added to the obtained<br>
residue and stirred at room temperature for 1 hour, and<br>
the solvent was evaporated under reduced pressure. The<br>
obtained residue was purified with reversed-phase<br>
silica gel column chromatography [eluent; 60-100%<br>
acetonitrile /0.1% trifluoroacetic acid aqueous<br>
solution] to obtain 4.8 mg of 2-(benzamido)-4-(2-<br>
cyclohexylethyl)benzoic acid as white solid.<br>
Hl-NMR (DMSO-de) 8: 0.89-0.98 (2H, m) , 1.12-1.27 (4H, m) ,<br>
1.48-1.78 (7H, m) , 2.65-2.69 (2H, m), 7.05 (1H, dd, J =<br>
8.2, 1.6 Hz), 7.58-7.67 (3H, m), 7.94-7.97 (3H, m),<br>
8.62 (1H, d, J = 1.6 Hz), 12.20-12.35 (1H, broad).<br>
[0230]<br>
Example 29<br><br>
The following compound was obtained in the<br>
same manner as in Example 28.<br>
2-(Benzamido)-4-(3-cyclohexylpropyl)benzoic acid<br>
1H-NMR (DMSO-de) 5: 0.80-0.91 (2H, m) , 1.09-1.24 (6H, m) ,<br>
1.59-1.70 (7H, m), 2.62-2.65 (2H, m), 7.05 (1H, dd, J=<br>
8.2, 1.6 Hz), 7.55-7.65 (3H, m), 7.94-7.98 (3H, m) ,<br>
8.62 (1H, d, J = 1.6 Hz), 12.25 (1H, s), 13.64 (1H, s) .<br><br><br>
148<br>
[0231]<br>
Example 30<br>
0.28 mL of triethylamine and 0.12 mL of<br>
benzoyl chloride were added to 3 mL of methylene<br>
chloride solution containing 0.31 g of tert-butyl 2-<br>
amino-4-(3-phenylpropyl)benzoate sequentially while<br>
ice-cooled and stirred at room temperature for 17 hours.<br>
The solvent was evaporated under reduced pressure, and<br>
the obtained residue was purified with silica gel<br>
column chromatography [eluent; hexane: ethyl acetate =<br>
20:1] to obtain 0.48 g of tert-butyl 2-(benzamido)-4-<br>
(3-phenylpropyl)benzoate as white solid.<br>
1H-NMR (CDC13) 5: 1.62 (9H, s) , 1.96-2.05 (2H, m) , 2.68<br>
(2H, t, J = 7.7 Hz), 2.72 (2H, t, J = 7.8 Hz), 6.92 (1H,<br>
dd, J = 8.3, 1.6 Hz), 7.18-7.22 (3H, m), 7.26-7.30 (2H,<br>
m), 7.52-7.56 (3H, m), 7.93 (1H, d, J = 8.3 Hz), 8.05-<br>
8.07 (2H, m), 8.81 (1H, d, J =1.6 Hz), 12.22 (1H, s).<br>
[0232]<br>
Example 31<br><br>
4.8 mL of trifluoroacetic acid solution<br>
containing 0.48 g of tert-butyl 2-(benzamido)-4-(3-<br><br>
149<br>
phenylpropyl)benzoate was stirred at room temperature<br>
for 2 hours. The solvent was evaporated under reduced<br>
pressure, and the obtained residue was purified with<br>
silica gel column chromatography [eluent; hexane: ethyl<br>
acetate = 1:1] to obtain 0.20 g of 2-(benzamido)-4-(3-<br>
phenylpropyl)benzoic acid as white solid.<br>
1H-NMR (DMSO-d6) 8: 1.89-1.97 (2H, m), 2.65 (2H, t, J =<br>
7.9 Hz), 2.69 (2H, t, J = 8.3 Hz), 7.07 (1H, dd, J =<br>
8.2, 1.6 Hz), 7.17-7.25 (3H, m), 7.28-7.32 (2H, m) ,<br>
7.58-7.65 (3H, m) , 7.95-7.99 (3H, m), 8.64 (1H, d, J =<br>
1.6 Hz), 12.23 (1H, s), 13.55-13.75 (1H, broad).<br>
[0233]<br>
Example 32<br><br>
0.34 mL of triethylamine and 0.15 mL of<br>
benzoyl chloride were added to 4 mL of methylene<br>
chloride solution containing 0.40 g tert-butyl 2-amino-<br>
4-(4-phenylbutyl)benzoate while ice-cooled sequentially<br>
and stirred at room temperature for 19 hours. The<br>
solvent was evaporated under reduced pressure, and the<br>
obtained residue was purified with silica gel column<br>
chromatography [eluent; hexane: ethyl acetate = 20:1]<br>
to obtain 0.50 g of tert-butyl 2-(benzamido)-4-(4-<br>
phenylbutyl)benzoate as white solid.<br>
1H-NMR (CDC13) 8: 1.55-1.73 (4H, m) , 1.62 (9H, s) , 2.64<br>
(2H, t, J = 7.2 Hz), 2.71 (2H, t, J = 7.2 Hz), 6.90 (1H,<br><br>
150<br>
dd, J = 8.3, 1.4 Hz), 7.15-7.20 (3H, m), 7.25-7.28 (2H,<br>
m) , 7.51-7.56 (3H, m) , 7.92 (1H, d, J = 8.3 Hz), 8.05-<br>
8.07 (2H, m) , 8.80 (1H, d, J = 1.4 Hz), 12.22 (1H, s) .<br>
[0234]<br>
Example 33<br><br>
4.9 mL solution of trifluoroacetic acid<br>
containing 0.50 g of tert-butyl 2-(benzamido)-4-(4-<br>
phenylbutyl)benzoate was stirred at room temperature<br>
for 2 hours and 30 minutes. A solid substance was<br>
separated by filtration to obtain 0.16 g of 2-<br>
(benzamido)-4-(4-phenylbutyl)benzoic acid as white<br>
solid.<br>
1H-NMR (DMSO-d6) 8: 1.55-1.70 (4H, m) , 2.60-2.74 (4H, m) ,<br>
7.04 (1H, dd, J = 8.2, 1.3 Hz), 7.14-7.21 (3H, m) ,<br>
7.25-7.28 (2H, m) , 7.58-7.65 (3H, m), 7.94-7.98 (3H, m) ,<br>
8.62 (1H, d, J = 1.3 Hz), 12.22 (1H, s).<br>
[0235]<br>
Example 34<br><br>
0.082 mL of triethylamine, 44 mg of 2-furoyl<br>
chloride and 2.0 mL of methylene chloride were added to<br><br>
151<br>
1.0 mL of methylene chloride solution containing 50 mg<br>
of tert-butyl 2-amino-4-phenethylbenzoate at room<br>
temperature and stirred at the same temperature for 2<br>
hours. 380 mg of aminomethylated polystyrene was added<br>
to the reaction mixture and stirred at room temperature<br>
overnight. A saturated sodium hydrogen carbonate<br>
aqueous solution was added to the reaction mixture, the<br>
organic layer was separated, and the solvent was<br>
evaporated under reduced pressure. The obtained residue<br>
was purified with silica gel column chromatography<br>
[Flash Tube 2008 manufactured by Trikonex Company,<br>
eluent; hexane: ethyl acetate =4:1] to obtain tert-<br>
butyl 2-(furan-2-carboxamido)-4-phenethylbenzoate.<br>
2.0 mL of trifluoroacetic acid was added to<br>
the obtained tert-butyl 2-(furan-2-carboxamide)-4-<br>
phenethylbenzoate and stirred at room temperature for 1<br>
hour. The solvent was evaporated under reduced pressure<br>
and diisopropyl ether was added to the obtained residue<br>
and a solid substance was separated by filtration to<br>
obtain 32 mg of 2-(furan-2-carboxamido)-4-<br>
phenethylbenzoic acid as white solid.<br>
1H-NMR (DMSO-de) 8: 2.91-2.98 (4H, m) , 6.75 (1H, dd, J =<br>
3.4, 1.7 Hz), 7.07 (1H, dd, J = 8.2, 1.3 Hz), 7.16-7.30<br>
(6H, m), 7.95 (1H, d, J = 8.3 Hz), 8.00 (1H, s) , 8.61<br>
(1H, s), 12.19 (1H, s), 13.50-13.70 (1H, broad).<br>
[0236]<br>
Examples 35 to 54<br>
The compounds shown in Table 10 were obtained<br>
in the same manner as in Example 34.<br><br>
152<br>
[0237]<br>
[Table 10]<br><br>
[0238]<br>
2-(2, 4-Difluorobenzamido)-4-phenethylbenzoic acid<br>
1H-NMR (DMSO-de) 8: 2.90-3.00 (4H, m) , 7.10 (1H, dd, J =<br>
8.0, 1.5 Hz), 7.16-7.20 (1H, m) , 7.26-7.33 (5H, m),<br>
7.50 (1H, ddd, J = 11.4, 9.2, 2.4 Hz), 7.94 (1H, d, J =<br>
8.0 Hz), 8.01 (1H, td, J = 8.8, 6.7 Hz), 8.63 (1H, s),<br>
11.96 (1H, s), 13.54-13.64 (1H, broad).<br>
[0239]<br>
2-(Cinnamamido)-4-phenethylbenzoic acid<br><br>
153<br>
1H-NMR (DMSO-de) 6: 2.89-2.98 (4H, m) , 6.88 (1H, d, J =<br>
15.6 Hz), 7.05 (1H, dd, J = 8.3, 1.5 Hz), 7.16-7.30 (5H,<br>
m) , 7.42-47 (3H, m), 7.62 (1H, d, J = 15.6 Hz), 7.73-<br>
7.75 (2H, m), 7.91 (1H, d, J = 8.0 Hz), 8.55 (1H, s),<br>
1  11.37 (1H, s), 13.40-13.60 (1H, broad).<br>
[0240]<br>
2-(Cyclohexanecarboxamido)-4-phenethylbenzoic acid<br>
XH-NMR (DMSO-de) 8: 1.17-1.47 (5H, m) , 1.63-1.76 (3H, m) ,<br>
1.87-1.95 (2H, m), 2.25-2.35 (1H, m) , 2.86-2.92 (4H, m),<br>
I  7.00 (1H, dd, J = 8.0, 1.7 Hz), 7.16-7.29 (5H, m), 7.88<br>
(1H, d, J = 8.3 Hz), 8.49 (1H, s), 11.22 (1H, s),<br>
13.35-13.55 (1H, broad).<br>
[0241]<br>
2-(4-Fluorobenzamido)-4-phenethylbenzoic acid<br>
  1H-NMR (DMSO-dg) 5: 2.90-3.00 (4H, m) , 7.09 (1H, dd, J =<br>
8.1,	1.7 Hz), 7.16-7.20 (1H, m), 7.26-7.30 (4H, m) ,<br>
7.45 (2H, t, J = 8.9 Hz), 7.96 (1H, d, J = 8.1 Hz),<br>
8.00-8.04 (2H, m), 8.62 (1H, d, J = 1.7 Hz), 12.16 (1H,<br>
s).<br>
I  [0242]<br>
4-Phenethyl-2-(thiophene-2-carboxamido)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 2.90-2.98 (4H, m) , 7.07 (1H, dd, J =<br>
8.2,	1.6 Hz), 7.16-7.30 (6H, m), 7.74 (1H, dd, J = 3.7,<br>
1.0 Hz), 7.93-7.96 (2H, m), 8.52 (1H, s), 12.20 (1H, s) .<br>
  [0243]<br>
2-(Cyclopropanecarboxamido)-4-phenethylbenzoic acid<br>
1H-NMR (DMSO-d6) 8: 0.85-0.87 (4H, m) , 1.67-1.73 (1H, m) ,<br>
2.86-2.91 (4H, m), 7.00 (1H, dd, J = 8.2, 1.6 Hz),<br><br>
154<br>
7.15-7.29 (5H, m), 7.88 (1H, d, J = 8.2 Hz), 8.41 (1H,<br>
d, J = 1.6 Hz), 11.38 (1H, s), 13.35-13.60 (1H, broad).<br>
[0244]<br>
4-Phenethyl-2-(2-phenoxyacetamido)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 2.88-2.98 (4H, m) , 4.73 (2H, s) ,<br>
7.00-7.10 (4H, m) , 7.16-7.37 (7H, m), 7.92 (1H, d, J =<br>
8.0 Hz), 8.63 (1H, d, J = 1.7 Hz), 12.19 (1H, s),<br>
13.50-13.75 (1H, broad).<br>
[0245]<br>
4-Phenethyl-2-(pyridine-2-carboxamido)benzole acid<br>
1H-NMR (DMSO-d6) 5: 2.92-2.99 (4H, m) , 7.08-7.10 (1H, m) ,<br>
7.16-7.20 (1H, m), 7.26-7.31 (4H, m), 7.67-7.70 (1H, m) ,<br>
7.96 (1H, d, J = 8.3 Hz), 8.09 (1H, td, J = 7.7, 1.5<br>
Hz), 8.20 (1H, d, J = 7.8 Hz), 8.70-8.75 (1H, m), 8.80<br>
(1H, d, J = 1.5 Hz), 13.07 (1H, s) , 13.44 (1H, s) .<br>
[0246]<br>
4-Phenethyl-2-(pyridine-3-carboxamido)benzoic acid<br>
trifluoroacetate<br>
1H-NMR (DMSO-de) 8: 2.91-3.01 (4H, m) , 7.11 (1H, dd, J =<br>
8.3, 1.5 Hz), 7.16-7.20 (1H, m), 7.27-7.29 (4H, m),<br>
7.65 (1H, dd, J = 7.8, 4.9 Hz), 7.97 (1H, d, J = 8.3<br>
Hz), 8.30 (1H, dt, J - 8.1, 1.9 Hz), 8.60 (1H, s), 8.82<br>
(1H, dd, J = 4.9, 1.2 Hz), 9.13 (1H, d, J = 2.2 Hz),<br>
12.20 (1H, s), 13.60-13.80 (1H, broad).<br>
[0247]<br>
4-Phenethyl-2-(2,2-diphenylacetamido)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 2.86-2.93 (4H, m) , 5.28 (1H, s) ,<br>
7.02 (1H, dd, J = 8.0, 1.7 Hz), 7.15-7.40 (15H, m),<br><br>
155<br>
7.84 (1H, d, J = 8.1 Hz), 8.48 (1H, s) , 11.34 (1H, s) ,<br>
13.30-13.40 (1H, broad).<br>
[0248]<br>
2-(Benzo[1,3]dioxole-5-carboxamido)-4-phenethylbenzoic<br>
acid<br>
1H-NMR (DMSO-de) 5: 2.91-2.98 (4H, m), 6.16 (2H, s) ,<br>
7.06 (1H, dd, J = 8.1, 1.7 Hz), 7.12 (1H, d, J = 8.3<br>
Hz), 7.15-7.20 (1H, m), 7.25-7.30 (4H, m), 7.42 (1H, d,<br>
J = 2.0 Hz), 7.53 (1H, dd, J = 8.2, 1.8 Hz), 7.95 (1H,<br>
d, J = 8.1 Hz), 8.63 (1H, s), 12.06 (1H, s) .<br>
[0249]<br>
2-(Isoxazole-5-carboxamido)-4-phenethylbenzoic acid<br>
1H-NMR (DMSO-de) 5: 2.90-3.01 (4H, m) , 7.14-7.30 (7H, m) ,<br>
7.97 (1H, d, 8.1 Hz), 8.53 (1H, s), 8.86 (1H, d, J =<br>
1.5 Hz), 12.41 (1H, s).<br>
[0250]<br>
2-(Benzothiophene-3-carboxamido)-4-phenethylbenzoic<br>
acid<br>
1H-NMR (DMSO-d6) 8: 2.94-3.01 (4H, m), 7.09 (1H, dd, J =<br>
8.2, 1.6 Hz), 7.17-7.21 (1H, m), 7.28-7.30 (4H, m),<br>
7.47-7.54 (2H, m), 7.96 (1H, d, J = 8.1 Hz), 8.11-8.13<br>
(1H, m) , 8.49-8.52 (2H, m), 8.62 (1H, d, J = 1.2 Hz),<br>
12.03 (1H, s), 13.50-13.70 (1H, broad).<br>
[0251]<br>
2-(Benzofuran-2-carboxamido)-4-phenethylbenzoic acid<br>
1H-NMR (DMSO-de) 8: 2.91-3.01 (4H, m) , 7.12 (1H, dd, J =<br>
8.4, 1.6 Hz), 7.17-7.21 (1H, m), 7.26-7.29 (4H, m) ,<br>
7.40 (1H, t, J = 7.6 Hz), 7.54 (1H, t, J = 7.2 Hz),<br>
7.70 (1H, d, J = 8.5 Hz), 7.73 (1H, s), 7.85 (1H, d, J<br><br>
156<br>
= 7.8 Hz), 7.98 (1H, d, J = 8.0 Hz), 8.66 (1H, s),<br>
12.54 (1H, s).<br>
[0252]<br>
2-(2,3-Dihydrobenzo[1,4]dioxin-6-carboxamido)-4-<br>
phenethylbenzoic acid<br>
1H-NMR (DMSO-d6) 6: 2.90-2.98 (4H, m) , 4.31-4.34 (4H, m) ,<br>
7.05 (2H, d, J = 8.3 Hz), 7.16-7.20 (1H, m) , 7.25-7.30<br>
(4H, m), 7.44-7.47 (2H, m), 7.94 (1H, d, J = 8.3 Hz),<br>
8.65 (1H, d, J = 1.5 Hz), 12.12 (1H, s).<br>
[0253]<br>
2-(Benzofuran-5-carboxamido)-4-phenethylbenzoic acid<br>
1H-NMR (DMSO-de) 8: 2.93-3.00 (4H, m), 7.08 (1H, dd, J=<br>
8.1, 1.7 Hz), 7.15-7.21 (2H, m), 7.28-7.31 (4H, m),<br>
7.81 (1H, d, J = 8.8 Hz), 7.93 (1H, dd, 8.8, 1.9 Hz),<br>
7.97 (1H, d, 8.3 Hz), 8.16 (1H, d, J = 2.2 Hz), 8.30<br>
(1H, d, J = 1.7 Hz), 8.69 (1H, s), 12.27 (1H, s) .<br>
[0254]<br>
2-(2-Morpholinopyridine-5-carboxamido)-4-<br>
phenethylbenzoic acid<br>
1H-NMR (DMSO-de) 5: 2.91-2.97 (4H, m) , 3.61-3.64 (4H, m) ,<br>
3.70-3.72 (4H, m), 6.98 (1H, d, J = 9.0 Hz), 7.04 (1H,<br>
dd, J = 8.3, 1.5 Hz), 7.16-7.20 (1H, m), 7.25-7.30 (4H,<br>
m), 7.94 (1H, d, J = 8.3 Hz), 8.02 (1H, dd, J = 9.0,<br>
2.5 Hz), 8.64 (1H, d, J = 1.5 Hz), 8.72 (1H, d, J = 2.5<br>
Hz), 12.00-12.10 (1H, broad).<br>
[0255]<br>
2-(Benzothiophene-5-carboxamido)-4-phenethylbenzoic<br>
acid<br><br>
157<br>
1H-NMR (DMSO-de) 5: 2.93-3.01 (4H, m) , 7.07-7.10 (1H, m) ,<br>
7.17-7.22 (1H, m), 7.28-7.31 (4H, m), 7.64 (1H, d, J =<br>
5.6 Hz), 7.91-7.98 (3H, m), 8.24 (1H, d, J = 8.3 Hz),<br>
8.50 (1H, s), 8.70 (1H, s), 12.35 (1H, s).<br>
[0256]<br>
2-(Benzothiazole-2-carboxamido)-4-phenethylbenzoic acid<br>
1H-NMR (DMSO-de) 8: 2.91-3.05 (4H, m) , 7.15-7.31 (6H, m) ,<br>
7.62-7.71 (2H, m), 8.00 (1H, d, J = 7.8 Hz), 8.19 (1H,<br>
d, J = 7.8 Hz), 8.29 (1H, d, J = 7.8 Hz), 8.69 (1H, s),<br>
12.98 (1H, s).<br>
[0257]<br>
4-Phenethyl-2-(l-phenyl-lH-pyrazole-5-<br>
carboxamido)benzoic acid<br>
1H-NMR (DMSO-de) 8: 2.84-2.94 (4H, m), 7.05 (1H, d, J =<br>
2.0 Hz), 7.08 (1H, dd, J = 8.1, 1.7 Hz), 7.14-7.27 (5H,<br>
m), 7.43-7.50 (5H, m), 7.86 (1H, d, J = 2.2 Hz), 7.94<br>
(1H, d, J - 8.1 Hz), 8.37 (1H, s) , 12.04 (1H, s) .<br>
[0258]<br>
Example 55<br><br>
0.082 mL of triethylamine, 39 mg of<br>
benzylsulfonyl chloride and 2.0 mL of methylene<br>
chloride were added to 1.0 mL of methylene chloride<br>
solution containing 50 mg of tert-butyl 2-amino-4-<br>
phenethylbenzoate at room temperature and stirred at<br><br>
158<br>
the same temperature for 2 hours. 380 mg of<br>
aminomethylated polystyrene was added to the reaction<br>
mixture and stirred at room temperature overnight. A<br>
saturated sodium hydrogen carbonate aqueous solution<br>
was added to the reaction mixture, and the organic<br>
layer was separated, and the solvent was evaporated<br>
under reduced pressure. The obtained residue was<br>
purified with silica gel column chromatography [Flash<br>
Tube 2008 manufactured by Trikonex Company, eluent;<br>
hexane: ethyl acetate =4:1] to obtain tert-butyl 2-<br>
(benzylsulfonamido)-4-phenethylbenzoate.<br>
2.0 mL of trifluoroacetic acid was added to<br>
the obtained tert-butyl 2-(benzylsulfonamido)-4-<br>
phenethylbenzoate and stirred at room temperature for 1<br>
hour. The solvent was evaporated under reduced pressure<br>
and the obtained residue was purified with reversed-<br>
phase silica gel column chromatography [eluent; 65-100%<br>
acetonitrile /0.1% trifluoroacetic acid aqueous<br>
solution] to obtain 5.1 mg of 2-(benzylsulfonamido)-4-<br>
phenethylbenzoic acid as white solid.<br>
1H-NMR (DMSO-d6) 8: 2.86-2.95 (4H, m), 4.53 (2H, s) ,<br>
7.03 (1H, dd, J = 7.9, 1.6 Hz), 7.11-7.15 (3H, m),<br>
7.21-7.33 (8H, m), 7.88 (1H, d, J = 8.0 Hz).<br>
[0259]<br>
Examples 56, 57<br>
The compounds shown in Table 11 were obtained<br>
in the same manner as in Example 55.<br>
[0260]<br>
[Table 11]<br><br><br>
[0261]<br>
4-Phenethyl-2-(((E)-2-phenylvinyl)sulfonamido)benzoic<br>
acid<br>
1H-NMR (DMSO-de) 8: 2.76-2.80 (2H, m) , 2.90-2.94 (2H, m) ,<br>
6.94 (1H, dd, J = 8.1, 1.5 Hz), 7.09-7.19 (5H, m),<br>
7.38-7.44 (5H, m) , 7.72-7.77 (3H, m), 7.84 (1H, d, J =<br>
8.1 Hz), 11.02 (1H, s).<br>
[0262]<br>
2-(Benzenesulfonamido)-4-phenethylbenzoic acid<br>
1H-NMR (DMSO-de) 8: 2.78-2.82 (2H, m) , 2.87-2.91 (2H, m) ,<br>
6.92 (1H, d, J = 8.0 Hz), 7.12-7.18 (3H, m) , 7.22-7.26<br>
(2H, m), 7.39 (1H, s), 7.52-7.56 (2H, m), 7.64 (1H, t,<br>
7.4 Hz), 7.74-7.78 (3H, m).<br>
[0263]<br>
Example 58<br><br><br>
160<br>
0.031 mL of 2-iodotoluene, 81 g of cesium<br>
carbonate, 12 mg of tetrabutylammonium bromide and 19<br>
mg of polymer supported di(acetato)<br>
dicyclohexylphosphino palladium(II) were added to 1.0<br>
mL of toluene solution containing 40 mg of tert-butyl<br>
2-(benzamido)-4-vinylbenzoate at room temperature and<br>
stirred at 110C for 24 hours. After the reaction<br>
mixture was cooled to room temperature, ethyl acetate<br>
and 10% citric acid aqueous solution were added. The<br>
organic layer was separated, and the solvent was<br>
evaporated under reduced pressure after washed with 10%<br>
citric acid aqueous solution. 5 mL of trifluoroacetic<br>
acid was added to the obtained residue and stirred at<br>
room temperature for 1 hour. The solvent was evaporated<br>
under reduced pressure and the obtained residue was<br>
purified with reversed-phase silica gel column<br>
chromatography [eluent; 65-100% acetonitrile /0.1%<br>
trifluoroacetic acid aqueous solution] to obtain 2.8 mg<br>
of 2-(benzamido)-4-((E)-2-(2-methylphenyl)vinyl)benzoic<br>
acid as white solid.<br>
1H-NMR (DMSO-d6) 8: 2.45 (3H, s), 7.21-7.25 (4H, m),<br>
7.52-7.69 (5H, m) , 7.76-7.78 (1H, m), 7.98-8.00 (2H, m) ,<br>
8.06 (1H, d, J = 8.3 Hz), 8.94 (1H, s) , 12.27 (1H, s).<br>
[0264]<br>
Examples 59 to 66<br>
The compounds shown in Table 12 were obtained<br>
in the same manner as in Example 58.<br><br>
161<br>
[0265]<br>
[Table 12]<br><br>
[0266]<br>
2-(Benzamido)-4-((E)-2-(4-fluorophenyl)vinyl)benzoic<br>
acid<br>
1H-NMR (DMSO-de) 8: 7.23-7.42 (4H, m) , 7.48 (1H, dd, J =<br>
8.2, 1.6 Hz), 7.60-7.69 (3H, m) , 7.75-7.79 (2H, m),<br>
7.99 (2H, d, J = 6.8 Hz), 8.06 (1H, d, J = 8.3 Hz),<br>
8.93 (1H, s), 12.28 (1H, s).<br>
[0267]<br>
2-(Benzamido)-4-((E)-2-(3-fluoro-4-<br>
methylphenyl)vinyl)benzoic acid<br>
1H-NMR (DMSO-de) 8: 2.26 (3H, s), 7.29-7.69 (9H, m),<br>
7.99 (2H, d, J = 7.1 Hz), 8.06 (1H, d, J = 8.3 Hz),<br>
8.93 (1H, s), 12.27 (1H, s).<br>
[0268]<br>
2-(Benzamido)-4-((E)-2-(3-nitrophenyl)vinyl)benzoic<br>
acid<br><br>
162<br>
1H-NMR (DMSO-de) 5: 7.54-7.73 (7H, m) , 7.98-8.00 (2H, m) ,<br>
8.09 (1H, d, J = 8.3 Hz), 8.15-8.20 (2H, m), 8.56 (1H,<br>
s), 8.98 (1H, d, J = 1.5 Hz), 12.24 (1H, s) .<br>
[0269]<br>
4-((E)-2-(4-acetylphenyl)vinyl)-2-(benzamido)benzoic<br>
acid<br>
1H-NMR (DMSO-d6) 8: 2.60 (3H, s) , 7.45-7.69 (6H, m) ,<br>
7.85 (2H, d, J = 8.3 Hz), 7.98-8.00 (4H, m), 8.08 (1H,<br>
d, J = 8.3 Hz), 8.97 (1H, d, J = 1.4 Hz), 12.27 (1H, s) .<br>
[0270]<br>
2-(Benzamido)-4-((E)-2-(4-methoxyphenyl)vinyl)benzoic<br>
acid<br>
1H-NMR (DMSO-d6) 8: 3.80 (3H, s) , 6.98 (1H, d, J = 8.8<br>
Hz), 7.18-7.22 (2H, m), 7.34 (1H, d, J = 16.3 Hz), 7.44<br>
(1H, dd, J = 8.3, 1.7 Hz), 7.57-7.69 (5H, m), 7.98-8.05<br>
(3H, m), 8.91 (1H, s), 12.29 (1H, s).<br>
[0271]<br>
2-(Benzamido)-4-((E)-2-(3-methoxyphenyl)vinyl)benzoic<br>
acid<br>
1H-NMR (DMSO-de) 8: 3.82 (3H, s), 6.89-6.91 (1H, m) ,<br>
7.26-7.38 (5H, m), 7.48 (1H, dd, J = 8.4, 1.6 Hz),<br>
7.59-7.69 (3H, m), 7.98-8.00 (2H, m), 8.06 (1H, d, J =<br>
8.3 Hz), 8.94 (1H, d, J = 1.7 Hz), 12.20-12.50 (1H,<br>
broad).<br>
[0272]<br>
2-(Benzamido)-4-((E)-2-(2,3-dihydrobenzo[1,4]dioxin-6-<br>
yl)vinyl)benzoic acid<br><br>
163<br>
1H-NMR (DMSO-d6) 8: 4.27 (4H, s) , 6.88 (1H, d, J = 8.3<br>
Hz), 7.16-7.28 (4H, m), 7.42 (1H, dd, J = 8.2, 1.3 Hz),<br>
7.59-7,68 (3H, m), 7.98-8.04 (3H, m), 8.89 (1H, s).<br>
[0273]<br>
2-(Benzamido)-4-((E)-2-(4-<br>
(trifluoromethyl)phenyl)vinyl)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 7.48 (1H, d, J = 16.6 Hz), 7.53-7.69<br>
(5H, m) , 7.76 (2H, d, J = 8.0 Hz), 7.93 (2H, d, J = 8.0<br>
Hz), 7.98-8.00 (2H, m), 8.08 (1H, d, J = 8.3 Hz), 8.97<br>
(1H, d, J = 1.5 Hz) .<br>
[0274]<br>
Example 67<br><br>
0.060 mL of 3-iodoanisole, 0.16 g of cesium<br>
carbonate, 24 mg of tetrabutylammonium bromide and 39<br>
mg of polymer supported<br>
di(acetato)dicyclohexylphosphino palladium(II) were<br>
added to 2.0 mL of toluene solution containing 80 mg of<br>
tert-butyl 2-(benzamido)-4-vinylbenzoate at room<br>
temperature and stirred at 110C for 24 hours. After<br>
the reaction mixture was cooled to room temperature,<br>
ethyl acetate and 10% citric acid aqueous solution were<br>
added. The organic layer was separated, and the solvent<br>
was evaporated under reduced pressure after washed with<br>
10% citric acid aqueous solution. 10 mL of<br><br>
164<br>
trifluoroacetic acid was added to the obtained residue<br>
and stirred at room temperature for 1 hour.  The solvent<br>
was evaporated under reduced pressure and the obtained<br>
residue was purified with reversed-phase silica gel<br>
column chromatography [eluent; 60-100% acetonitrile<br>
/0.1% trifluoroacetic acid aqueous solution] to obtain<br>
2-(benzamido)-4-((E)-2-(3-methoxyphenyl)vinyl)benzoic<br>
acid.<br>
1.0 mL of methanol, 2.0 mL of ethyl acetate<br>
and 2.0 mg of 5% palladium-carbon were added to the<br>
obtained 2-(benzamido)-4-((E)-2-(3-<br>
methoxyphenyl)vinyl)benzoic acid and stirred under<br>
hydrogen atmosphere at room temperature for 2 hours.<br>
Insoluble were removed by filtration, and the solvent<br>
was evaporated under reduced pressure to obtain 6.3 mg<br>
of 2-(benzamido)-4-(2-3-methoxyphenyl)ethyl)benzoic<br>
acid as white solid.<br>
1H-NMR (DMSO-de) 8: 2.87 (4H, s) , 3.73 (3H, s) , 6.74 (1H,<br>
ddd, J = 8.2, 2.5, 1.0 Hz), 6.83-6.88 (3H, m), 7.17-<br>
7.21 (1H, m), 7.52-7.60 (3H, m), 7.92 (1H, d, J = 7.8<br>
Hz), 8.02-8.05 (2H, m), 8.61 (1H, d, J = 1.7 Hz).<br>
[0275]<br>
Examples 68 to 70<br>
The compounds shown in Table 13 were obtained<br>
in the same manner as in Example 67.<br>
[0276]<br>
[Table 13]<br><br><br>
[0277]<br>
2-(Benzamido)-4-(2-(3-fluoro-4-<br>
methylphenyl)ethyl)benzoic acid<br>
1H-NMR (DMSO-de) 8: 2.18 (3H, s) , 2.91 (4H, s) , 6.96-<br>
7.00 (2H, m), 7.05 (1H, d, J = 11.0 Hz), 7.17 (1H, t, J<br>
= 7.9 Hz), 7.55-7.63 (3H, m), 7.94 (1H, d, J = 8.0 Hz),<br>
8.00 (2H, d, J = 6.8 Hz), 8.62 (1H, s).<br>
[0278]<br>
2-(Benzamido)-4-(2-(4-ethylphenyl)ethyl)benzoic acid<br>
1H-NMR (DMSO-de) 8: 1.15 (3H, t, J = 7.6 Hz), 2.56 (2H,<br>
q, J = 7.6 Hz), 2.86-2.96 (4H, m), 7.05 (1H, d, J = 8.3<br>
Hz), 7.12 (2H, d, J = 7.9 Hz), 7.18 (2H, d, J = 8.0 Hz),<br>
7.57-7.66 (3H, m), 7.95-7.99 (3H, m), 8.67 (1H, s),<br>
12.65-12.95 (1H, broad).<br>
[0279]<br>
2-(Benzamido)-4-(2-(2-methylphenyl)ethyl)benzoic acid<br>
1H-NMR (DMSO-de) 8: 2.31 (3H, s) , 2.89 (4H, s) , 7.05-<br>
7.21 (5H, m), 7.57-7.66 (3H, m), 7.97-7.99 (3H, m),<br>
8.69 (1H, d, J = 1.5 Hz), 12.55-12.85 (1H, broad).<br><br><br>
0.087 mL of 4-bromobenzotrifluoride, 0.20 g<br>
of cesium carbonate, 30 mg of tetrabutylammonium<br>
bromide and 4 9 mg of polymer supported<br>
di(acetato)dicyclohexylphosphino palladium(II) were<br>
added to 2.0 mL of toluene solution containing 100 mg<br>
of tert-butyl 2-(benzamido)-4-vinylbenzoate at room<br>
temperature and stirred at 110C for 48 hours. After<br>
the reaction mixture was cooled to room temperature,<br>
ethyl acetate and 10% citric acid aqueous solution were<br>
added. The organic layer was separated, and the solvent<br>
was evaporated under reduced pressure after washed with<br>
10% citric acid aqueous solution. 2.4 mL of<br>
tetrahydrofuran, 0.6 mL of water, 0.42 g of sodium<br>
formate, 0.44 mL of acetic acid and 50 mg of 3.9%<br>
palladium-carbon (ethylenediamine complex) were added<br>
to the obtained residue and stirred at 50C for 12 hours.<br>
The reaction mixture was cooled to room temperature and<br>
ethyl acetate and 10% citric acid aqueous solution were<br>
added. The organic layer was separated and the solvent<br>
was evaporated under reduced pressure. 10 mL of<br>
trifluoroacetic acid was added to the obtained residue<br>
and stirred at room temperature for 1 hour. The solvent<br><br>
167<br>
was evaporated under reduced pressure and the obtained<br>
residue was purified with reversed-phase silica gel<br>
column chromatography [eluent; 60-100% acetonitrile<br>
/0.1% trifluoroacetic acid aqueous solution] to obtain<br>
21 mg of 2-(benzamido)-4-(2-(4-<br>
(trifluoromethyl)phenyl)ethyl)benzoic acid as white<br>
solid.<br>
1H-NMR (DMSO-d6) 8: 3.00-3.06 (4H, m), 7.09 (1H, dd, J=<br>
8.1, 1.5 Hz), 7.50 (2H, d, J = 8.1 Hz), 7.58-7.67 (5H,<br>
m), 7.95-7.98 (3H, m), 8.66 (1H, s), 12.24 (1H, s).<br>
[0281]<br>
Example 72<br><br>
The following compound was obtained in the<br>
same manner as in Example 71.<br>
2-(Benzamido)-4-(2-(4-fluorophenyl)ethyl)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 2.91-2.98 (4H, m) , 7.06-7.12 (3H, m) ,<br>
7.28-7.31 (2H, m) , 7.58-7.67 (3H, m), 7.96 (3H, d, J =<br>
7.8 Hz), 8.66 (1H, d, J = 1.2 Hz), 12.21 (1H, s).<br>
[0282]<br>
Example 73<br><br><br>
168<br>
0.35 g of potassium permanganate was added to<br>
a suspension of 7 mL of pyridine and 7 mL of water<br>
containing 0.70 g of N-((5-benzoyl-2-<br>
methyl)phenyl)benzamide at room temperature, and the<br>
resulting mixture was heated to reflux for 30 minutes.<br>
After the reaction mixture was cooled to room<br>
temperature, 0.35 g of potassium permanganate was added<br>
and the resulting mixture was heated to reflux for 30<br>
minutes. After the reaction mixture was cooled to room<br>
temperature, 0.35 g of potassium permanganate was added<br>
and the resulting mixture was heated to reflux for 30<br>
minutes. Ethyl acetate was added after the reaction<br>
mixture was cooled and pH was adjusted to pH 1.3 with<br>
6.0 mol/L hydrochloric acid. Insoluble were removed by<br>
filtration. The organic layer was separated and dried<br>
over anhydrous magnesium sulfate after washed with 1.0<br>
mol/L hydrochloric acid and a saturated sodium chloride<br>
aqueous solution sequentially, and the solvent was<br>
evaporated under reduced pressure. Hexane and<br>
diisopropyl ether were added to the obtained residue<br>
and a solid substance was separated by filtration to<br>
obtain 0.42 g of 2-(benzamido)-4-benzoylbenzoic acid as<br>
white solid.<br>
1H-NMR (DMSO-de) 8: 7.52-7.83 {9H, m) , 7.95-7.97 (2H, m) ,<br>
8.21 (1H, d, J = 8.3 Hz), 9.05 (1H, d, J = 1.7 Hz),<br>
12.20 (1H, s).<br>
30 mg of 5% palladium-carbon was added to a<br>
mixed solution of 1.5 mL of methanol and 2 mL of ethyl<br>
acetate containing the obtained 0.15 g of 2-<br><br>
169<br>
(benzamido)-4-benzoylbenzoic acid and stirred under<br>
hydrogen atmosphere at room temperature for ten hours.<br>
Insoluble were removed by filtration and the solvent<br>
was evaporated under reduced pressure. Hexane was added<br>
to the obtained residue and a solid substance was<br>
separated by filtration to obtain 0.11 g of 2-<br>
(benzamido)-4-benzylbenzoic acid as white solid.<br>
1H-NMR (DMSO-de) 8: 4.03 (2H, s), 7.07 (1H, dd, J= 8.1,<br>
1.4 Hz), 7.20-7.34 (5H, m), 7.57-7.66 (3H, m), 7.93-<br>
7.95 (2H, m), 7.98 (1H, d, J = 8.1 Hz), 8.66 (1H, d, J<br>
=1.4 Hz), 12.36 (1H, s).<br>
[0283]<br>
Example 74<br><br>
0.056 mL of triethylamine and 0.029 mL of 3-<br>
bromobenzoyl chloride were added to 3.0 mL of methylene<br>
chloride solution containing 57 mg of tert-butyl 2-<br>
amino-4-phenoxybenzoate at room temperature<br>
sequentially and stirred at the same temperature for 1<br>
hour. A saturated sodium hydrogen carbonate aqueous<br>
solution was added to the reaction mixture. The organic<br>
layer was separated and the solvent was evaporated<br>
under reduced pressure. The obtained residue was<br>
purified with silica gel column chromatography [Flash<br>
Tube 2008 manufactured by Trikonex Company, eluent;<br><br>
170<br>
hexane: ethyl acetate =4:1] to obtain tert-butyl 2-(3-<br>
bromobenzamido)-4-phenoxybenzoate.<br>
5 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 2-(3-bromobenzamido)-4-<br>
phenoxybenzoate and stirred at room temperature for 5<br>
minutes. The solvent was evaporated under reduced<br>
pressure and diisopropyl ether was added to the<br>
obtained residue and a solid substance was separated by<br>
filtration to obtain 31 mg of 2-(3-bromobenzamido)-4-<br>
phenoxybenzoic acid as white solid.<br>
1H-NMR (DMSO-de) 8: 6.79 (1H, dd, J = 8.9, 2.5 Hz),<br>
7.15-7.22 (2H, m) , 7.26-7.32 (1H, m) , 7.46-7.53 (2H, m) ,<br>
7.56 (1H, t, J = 7.9 Hz), 7.83-7.88 (1H, m) , 7.88-7.92<br>
(1H, m) , 8.05-8.10 (2H, m), 8.33 (1H, d, J = 2.5 Hz),<br>
12.44 (1H, s), 13.70-13.90 (1H, broad).<br>
[0284]<br>
Example 75<br><br>
1.5 mL of toluene suspension containing 0.15<br>
g of methyl 2-(benzamido)-4-ethynylbenzoate, 0.090 mL<br>
of iodinated benzene, 5 mg of copper(I) iodide, 20 mg<br>
of bis(triphenylphosphine)palladium(II) chloride and<br>
0.15 mL of triethylamine was stirred under nitrogen<br>
atmosphere at room temperature for 2 hours. Ethyl<br>
acetate and 1.0 mol/L hydrochloric acid were added to<br>
the reaction mixture. The organic layer was separated<br><br>
171<br>
and dried over anhydrous magnesium sulfate after washed<br>
with a saturated sodium chloride aqueous solution, and<br>
the solvent was evaporated under reduced pressure. The<br>
obtained residue was purified with silica gel column<br>
chromatography [eluent; hexane: ethyl acetate =8:1] to<br>
obtain 0.13 g of methyl 2-(benzamido)-4-<br>
(phenylethynyl)benzoate as white solid.<br>
1H-NMR (CDC13) 8: 3.98 (3H, s), 7.27 (1H, dd, J = 8.2,<br>
1.6 Hz), 7.37-7.39 (3H, m) , 7.52-7.58 (5H, m), 8.05-<br>
8.08 (3H, m), 9.16 (1H, d, J = 1.6 Hz), 12.07 (1H, s).<br>
[0285]<br>
Example 76<br><br>
0.24 mL of 2.0 mol/L aqueous sodium hydroxide<br>
was added dropwise to a mixed solution of 1 mL of<br>
methanol and 2 mL of tetrahydrofuran containing 0.13 g<br>
of methyl 2-(benzamido)-4-(phenylethynyl)benzoate at<br>
room temperature and stirred at the same temperature<br>
for 1 hour and 30 minutes. The solvent was evaporated<br>
under reduced pressure and water was added and pH was<br>
adjusted to pH 4.0 while ice-cooled with 1.0 mol/L<br>
hydrochloric acid. A solid substance was separated by<br>
filtration to obtain 0.11 g of 2-(benzamido)-4-<br>
(phenylethynyl)benzoic acid as white solid.<br><br>
172<br>
1H-NMR (DMSO-d6) S: 7.27 (1H, dd, J = 8.0, 1.6 Hz),<br>
7.45-7.46 (3H, m), 7.56-7.63 (5H, m), 8.03 (2H, d, J =<br>
6.8 Hz), 8.09 (1H, d, J = 8.0 Hz), 8.89 (1H, d, J = 1.6<br>
Hz), 14.30-14.50 (1H, broad).<br>
[0286]<br>
Example 77<br><br>
2.6 g potassium permanganate was added to a<br>
suspension of 8 mL of tert-butyl alcohol and 8 mL of<br>
water containing 1.7 g of N-((2-methyl-5-<br>
I phenoxy)phenyl)benzamide and 2.0 g of anhydrous<br>
magnesium sulfate at room temperature, and the<br>
resulting mixture was heated to reflux for 5 hours.<br>
After the reaction mixture was cooled to room<br>
temperature, 0.86 g of potassium permanganate and 0.66<br>
g of anhydrous magnesium sulfate were added and the<br>
resulting mixture was heated to reflux for 2 hours.<br>
After the reaction mixture was cooled to room<br>
temperature, ethyl acetate and 1.0 mol/L hydrochloric<br>
acid were added and insoluble were removed by<br>
filtration. The organic layer was separated and dried<br>
over anhydrous magnesium sulfate after washed with 1.0<br>
mol/L hydrochloric acid and a saturated sodium chloride<br>
aqueous solution sequentially, and the solvent was<br>
evaporated under reduced pressure. The obtained residue<br>
was purified with silica gel column chromatography<br><br>
173<br>
[eluent; hexane: ethyl acetate =2:1] to obtain 0.30 g<br>
of 2-(benzamido)-4-phenoxybenzoic acid as white solid.<br>
1H-NMR (CDC13) 5: 6.71 (1H, dd, J = 9.0, 2.5 Hz), 7.13-<br>
7.15 (2H, m), 7.21-7.25 (1H, m), 7.41-7.58 (5H, m),<br>
7.98-8.00 (2H, m), 8.12 (1H, d, J = 9.0 Hz), 8.63 (1H,<br>
d, J = 2.5 Hz), 11.94 (1H, s) .<br>
[0287]<br>
Example 78<br><br>
0.029 mL of 2-phenoxyacetyl chloride was<br>
added to 2.5 mL of methylene chloride solution<br>
containing 40 mg of tert-butyl 2-amino-4-<br>
phenoxybenzoate and 0.039 mL of triethylamine at room<br>
temperature and stirred at the same temperature for 2<br>
hours. 0.25 g of aminomethylated polystyrene was added<br>
to the reaction mixture and after stirred at the same<br>
temperature overnight, 5 mL of 10% citric acid aqueous<br>
solution was added. The organic layer was separated and<br>
the solvent was evaporated under reduced pressure. The<br>
obtained residue was purified with silica gel column<br>
chromatography [Flash Tube 2008 manufactured by<br>
Trikonex Company, eluent; hexane: ethyl acetate: acetic<br>
acid = 20:5:1] to obtain tert-butyl 4-phenoxy-2-(2-<br>
phenoxyacetamido)benzoate.<br><br>
174<br>
3 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 4-phenoxy-2-(2-<br>
phenoxyacetamido)benzoate and stirred at room<br>
temperature for 1 hour. The solvent was evaporated<br>
under reduced pressure and diisopropyl ether was added<br>
to the obtained residue and a solid substance was<br>
separated by filtration to obtain 38 mg of 4-phenoxy-2-<br>
2-phenoxyacetamido)benzoic acid as white solid.<br>
1H-NMR (DMSO-de) 5: 4.70 (2H, s), 6.74 (1H, dd, J= 9.0,<br>
2.5 Hz), 7.01 (1H, t, J = 7.4 Hz), 7.08 (2H, d, J = 8.1<br>
Hz), 7.16 (2H, d, J = 7.8 Hz), 7.27 (1H, t, J = 7.9 Hz),<br>
7.35 (2H, t, J = 7.9 Hz), 7.47 (2H, t, J = 7.9 Hz),<br>
8.03 (1H, d, J = 9.0 Hz), 8.37 (1H, d, J = 2.5 Hz),<br>
12.32 (1H, s), 13.63 (1H, s).<br>
[0288]<br>
Examples 79 to 97<br>
The compounds shown in Table 14 were obtained<br>
in the same manner as in Example 78.<br>
[Table 14]<br><br><br>
[0289]<br>
4-Phenoxy-2-(pyridine-3-carboxamido)benzoic acid<br>
1H-NMR (DMSO-de) 5: 6.81 (1H, dd, J = 8.8, 2.4 Hz), 7.18<br>
(2H, d, J = 7.8 Hz), 7.29 (1H, t, J = 7.5 Hz), 7.48-<br>
7.51 (2H, m), 7.63 (1H, dd, J = 8.0, 4.9 Hz), 8.08 (1H,<br>
d, J = 8.8 Hz), 8.25 (1H, d, J = 8.0 Hz), 8.34 (1H, d,<br>
J = 2.4 Hz), 8.81 (1H, d, J = 4.9 Hz), 9.08 (1H, d, J =<br>
1.5 Hz), 12.52 (1H, s).<br>
[0290]<br>
2-(Benzo[1,3]dioxole-5-carboxamido)-4-phenoxybenzoic<br>
acid<br><br>
176<br>
1H-NMR (DMSO-d6) 8: 6.15 (2H, s) , 6.76 (1H, dd, J = 8.8,<br>
2.4 Hz), 7.10 (1H, d, J = 8.1 Hz), 7.17 (2H, d, J = 7.8<br>
Hz), 7.28 (1H, t, J = 7.4 Hz), 7.38 (1H, d, J = 1.7 Hz),<br>
7.47-7.50 (3H, m), 8.06 (1H, d, J = 8.8 Hz), 8.36 (1H,<br>
d, J = 2.4 Hz), 12.33 (1H, s), 13.55-13.80 (1H, broad).<br>
[0291]<br>
2-(Isoxazole-5-carboxamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-de) 5: 6.83 (1H, dd, J = 8.9, 2.5 Hz), 7.19<br>
(2H, d, J = 7.8 Hz), 7.22 (1H, t, J = 1.0), 7.28-7.31<br>
(1H, m) , 7.47-7.51 (2H, m), 8.08 (1H, d, J = 8.9 Hz),<br>
8.27 (1H, d, J = 2.5 Hz), 8.86 (1H, t, J = 1.0), 12.63<br>
(1H, s) .<br>
[0292]<br>
4-Phenoxy-2-(2-phenylthiazole-4-carboxamido)benzoic<br>
acid<br>
1H-NMR (DMSO-d6) 8: 6.78 (1H, dd, J = 8.9, 2.6 Hz), 7.20<br>
(2H, d, J = 7.8 Hz), 7.29 (1H, t, J = 7.4 Hz), 7.50 (2H,<br>
t, J = 7.9 Hz), 7.56-7.57 (3H, m), 8.09 (1H, d, J = 8.8<br>
Hz), 8.11-8.13 (2H, m), 8.52-8.53 (2H, m) , 13.08 (1H,<br>
s), 13.69 (1H, s).<br>
[0293]<br>
2-(2,3-Dihydrobenzo[1,4]dioxin-6-carboxamido)-4-<br>
phenoxybenzoic acid<br>
1H-NMR (DMSO-d6) 8: 4.30-4.34 (4H, m), 6.75 (1H, dd, J=<br>
8.8, 2.6 Hz), 7.04 (1H, d, J = 8.3 Hz), 7.17 (2H, d, J<br>
= 7.8 Hz), 7.28 (1H, t, J = 7.4 Hz), 7.39-7.43 (2H, m) ,<br>
7.48 (2H, d, J = 7.9 Hz), 8.06 (1H, d, J = 8.8 Hz),<br>
8.38 (1H, d, J = 2.6 Hz), 12.31 (1H, s), 13.65 (1H, s).<br><br>
177<br>
[0294]<br>
2-(Benzothiophene-3-carboxamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.77 (1H, dd, J = 8.8, 2.7 Hz), 7.20<br>
(2H, d, J = 8.0 Hz), 7.29 (1H, t, J = 7.4 Hz), 7.45-<br>
7.52 (4H, m), 8.08 (1H, d, J = 8.8 Hz), 8.10-8.12 (1H,<br>
m) , 8.38 (1H, d, J = 2.7 Hz), 8.41-8.43 (1H, m), 8.51<br>
(1H, s), 12.25 (1H, s), 13.64 (1H, s).<br>
[0295]<br>
2-(Cyclohexanecarboxamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-de) 8: 1.14-1.42 (5H, m) , 1.61-1.74 (3H, m) ,<br>
1.86-1.88 (2H, m), 2.23-2.30 (1H, m), 6.69 (1H, dd, J=<br>
8.8, 2.6 Hz), 7.12-7.14 (2H, m), 7.26 (1H, t, J = 7.5<br>
Hz), 7.46 (2H, t, J = 7.5 Hz), 8.00 (1H, d, J = 8.8 Hz),<br>
8.24 (1H, d, J = 2.6 Hz), 11.43 (1H, s) , 13.47 (1H, s) .<br>
[0296]<br>
4-Phenoxy-2-(thiophene-2-carboxamido)benzoic acid<br>
1H-NMR (DMSO-de) 8: 6.76 (1H, dd, J = 8.8, 2.6 Hz), 7.17<br>
(2H, d, J = 8.1 Hz), 7.26-7.30 (2H, m) , 7.47-7.51 (2H,<br>
m), 7.72 (1H, d, J = 3.6 Hz), 7.94 (1H, d, J = 4.9 Hz),<br>
8.06 (1H, d, J = 8.8 Hz), 8.26 (1H, d, J = 2.6 Hz).<br>
[0297]<br>
2-(Benzylsulfonamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-d6) 8: 4.65 (2H, s) , 6.66 (1H, dd, J = 8.9,<br>
2.3 Hz), 7.09 (1H, d, J = 2.3 Hz), 7.18 (4H, d, J = 7.6<br>
Hz), 7.28-7.33 (4H, m), 7.50 (2H, m), 7.97 (1H, d, J =<br>
8.8 Hz), 10.87 (1H, s).<br>
[0298]<br>
2-(Benzenesulfonamido)-4-phenoxybenzoic acid<br><br>
178<br>
1H-NMR (DMSO-de) 5: 6.70 (1H, dd, J = 8.8, 2.4 Hz), 6.86<br>
(1H, d, J = 2.4 Hz), 7.05-7.07 (2H, m), 7.34 (1H, t, J<br>
= 7.5 Hz), 7.50-7.60 (4H, m), 7.63-7.70 (3H, m), 7.90<br>
(1H, d, J = 8.9 Hz).<br>
[0299]<br>
2-(4-Fluorobenzamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-de) 8: 6.78 (1H, dd, J = 8.8, 2.5 Hz), 7.18<br>
(2H, d, J = 7.6 Hz), 7.28 (1H, t, J = 7.2 Hz), 7.41-<br>
7.51 (4H, m), 7.96-8.00 (2H, m), 8.07 (1H, d, J = 8.8<br>
Hz), 8.37 (1H, d, J = 2.5 Hz), 12.39 (1H, s).<br>
[0300]<br>
2-(2,4-Difluorobenzamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-de) 8: 6.79 (1H, dd, J = 8.8, 2.6 Hz),<br>
7.17-7.19 (2H, m) , 7.26-7.31 (2H, m), 7.47-7.53 (3H, m) ,<br>
7.97 (1H, td, J = 8.8, 6.6 Hz), 8.06 (1H, d, J = 8.8<br>
Hz), 8.39 (1H, d, J  2.6 Hz), 12.16 (1H, s).<br>
[0301]<br>
2-(Cinnamamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-de) 8: 6.74 (1H, dd, J = 8.8, 2.4 Hz), 6.85<br>
(1H, d, J = 15.5 Hz), 7.17 (2H, d, J = 7.6 Hz), 7.28<br>
(1H, t, J = 7.6 Hz), 7.42-7.51 (5H, m), 7.60 (1H, d, J<br>
= 15.5 Hz), 7.72-7.74 (2H, m) , 8.03 (1H, d, J = 8.8 Hz),<br>
8.35 (1H, d, J = 2.4 Hz), 11.57 (1H, s).<br>
[0302]<br>
2-(Cyclopropanecarboxamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-de) 8: 0.82-0.87 (4H, m) , 1.64-1.70 (1H, m) ,<br>
6.70 (1H, dd, J = 8.8, 2.6 Hz), 7.12 (2H, d, J = 8.3<br>
Hz), 7.25 (1H, t, J = 7.5 Hz), 7.46 (2H, t, J = 7.9 Hz),<br><br>
179<br>
8.00 (1H, d, J = 8.8 Hz), 8.17 (1H, d, J = 2.6 Hz),<br>
11.63 (1H, s).<br>
[0303]<br>
2-(l-Methyl-lH-pyrrole-2-carboxamido)-4-phenoxybenzoic<br>
acid<br>
1H-NMR (DMSO-d6) 5: 3.86 (3H, s), 6.15 (1H, dd, J= 4.0,<br>
2.7 Hz), 6.68 (1H, dd, J = 8.9, 2.5 Hz), 6.83 (1H, dd,<br>
J = 4.0, 1.6 Hz), 7.08 (1H, s), 7.16 (2H, d, J = 7.6<br>
Hz), 7.26 (1H, t, J = 7.3 Hz), 7.48 (2H, t, J = 7.9 Hz),<br>
8.03	(1H, d, J = 8.9 Hz), 8.33 (1H, d, J = 2.5 Hz),<br>
12.10 (1H, s).<br>
[0304]<br>
2-(Benzofuran-2-carboxamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-d6) 5: 6.80 (1H, dd, J = 8.8, 2.4 Hz), 7.19<br>
(2H, d, J = 7.6 Hz), 7.29 (1H, t, J = 7.4 Hz), 7.39 (1H,<br>
t, J = 7.5 Hz), 7.48-7.56 (3H, m), 7.67-7.71 (2H, m),<br>
7.83 (1H, d, J = 7.8 Hz), 8.09 (1H, d, J = 8.8 Hz),<br>
8.39 (1H, d, J = 2.4 Hz), 12.74 (1H, s).<br>
[0305]<br>
2-(l-Methyl-lH-benzotriazole-5-carboxamido)-4-<br>
phenoxybenzoic acid<br>
1H-NMR (DMSO-d6) 8: 4.37 (3H, s), 6.81 (1H, dd, J = 8.8,<br>
2.4	Hz), 7.19 (2H, d, J = 7.6 Hz), 7.29 (1H, t, J = 7.7<br>
Hz), 7.50 (2H, t, J = 7.9 Hz), 8.03-8.10 (3H, m), 8.40<br>
(1H, d, J = 2.4 Hz), 8.59 (1H, s) .<br>
[0306]<br>
2-(Benzofuran-5-carboxamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.73-6.77 (1H, m) , 7.08-7.29 (4H, m) ,<br>
7.49 (2H, t, J = 7.9 Hz), 7.78 (1H, d, J = 8.6 Hz),<br><br>
180<br>
7.90 (1H, d, J = 7.9 Hz), 8.08 (1H, d, J = 8.8 Hz),<br>
8.14 (1H, d, J = 2.2 Hz), 8.27 (1H, s), 8.43 (1H, d, J<br>
= 2.2 Hz).<br>
[0307]<br>
2-(Benzothiazole-2-carboxamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-de) 8: 6.85 (1H, dd, J = 8.9, 2.5 Hz), 7.21<br>
(2H, d, J = 7.6 Hz), 7.30 (1H, t, J = 7.4 Hz), 7.51 (2H,<br>
t, J - 7.9 Hz), 7.61-7.70 (2H, m), 8.10 (1H, d, J = 8.9<br>
Hz), 8.18 (1H, d, J = 7.6 Hz), 8.28 (1H, d, J = 7.6 Hz),<br>
8.38 (1H, d, J = 2.5 Hz), 13.15 (1H, s), 13.71 (1H, s) .<br>
[0308]<br>
Example 98<br><br>
82 mg of potassium carbonate and 0.047 mL of<br>
benzyl bromide were added to 1 mL of N,N-<br>
dimethylformamide solution containing 80 mg of methyl<br>
2-(benzamido)-4-hydroxybenzoate at room temperature and<br>
stirred at the same temperature for 3 hours. Ethyl<br>
acetate and 1.0 mol/L hydrochloric acid were added to<br>
the reaction mixture. The organic layer was separated<br>
and dried over anhydrous magnesium sulfate after washed<br>
with a saturated sodium hydrogen carbonate aqueous<br>
solution and a saturated sodium chloride aqueous<br>
solution sequentially, and the solvent was evaporated<br>
under reduced pressure. Hexane was added to the<br>
obtained residue and a solid substance was separated by<br><br>
181<br>
filtration to obtain 75 mg of methyl 2-(benzamido)-4-<br>
(benzyloxy)benzoate as white solid.<br>
1H-NMR (CDC13) 8: 3.93 (3H, s) , 5.20 (2H, s) , 6.72 (1H,<br>
dd, J = 9.0, 2.5 Hz), 7.32-7.36 (1H, m), 7.39-7.42 (2H,<br>
m), 7.47-7.49 (2H, m) , 7.51-7.57 (3H, m), 8.02 (1H, d,<br>
J = 9.0 Hz), 8.05-8.08 (2H, m), 8.76 (1H, d, J = 2.5<br>
Hz), 12.26 (1H, s).<br>
[0309]<br>
Example 99<br><br>
0.11 mL of 2.0 mol/L aqueous sodium hydroxide<br>
was added dropwise to a mixed solution of 1 mL of<br>
methanol and 2 mL of tetrahydrofuran containing 70 mg<br>
of methyl 2-(benzamido)-4-(benzyloxy)benzoate at room<br>
temperature, and stirred at the same temperature for 6<br>
hours and 30 minutes, at 40C for 1 hour and 30 minutes<br>
and at 50C for 2 hours. After the reaction mixture was<br>
cooled to room temperature, the solvent was evaporated<br>
under reduced pressure and water and diethyl ether were<br>
added. The aqueous layer was separated and pH was<br>
adjusted to pH 4.0 with 1.0 mol/L hydrochloric acid. A<br>
solid substance was separated by filtration to obtain<br>
35 mg of 2-(benzamido)-4-(benzyloxy)benzoic acid as<br>
white solid.<br>
1H-NMR (DMSO-d6) 5: 5.22 (2H, s), 6.86 (1H, dd, J = 8.9,<br>
2.7 Hz), 7.34-7.38 (1H, m), 7.40-7.44 (2H, m) , 7.49-<br><br>
182<br>
7.51 (2H, m), 7.58-7.68 (3H, m), 7.95-7.97 (2H, m),<br>
8.02 (1H, d, J = 8.9 Hz), 8.52 (1H, d, J = 2.7 Hz),<br>
12.45 (1H, s), 13.30-13.70 (1H, broad).<br>
[0310]<br>
Example 100<br><br>
0.13 g of potassium carbonate and 0.10 mL of<br>
(2-bromoethyl)benzene were added to 2 mL of N-<br>
dimethylformamide solution containing 0.13 g of methyl<br>
2-(benzamido)-4-hydroxybenzoate, and stirred at room<br>
temperature for 3 hours. 0.10 mL of (2-<br>
bromoethyl)benzene was added to the reaction mixture<br>
and stirred at 50C for 4 hours and at 80C for 3 hours.<br>
After the reaction mixture was cooled to room<br>
temperature, 0.10 g of potassium carbonate and 0.10 mL<br>
of (2-bromoethyl)benzene were added and stirred at 80C<br>
for 2 hours and 30 minutes. After the reaction mixture<br>
was cooled to room temperature, ethyl acetate and 1.0<br>
mol/L hydrochloric acid were added. The organic layer<br>
was separated and dried over anhydrous magnesium<br>
sulfate after washed with a saturated sodium chloride<br>
aqueous solution, and the solvent was evaporated under<br>
reduced pressure. The obtained residue was purified<br>
with silica gel column chromatography [eluent; hexane:<br>
ethyl acetate =8:1] to obtain 0.19 g of methyl 2-<br>
(benzamido)-4-(phenethyloxy)benzoate as colorless oil.<br><br>
183<br>
1H-NMR (CDCI3) S: 3.14 (2H, t, J= 7.1 Hz), 3.93 (3H, s) ,<br>
4.31 (2H, t, J = 7.1 Hz), 6.64 (1H, dd, J = 9.0, 2.5<br>
Hz), 7.23-7.35 (5H, m), 7.50-7.56 (3H, m), 7.99 (1H, d,<br>
J = 9.0 Hz), 8.04-8.07 (2H, m), 8.63 (1H, d, J = 2.5<br>
Hz), 12.24 (1H, s).<br>
[0311]<br>
Example 101<br><br>
0.30 mL of 2.0 mol/L aqueous sodium hydroxide<br>
was added dropwise to a mixed solution of 2 mL of<br>
methanol and 2 mL of tetrahydrofuran containing 0.19 g<br>
of methyl 2-(benzamido)-4-(phenethyloxy)benzoate while<br>
ice-cooled, and stirred at room temperature for 14<br>
hours and 30 minutes. The solvent was evaporated under<br>
reduced pressure and ethyl acetate and 1.0 mol/L<br>
hydrochloric acid were added. The organic layer was<br>
separated, the solvent was evaporated under reduced<br>
pressure and the residue was purified with silica gel<br>
column chromatography [eluent; hexane: ethyl acetate =<br>
2:1] to obtain 85 mg of 2-(benzamido)-4-<br>
(phenethyloxy)benzoic acid as white solid.<br>
1H-NMR (DMSO-de) 5: 3.09 (2H, t, J = 6.8 Hz), 4.29 (2H,<br>
t, J = 6.8 Hz), 6.78 (1H, dd, J = 8.9, 2.5 Hz), 7.22-<br>
7.26 (1H, m), 7.31-7.38 (4H, m), 7.58-7.68 (3H, m) ,<br>
7.94-7.96 (2H, m), 8.00 (1H, d, J = 8.9 Hz), 8.42 (1H,<br>
d, J = 2.5 Hz), 12.44 (1H, s).<br><br><br>
184<br>
[0312]<br>
Example 102<br>
0.28 mL of 40% diisopropyl azodicarboxylate /<br>
toluene was added dropwise to 1 mL of tetrahydrofuran<br>
solution containing 0.10 g of methyl 2-(benzamido)-4-<br>
hydroxybenzoate, 0.060 mL of 3-phenyl-l-propanol and<br>
0.15 g of triphenylphosphine at room temperature, and<br>
stirred at the same temperature for 2 hours and 30<br>
minutes. The solvent was evaporated under reduced<br>
pressure, and the obtained residue was purified with<br>
silica gel column chromatography [eluent; hexane: ethyl<br>
acetate = 10:1] to obtain 45 mg of methyl 2-<br>
(benzamido)-4-(3-phenylpropoxy)benzoate as white solid.<br>
1H-NMR (CDC13) 8: 2.11-2.18 (2H, m), 2.83 (2H, t, J =<br>
7.7 Hz), 3.94 (3H, s), 4.12 (2H, t, J = 6.2 Hz), 6.65<br>
(1H, dd, J= 9.0, 2.7 Hz), 7.18-7.31 (5H, m), 7.51-7.57<br>
(3H, m), 8.01 (1H, d, J = 9.0 Hz), 8.05-8.07 (2H, m) ,<br>
8.62 (1H, d, J = 2.7 Hz), 12.24 (1H, s).<br>
[0313]<br>
Example 103<br><br><br>
185<br>
0.090 mL of 2.0 mol/L aqueous sodium<br>
hydroxide was added dropwise to a mixed solution of 1<br>
mL of methanol and 1 mL of tetrahydrofuran containing<br>
45 mg of methyl 2-(benzamido)-4-(3-<br>
phenylpropoxy)benzoate while ice-cooled and stirred at<br>
room temperature for 14 hours and 30 minutes. 0.15 mL<br>
of 2.0 mol/L aqueous sodium hydroxide was added<br>
dropwise and stirred at the same temperature for 5<br>
hours and 30 minutes. The solvent was evaporated under<br>
reduced pressure and water was added and pH was<br>
adjusted to pH 4.0 with 1.0 mol/L hydrochloric acid. A<br>
solid substance was separated by filtration to obtain<br>
32 mg of 2-(benzamido)-4-(3-phenylpropoxy)benzoic acid<br>
as white solid.<br>
1H-NMR (DMSO-de) 5: 2.01-2.08 (2H, m), 2.77 (2H, t, J =<br>
7.7 Hz), 3.99 (2H, t, J = 6.2 Hz), 6.56 (1H, dd, J =<br>
8.6, 2.5 Hz), 7.17-7.21 (1H, m), 7.24-7.31 (4H, m) ,<br>
7.51-7.60 (3H, m), 7.94 (1H, d, J = 8.6 Hz), 8.03-8.05<br>
(2H, m), 8.34 (1H, d, J = 2.5 Hz).<br>
I  [0314]<br>
Example 104<br><br>
0.20 mL of 40% diisopropyl azodicarboxylate /<br>
toluene was added dropwise to 1 mL of tetrahydrofuran<br>
solution containing 90 mg of methyl 2-(benzamido)-4-<br>
hydroxybenzoate, 0.035 mL of cyclohexanol and 0.10 g of<br><br>
186<br>
triphenylphosphine at room temperature, and stirred at<br>
the same temperature for 5 hours. Ethyl acetate and 1.0<br>
mol/L hydrochloric acid were added to the reaction<br>
mixture. The organic layer was separated and dried over<br>
anhydrous magnesium sulfate after washed with saturated<br>
sodium hydrogen carbonate aqueous solution and<br>
saturated sodium chloride aqueous solution sequentially,<br>
and the solvent was evaporated under reduced pressure.<br>
The obtained residue was purified with silica gel<br>
column chromatography [eluent; hexane: ethyl acetate =<br>
10:1] to obtain 36 mg of methyl 2-(benzamido)-4-<br>
(cyclohexyloxy)benzoate as white solid.<br>
1H-NMR (CDC13) 5: 1.30-1.49 (4H, m) , 1.54-1.64 (2H, m) ,<br>
1.77-1.87 (2H, m), 1.98-2.07 (2H, m), 3.93 (3H, s),<br>
4.45-4.49 (1H, m), 6.63 (1H, dd, J = 9.0, 2.4 Hz),<br>
7.51-7.58 (3H, m), 7.99 (1H, d, J = 9.0 Hz), 8.05-8.07<br>
(2H, m), 8.61 (1H, d, J = 2.4 Hz), 12.21 (1H, s).<br>
[0315]<br>
Example 105<br><br>
0.077 mL of 2.0 mol/L aqueous sodium<br>
hydroxide was added dropwise to a mixed solution of 1<br>
mL of methanol and 1 mL of tetrahydrofuran containing<br>
35 mg of methyl 2-(benzamido)-4-(cyclohexyloxy)benzoate<br>
at room temperature and stirred at the same temperature<br>
overnight and at 40C for 6 hours and 30 minutes. 0.050<br><br>
187<br>
mL of 2.0 mol/L aqueous sodium hydroxide was added at<br>
room temperature and stirred at the same temperature<br>
for 4 hours and 30 minutes. The solvent was evaporated<br>
under reduced pressure and water was added and pH was<br>
5  adjusted to pH 4.0 with 1.0 mol/L hydrochloric acid. A<br>
solid substance was separated by filtration to obtain<br>
25 mg of 2-(benzamido)-4-(cyclohexyloxy)benzoic acid as<br>
white solid.<br>
1H-NMR (DMSO-d6) 8: 1.20-1.60 (6H, m) , 1.68-1.78 (2H, m) ,<br>
1.92-2.00 (2H, m), 4.32-4.39 (1H, m), 6.59 (1H, dd, J=<br>
8.7, 2.4 Hz), 7.52-7.59 (3H, m), 7.93 (1H, d, J = 8.7<br>
Hz), 8.01-8.03 (2H, m), 8.33 (1H, d, J = 2.4 Hz).<br>
[0316]<br>
Example 106<br><br>
0.31 g of iron powder was added to a mixed<br>
solution of 5.3 mL of methanol and 1.6 mL of acetic<br>
acid containing 0.53 g of methyl 2-nitro-4-<br>
(phenoxymethyl)benzoate, and the resulting mixture was<br>
heated to reflux for 3 hours. The reaction mixture was<br>
cooled to room temperature and ethyl acetate and a<br>
saturated sodium hydrogen carbonate aqueous solution<br>
were added and insoluble were removed by filtration.<br>
The organic layer was separated and dried over<br>
anhydrous magnesium sulfate after washed with saturated<br>
sodium hydrogen carbonate aqueous solution and<br><br>
188<br>
saturated sodium chloride aqueous solution sequentially,<br>
and the solvent was evaporated under reduced pressure.<br>
The obtained residue was dissolved in 5.3 mL of<br>
methylene chloride and 0.51 mL of triethylamine and<br>
0.26 mL of benzoyl chloride were added while ice-cooled<br>
sequentially and stirred at room temperature for 15<br>
hours. The solvent was evaporated under reduced<br>
pressure and ethyl acetate and 1.0 mol/L hydrochloric<br>
acid were added to the obtained residue. The organic<br>
layer was separated and washed with saturated sodium<br>
chloride aqueous solution and dried over anhydrous<br>
magnesium sulfate, and the solvent was evaporated under<br>
reduced pressure. Hexane and diisopropyl ether were<br>
added to the obtained residue and a solid substance was<br>
separated by filtration to obtain 0.31 g of methyl 2-<br>
(benzamido)-4-(phenoxymethyl)benzoate as white solid.<br>
1H-NMR (CDC13) 8: 3.97 (3H, s) , 5.17 (2H, s) , 6.95-7.00<br>
(3H, m) , 7.25-7.31 (3H, m), 7.54-7.58 (3H, m), 8.05-<br>
8.07 (2H, m), 8.10 (1H, d, J = 8.3 Hz), 9.04 (1H, d, J<br>
= 1.2 Hz), 12.10 (1H, s).<br>
[0317]<br>
Example 107<br><br>
0.51 mL of 2.0 mol/L aqueous sodium hydroxide<br>
was added dropwise to a mixed solution of 3 mL of<br>
methanol and 3 mL of tetrahydrofuran containing 0.31 g<br><br>
189<br>
of methyl 2-(benzamido)-4-(phenoxymethyl)benzoate while<br>
ice-cooled and stirred at room temperature for 5 hours<br>
and 30 minutes. The solvent was evaporated under<br>
reduced pressure and water was added and pH was<br>
adjusted to pH 4.0 with 1.0 mol/L hydrochloric acid. A<br>
solid substance was separated by filtration to obtain<br>
0.27 g of 2-(benzamido)-4-(phenoxymethyl)benzoic acid<br>
as white solid.<br>
1H-NMR (DMSO-d6) 8: 5.16 (2H, s), 6.95 (1H, t, J = 7.3<br>
Hz), 7.02-7.04 (2H, m) , 7.17 (1H, dd, J = 8.0, 1.2 Hz),<br>
7.28-7.32 (2H, m) , 7.54-7.61 (3H, m) , 8.00-8.02 (2H, m) ,<br>
8.05 (1H, d, J = 8.0 Hz), 8.82 (1H, d, J = 1.2 Hz).<br>
[0318]<br>
Example 108<br><br>
0.52 mL of triethylamine and 0.16 mL of<br>
benzoyl chloride were added to 3.8 mL of methylene<br>
chloride suspension containing 0.39 g of methyl 2-<br>
amino-4-((phenylthio)methyl)benzoate hydrochloride<br>
while ice-cooled and stirred at room temperature for 3<br>
hours and 30 minutes. The solvent was evaporated under<br>
reduced pressure and ethyl acetate and 1.0 mol/L<br>
hydrochloric acid were added to the obtained residue.<br>
The organic layer was separated and dried over<br>
anhydrous magnesium sulfate after washed with a<br>
saturated sodium hydrogen carbonate aqueous solution<br><br>
190<br>
and a saturated sodium chloride aqueous solution<br>
sequentially, and the solvent was evaporated under<br>
reduced pressure. Hexane and diisopropyl ether were<br>
added to the obtained residue and a solid substance was<br>
separated by filtration to obtain 0.29 g of methyl 2-<br>
(benzamido)-4-((phenylthio)methyl)benzoate as white<br>
solid.<br>
1H-NMR (CDC13) 5: 3.95 (3H, s) , 4.17 (2H, s) , 7.08 (1H,<br>
dd, J = 8.3, 1.6 Hz), 7.16-7.20 (1H, m) , 7.24-7.27 (2H,<br>
m), 7.32-7.34 (2H, m) , 7.51-7.57 (3H, m), 7.99 (1H, d,<br>
J = 8.3 Hz), 8.04-8.06 (2H, m), 8.95 (1H, d, J = 1.6<br>
Hz), 12.04 (1H, s).<br>
[0319]<br>
Example 109<br><br>
0.50 mL of 2.0 mol/L aqueous sodium hydroxide<br>
was added dropwise to a mixed solution of 3 mL of<br>
methanol and 3 mL of tetrahydrofuran containing 0.29 g<br>
of methyl 2-(benzamido)-4-((phenylthio)methyl)benzoate<br>
while ice-cooled and stirred at room temperature for 5<br>
hours. 0.25 mL of 2.0 mol/L aqueous sodium hydroxide<br>
was added dropwise and stirred at the same temperature<br>
for 14 hours. The solvent was evaporated under reduced<br>
pressure and water was added and pH was adjusted to pH<br>
4.0 with 1.0 mol/L hydrochloric acid. A solid substance<br>
was separated by filtration to obtain 0.28 g of 2-<br><br>
191<br>
(benzamido)-4-((phenylthio)methyl)benzoic acid as white<br>
solid.<br>
1H-NMR (DMSO-de) 8: 4.24 (2H, s) , 6.99 (1H, dd, J = 7.9,<br>
1.8 Hz), 7.15-7.19 (1H, m) , 7.27-7.31 (2H, m), 7.34-<br>
7.37 (2H, m), 7.52-7.59 (3H, m), 7.93 (1H, d, J = 7.9<br>
Hz), 8.01-8.04 (2H, m), 8.76 (1H, d, J = 1.8 Hz).<br>
[0320]<br>
Example 110<br><br>
0.16 mL of aniline, 0.12 g of 1,1'-<br>
bis(diphenylphosphino)ferrocene, 0.057 g of (1,1'-<br>
bis(diphenylphosphino)ferrocene)palladium(II)<br>
dichloride methylene chloride complex and 0.17 g of<br>
sodium tert-butoxide were added to 6 mL of dioxane<br>
solution containing 0.58 g of methyl 2-(benzamido)-4-<br>
bromobenzoate, and the resulting mixture was heated to<br>
reflux under nitrogen atmosphere for 4 hours. After the<br>
reaction mixture was cooled to room temperature, 1 mL<br>
of acetic acid was added and the solvent was evaporated<br>
under reduced pressure. The obtained residue was<br>
purified with silica gel column chromatography [eluent;<br>
hexane: ethyl acetate = 5:1] to obtain 0.43 g of methyl<br>
4-(anilino)-2-(benzamido)benzoate as colorless oil.<br>
1H-NMR (DMSO-de) 8: 3.86 (3H, s), 6.79 (1H, dd, J = 9.0,<br>
2.4 Hz), 7.04 (1H, t, J = 7.3 Hz), 7.25 (2H, d, J = 7.6<br>
Hz), 7.35-7.39 (2H, m), 7.59-7.68 (3H, m), 7.89 (1H, d,<br><br>
192<br>
J = 9.0 Hz), 7.95-7.97 (2H, m) , 8.55 (1H, d, J = 2.4<br>
Hz), 9.03 (1H, s), 12.09 (1H, s).<br>
[0321]<br>
Example 111<br><br>
1 mL of 10% aqueous sodium hydroxide was<br>
added to 4 mL of ethanol suspension containing 0.43 g<br>
of methyl 4-(anilino)-2-(benzamido)benzoate at room<br>
temperature, and the resulting mixture was heated to<br>
reflux for 2 hours. After the reaction mixture was<br>
cooled to room temperature, 1.0 mol/L hydrochloric acid<br>
and ethyl acetate were added. The organic layer was<br>
separated and dried over anhydrous magnesium sulfate,<br>
and the solvent was evaporated under reduced pressure.<br>
Diisopropyl ether and hexane were added to the obtained<br>
residue and a solid substance was separated by<br>
filtration to obtain 0.36 g of 4-(anilino)-2-<br>
(benzamido)benzoic acid as white solid.<br>
1H-NMR (DMSO-de) 8: 6.78 (1H, dd, J = 8.9, 2.3 Hz), 7.03<br>
(1H, t, J = 7.3 Hz), 7.25 (1H, d, J = 7.8 Hz), 7.36 (2H,<br>
t, J = 7.7 Hz), 7.57-7.67 (3H, m), 7.90 (1H, d, J = 8.9<br>
Hz), 7.96 (2H, d, J = 7.1 Hz), 8.57 (1H, d, J = 2.3 Hz),<br>
8.97 (1H, s), 12.50 (1H, s), 12.80-13.20 (1H, broad).<br>
[0322]<br>
Example 112<br><br><br>
0.16 mL of thiophenol, 0.43 g of potassium<br>
carbonate and 0.030 g of copper(I) iodide were added to<br>
6 mL of ethylene glycol dimethyl ether solution<br>
containing 0.60 g of methyl 2-(benzamido)-4-<br>
iodobenzoate, and the resulting mixture was heated to<br>
reflux under argon atmosphere for 13 hours. After the<br>
reaction mixture was cooled to room temperature, 1.0<br>
mol/L hydrochloric acid and ethyl acetate were added.<br>
The organic layer was separated and dried over<br>
anhydrous magnesium sulfate, and the solvent was<br>
evaporated under reduced pressure. The obtained residue<br>
was purified with silica gel column chromatography<br>
[eluent; hexane: ethyl acetate =5:1] to obtain 0.30 g<br>
of methyl 2-(benzamido)-4-(phenylthio)benzoate as white<br>
solid.<br>
1H-NMR (DMSO-de) 8: 3.88 (3H, s), 6.95 (1H, dd, J = 8.4,<br>
1.8 Hz), 7.50-7.67 (8H, m), 7.91-7.96 (3H, m), 8.51 (1H,<br>
d, J = 1.8 Hz), 11.73 (1H, s).<br>
[0323]<br>
Example 113<br><br><br>
194<br>
0.4 iriL of 10% aqueous sodium hydroxide was<br>
added to 6 mL of ethanol suspension containing 0.30 g<br>
of methyl 2-(benzamido)-4-(phenylthio)benzoate at room<br>
temperature, and the resulting mixture was heated to<br>
reflux for 1 hour. After the reaction mixture was<br>
cooled to room temperature, 1.0 mol/L hydrochloric acid<br>
and ethyl acetate were added. The organic layer was<br>
separated and dried over anhydrous magnesium sulfate,<br>
and the solvent was evaporated under reduced pressure.<br>
Diisopropyl ether and hexane were added to the obtained<br>
residue and a solid substance was separated by<br>
filtration to obtain 0.28 g of 2-(benzamido)-4-<br>
(phenylthio)benzoic acid as white solid.<br>
1H-NMR (DMSO-de) 8: 6.92 (1H, dd, J = 8.4, 1.8 Hz),<br>
7.47-7.67 (8H, m) , 7.90-7.92 (2H, m), 7.97 (1H, d, J =<br>
8.4 Hz), 8.63 (1H, d, J = 1.8 Hz), 12.25 (1H, s).<br>
[0324]<br>
Example 114<br><br>
0.15 mL of triethylamine and 0.068 mL of<br>
benzyl mercaptan were added to 2 mL of toluene<br>
suspension containing 0.20 g of methyl 2-(benzamido)-4-<br>
iodobenzoate, 36 mg of 1,1'-bis(diphenylphosphino)-<br>
ferrocene and 24 mg of tris(dibenzylideneacetone)-<br>
dipalladium(O) and stirred under nitrogen atmosphere at<br>
80C for 2 hours. Insoluble were removed by filtration<br><br>
195<br>
and the solvent was evaporated under reduced pressure.<br>
The obtained residue was purified with silica gel<br>
column chromatography [eluent; hexane: ethyl acetate =<br>
10:1] to obtain 0.16 g of methyl 2-(benzamido)-4-<br>
(benzylthio)benzoate as white solid.<br>
1H-NMR (CDC13) 5: 3.94 (3H, s), 4.31 (2H, s), 6.95 (1H,<br>
dd, J = 8.5, 2.0 Hz), 7.24-7.27 (1H, m), 7.30-7.34 (2H,<br>
m), 7.44-7.46 (2H, m), 7.51-7.57 (3H, m), 7.92 (1H, d,<br>
J = 8.5 Hz), 8.04-8.07 (2H, m), 9.03 (1H, d, J = 2.0<br>
Hz), 12.12 (1H, s).<br>
[0325]<br>
Example 115<br><br>
0.43 mL of 2.0 mol/L aqueous sodium hydroxide<br>
was added dropwise to a mixed solution of 1.5 mL of<br>
methanol and 1.5 mL of tetrahydrofuran containing 0.16<br>
g of methyl 2-(benzamido)-4-(benzylthio)benzoate while<br>
ice-cooled and stirred at room temperature for 18 hours.<br>
The solvent was evaporated under reduced pressure and<br>
water was added and pH was adjusted to pH 4.0 with 1.0<br>
mol/L hydrochloric acid. A solid substance was<br>
separated by filtration to obtain 0.14 g of 2-<br>
(benzamido)-4-(benzylthio)benzoic acid as white solid.<br>
1H-NMR (DMSO-de) 8: 4.37 (2H, s) , 7.15 (1H, dd, J = 8.5,<br>
2.0 Hz), 7.24-7.28 (1H, m) , 7.31-7.35 (2H, m), 7.48 (2H,<br><br>
196<br>
d, J = 7.3 Hz), 7.58-7.68 (3H, m) , 7.94-7.97 (3H, m) ,<br>
8.77 (1H, d, J= 2.0 Hz), 12.30 (1H, s).<br>
[0326]<br>
Example 116<br><br>
53 mg of tris(dibenzylideneacetone)-<br>
dipalladium(O) and 0.17 g sodium tert-butoxide were<br>
added to 5 mL of toluene solution containing 0.50 g of<br>
tert-butyl 2-(benzamido)-4-iodobenzoate, 0.25 mL of 3-<br>
phenylpropylamine and 36 mg of rac-2,2'-<br>
bis(diphenylphosphino)-1,1-binaphthyl at room<br>
temperature and stirred at 80C for 7 hours. After the<br>
reaction mixture was cooled to room temperature,<br>
insoluble were removed by filtration, and the solvent<br>
was evaporated under reduced pressure. The obtained<br>
residue was purified with silica gel column<br>
chromatography [eluent; hexane: ethyl acetate = 6:1] to<br>
obtain 0.11 g of tert-butyl 2-(benzamido)-4-(3-<br>
phenylpropylamino)benzoate as brown oil.<br>
1H-NMR (CDC13) 5: 1.59 (9H, s) , 1.95-2.02 (2H, m) , 2.72-<br>
2.77 (1H, m) , 3.25-3.29 (1H, m), 6.21 (1H, dd, J = 8.8,<br>
2.5 Hz), 7.19-7.22 (3H, m) , 7.26-7.32 (2H, m), 7.49-<br>
7.55 (3H, m), 7.82 (1H, d, J = 8.8 Hz), 8.05-8.07 (2H,<br>
m) , 8.24 (1H, d, J = 2.5 Hz), 12.44-12.46 (1H, broad).<br>
[0327]<br>
Example 117<br><br><br>
The following compound was obtained in the<br>
same manner as in Example 116.<br>
tert-Butyl 2-(benzamido)-4-((2-<br>
phenylethyl)amino)benzoate<br>
1H-NMR (CDC13) 8: 1.60 (9H, s) , 2.93-2.98 (2H, m) , 3.50-<br>
3.55 (2H, m), 4.23-4.28 (1H, broad), 6.25 (1H, dd, J=<br>
8.8, 2.4 Hz), 7.23-7.27 (3H, m), 7.31-7.35 (2H, m),<br>
7.50-7.55 (3H, m), 7.83 (1H, d, J = 8.8 Hz), 8.05-8.07<br>
(2H, m), 8.27 (1H, d, J = 2.4 Hz), 12.44-12.48 (1H,<br>
broad).<br>
[0328]<br>
Example 118<br><br>
1.0 mL of trifluoroacetic acid solution<br>
containing 0.11 g of tert-butyl 2-(benzamido)-4-((3-<br>
phenylpropyl)amino)benzoate was stirred at room<br>
temperature for 2 hours. The solvent was evaporated<br>
under reduced pressure and ethyl acetate and water were<br>
added and pH was adjusted to pH 6.3 with a saturated<br>
sodium hydrogen carbonate aqueous solution. The organic<br>
layer was separated and dried over anhydrous magnesium<br>
sulfate after washed with a saturated sodium chloride<br><br>
198<br>
aqueous solution, and the solvent was evaporated under<br>
reduced pressure. Hexane and diisopropyl ether were<br>
added to the obtained residue and a solid substance was<br>
separated by filtration to obtain 71 mg of 2-<br>
3  (benzamido)-4-((3-phenylpropyl)amino)benzoic acid as<br>
white solid.<br>
1H-NMR (DMSO-de) 8: 1.85-1.92 (2H, m) , 2.68-2.72 (2H, m) ,<br>
3.09-3.14 (2H, m), 6.33 (1H, dd, J = 9.0, 2.2 Hz),<br>
6.83-6.86 (1H, m) , 7.16-7.32 (5H, m) , 7.57-7.66 (3H, m) ,<br>
7.77 (1H, d, J = 9.0 Hz), 7.94-7.96 (2H, m), 8.08 (1H,<br>
d, J = 2.2 Hz), 12.54-12.58 (1H, broad), 12.65-12.74<br>
(1H, broad).<br>
[0329]<br>
Example 119<br><br>
The following compound was obtained in the<br>
same manner as in Example 118.<br>
2-(Benzamido)-4-((2-phenylethyl)amino)benzoic acid<br>
1H-NMR (DMSO-d6-D2O) 5: 2.87-2.91 (2H, m) , 3.32-3.36 (2H,<br>
m), 6.39 (1H, dd, J = 9.0, 2.1 Hz), 7.21-7.26 (1H, m),<br>
7.32-7.33 (4H, m), 7.57-7.66 (3H, m), 7.79 (1H, d, J =<br>
9.0 Hz), 7.94-7.96 (2H, m), 8.11 (1H, d, J = 2.1 Hz).<br>
[0330]<br>
Example 120<br><br><br>
0.12 g of 4-iodophenol, 0.18 mL of<br>
tributylamine and 4.2 mg of palladium acetate were<br>
added to 2.4 mL of N,N-dimethylacetamide solution<br>
containing 0.12 g of tert-butyl 2-(benzamido)-4-<br>
vinylbenzoate sequentially at room temperature and<br>
stirred under nitrogen atmosphere at 110C for 6 hours.<br>
After the reaction mixture was cooled to room<br>
temperature, 10% citric acid aqueous solution and ethyl<br>
acetate were added. The organic layer was separated and<br>
dried over anhydrous magnesium sulfate after washed<br>
with 10% citric acid aqueous solution, a saturated<br>
sodium thiosulfate aqueous solution and a saturated<br>
sodium chloride aqueous solution sequentially, and the<br>
solvent was evaporated under reduced pressure. The<br>
obtained residue was purified with silica gel column<br>
chromatography [PSQ100B (spherical) manufactured by<br>
Fuji Silysia Chemical Ltd., eluent; hexane: ethyl<br>
acetate = 1:1] to obtain 0.10 g of tert-butyl 2-<br>
(benzamido)-4-((E)-2-(4-hydroxyphenyl)vinyl)benzoate as<br>
yellow solid.<br>
1H-NMR (DMSO-de) 5: 1.56 (9H, s) , 6.77-6.83 (2H, m) ,<br>
7.11 (1H, d, J = 15.9 Hz), 7.27 (1H, d, J = 15.9 Hz),<br>
7.42 (1H, d, J = 8.4 Hz), 7.50-7.55 (2H, m), 7.59-7.69<br>
(3H, m), 7.94 (1H, d, J = 8.4 Hz), 7.96-8.01 (2H, m) ,<br>
8.68-8.72 (1H, m), 9.71 (1H, s), 11.70 (1H, s).<br><br>
200<br>
[0331]<br>
Examples 121, 122<br>
The compounds shown in Table 15 were obtained<br>
in the same manner as in Example 120.<br>
[0332]<br>
[Table 15]<br><br>
[0333]<br>
tert-Butyl 2-(benzamido)-4-((E)-2-(2-<br>
hydroxyphenyl)vinyl)benzoate<br>
1H-NMR (DMSO-de) 5: 1.57 (9H, s) , 6.78-6.93 (2H, m) ,<br>
7.10-7.18 (1H, m), 7.30 (1H, d, J = 16.3 Hz), 7.41 (1H,<br>
dd, J = 8.4, 1.6 Hz), 7.58-7.70 (5H, m), 7.96 (1H, d, J<br>
= 8.4 Hz), 7.98-8.02 (2H, m), 8.76 (1H, d, J = 1.6 Hz),<br>
9.94 (1H, s), 11.71 (1H, s).<br>
[0334]<br>
tert-Butyl 2-(benzamido)-4-((E)-2-(3,5-<br>
dichlorophenyl)vinyl)benzoate<br>
1H-NMR (DMSO-de) 8: 1.56 (9H, s) , 7.36 (1H, d, J = 16.4<br>
Hz), 7.49 (1H, dd, J = 8.3, 1.2 Hz), 7.53 (1H, t, J =<br>
1.8 Hz), 7.56-7.68 (4H, m), 7.82 (2H, d, J = 1.7 Hz),<br><br>
201<br>
7.97-8.02 (3H, m), 8.74 (1H, d, J = 1.4 Hz), 11.65 (1H,<br>
s) .<br>
[0335]<br>
Example 123<br><br>
0.14 g of l-bromo-4-nitrobenzene, 0.22 mL of<br>
tributylamine and 5.2 mg of palladium acetate were<br>
added to 2.0 mL of N,N-dimethylacetamide solution<br>
containing 0.15 g of tert-butyl 2-(benzamido)-4-<br>
vinylbenzoate at room temperature and stirred under<br>
nitrogen atmosphere at 110C for 1 hour and 20 minutes.<br>
After the reaction mixture was cooled to room<br>
temperature, 10% citric acid aqueous solution and ethyl<br>
acetate were added. The organic layer was separated and<br>
dried over anhydrous magnesium sulfate after washed<br>
with 10% citric acid aqueous solution, a saturated<br>
sodium thiosulfate aqueous solution and a saturated<br>
sodium chloride aqueous solution sequentially, and the<br>
solvent was evaporated under reduced pressure. The<br>
obtained residue was purified with silica gel column<br>
chromatography [Flash Tube 2008 manufactured by<br>
Trikonex Company, eluent; hexane: ethyl acetate = 4:1]<br>
to obtain 0.15 g of tert-butyl 2-(benzamido)-4-((E)-2-<br>
(4-nitrophenyl)vinyl)benzoate as yellow solid.<br><br>
202<br>
1H-NMR (DMSO-d6) 5: 1.57 (9H, s) , 7.50-7.68 (6H, m) ,<br>
7.96-8.02 (5H, m) , 8.24-8.28 (2H, m), 8.77 (1H, d, J =<br>
1.5 Hz), 11.64 (1H, s).<br>
[0336]<br>
j Example 124<br><br>
0.10 mL of l-bromo-4-(trifluoromethoxy)-<br>
benzene, 0.22 mL of tributylamine and 5.2 mg of<br>
palladium acetate were added to 2.0 mL of N,N-<br>
dimethylacetamide solution containing 0.15 g of tert-<br>
butyl 2-(benzamido)-4-vinylbenzoate at room temperature<br>
and stirred under nitrogen atmosphere at 110C for 3<br>
hours. After the reaction mixture was cooled to room<br>
temperature, 0.07 mL of l-bromo-4-<br>
(trifluoromethoxy)benzene, 0.11 mL of tributylamine and<br>
5.2 mg of palladium acetate were added at room<br>
temperature and stirred under nitrogen atmosphere at<br>
110C for 2 hours. After the reaction mixture was<br>
cooled to room temperature, 10% citric acid aqueous<br>
solution and ethyl acetate were added. The organic<br>
layer was separated and dried over anhydrous magnesium<br>
sulfate after washed with 10% citric acid aqueous<br>
solution, a saturated sodium thiosulfate aqueous<br>
solution and a saturated sodium chloride aqueous<br>
solution sequentially, and the solvent was evaporated<br><br>
203<br>
under reduced pressure. The obtained residue was<br>
purified with silica gel column chromatography [PSQ100B<br>
(spherical) manufactured by Fuji Silysia Chemical Ltd.,<br>
eluent; toluene: ethyl acetate = 20:1] to obtain 0.10 g<br>
of tert-butyl 2-(benzamido)-4-((E)-2-(4-<br>
(trifluoromethoxy)phenyl)vinyl)benzoate as white solid.<br>
1H-NMR (DMSO-de) 8: 1.56 (9H, s) , 7.38-7.43 (4H, m) ,<br>
7.51 (1H, dd, J = 8.4, 1.5 Hz), 7.59-7.70 (3H, m),<br>
7.81-7.86 (2H, m), 7.95-8.02 (3H, m), 8.74 (1H, d, J =<br>
1.5 Hz), 11.66 (1H, s).<br>
[0337]<br>
Example 125<br><br>
The following compound was obtained in the<br>
same manner as in Example 124.<br>
tert-Butyl 2-(benzamido)-4-((E)-2-(3,5-<br>
difluorophenyl)vinyl)benzoate<br>
1H-NMR (DMSO-de) 8: 1.56 (9H, s), 7.18 (1H, tt, J= 9.3,<br>
2.3	Hz), 7.37 (1H, d, J = 16.4 Hz), 7.44-7.54 (4H, m) ,<br>
7.60-7.70 (3H, m), 7.97-8.01 (3H, m), 8.74 (1H, d, J =<br>
1.3	Hz), 11.65 (1H, s).<br>
[0338]<br>
Example 126<br><br><br>
204<br>
0.20 g of 6-bromo-2-oxoindoline, 0.40 mL of<br>
N,N-dicyclohexylmethylamine and 18 mg of trans-di(n~<br>
acetato)bis-o-(di-o-tolylphosphino)benzyl<br>
dipalladium(II) were added to 2.0 mL of N,N-<br>
dimethylacetamide solution containing 0.4 6 g of tert-<br>
butyl 2-(benzamido)-4-vinylbenzoate at room temperature<br>
and stirred under nitrogen atmosphere at 110C for 7<br>
hours. After the reaction mixture was cooled to room<br>
temperature, a saturated sodium hydrogen carbonate<br>
aqueous solution and ethyl acetate were added. The<br>
organic layer was separated and dried over anhydrous<br>
magnesium sulfate after washed with 10% citric acid<br>
aqueous solution and a saturated sodium chloride<br>
aqueous solution sequentially, and the solvent was<br>
evaporated under reduced pressure. The obtained residue<br>
was purified with silica gel column chromatography<br>
[PSQ100B (spherical) manufactured by Fuji Silysia<br>
Chemical Ltd., eluent; hexane: ethyl acetate =1:1] to<br>
obtain 0.15 g of tert-butyl 2-(benzamido)-4-((E)-2-(2-<br>
oxoindolin-6-yl)vinyl)benzoate as green solid.<br>
1H-NMR (DMSO-d6) 8: 1.56 (9H, s), 3.50 (2H, s) , 7.11 (1H,<br>
s), 7.21-7.39 (4H, m), 7.50 (1H, dd, J = 8.3, 1.5 Hz),<br>
7.59-7.70 (3H, m), 7.95 (1H, d, J = 8.3 Hz), 7.97-8.02<br>
(2H, m) , 8.69-8.74 (1H, m), 10.50 (1H, s), 11.65 (1H,<br>
s) .<br>
[0339]<br>
Example 127<br><br><br>
0.076 mL of 3-chlorostyrene, 0.19 mL of<br>
tributylamine, 2.9 mg of tri-tert-butylphosphine<br>
tetrafluoroborate and 4.5 mg of palladium acetate were<br>
added to 2.0 mL of N,N-dimethylacetamide solution<br>
containing 0.15 g of tert-butyl 2-(benzamido)-4-<br>
bromobenzoate at room temperature and stirred under<br>
nitrogen atmosphere at 110C for 4 hours and 30 minutes.<br>
After the reaction mixture was cooled to room<br>
temperature, 0.025 mL of 3-chlorostyrene, 2.9 mg of<br>
tri-tert-butylphosphine tetrafluoroborate and 4.5 mg of<br>
palladium acetate were added at room temperature and<br>
stirred under nitrogen atmosphere at 110C for 1 hour<br>
and 20 minutes. After the reaction mixture was cooled<br>
to room temperature, 10% citric acid aqueous solution<br>
and ethyl acetate were added. The organic layer was<br>
separated and dried over anhydrous magnesium sulfate<br>
after washed with 10% citric acid aqueous solution, a<br>
saturated sodium thiosulfate aqueous solution and a<br>
saturated sodium chloride aqueous solution sequentially,<br>
and the solvent was evaporated under reduced pressure.<br>
The obtained residue was purified with silica gel<br>
column chromatography [PSQ100B (spherical) manufactured<br>
by Fuji Silysia Chemical Ltd., eluent; hexane: ethyl<br>
acetate = 10:1] to obtain 86 mg of tert-butyl 2-<br><br>
206<br>
(benzamido)-4-((E)-2-(3-chlorophenyl)vinyl)benzoate as<br>
white solid.<br>
1H-NMR (CDC13) 6: 1.56 (9H, s), 7.13-7.34 (5H, m), 7.40-<br>
7.45 (1H, m), 7.52-7.59 (4H, m), 8.01 (1H, d, J = 8.3<br>
Hz), 8.06-8.11 (2H, m), 9.16 (1H, d, J = 1.7 Hz), 12.27<br>
(1H, s).<br>
[0340]<br>
Example 128<br><br>
3.0 mL of trifluoroacetic acid suspension<br>
containing 0.17 g of tert-butyl 2-(benzamido)-4-((E)-2-<br>
(2-hydroxyphenyl)vinyl)benzoate was stirred at room<br>
temperature for 30 minutes. The solvent was evaporated<br>
under reduced pressure, toluene was added, and the<br>
solvent was evaporated under reduced pressure. Hexane<br>
was added to the obtained residue and a solid substance<br>
was separated by filtration to obtain 0.12 g of 2-<br>
(benzamido)-4-((E)-2-(2-hydroxyphenyl)vinyl)benzoic<br>
acid as yellow solid.<br>
1H-NMR (DMSO-de) 5: 6.79-6.94 (2H, m) , 7.10-7.19 (1H, m) ,<br>
7.31 (1H, d, J = 16.6 Hz), 7.40 (1H, dd, J = 8.4, 1.6<br>
Hz), 7.55-7.70 (5H, m), 7.97-8.02 (2H, m), 8.05 (1H, d,<br>
J = 8.4 Hz), 8.95 (1H, d, J = 1.6 Hz), 9.94 (1H, s),<br>
12.26 (1H, s).<br><br>
207<br>
[0341]<br>
Examples 129 to 135<br>
The compounds shown in Table 16 were obtained<br>
in the same manner as in Example 128.<br>
[0342]<br>
[Table 16]<br><br>
[0343]<br>
2-(Benzamido)-4-((E)-2-(4-nitrophenyl)vinyl)benzoic<br>
acid<br>
1H-NMR (DMSO-d6) 8: 7.50-7.70 (6H, m) , 7.96-8.03 (4H, m) ,<br>
8.09 (1H, d, J = 8.3 Hz), 8.26 (2H, d, J = 8.8 Hz),<br>
8.99 (1H, d, J = 1.4 Hz), 12.23 (1H, s).<br>
[0344]<br>
2-(Benzamido)-4-((E)-2-(3, 5-<br>
difluorophenyl)vinyl)benzoic acid<br>
1H-NMR (DMSO-d6) 6: 7.13-7.22 (1H, m) , 7.38 (1H, d, J =<br>
16.1 Hz), 7.45-7.70 (7H, m), 7.96-8.02 (2H, m) , 8.08<br>
(1H, d, J = 8.3 Hz), 8.95 (1H, s).<br><br>
208<br>
[0345]<br>
2-(Benzamido)-4-((E)-2-(4-<br>
(trifluoromethoxy)phenyl)vinyl)benzoic acid<br>
1H-NMR (DMSO-de) 5: 7.37-7.44 (4H, m) , 7.47-7.53 (1H, m) ,<br>
7.58-7.70 (3H, m), 7.84 (2H, d, J = 8.6 Hz), 7.96-8.02<br>
(2H, m), 8.07 (1H, d, J = 8.1 Hz), 8.95 (1H, d, J = 1.4<br>
Hz) .<br>
[0346]<br>
2-(Benzamido)-4-((E)-2-(4-hydroxyphenyl)vinyl)benzoic<br>
acid<br>
1H-NMR (DMSO-de) 8: 6.80 (2H, d, J = 8.5 Hz), 7.12 (1H,<br>
d, J = 16.3 Hz), 7.29 (1H, d, J = 16.3 Hz), 7.42 (1H,<br>
dd, J = 8.5, 1.6 Hz), 7.53 (2H, d, J = 8.5 Hz), 7.58-<br>
7.70 (3H, m), 7.96-8.01 (2H, m), 8.03 (1H, d, J = 8.5<br>
Hz), 8.89 (1H, d, J = 1.6 Hz), 9.72 (1H, s) , 12.25 (1H,<br>
s), 13.54-13.80 (1H, broad).<br>
[0347]<br>
2-(Benzamido)-4-((E)-2-(2-oxoindolin-6-yl)vinyl)benzoic<br>
acid<br>
1H-NMR (DMSO-de) 8: 3.50 (2H, s) , 7.12 (1H, s) , 7.21-<br>
7.40 (4H, m), 7.49 (1H, dd, J = 8.3, 1.4 Hz), 7.58-7.69<br>
(3H, m), 7.96-8.02 (2H, m), 8.05 (1H, d, J = 8.3 Hz),<br>
8.91 (1H, d, J = 1.4 Hz), 10.50 (1H, s).<br>
[0348]<br>
2-(Benzamido)-4-((E)-2-(3-chlorophenyl)vinyl)benzoic<br>
acid<br>
1H-NMR (DMSO-de) 8: 7.32-7.51 (5H, m) , 7.56-7.69 (4H, m) ,<br>
7.81 (1H, s), 7.94-8.00 (2H, m), 8.05 (1H, d, J = 8.0<br>
Hz), 8.93 (1H, d, J = 1.2 Hz), 12.23 (1H, s).<br><br>
209<br>
[0349]<br>
2-(Benzamido)-4-((E)-2- (3,5-<br>
dichlorophenyl)vinyl)benzoic acid<br>
1H-NMR (DMSO-d6) 5: 7.37 (1H, d, J = 16.6 Hz), 7.49 (1H,<br>
dd, J = 8.4, 1.3 Hz), 7.53 (1H, t, J = 1.9 Hz), 7.58-<br>
7.68 (4H, m), 7.83 (2H, d, J = 1.9 Hz), 7.97-8.01 (2H,<br>
m), 8.08 (1H, d, J = 8.4 Hz), 8.95 (1H, d, J = 1.3 Hz),<br>
12.23 (1H, s).<br>
[0350]<br>
Example 136<br><br>
12 mg of 5% palladium-carbon was added to a<br>
mixed solution of 1.5 mL of methanol and 1.5 mL of<br>
ethyl acetate containing 60 mg of 2-(benzamido)-4-((E)-<br>
2-(2-hydroxyphenyl)vinyl)benzoic acid and stirred under<br>
hydrogen atmosphere at room temperature for 3 hours and<br>
30 minutes.  6.0 mg of 5% palladium-carbon was added to<br>
the reaction mixture and stirred under hydrogen<br>
atmosphere at room temperature for 3 hours and 20<br>
minutes. 6.0 mg of 5% palladium-carbon was added to the<br>
reaction mixture and stirred under hydrogen atmosphere<br>
at room temperature for 2 hours and 40 minutes.<br>
Insoluble were removed by filtration and the solvent<br>
was evaporated under reduced pressure. Diisopropyl<br>
ether was added to the obtained residue and a solid<br>
substance was separated by filtration to obtain 47 mg<br><br>
210<br>
of 2-(benzamido)-4-(2-(2-hydroxyphenyl)ethyl)benzoic<br>
acid as white solid.<br>
1H-NMR (DMSO-d6) 5: 2.81-2.94 (4H, m) , 6.68-6.72 (1H, m) ,<br>
6.79-6.82 (1H, m) , 6.98-7.12 (3H, m), 7.57-7.68 (3H, m) ,<br>
7.95-8.01 (3H, m), 8.68 (1H, s), 9.37 (1H, s).<br>
[0351]<br>
Examples 137 to 139<br>
The compounds shown in Table 17 were obtained<br>
in the same manner as in Example 136.<br>
[0352]<br>
[Table 17]<br><br>
[0353]<br>
2-(Benzamido)-4-(2-(3,5-difluorophenyl)ethyl)benzoic<br>
acid<br>
1H-NMR (DMSO-de) 8: 2.95-3.00 (4H, m) , 6.99-7.10 (4H, m) ,<br>
7.56-7.68 (3H, m), 7.94-8.00 (3H, m), 8.65 (1H, d, J =<br>
1.2 Hz).<br><br>
211<br>
[0354]<br>
2-(Benzamido)-4-(2-(4-(trifluoromethoxy)phenyl)-<br>
ethyl)benzoic acid<br>
1H-NMR (DMSO-de) 8: 2.96 (4H, s) , 6.98-7.05 (1H, m) ,<br>
7.24-7.30 (2H, m) , 7.37-7.42 (2H, m), 7.55-7.66 (3H, m) ,<br>
7.93-8.00 (3H, m), 8.64 (1H, d, J = 1.5 Hz).<br>
[0355]<br>
2-(Benzamido)-4-(2-(4-hydroxyphenyl)ethyl)benzoic acid<br>
1H-NMR (DMSO-de) 8: 2.78-2.85 (2H, m) , 2.87-2.95 (2H, m) ,<br>
6.64-6.69 (2H, m) , 7.02-7.08 (3H, m) , 7.57-7.68 (3H, m) ,<br>
7.93-7.99 (3H, m), 8.66 (1H, d, J = 1.5 Hz), 9.15 (1H,<br>
s), 12.23 (1H, s).<br>
[0356]<br>
Example 140<br><br>
9 mg of 5% palladium-carbon was added to a<br>
mixed solution of 2.7 mL of methanol and 2.7 mL of<br>
ethyl acetate containing 30 mg of 2-benzamido -4-((E)-<br>
2-(3-chlorophenyl)vinyl)benzoic acid and stirred under<br>
hydrogen atmosphere at room temperature for 3 hours.<br>
Insoluble were removed by filtration and the solvent<br>
was evaporated under reduced pressure. The obtained<br>
residue was purified with reversed-phase silica gel<br>
column chromatography [eluent; 60-100% acetonitrile<br>
/0.1% trifluoroacetic acid aqueous solution] to obtain<br><br>
212<br>
2.0 mg of 2-(benzamido)-4-(2-(3-<br>
chlorophenyl)ethyl)benzoic acid as white solid.<br>
1H-NMR (DMSO-de) 8: 2.91-3.03 (4H, m) , 7.09 (1H, dd, J =<br>
8.2, 1.5 Hz), 7.22-7.35 (3H, m), 7.37-7.40 (1H, m),<br>
7.57-7.69 (3H, m), 7.94-8.02 (3H, m), 8.67 (1H, d, J =<br>
1.5 Hz), 12.22 (1H, s).<br>
[0357]<br>
Example 141<br><br>
0.030 mL of 2,4-difluoroiodobenzene, 81 mg of<br>
cesium carbonate, 12 mg of tetrabutylammonium bromide<br>
and 19 mg of polymer supported bis(acetato)-<br>
triphenylphosphine palladium(II) were added to 1.0 mL<br>
of toluene solution containing 40 mg of tert-butyl 2-<br>
(benzamido)-4-vinylbenzoate at room temperature and<br>
stirred at 110C for 24 hours. After the reaction<br>
mixture was cooled to room temperature, 19 mg of<br>
polymer supported bis(acetato)triphenylphosphine<br>
palladium(II) was added and stirred at 110C for 24<br>
hours. After the reaction mixture was cooled to room<br>
temperature, ethyl acetate and 10% citric acid aqueous<br>
solution were added. The organic layer was separated<br>
and dried over anhydrous magnesium sulfate after washed<br>
with 10% citric acid aqueous solution and a saturated<br>
sodium chloride aqueous solution sequentially, and the<br>
solvent was evaporated under reduced pressure. 10 mL of<br><br>
213<br>
trifluoroacetic acid was added to the obtained residue<br>
and stirred at room temperature for 1 hour. The solvent<br>
was evaporated under reduced pressure and methanol was<br>
added to the obtained residue and a solid substance was<br>
separated by filtration to obtain 15 mg of 2-<br>
(benzamido)-4-((E)-2-(2,4-difluorophenyl)vinyl)benzoic<br>
acid as brown solid.<br>
1H-NMR (DMSO-de) 8: 7.15-7.21 (1H, m) , 7.31-7.46 (3H, m) ,<br>
7.50 (1H, dd, J = 8.3, 1.7 Hz), 7.58-7.71 (3H, m) ,<br>
7.94-8.02 (3H, m), 8.07 (1H, d, J = 8.3 Hz), 8.96 (1H,<br>
s), 12.24 (1H, s), 13.70-13.90 (1H, broad).<br>
[0358]<br>
Example 142<br><br>
The following compound was obtained in the<br>
same manner as in Example 141.<br>
2-(Benzamido)-4-((E)-2-(benzo[1,3]dioxol-5-<br>
yl)vinyl)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.07 (2H, s), 6.95 (1H, d, J = 8.1<br>
Hz), 7.14 (1H, dd, J = 8.3, 1.5 Hz), 7.23 (1H, d, J =<br>
16.4 Hz), 7.32 (1H, d, J = 16.4 Hz), 7.41 (1H, d, J =<br>
1.7 Hz), 7.44 (1H, dd, J = 8.3, 1.7 Hz), 7.58-7.70 (3H,<br>
m), 7.95-8.01 (2H, m), 8.04 (1H, d, J = 8.3 Hz), 8.90<br>
(1H, d, J = 1.5 Hz), 12.25 (1H, s) , 13.71 (1H, s) .<br><br>
214<br>
[0359]<br>
Example 14 3<br><br>
66 mg of 5-bromobenzothiophene, 0.10 g of<br>
cesium carbonate, 15 mg of tetrabutylammonium bromide<br>
and 24 mg of polymer supported<br>
bis(acetato)triphenylphosphine palladium(II) were added<br>
to 1.0 mL of toluene solution containing 50 mg of tert-<br>
butyl 2-(benzamido)-4-vinylbenzoate at room temperature<br>
and stirred at 110C for 24 hours. After the reaction<br>
mixture was cooled to room temperature, 24 mg of<br>
polymer supported bis(acetato)triphenylphosphine<br>
palladium(II) was added and stirred at 110C for 24<br>
hours. After the reaction mixture was cooled to room<br>
temperature, ethyl acetate and 10% citric acid aqueous<br>
solution were added. The organic layer was separated<br>
and dried over anhydrous magnesium sulfate after washed<br>
with 10% citric acid aqueous solution and a saturated<br>
sodium chloride aqueous solution sequentially, and the<br>
solvent was evaporated under reduced pressure. 10 mL of<br>
trifluoroacetic acid was added to the obtained residue<br>
and stirred at room temperature for 1 hour. The solvent<br>
was evaporated under reduced pressure and methanol was<br>
added to the obtained residue and a solid substance was<br>
separated by filtration to obtain 26 mg of 2-<br><br>
215<br>
(benzamido)-4-((E)-2-(benzothiophene-5-yl)vinyl)benzoic<br>
acid as white solid.<br>
1H-NMR (DMSO-de) 8: 7.41-7.70 (7H, m), 7.77 (1H, dd, J =<br>
8.5, 1.2 Hz), 7.81 (1H, d, J = 5.6 Hz), 7.97-8.10 (4H,<br>
m), 8.18 (1H, d, J = 1.0 Hz), 8.97 (1H, d, J = 1.7 Hz),<br>
12.26 (1H, s), 13.60-13.91 (1H, broad).<br>
[0360]<br>
Example 144<br><br>
The following compound was obtained in the<br>
same manner as in Example 143.<br>
2-(Benzamido)-4-((E)-2-(quinoxalin-6-yl)vinyl)benzoic<br>
acid<br>
1H-NMR (DMSO-de) 8: 7.58-7.72 (6H, m) , 7.98-8.03 (2H, m) ,<br>
8.08-8.13 (2H, m) , 8.31-8.38 (2H, m), 8.91-9.02 (3H, m) ,<br>
12.24 (1H, s), 13.70-13.90 (1H, broad).<br>
[0361]<br>
Example 14 5<br><br>
54 mg of 3-iodophenol, 81 mg of cesium<br>
carbonate, 12 mg of tetrabutylammonium bromide and 19<br>
mg of polymer supported bis(acetato)triphenylphosphine<br>
palladium(II) were added to 1.0 mL of toluene solution<br><br>
216<br>
containing 40 mg of tert-butyl 2-(benzamido)-4-<br>
vinylbenzoate at room temperature and stirred at 110C<br>
for 24 hours. After the reaction mixture was cooled to<br>
room temperature, 19 mg of polymer supported<br>
bis(acetato)triphenylphosphine palladium(II) was added<br>
and stirred at 110C for 24 hours. After the reaction<br>
mixture was cooled to room temperature, ethyl acetate<br>
and 10% citric acid aqueous solution were added. The<br>
organic layer was separated and dried over anhydrous<br>
magnesium sulfate after washed with 10% citric acid<br>
aqueous solution and a saturated sodium chloride<br>
aqueous solution sequentially, and the solvent was<br>
evaporated under reduced pressure.  10 mL of<br>
trifluoroacetic acid was added to the obtained residue<br>
and stirred at room temperature for 1 hour. The solvent<br>
was evaporated under reduced pressure and the obtained<br>
residue was purified with reversed-phase silica gel<br>
column chromatography [eluent; 40-90% acetonitrile<br>
/0.1% trifluoroacetic acid aqueous solution] to obtain<br>
25 mg of 2-(benzamido)-4-((E)-2-(3-<br>
hydroxyphenyl)vinyl)benzoic acid as white solid.<br>
1H-NMR (DMSO-de) 5: 6.70-6.80 (1H, m) , 7.03-7.07 (1H, m) ,<br>
7.11-7.15 (1H, m) , 7.18-7.33 (3H, m), 7.48 (1H, dd, J =<br>
8.4, 1.5 Hz), 7.58-7.70 (3H, m), 7.96-8.02 (2H, m) ,<br>
8.05 (1H, d, J = 8.4 Hz), 8.91 (1H, s), 9.50 (1H, s),<br>
12.20-12.35 (1H, broad), 13.65-13.85 (1H, broad).<br>
[0362]<br>
Example 146<br><br><br>
The following compound was obtained in the<br>
same manner as in Example 145.<br>
2-(Benzamido)-4-((E)-2-(2,1,3-benzothiadiazol-4-<br>
yl)vinyl)benzoic acid<br>
1H-NMR (DMSO-d6) 5: 7.56-7.72 (4H, m), 7.80 (1H, dd, J=<br>
8.8, 7.1 Hz), 7.87 (1H, d, J = 16.4 Hz), 7.98-8.14 (5H,<br>
m), 8.21 (1H, d, J = 16.4 Hz), 9.06 (1H, s), 12.25-<br>
12.45 (1H, broad).<br>
[0363]<br>
Example 147<br><br>
0.030 mL of 3-bromopyridine, 0.10 g of cesium<br>
carbonate, 15 mg of tetrabutylammonium bromide and 24<br>
mg of polymer supported bis(acetato)triphenylphosphine<br>
palladium(II) were added to 1.0 mL of toluene solution<br>
containing 50 mg of tert-butyl 2-(benzamido)-4-<br>
vinylbenzoate at room temperature and stirred at 110C<br>
for 24 hours. After the reaction mixture was cooled to<br>
room temperature, 24 mg of polymer supported<br>
bis(acetato)triphenylphosphine palladium(II) was added<br>
and stirred at 110C for 24 hours. After the reaction<br><br>
218<br>
mixture was cooled to room temperature, ethyl acetate<br>
and 10% citric acid aqueous solution were added. The<br>
organic layer was separated and dried over anhydrous<br>
magnesium sulfate after washed with 10% citric acid<br>
aqueous solution and a saturated sodium chloride<br>
aqueous solution sequentially, and the solvent was<br>
evaporated under reduced pressure. 10 mL of<br>
trifluoroacetic acid was added to the obtained residue<br>
and stirred at room temperature for 1 hour. The solvent<br>
was evaporated under reduced pressure and the obtained<br>
residue was purified with reversed-phase silica gel<br>
column chromatography [eluent; 40-90% acetonitrile<br>
/0.1% trifluoroacetic acid aqueous solution]. Ethyl<br>
acetate and water were added to the obtained purified<br>
substance and pH was adjusted to pH 6.0 with a<br>
saturated sodium hydrogen carbonate aqueous solution.<br>
The organic layer was separated and dried over<br>
anhydrous magnesium sulfate after washed with water,<br>
and the solvent was evaporated under reduced pressure<br>
to obtain 2.3 mg of 2-(benzamido)-4-((E)-2-(pyridin-3-<br>
yl)vinyl)benzoic acid as white solid.<br>
1H-NMR (DMSO-de) 5: 7.39-7.70 (7H, m) , 7.97-8.03 (2H, m) ,<br>
8.08	(1H, d, J = 8.3 Hz), 8.17 (1H, dt, J = 7.9, 1.9<br>
Hz), 8.51 (1H, dd, J = 4.6, 1.5 Hz), 8.86 (1H, d, J =<br>
1.9	Hz), 8.96 (1H, d, J = 1.5 Hz), 12.25-12.50 (1H,<br>
broad).<br>
[0364]<br>
Example 148<br><br><br>
61 mg of 5-benzofuran, 0.10 g of cesium<br>
carbonate, 15 mg of tetrabutylammonium bromide and 24<br>
mg of polymer supported bis(acetato)triphenylphosphine<br>
palladium(II) were added to 1.0 mL of toluene solution<br>
containing 50 mg of tert-butyl 2-(benzamido)-4-<br>
vinylbenzoate at room temperature and stirred at 110C<br>
for 24 hours. After the reaction mixture was cooled to<br>
room temperature, 24 mg of polymer supported<br>
bis(acetato)triphenylphosphine palladium(II) was added<br>
and stirred at 110C for 24 hours. After the reaction<br>
mixture was cooled to room temperature, ethyl acetate<br>
and 10% citric acid aqueous solution were added. The<br>
organic layer was separated and dried over anhydrous<br>
magnesium sulfate after washed with 10% citric acid<br>
aqueous solution and a saturated sodium chloride<br>
aqueous solution sequentially, and the solvent was<br>
evaporated under reduced pressure. 10 mL of<br>
trifluoroacetic acid was added to the obtained residue<br>
and stirred at room temperature for 1 hour. The solvent<br>
was evaporated under reduced pressure and the obtained<br>
residue was purified with reversed-phase silica gel<br>
column chromatography [eluent; 60-100% acetonitrile<br>
/0.1% trifluoroacetic acid aqueous solution] to obtain<br><br>
220<br>
2.4 mg of 2-(benzamido)-4-((E)-2-(benzofuran-5-<br>
yl)vinyl)benzoic acid.<br>
Hi-NMR (DMSO-de) 5: 6.97-7.02 (1H, m) , 7.35 (1H, d, J =<br>
16.3 Hz), 7.46-7.53 (2H, m) , 7.59-7.74 (5H, m), 7.97-<br>
8.08 (5H, m), 8.95 (1H, s), 12.29-12.47 (1H, broad).<br>
[0365]<br>
Example 149<br><br>
0.12 g of 5-bromobenzofuran, 0.20 g of cesium<br>
carbonate, 30 mg of tetrabutylammonium bromide and 48<br>
mg of polymer supported<br>
di(acetato)dicyclohexylphenylphosphine palladium(II)<br>
were added to 2.0 mL of toluene solution containing<br>
0.10 g of tert-butyl 2-(benzamido)-4-vinylbenzoate at<br>
room temperature and stirred at 110C for 24 hours.<br>
After the reaction mixture was cooled to room<br>
temperature, 48 mg of polymer supported di(acetato)<br>
dicyclohexylphenyl-phosphine palladium(II) was added<br>
and stirred at 110C for 24 hours. After the reaction<br>
mixture was cooled to room temperature, ethyl acetate<br>
and 10% citric acid aqueous solution were added. The<br>
organic layer was separated and dried over anhydrous<br>
magnesium sulfate after washed with 10% citric acid<br>
aqueous solution and a saturated sodium chloride<br>
aqueous solution sequentially, and the solvent was<br>
evaporated under reduced pressure. 2.4 mL of<br><br>
221<br>
tetrahydrofuran, 0.6 mL of water, 0.44 mL of acetic<br>
acid, 0.42 g sodium formate and 50 mg of 3.9%<br>
palladium-carbon (ethylenediamine complex) were added<br>
to the obtained residue and stirred at 50C for 12 hours.<br>
After the reaction mixture was cooled to room<br>
temperature, ethyl acetate and 10% citric acid aqueous<br>
solution were added. The organic layer was separated<br>
and dried over anhydrous magnesium sulfate after washed<br>
with 10% citric acid aqueous solution and a saturated<br>
sodium chloride aqueous solution sequentially, and the<br>
solvent was evaporated under reduced pressure. 10 mL of<br>
trifluoroacetic acid was added to the obtained residue<br>
and stirred at room temperature for 1 hour. The solvent<br>
was evaporated under reduced pressure and the obtained<br>
residue was purified with reversed-phase silica gel<br>
column chromatography [eluent; 60-100% acetonitrile<br>
/0.1% trifluoroacetic acid aqueous solution] to obtain<br>
8.6 mg of 2-(benzamido)-4-(2-(benzofuran-5-<br>
yl)ethyl)benzoic acid as white solid.<br>
1H-NMR (DMSO-d6) 8: 3.02 (4H, s), 6.89 (1H, dd, J = 2.2,<br>
1.0 Hz), 7.09 (1H, dd, J = 8.3, 1.7 Hz), 7.22 (1H, dd,<br>
J = 8.3, 1.6 Hz), 7.49 (1H, d, J = 8.3 Hz), 7.53 (1H, d,<br>
J = 1.7 Hz), 7.57-7.69 (3H, m), 7.92-8.00 (4H, m), 8.69<br>
(1H, d, J = 1.6 Hz), 12.25 (1H, s), 13.54-13.79 (1H,<br>
broad).<br>
[0366]<br>
Example 150<br><br><br>
0.055 mL of triethylamine and 0.036 mL of 4-<br>
fluorobenzoyl chloride were added to 3.5 mL of<br>
methylene chloride solution containing 60 mg of tert-<br>
butyl 2-amino-4-(2,4-difluorophenyl)benzoate at room<br>
temperature sequentially and stirred at the same<br>
temperature for 1 hour. 0.014 mL of triethylamine and<br>
0.012 mL of 4-fluorobenzoyl chloride were added to the<br>
reaction mixture at room temperature sequentially and<br>
stirred at the same temperature for 1 hour. A saturated<br>
sodium hydrogen carbonate aqueous solution was added to<br>
the reaction mixture, and the organic layer was<br>
separated, and the solvent was evaporated under reduced<br>
pressure. The obtained residue was purified with silica<br>
gel column chromatography [Flash Tube 2008 manufactured<br>
by Trikonex Company, eluent; hexane: ethyl acetate =<br>
4:1] to obtain tert-butyl 4-(2,4-difluorophenyl)-2-(4-<br>
fluorobenzamido)benzoate.<br>
10 mL of trifluoroacetic acid was added to<br>
the obtained tert-butyl 4-(2,4-difluorophenyl)-2-(4-<br>
fluorobenzamido)benzoate and stirred at room<br>
temperature for 2 hours. The solvent was evaporated<br>
under reduced pressure and diisopropyl ether was added<br>
to the obtained residue and a solid substance was<br>
separated by filtration to obtain 46 mg of 4-(2,4-<br><br>
223<br>
difluorophenyl)-2-(4-fluorobenzamido)benzoic acid as<br>
white solid.<br>
1H-NMR (DMSO-d6) 6: 7.27 (1H, td, J = 8.5, 2.5 Hz),<br>
7.36-7.50 (4H, m) , 7.63-7.70 (1H, m), 8.00-8.08 (2H, m) ,<br>
8.14 (1H, d, J = 8.3 Hz), 8.89 (1H, s) , 12.24 (1H, s).<br>
[0367]<br>
Examples 151 to 155<br>
The compounds shown in Table 18 were obtained<br>
in the same manner as in Example 150.<br>
[0368]<br>
[Table 18]<br><br>
[0369]<br>
2-(Benzo[1,3]dioxole-5-carboxamido)-4-(2,4-<br>
difluorophenyl)benzoic acid<br>
1H-NMR (DMSO-d6) 6: 6.17 (2H, s) , 7.13 (1H, d, J = 8.0<br>
Hz), 7.26 (1H, td, J = 8.5, 2.5 Hz), 7.36 (1H, d, J -<br>
8.3 Hz), 7.40-7.48 (2H, m), 7.52-7.57 (1H, m), 7.62-<br><br>
224<br>
7.69 (1H, m), 8.13 (1H, d, J = 8.3 Hz), 8.91 (1H, s) ,<br>
12.10 (1H, s).<br>
[0370]<br>
2-(Benzothiazole-2-carboxamido)-4-(2,4-<br>
difluorophenyl)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 7.24-7.32 (1H, m) , 7.42-7.50 (2H, m) ,<br>
7.61-7.73 (3H, m) , 8.16-8.23 (2H, m), 8.27-8.32 (1H, m) ,<br>
8.96-8.98 (1H, m), 13.03 (1H, s).<br>
[0371]<br>
4-(2,4-Difluorophenyl)-2-(4-<br>
(trifluoromethyl)benzamido)benzoic acid<br>
1H-NMR (DMSO-de) 5: 7.23-7.31 (1H, m) , 7.38-7.49 (2H, m) ,<br>
7.64-7.71 (1H, m), 8.00 (2H, d, J = 8.3 Hz), 8.13-8.18<br>
(3H, m) , 8.88-8.89 (1H, m) , 12.32 (1H, s) .<br>
[0372]<br>
4-(2,4-Difluorophenyl)-2-(4-nitrobenzamido)benzoic acid<br>
1H-NMR (DMSO-de) 8: 7.22-7.32 (1H, m) , 7.40-7.49 (2H, m) ,<br>
7.64-7.73 (1H, m) , 8.13-8.23 (3H, m) , 8.42-8.47 (2H, m) ,<br>
8.84-8.85 (1H, m), 12.33 (1H, s).<br>
[0373]<br>
2-Cinnamamido-4-(2,4-difluorophenyl)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.92 (1H, d, J = 15.9 Hz), 7.26 (1H,<br>
td, J = 8.4, 2.3 Hz), 7.36 (1H, dt, J = 8.2, 1.7 Hz),<br>
7.39-7.49 (4H, m) , 7.60-7.70 (2H, m) , 7.71-7.79 (2H, m) ,<br>
8.10 (1H, d, J = 8.3 Hz), 8.84 (1H, s), 11.40 (1H, s).<br>
[0374]<br>
Example 156<br><br><br>
0.056 mL of triethylamine and 0.036 mL of 4-<br>
fluorobenzoyl chloride were added to 3.5 mL of<br>
methylene chloride solution containing 60 mg of tert-<br>
butyl 2-amino-4-((E)-2-(3-methoxyphenyl)vinyl)benzoate<br>
at room temperature sequentially and stirred at the<br>
same temperature for 1 hour. 0.014 mL of triethylamine<br>
and 0.012 mL of 4-fluorobenzoyl chloride were added to<br>
the reaction mixture at room temperature sequentially<br>
and stirred at the same temperature for 1 hour. A<br>
saturated sodium hydrogen carbonate aqueous solution<br>
was added to the reaction mixture, and the organic<br>
layer was separated, and the solvent was evaporated<br>
under reduced pressure. The obtained residue was<br>
purified with silica gel column chromatography [Flash<br>
Tube 2008 manufactured by Trikonex Company, eluent;<br>
hexane: ethyl acetate =4:1] to obtain tert-butyl 2-(4-<br>
fluorobenzamido)-4-((E)-2-(3-<br>
methoxyphenyl)vinyl)benzoate.<br>
10 mL of trifluoroacetic acid was added to<br>
the obtained tert-butyl 2-(4-fluorobenzamido)-4-((E)-2-<br>
(3-methoxyphenyl)vinyl)benzoate and stirred at room<br>
temperature for 2 hours. The solvent was evaporated<br>
under reduced pressure and diisopropyl ether was added<br>
to the obtained residue and a solid substance was<br><br>
226<br>
separated by filtration to obtain 45 mg of 2-(4-<br>
fluorobenzamido)-4-((E)-2-(3-<br>
methoxyphenyl)vinyl)benzoic acid as white solid.<br>
1H-NMR (DMSO-d6) S: 3.82 (3H, s) , 6.90 (1H, dd, J = 7.9,<br>
2.3 Hz), 7.24-7.43 (4H, m), 7.43-7.52 (3H, m), 8.02-<br>
8.08 (3H, m), 8.89 (1H, s), 12.22 (1H, s).<br>
[0375]<br>
Examples 157 to 161<br>
The compounds shown in Table 19 were obtained<br>
in the same manner as in Example 156.<br>
[0376]<br>
[Table 19]<br><br>
[0377]<br>
2-(Benzo[1,3]dioxole-5-carboxamido)-4-((E)-2-(3-<br>
methoxyphenyl)vinyl)benzoic acid<br>
1H-NMR (DMSO-de) 8: 3.82 (3H, s), 6.17 (2H, s) , 6.88-<br>
6.91 (1H, m), 7.13 (1H, d, J = 8.1 Hz), 7.23-7.43 (5H,<br><br>
227<br>
m) , 7.44-7.49 (2H, m), 7.56 (1H, dd, J = 8.3, 1.8 Hz),<br>
8.04 (1H, d, J = 8.3 Hz), 8.90 (1H, s), 12.10 (1H, s),<br>
13.60-13.85 (1H, broad).<br>
[0378]<br>
2-(Benzothiazole-2-carboxamido)-4-((E)-2-(3-<br>
methoxyphenyl)vinyl)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 3.83 (3H, s) , 6.88-6.94 (1H, m) ,<br>
7.25-7.46 (5H, m), 7.54 (1H, d, J = 7.9 Hz), 7.61-7.73<br>
(2H, m), 8.09 (1H, d, J = 7.9 Hz), 8.20 (1H, d, J = 7.8<br>
Hz), 8.30 (1H, d, J = 7.8 Hz), 8.96 (1H, s).<br>
[0379]<br>
4-((E)-2-(3-methoxyphenyl)vinyl)-2-(4-<br>
(trifluoromethyl)benzamido)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 3.82 (3H, s) , 6.88-6.92 (1H, m) ,<br>
7.24-7.44 (5H, m), 7.39 (2H, d, J = 4.9 Hz), 7.52 (1H,<br>
dd, J = 8.3, 1.4 Hz), 8.01 (2H, d, J = 8.2 Hz), 8.07<br>
(1H, d, J = 8.3 Hz), 8.18 (2H, d, J = 8.2 Hz), 8.88 (1H,<br>
d, J = 1.4 Hz), 12.30 (1H, s).<br>
[0380]<br>
4-((E)-2-(3-methoxyphenyl)vinyl)-2-(4-<br>
nitrobenzamido)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 3.82 (3H, s) , 6.90 (1H, dd, J = 7.7,<br>
1.8 Hz), 7.20-7.46 (5H, m), 7.54 (1H, dd, J = 8.3, 1.6<br>
Hz), 8.07 (1H, d, J = 8.3 Hz), 8.17-8.24 (2H, m), 8.46<br>
(2H, d, J = 8.8 Hz), 8.85 (1H, d, J = 1.6 Hz), 12.32<br>
(1H, s).<br>
[0381]<br>
2-cinnamamido-4-((E)-2-(3-methoxyphenyl)vinyl)benzoic<br>
acid<br><br>
228<br>
1H-NMR (DMSO-de) 5: 3.82 (3H, s) , 6.86-6.96 (2H, m) ,<br>
7.22-7.40 (5H, m), 7.42-7.50 (4H, m) , 7.65 (1H, d, J =<br>
15.6 Hz), 7.72-7.79 (2H, m), 8.01 (1H, d, J = 8.3 Hz),<br>
8.82 (1H, s), 11.38 (1H, s) .<br>
[0382]<br>
Example 162<br><br>
0.055 mL of triethylamine and 0.036 mL of 4-<br>
fluorobenzoyl chloride were added to 3.5 mL of<br>
methylene chloride solution containing 60 mg of tert-<br>
butyl 2-amino-4-(3-chlorophenyl)benzoate at room<br>
temperature sequentially and stirred at the same<br>
temperature for 1 hour. 0.014 mL of triethylamine and<br>
0.012 mL of 4-fluorobenzoyl chloride were added to the<br>
reaction mixture at room temperature sequentially and<br>
stirred at the same temperature for 1 hour. A saturated<br>
sodium hydrogen carbonate aqueous solution was added to<br>
the reaction mixture, and the organic layer was<br>
separated, and the solvent was evaporated under reduced<br>
pressure. The obtained residue was purified with silica<br>
gel column chromatography [Flash Tube 2008 manufactured<br>
by Trikonex Company, eluent; hexane: ethyl acetate =<br>
4:1] to obtain tert-butyl 4-(3-chlorophenyl)-2-(4-<br>
fluorobenzamido)benzoate.<br><br>
229<br>
10 mL of trifluoroacetic acid was added to<br>
the obtained tert-butyl 4-(3-chlorophenyl)-2-(4-<br>
fluorobenzamido)benzoate and stirred at room<br>
temperature for 2 hours. The solvent was evaporated<br>
under reduced pressure and diisopropyl ether was added<br>
to the obtained residue and a solid substance was<br>
separated by filtration to obtain 59 mg of 4-(3-<br>
chlorophenyl)-2-(4-fluorobenzamido)benzoic acid as<br>
white solid.<br>
1H-NMR (DMSO-de) 8: 7.46 (2H, t, J = 8.8 Hz), 7.51-7.62<br>
(3H, m) , 7.68-7.74 (1H, m), 7.76 (1H, s), 8.05 (2H, dd,<br>
J = 8.8, 5.4 Hz), 8.14 (1H, d, J = 8.3 Hz), 9.01 (1H, d,<br>
J = 1.7 Hz), 12.20 (1H, s).<br>
[0383]<br>
Examples 163 to 167<br>
The compounds shown in Table 20 were obtained<br>
in the same manner as in Example 162.<br>
[0384]<br>
[Table 20]<br><br><br>
230<br>
[0385]<br>
2-(Benzo[1,3]dioxole-5-carboxamido)-4-(3-<br>
chlorophenyl)benzoic acid<br>
1H-NMR (DMSO-de) 8: 6.17 (2H, s) , 7.14 (1H, d, J = 8.3<br>
Hz), 7.45 (1H, d, J = 1.7 Hz), 7.51-7.60 (4H, m), 7.70<br>
(1H, d, J = 7.6 Hz), 7.76 (1H, s), 8.13 (1H, d, J = 8.3<br>
Hz), 9.02 (1H, d, J = 1.7 Hz), 12.13 (1H, s).<br>
[0386]<br>
2-(Benzothiazole-2-carboxamido)-4-(3-<br>
chlorophenyl)benzoic acid<br>
1H-NMR (DMSO-de) 8: 7.52-7.80 (7H, m) , 8.15-8.23 (2H, m) ,<br>
8.30 (1H, d, J = 8.0 Hz), 9.07 (1H, d, J = 1.7 Hz),<br>
13.03 (1H, s).<br>
[0387]<br>
4-(3-Chlorophenyl)-2-(4-<br>
(trifluoromethyl)benzamido)benzoic acid<br>
1H-NMR (DMSO-de) 8: 7.52-7.62 (3H, m) , 7.71 (1H, dt, J =<br>
7.5, 1.6 Hz), 7.77 (1H, t, J = 1.6 Hz), 8.01 (2H, d, J<br>
= 8.2 Hz), 8.15 (1H, d, J = 8.3 Hz), 8.18 (2H, d, J =<br>
8.2 Hz), 8.99 (1H, d, J = 2.0 Hz), 12.30 (1H, s) .<br>
[0388]<br>
4-(3-Chlorophenyl)-2-(4-nitrobenzamido)benzoic acid<br>
1H-NMR (DMSO-de) 8: 7.51-7.66 (3H, m) , 7.71 (1H, d, J =<br>
7.6 Hz), 7.78 (1H, s), 8.15 (1H, d, J = 8.3 Hz), 8.21<br>
(2H, d, J = 8.8 Hz), 8.45 (2H, d, J = 8.8 Hz), 8.96 (1H,<br>
d, J = 1.5 Hz), 12.32-12.42 (1H, broad).<br>
[0389]<br>
4-(3-Chlorophenyl)-2-cinnamamidobenzoic acid<br><br>
231<br>
1H-NMR (DMSO-de) 8: 6.94 (1H, d, J = 15.6 Hz), 7.40-7.49<br>
(3H, m), 7.50-7.60 (3H, m), 7.62-7.79 (5H, m), 8.10 (1H,<br>
d, J = 8.3 Hz), 8.96 (1H, d, J = 1.7 Hz), 11.40 (1H, s)<br>
[0390]<br>
Example 168<br><br>
0.054 mL of triethylamine and 0.035 mL of 4-<br>
fluorobenzoyl chloride were added to 3.5 mL of<br>
methylene chloride solution containing 60 mg of tert-<br>
butyl 2-amino-4-(benzofuran-2-yl)benzoate at room<br>
temperature sequentially and stirred at the same<br>
temperature for 5 hours. A saturated sodium hydrogen<br>
carbonate aqueous solution was added to the reaction<br>
mixture, and the organic layer was separated, and the<br>
solvent was evaporated under reduced pressure. The<br>
obtained residue was purified with silica gel column<br>
chromatography [Flash Tube 2008 manufactured by<br>
Trikonex Company, eluent; hexane: ethyl acetate = 4:1]<br>
to obtain tert-butyl 4-(benzofuran-2-yl)-2-(4-<br>
fluorobenzamido)benzoate.<br>
10 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 4-(benzofuran-2-yl)-2-(4-<br>
fluorobenzamido)benzoate and stirred at room<br>
temperature for 2 hours. The solvent was evaporated<br>
under reduced pressure and diisopropyl ether was added<br><br>
232<br>
to the obtained residue and a solid substance was<br>
separated by filtration to obtain 52 mg of 4-<br>
(benzofuran-2-yl)-2-(4-fluorobenzamido)benzoic acid as<br>
white solid.<br>
1H-NMR (DMSO-d6) 6: 7.28-7.35 (1H, m) , 7.38-7.42 (1H, m) ,<br>
7.44-7.52 (2H, m), 7.63 (1H, s) , 7.70-7.81 (3H, m) ,<br>
8.04-8.11 (2H, m), 8.16 (1H, d, J = 8.3 Hz), 9.26-9.27<br>
(1H, m), 12.26 (1H, s).<br>
[0391]<br>
Examples 169 to 172<br>
The compounds shown in Table 21 were obtained<br>
in the same manner as in Example 168.<br>
[0392]<br>
[Table 21]<br><br>
[0393]<br>
2-(Benzo[1,3]dioxole-5-carboxamido)-4-(benzofuran-2-<br>
yl)benzoic acid<br>
1H-NMR   (DMSO-d6)   8:   6.18    (2H,   s),   7.15   (1H,   d,   J =   8.0<br>
Hz),   7.28-7.35   (1H,   m),   7.37-7.44   (1H,   m),   7.47   (1H,   d,<br>
J =  1.7  Hz),   7.58   (1H,   dd,   J =  8.2,   1.7   Hz),   7.62   (1H,<br><br>
233<br>
s), 7.70-7.79 (3H, m), 8.15 (1H, d, J = 8.2 Hz), 9.28<br>
(1H, d, J = 1.7 Hz), 12.18 (1H, s).<br>
[0394]<br>
4-(Benzofuran-2-yl)-2-(4-<br>
(trifluoromethyl)benzamido)benzoic acid<br>
1H-NMR (DMSO-d6) 5: 7.29-7.35 (1H, m) , 7.39-7.43 (1H, m) ,<br>
7.63 (1H, d, J = 0.9 Hz), 7.70-7.76 (2H, m), 7.80 (1H,<br>
dd, J = 8.4, 1.7 Hz), 8.01 (2H, d, J = 8.2 Hz), 8.15<br>
(1H, d, J = 8.4 Hz), 8.19 (2H, d, J = 8.2 Hz), 9.24-<br>
9.26 (1H, m), 12.37 (1H, s).<br>
[0395]<br>
4-(Benzofuran-2-yl)-2-(4-nitrobenzamido)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 7.29-7.34 (1H, m) , 7.37-7.43 (1H, m) ,<br>
7.63 (1H, s), 7.70-7.74 (2H, m), 7.81 (1H, dd, J= 8.4,<br>
1.7 Hz), 8.16 (1H, d, J = 8.4 Hz), 8.22 (2H, d, J = 8.8<br>
Hz), 8.45 (2H, d, J = 8.8 Hz), 9.21 (1H, d, J = 1.7 Hz),<br>
12.40 (1H, s).<br>
[0396]<br>
4-(Benzofuran-2-yl)-2-(cinnamamido)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.95 (1H, d, J = 15.4 Hz), 7.29-7.34<br>
(1H, m) , 7.37-7.50 (4H, m), 7.60 (1H, s), 7.66-7.81 (6H,<br>
m), 8.12 (1H, d, J = 8.3 Hz), 9.21 (1H, d, J = 1.7 Hz),<br>
11.47 (1H, s).<br>
[0397]<br>
Example 173<br><br><br>
234<br>
0.044 mL of triethylamine and 0.028 mL of 4-<br>
fluorobenzoyl chloride were added to 3.5 mL of<br>
methylene chloride solution containing 60 mg tert-butyl<br>
2-amino-4-(4-(tert-butoxycarbonyl)oxyphenyl)benzoate at<br>
room temperature sequentially and stirred at the same<br>
temperature for 5 hours. A saturated sodium hydrogen<br>
carbonate aqueous solution was added to the reaction<br>
mixture, and the organic layer was separated, and the<br>
solvent was evaporated under reduced pressure. The<br>
obtained residue was purified with silica gel column<br>
chromatography [Flash Tube 2008 manufactured by<br>
Trikonex Company, eluent; hexane: ethyl acetate = 4:1]<br>
to obtain tert-butyl 4-(4-(tert-<br>
butoxycarbonyl) oxyphenyl)-2-(4-fluorobenzamido)benzoate.<br>
10 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 4-(4-(tert-<br>
butoxycarbonyl) oxyphenyl)-2-(4-fluorobenzamido)benzoate<br>
and stirred at room temperature for 2 hours. The<br>
solvent was evaporated under reduced pressure and<br>
diisopropyl ether was added to the obtained residue and<br>
a solid substance was separated by filtration to obtain<br>
49 mg of 4-(4-hydroxyphenyl)-2-(4-<br>
fluorobenzamido)benzoic acid as white solid.<br>
1H-NMR (DMSO-d6) 6: 6.92 (2H, d, J = 8.8 Hz), 7.42-7.50<br>
(3H, m), 7.58 (2H, d, J = 8.8 Hz), 8.00-8.10 (3H, m) ,<br>
8.98 (1H, d, J = 1.7 Hz), 9.79 (1H, s), 12.24 (1H, s).<br>
[0398]<br>
Examples 174 to 178<br><br>
235<br>
The compounds shown in Table 22 were obtained<br>
in the same manner as in Example 173.<br>
[0399]<br>
[Table 22]<br><br>
[0400]<br>
2-(Benzo[1,3]dioxole-5-carboxamido)-4-(4-<br>
hydroxyphenyl)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.17 (2H, s) , 6.91 (2H, d, J = 8.8<br>
Hz), 7.13 (1H, d, J = 8.4 Hz), 7.42 (1H, dd, J = 8.4,<br>
1.8 Hz), 7.45 (1H, d, J = 1.8 Hz), 7.52-7.61 (3H, m) ,<br>
8.07 (1H, d, J = 8.3 Hz), 8.99 (1H, d, J = 1.6 Hz),<br>
9.78 (1H, s), 12.14 (1H, s), 13.55-13.85 (1H, broad).<br>
[0401]<br>
2-(Benzothiazole-2-carboxamido)-4-(4-<br>
hydroxyphenyl)benzoic acid<br>
1H-NMR (DMSO-d6) 5: 6.93 (2H, d, J = 8.7 Hz) , 7.52 (1H,<br>
dd, J = 8.4, 1.8 Hz), 7.58-7.72 (4H, m), 8.11 (1H, d, J<br>
= 8.4 Hz), 8.17-8.23 (1H, m), 8.28-8.33 (1H, m), 9.03<br><br>
236<br>
(1H, d, J = 1.9 Hz), 9.81 (1H, s), 13.05 (1H, s) ,<br>
13.60-14.00 (1H, broad).<br>
[0402]<br>
4-(4-Hydroxyphenyl)-2- (4-<br>
(trifluoromethyl)benzamido)benzoic acid<br>
1H-NMR (DMSO-d6) 5: 6.90-6.96 (2H, m) , 7.48 (1H, dd, J =<br>
8.5, 1.8 Hz), 7.56-7.63 (2H, m), 8.01 (2H, d, J = 8.2<br>
Hz), 8.09 (1H, d, J = 8.5 Hz), 8.17 (2H, d, J = 8.2 Hz),<br>
8.97 (1H, d, J = 1.8 Hz), 9.70-9.90 (1H, broad), 12.34<br>
(1H, s).<br>
[0403]<br>
4-(4-Hydroxyphenyl)-2-(4-nitrobenzamido)benzoic acid<br>
1H-NMR (DMSO-de) 8: 6.90-6.95 (2H, m) , 7.49 (1H, dd, J =<br>
8.3, 1.9 Hz), 7.56-7.62 (2H, m) , 8.09 (1H, d, J = 8.3<br>
Hz), 8.17-8.23 (2H, m) , 8.41-8.48 (2H, m), 8.94 (1H, d,<br>
J = 1.9 Hz), 9.80 (1H, s), 12.35 (1H, s).<br>
[0404]<br>
2-(Cinnamamido)-4-(4-hydroxyphenyl)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.88-6.95 (3H, m) , 7.38-7.48 (4H, m) ,<br>
7.53-7.59 (2H, m), 7.65 (1H, d, J = 15.6 Hz), 1.12-1.IS<br>
(2H, m), 8.04 (1H, d, J = 8.6 Hz), 8.92 (1H, d, J = 2.0<br>
Hz), 9.77 (1H, s), 11.43 (1H, s), 13.45-13.70 (1H,<br>
broad).<br>
[0405]<br>
Example 179<br><br><br>
237<br>
0.054 mL of triethylamine and 0.034 mL of 4-<br>
fluorobenzoyl chloride were added to 3.5 mL of<br>
methylene chloride solution containing 60 mg of tert-<br>
butyl 2-amino-4-(benzo[l,3]dioxol-5-yl)benzoate at room<br>
temperature sequentially and stirred at the same<br>
temperature for 5 hours. A saturated sodium hydrogen<br>
carbonate aqueous solution was added to the reaction<br>
mixture, and the organic layer was separated, and the<br>
solvent was evaporated under reduced pressure. The<br>
obtained residue was purified with silica gel column<br>
chromatography [Flash Tube 2008 manufactured by<br>
Trikonex Company, eluent; hexane: ethyl acetate = 4:1]<br>
to obtain tert-butyl 4-(benzo[1,3]dioxol-5-yl)-2-(4-<br>
fluorobenzamido)benzoate.<br>
10 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 4-(benzo[1,3]dioxol-5-yl)-2-(4-<br>
fluorobenzamido)benzoate and stirred at room<br>
temperature for 2 hours. The solvent was evaporated<br>
under reduced pressure and diisopropyl ether was added<br>
to the obtained residue and a solid substance was<br>
separated by filtration to obtain 39 mg of 4-<br>
(benzo[1,3]dioxol-5-yl)-2-(4-fluorobenzamido)benzoic<br>
acid as white solid.<br>
1H-NMR (DMSO-de) 5: 6.11 (2H, s) , 7.08 (1H, d, J = 8.0<br>
Hz), 7.23 (1H, dd, J = 8.0, 1.9 Hz), 7.29 (1H, d, J =<br>
1.9 Hz), 7.43-7.50 (3H, m) , 8.00-8.16 (3H, m), 8.96 (1H,<br>
d, J = 1.9 Hz), 12.20 (1H, s).<br>
[0406]<br>
Examples 180 to 183<br><br>
238<br>
The compounds shown in Table 23 were obtained<br>
in the same manner as in Example 17 9.<br>
[0407]<br>
[Table 23]<br><br>
[0408]<br>
2-(Benzo[1,3]dioxole-5-carboxamido)-4-<br>
(benzo[1,3]dioxol-5-yl)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.11 (2H, s) , 6.17 (2H, s) , 7.07 (1H,<br>
d, J = 8.2 Hz), 7.13 (1H, d, J = 8.2 Hz), 7.23 (1H, dd,<br>
J = 8.2, 1.9 Hz), 7.28 (1H, d, J = 1.9 Hz), 7.42-7.47<br>
(2H, m), 7.55 (1H, dd, J = 8.3, 1.9 Hz), 8.07 (1H, d, J<br>
= 8.3 Hz), 8.97 (1H, d, J = 2.0 Hz), 12.12 (1H, s),<br>
13.65-13.85 (1H, broad).<br>
[0409]<br>
4-(Benzo[1,3]dioxol-5-yl)-2-(benzothiazole-2-<br>
carboxamido)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.12 (2H, s), 7.09 (1H, d, J = 8.0<br>
Hz), 7.22-7.28 (1H, m), 7.31 (1H, d, J = 1.5 Hz), 7.51-<br>
7.57 (1H, m), 7.60-7.75 (2H, m), 8.12 (1H, d, J = 7.8<br><br>
239<br>
Hz), 8.16-8.24 (1H, m), 8.30 (1H, d, J = 7.8 Hz), 9.02<br>
(1H, s) , 13.02 (1H, s) .<br>
[0410]<br>
4-(Benzo[l,3]dioxol-5-yl)-2-(4-<br>
(trifluoromethyl)benzamido)benzoic acid<br>
1H-NMR (DMSO-de) 5: 6.11 (2H, s) , 7.08 (1H, d, J = 8.1<br>
Hz), 7.24 (1H, dd, J = 8.1, 1.8 Hz), 7.30 (1H, d, J =<br>
1.8	Hz), 7.50 (1H, dd, J = 8.4, 1.9 Hz), 8.01 (2H, d, J<br>
= 8.3 Hz), 8.09 (1H, d, J = 8.4 Hz), 8.17 (2H, d, J =<br>
8.3 Hz), 8.95 (1H, d, J = 1.9 Hz), 12.35 (1H, s) .<br>
[0411]<br>
4-(Benzo[l,3]dioxol-5-yl)-2-(cinnamamido)benzoic acid<br>
1H-NMR (DMSO-d6) 5: 6.11 (2H, s), 6.92 (1H, d, J = 15.6<br>
Hz), 7.07 (1H, d, J = 8.1 Hz), 7.21 (1H, dd, J = 8.1,<br>
1.9	Hz), 7.27 (1H, d, J = 1.9 Hz), 7.41-7.49 (4H, m),<br>
7.65 (1H, d, J = 15.6 Hz), 7.72-7.78 (2H, m), 8.04 (1H,<br>
d, J = 8.3 Hz), 8.90 (1H, d, J = 2.0 Hz), 11.43 (1H, s) .<br>
[0412]<br>
Example 184<br><br>
1.7 mL of methylene chloride, 1.0 jiL of N,N-<br>
dimethylformamide and 0.025 mL of oxalyl chloride were<br>
added to 41 mg of 2,3-dimethylbenzoic acid at room<br>
temperature sequentially and stirred at the same<br>
temperature for 1 hour. The reaction mixture was added<br><br>
240<br>
to a mixed solution of 2.8 mL of methylene chloride and<br>
0.36 mL of triethylamine containing 50 mg of tert-butyl<br>
2-amino-4-(benzofuran-2-yl)benzoate and stirred at room<br>
temperature for 1 hour. A saturated sodium hydrogen<br>
carbonate aqueous solution was added to the reaction<br>
mixture, and the organic layer was separated, and the<br>
solvent was evaporated under reduced pressure. The<br>
obtained residue was purified with silica gel column<br>
chromatography [Flash Tube 2008 manufactured by<br>
Trikonex Company, eluent; hexane: ethyl acetate = 4:1]<br>
to obtain tert-butyl 4-(benzofuran-2-yl)-2-(2,3-<br>
dimethylbenzamido)benzoate.<br>
10 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 4-(benzofuran-2-yl)-2-(2, 3-<br>
dimethylbenzamido)benzoate and stirred at room<br>
temperature for 2 hours. The solvent was evaporated<br>
under reduced pressure and ethyl acetate was added to<br>
the obtained residue and a solid substance was<br>
separated by filtration to obtain 15 mg of 4-<br>
(benzofuran-2-yl)-2-(2,3-dimethylbenzamido)benzoic acid<br>
as white solid.<br>
1H-NMR (DMSO-de) 8: 2.33 (3H, s) , 2.35 (3H, s) , 7.25 (1H,<br>
t, J = 7.6 Hz), 7.29-7.46 (4H, m), 7.64 (1H, s), 7.71-<br>
7.76 (2H, m), 7.78 (1H, dd, J = 8.3, 1.7 Hz), 8.13 (1H,<br>
d, J = 8.3 Hz), 9.26-9.28 (1H, m) , 11.65 (1H, s).<br>
[0413]<br>
Example 185<br><br><br>
The following compound was obtained in the<br>
same manner as in Example 184.<br>
4-(Benzofuran-2-yl)-2-(5-(lH-pyrrol-l-yl)pyridine-3-<br>
carboxamide)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.39-6.41 (2H, m) , 7.30-7.43 (2H, m) ,<br>
7.59-7.63 (2H, m), 7.65 (1H, s), 1.11-1.16 (1H, m),<br>
7.83 (1H, dd, J = 8.4, 1.6 Hz), 8.17 (1H, d, J = 8.4<br>
Hz), 8.48-8.51 (1H, m), 9.01 (1H, d, J = 1.5 Hz), 9.18<br>
(1H, d, J = 2.4 Hz), 9.22 (1H, d, J = 1.4 Hz), 12.33<br>
(1H, s).<br>
[0414]<br>
Example 186<br><br>
1.7 mL of methylene chloride, 1.0 \xL of N,N-<br>
dimethylformamide and 0.025 mL of oxalyl chloride were<br>
added to 41 mg of 2,3-dimethylbenzoic acid at room<br>
temperature sequentially and stirred at the same<br>
temperature for 1 hour. The reaction mixture was added<br>
to a mixed solution of 62 mg of tert-butyl 2-amino-4-<br>
(4-(tert-butoxycarbonyl)oxyphenyl)benzoate, 2.8 mL of<br>
methylene chloride and 0.36 mL triethylamine and<br><br>
242<br>
stirred at room temperature for 1 hour. A saturated<br>
sodium hydrogen carbonate aqueous solution was added to<br>
the reaction mixture, and the organic layer was<br>
separated, and the solvent was evaporated under reduced<br>
pressure. The obtained residue was purified with silica<br>
gel column chromatography [Flash Tube 2008 manufactured<br>
by Trikonex Company, eluent; hexane: ethyl acetate =<br>
4:1] to obtain tert-butyl 2-(2,3-dimethylbenzamido)-4-<br>
(4-(tert-butoxycarbonyl)oxyphenyl)benzoate.<br>
10 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 2-(2,3-dimethylbenzamido)-4-(4-<br>
(tert-butoxycarbonyl)oxyphenyl)benzoate and stirred at<br>
room temperature for 2 hours. The solvent was<br>
evaporated under reduced pressure and ethyl acetate was<br>
added to the obtained residue and a solid substance was<br>
separated by filtration to obtain 20 mg of 2-(2,3-<br>
dimethylbenzamido)-4-(4-hydroxyphenyl)benzoic acid as<br>
white solid.<br>
1H-NMR (DMSO-de) 5: 2.31 (3H, s) , 2.33 (3H, s) , 6.90-<br>
6.95 (2H, m), 7.23 (1H, t, J = 7.5 Hz), 7.34 (1H, d, J<br>
= 7.5 Hz), 7.40 (1H, d, J = 7.5 Hz), 7.44 (1H, dd, J =<br>
8.3, 1.7 Hz), 7.56-7.60 (2H, m), 8.05 (1H, d, J = 8.3<br>
Hz), 8.97-8.99 (1H, m), 9.75-9.85 (1H, broad), 11.59<br>
(1H, s), 13.40-13.70 (1H, broad).<br>
[0415]<br>
Example 187<br><br><br>
The following compound was obtained in the<br>
same manner as in Example 186.<br>
4-(4-Hydroxyphenyl)-2-(5-(lH-pyrrol-l-yl)pyridine-3-<br>
carboxamido)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.39 (2H, s), 6.93 (2H, d, J = 8.5<br>
Hz), 7.50 (1H, dd, J = 8.4, 1.3 Hz), 7.56-7.65 (4H, m),<br>
8.09 (1H, d, J = 8.0 Hz), 8.47 (1H, s), 8.93-8.99 (2H,<br>
m) , 9.17 (1H, d, J = 2.2 Hz), 9.80 (1H, s), 12.31 (1H,<br>
s).<br>
[0416]<br>
Example 188<br><br>
1.7 mL of methylene chloride, 1.0 |J.L N,N-<br>
dimethylformamide and 0.025 mL of oxalyl chloride were<br>
added to 41 mg of 2,3-dimethylbenzoic acid at room<br>
temperature sequentially and stirred at the same<br>
temperature for 1 hour. The reaction mixture was added<br>
to a mixed solution of 50 mg of tert-butyl 2-amino-4-<br>
(benzo[l,3]dioxol-5-yl)benzoate, 2.8 mL of methylene<br>
chloride and 0.36 mL of triethylamine and stirred at<br><br>
244<br>
room temperature for 1 hour. A saturated sodium<br>
hydrogen carbonate aqueous solution was added to the<br>
reaction mixture, and the organic layer was separated,<br>
and the solvent was evaporated under reduced pressure.<br>
The obtained residue was purified with silica gel<br>
column chromatography [Flash Tube 2008 manufactured by<br>
Trikonex Company, eluent; hexane: ethyl acetate = 4:1]<br>
to obtain tert-butyl 4-(benzo[1,3]dioxol-5-yl)-2-(2,3-<br>
dimethylbenzamido)benzoate.<br>
10 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 4-(benzo[1,3]dioxol-5-yl)-2-(2,3-<br>
dimethylbenzamido)benzoate and stirred at room<br>
temperature for 2 hours. The solvent was evaporated<br>
under reduced pressure and methanol was added to the<br>
obtained residue and a solid substance was separated by<br>
filtration to obtain 31 mg of 4-(benzo[1,3]dioxol-5-<br>
yl)-2-(2,3-dimethylbenzamido)benzoic acid as white<br>
solid.<br>
1H-NMR (DMSO-d6) 8: 2.31 (3H, s) , 2.33 (3H, s) , 6.11 (2H,<br>
s), 7.08 (1H, d, J = 8.1 Hz), 7.20-7.27 (2H, m), 7.29<br>
(1H, d, J = 1.7 Hz), 7.34 (1H, d, J = 7.3 Hz), 7.40 (1H,<br>
d, J = 7.3 Hz), 7.46 (1H, dd, J = 8.4, 1.8 Hz), 8.05<br>
(1H, d, J = 8.4 Hz), 8.93-9.00 (1H, broad), 11.58 (1H,<br>
s), 13.55-13.75 (1H, broad).<br>
[0417]<br>
Example 189<br><br><br>
1.7 mL of methylene chloride, 1.0 |4.L of N,N-<br>
dimethylformamide and 0.025 mL of oxalyl chloride were<br>
added to 41 mg of 2,3-dimethylbenzoic acid at room<br>
temperature sequentially and stirred at the same<br>
temperature for 1 hour. The reaction mixture was added<br>
to a mixed solution of 49 mg of tert-butyl 2-amino-4-<br>
(2,4-difluorophenyl)benzoate, 2.8 mL of methylene<br>
chloride and 0.36 mL of triethylamine and stirred at<br>
room temperature for 1 hour. A saturated sodium<br>
hydrogen carbonate aqueous solution was added to the<br>
reaction mixture, and the organic layer was separated,<br>
and the solvent was evaporated under reduced pressure.<br>
The obtained residue was purified with silica gel<br>
column chromatography [Flash Tube 2008 manufactured by<br>
Trikonex Company, eluent; hexane: ethyl acetate = 4:1]<br>
to obtain tert-butyl 4-(2,4-difluorophenyl)-2-(2,3-<br>
dimethylbenzamido)benzoate.<br>
10 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 4-(2,4-difluorophenyl)-2-(2,3-<br>
dimethylbenzamido)benzoate and stirred at room<br>
temperature for 2 hours. The solvent was evaporated<br>
under reduced pressure and methanol was added to the<br>
obtained residue and a solid substance was separated by<br><br>
246<br>
filtration to obtain 17 mg of 4-(2,4-difluorophenyl)-2-<br>
(2,3-dimethylbenzamido)benzoic acid as white solid.<br>
1H-NMR (DMSO-d6) 6: 2.31 (3H, s), 2.31 (3H, s), 7.21-<br>
7.30 (2H, m), 7.31-7.49 (4H, m), 7.63-7.70 (1H, m),<br>
8.11 (1H, d, J = 8.0 Hz), 8.89 (1H, s) , 11.58 (1H, s).<br>
[0418]<br>
Example 190<br><br>
The following compound was obtained in the<br>
same manner as in Example 189.<br>
4-(2,4-Difluorophenyl)-2-(5-(lH-pyrrol-l-yl)pyridine-3-<br>
carboxamido)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.39 (2H, t, J = 2.2 Hz), 7.28 (1H,<br>
td, J = 8.7, 2.2 Hz), 7.42-7.48 (2H, m), 7.59 (2H, t, J<br>
= 2.2 Hz), 7.68 (1H, td, J = 8.7, 6.6 Hz), 8.16 (1H, d,<br>
J = 8.0 Hz), 8.46 (1H, t, J = 2.2 Hz), 8.85 (1H, d, J =<br>
1.4 Hz), 8.97 (1H, d, J = 1.7 Hz), 9.17 (1H, d, J = 2.3<br>
Hz), 12.22 (1H, s).<br>
[0419]<br>
Example 191<br><br><br>
247<br>
1.7 mL of methylene chloride, 1.0 (iL of N,N-<br>
dimethylformamide and 0.025 mL of oxalyl chloride were<br>
added to 41 mg of 2,3-dimethylbenzoic acid at room<br>
temperature sequentially and stirred at the same<br>
temperature for 1 hour. The reaction mixture was added<br>
to a mixed solution of 52 mg of tert-butyl 2-amino-4-<br>
((E)-2-(3-methoxyphenyl)vinyl)benzoate, 2.8 mL of<br>
methylene chloride and 0.36 mL of triethylamine and<br>
stirred at room temperature for 1 hour. A saturated<br>
sodium hydrogen carbonate aqueous solution was added to<br>
the reaction mixture, and the organic layer was<br>
separated, and the solvent was evaporated under reduced<br>
pressure. The obtained residue was purified with silica<br>
gel column chromatography [Flash Tube 2008 manufactured<br>
by Trikonex Company, eluent; hexane: ethyl acetate =<br>
4:1] to obtain tert-butyl 2-(2,3-dimethylbenzamido)-4-<br>
((E)-2-(3-methoxyphenyl)vinyl)benzoate.<br>
10 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 2-(2,3-dimethylbenzamido)-4-((E)-2-<br>
(3-methoxyphenyl)vinyl)benzoate and stirred at room<br>
temperature for 2 hours. The solvent was evaporated<br>
under reduced pressure and methanol was added to the<br>
obtained residue and a solid substance was separated by<br>
filtration to obtain 15 mg of 2-(2,3-<br>
dimethylbenzamido)-4-((E)-2-(3-<br>
methoxyphenyl)vinyl)benzoic acid as white solid.<br>
1H-NMR (DMSO-de) 8: 2.31 (3H, s) , 2.33 (3H, s) , 3.82 (3H,<br>
s), 6.88-6.91 (1H, m) , 7.21-7.52 (9H, m), 8.02 (1H, d,<br>
J = 8.3 Hz), 8.89 (1H, s), 11.59 (1H, s), 13.60 (1H, s).<br><br><br>
The following compound was obtained in the<br>
same manner as in Example 191.<br>
4-((E)-2-(3-Methoxyphenyl)vinyl)-2- (5-(lH-pyrrol-1-<br>
yl)pyridine-3-carboxamido)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 3.83 (3H, s), 6.40 (2H, t, J = 2.2<br>
Hz), 6.91 (1H, ddd, J = 8.0, 2.5, 0.9 Hz), 7.25-7.44<br>
(5H, m), 7.53 (1H, dd, J = 8.3, 1.6 Hz), 7.59 (2H, t, J<br>
= 2.2 Hz), 8.07 (1H, d, J = 8.3 Hz), 8.45-8.47 (1H, m) ,<br>
8.84 (1H, d, J = 1.7 Hz), 8.99 (1H, d, J = 1.6 Hz),<br>
9.17 (1H, d, J = 2.4 Hz), 12.20-12.35 (1H, broad).<br>
[0421]<br>
Example 193<br><br>
1.7 mL of methylene chloride, 1.0 ^L of N,N-<br>
dimethylformamide and 0.025 mL of oxalyl chloride were<br>
added to 41 mg of 2,3-dimethylbenzoic acid at room<br>
temperature sequentially and stirred at the same<br>
temperature for 1 hour. The reaction mixture was added<br><br>
249<br>
to a mixed solution of 49 mg of tert-butyl 2-amino-4-<br>
(3-chlorophenyl)benzoate, 2.8 mL of methylene chloride<br>
and 0.36 mL of triethylamine and stirred at room<br>
temperature for 1 hour. A saturated sodium hydrogen<br>
carbonate aqueous solution was added to the reaction<br>
mixture, and the organic layer was separated, and the<br>
solvent was evaporated under reduced pressure. The<br>
obtained residue was purified with silica gel column<br>
chromatography [Flash Tube 2008 manufactured by<br>
Trikonex Company, eluent; hexane: ethyl acetate = 4:1]<br>
to obtain tert-butyl 4-(3-chlorophenyl)-2-(2,3-<br>
dimethylbenzamido)benzoate.<br>
10 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 4-(3-chlorophenyl)-2-(2,3-<br>
dimethylbenzamido)benzoate and stirred at room<br>
temperature for 2 hours. The solvent was evaporated<br>
under reduced pressure and methanol was added to the<br>
obtained residue and a solid substance was separated by<br>
filtration to obtain 32 mg of 4-(3-chlorophenyl)-2-<br>
(2,3-dimethylbenzamido)benzoic acid as white solid.<br>
1H-NiyiR (DMSO-d6) 8: 2.31 (3H, s), 2.33 (3H, s) , 7.24 (1H,<br>
t, J = 7.5 Hz), 7.34 (1H, d, J = 7.5 Hz), 7.41 (1H, d,<br>
J = 7.5 Hz), 7.52-7.61 (3H, m) , 7.69-7.78 (2H, m), 8.11<br>
(1H, d, J = 8.3 Hz), 9.01 (1H, s), 11.58 (1H, s),<br>
13.60-13.90 (1H, broad).<br>
[0422]<br>
Examples 194, 195<br>
The compounds shown in Table 24 were obtained<br>
in the same manner as in Example 193.<br><br><br>
[0424]<br>
4-(3-Chlorophenyl)-2-(5-(lH-pyrrol-1-yl)pyridine-3-<br>
carboxamido)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.39 (2H, t, J = 2.2 Hz), 7.52-7.64<br>
(5H, m), 7.72 (1H, dt, J = 7.6, 1.6 Hz), 7.78 (1H, t, J<br>
= 1.6 Hz), 8.15 (1H, d, J = 8.3 Hz), 8.46-8.48 (1H, m),<br>
8.96 (1H, d, J = 1.7 Hz), 8.99 (1H, d, J = 1.7 Hz),<br>
9.17 (1H, d, J = 2.7 Hz), 12.23 (1H, s) .<br>
[0425]<br>
1H-NMR (DMSO-d6) 8: 2.32 (3H, s) , 7.39 (2H, d, J = 8.5<br>
Hz), 7.52-7.62 (3H, m) , 7.68-7.74 (1H, m), 7.77 (1H, s),<br>
8.03 (2H, d, J = 8.5 Hz), 8.14 (1H, d, J = 8.3 Hz),<br>
9.03 (1H, d, J = 1.7 Hz), 12.23 (1H, s).<br>
[0426]<br>
Example 196<br><br><br>
251<br>
7.6 mg of potassium carbonate was added to a<br>
mixed solution of 0.5 mL of methanol and 0.5 mL of<br>
tetrahydrofuran containing 15 mg of 2-(4-<br>
acetoxybenzamido)-4-(3-chlorophenyl)benzoic acid and<br>
stirred at room temperature for 2 hours. After<br>
insoluble were removed by filtration, 10% citric acid<br>
aqueous solution was added and a solid substance was<br>
separated by filtration to obtain 10 mg of 4-(3-<br>
chlorophenyl)-2-(4-hydroxybenzamido)benzoic acid as<br>
white solid.<br>
1H-NMR (DMSO-d6) 5: 6.91-6.97 (2H, m) , 7.47-7.60 (3H, m) ,<br>
7.69 (1H, dt, J = 7.5, 1.6 Hz), 7.75 (1H, t, J = 1.6<br>
Hz), 7.83-7.89 (2H, m), 8.12 (1H, d, J = 8.3 Hz), 9.07<br>
(1H, d, J = 1.9 Hz), 10.28 (1H, s) .<br>
[0427]<br>
Example 197<br><br>
0.21 mL of cyclopentene, 0.14 g of potassium<br>
acetate, 0.13 g of tetrabutylammonium chloride, 3.1 mg<br>
of triphenylphosphine and 2.7 mg of palladium acetate<br>
were added to 1.0 mL of N-dimethylformamide solution<br>
containing 0.20 g of tert-butyl 2-(benzamido)-4-<br>
iodobenzoate at room temperature and stirred under<br>
nitrogen atmosphere at the same temperature for 17<br>
hours.  0.21 mL of cyclopentene, 23 mg of potassium<br>
acetate, 3.1 mg of triphenylphosphine and 2.7 mg of<br><br>
252<br>
palladium acetate were added to the reaction mixture<br>
and stirred at 70C for 3 hours after stirred at room<br>
temperature for 9 hours. After the reaction mixture was<br>
cooled to room temperature, ethyl acetate and 10%<br>
citric acid aqueous solution were added. The organic<br>
layer was separated and dried over anhydrous magnesium<br>
sulfate after washed with 10% citric acid aqueous<br>
solution and a saturated sodium chloride aqueous<br>
solution sequentially, and the solvent was evaporated<br>
under reduced pressure. The obtained residue was<br>
purified with silica gel column chromatography [eluent;<br>
toluene] to obtain 94 mg of tert-butyl 2-(benzamido)-4-<br>
(2-cyclopenten-l-yl)benzoate as white solid.<br>
1H-NMR (CDC13) 8: 1.62 (9H, s) , 1.72-1.84 (1H, m) , 2.37-<br>
2.61 (3H, m), 3.94-4.03 (1H, m) , 5.78-5.82 (1H, m) ,<br>
5.98-6.03 (1H, m), 6.93 (1H, dd, J = 8.3, 1.6 Hz),<br>
7.49-7.59 (3H, m), 7.94 (1H, d, J = 8.3 Hz), 8.04-8.09<br>
(2H, m), 8.80 (1H, d, J = 1.6 Hz), 12.22 (1H, s).<br>
[0428]<br>
Example 198<br><br>
10 mL of trifluoroacetic acid solution<br>
containing 87 mg of tert-butyl 2-(benzamido)-4-(2-<br>
cyclopenten-1-yl)benzoate was stirred at room<br>
temperature for 1 hour. The solvent was evaporated<br>
under reduced pressure and methanol was added to the<br><br>
253<br>
obtained residue and a solid substance was separated by<br>
filtration to obtain 52 mg of 2-(benzamido)-4-(2-<br>
cyclopenten-l-yl)benzoic acid as white solid.<br>
1H-NMR (DMSO-de) 5: 1.62-1.74 (1H, m) , 2.35-2.55 (3H, m) ,<br>
3.92-4.00 (1H, m) , 5.78-5.83 (1H, m) , 6.00-6.04 (1H, m) ,<br>
7.03 (1H, dd, J = 8.2, 1.5 Hz), 7.57-7.68 (3H, m) ,<br>
7.93-8.01 (3H, m), 8.63 (1H, d, J = 1.5 Hz), 12.24 (1H,<br>
s) .<br>
[0429]<br>
Example 199<br><br>
5.0 mg of 5% palladium-carbon was added to a<br>
mixed solution of 1.0 mL of methanol and 0.5 mL of<br>
ethyl acetate containing 25 mg of 2-(benzamido)-4-(2-<br>
cyclopenten-1-yl)benzoic acid and stirred at room<br>
temperature under hydrogen atmosphere for 7 hours and<br>
then at 40C for 8 hours and stirred at 45C for 15<br>
hours.  Insoluble were removed by filtration and the<br>
solvent was evaporated under reduced pressure. Methanol<br>
was added to the obtained residue and a solid substance<br>
was separated by filtration to obtain 16 mg of 2-<br>
(benzamido)-4-cyclopentyl benzoic acid as white solid.<br>
1H-NMR (DMSO-de) 8: 1.52-1.86 (6H, m) , 1.98-2.12 (2H, m) ,<br>
3.02-3.12 (1H, m), 7.10 (1H, dd, J = 8.0, 1.6 Hz),<br>
7.57-7.68 (3H, m), 7.94-8.00 (3H, m), 8.70 (1H, d, J =<br>
1.6 Hz), 12.22 (1H, s).<br><br><br>
0.11 g of 4-nitrophenylboronic acid, 0.11 g of<br>
sodium hydrogen carbonate, 1.2 mL of ethanol, 0.6 mL of<br>
water and 31 mg of<br>
tetrakis(triphenylphosphine)palladium(O) were added to<br>
4.0 mL of toluene solution containing 0.20 g of tert-<br>
butyl 2-(benzamido)-4-bromobenzoate, and the resulting<br>
mixture was heated to reflux under nitrogen atmosphere<br>
for 3 hours. A saturated sodium hydrogen carbonate<br>
aqueous solution was added after the reaction mixture<br>
was cooled to room temperature. The organic layer was<br>
separated and dried over anhydrous magnesium sulfate<br>
after washed with a saturated sodium chloride aqueous<br>
solution, and the solvent was evaporated under reduced<br>
pressure. The obtained residue was purified with silica<br>
gel column chromatography [PSQ100B (spherical)<br>
manufactured by Fuji Silysia Chemical Ltd., eluent;<br>
hexane: ethyl acetate = 10:1] to obtain 40 mg of tert-<br>
butyl 2-(benzamido)-4-(4-nitrophenyl)benzoate as white<br>
solid.<br>
1H-NMR (DMSO-d6) 8: 1.57 (9H, s), 7.60-7.70 (4H, m) ,<br>
7.98-8.04 (3H, m), 8.09 (1H, d, J = 8.8 Hz), 8.35-8.40<br>
(3H, m), 8.90 (1H, d, J = 1.7 Hz), 11.66 (1H, s).<br><br>
255<br>
[0431]<br>
Examples 201 to 205<br>
The compounds shown in Table 25 were obtained<br>
in the same manner as in Example 200.<br>
[0432]<br>
[Table 25]<br><br>
[0433]<br>
tert-Butyl 2-(benzamido)-4-(4-chlorophenyl)benzoate<br>
1H-NMR (DMSO-de) 5: 1.57 (9H, s) , 7.55 (1H, dd, J = 8.4,<br>
1.6 Hz), 7.58-7.70 (5H, m) , 7.73-7.78 (2H, m), 7.97-<br>
8.02 (2H, m), 8.04 (1H, d, J = 8.4 Hz), 8.85 (1H, d, J<br>
=1.6 Hz), 11.69 (1H, s).<br>
[0434]<br>
tert-Butyl 2-(benzamido)-4-(3,5-dichlorophenyl)benzoate<br>
1H-NMR (DMSO-de) 8: 1.56 (9H, s) , 7.60-7.70 (4H, m) ,<br>
7.72-7.73 (1H, m), 7.77 (2H, d, J = 1.7 Hz), 7.98-8.04<br>
(3H, m) , 8.77 (1H, d, J = 2.0 Hz), 11.58 (1H, s) .<br>
[0435]<br>
tert-Butyl 2-(benzamido)-4-(3,5-dimethyl-4-<br>
hydroxyphenyl)benzoate<br><br>
256<br>
1H-NMR (CDCI3) 8: 1.65 (9H, s) , 2.33 (6H, s) , 4.78 (1H,<br>
s), 7.29 (1H, dd, J = 8.4, 1.8 Hz), 7.36 (2H, s), 7.51-<br>
7.60 (3H, m), 8.03 (1H, d, J = 8.4 Hz), 8.06-8.11 (2H,<br>
m) , 9.18 (1H, d, J = 1.8 Hz), 12.28 (1H, s) .<br>
[0436]<br>
tert-Butyl 2-(benzamido)-4-(2-oxoindolin-5-yl)benzoate<br>
1H-NMR (CDCI3) 5: 1.65 (9H, s) , 3.64 (2H, s) , 6.96 (1H,<br>
d, J = 8.1 Hz), 7.29 (1H, dd, J = 8.5, 1.9 Hz), 7.52-<br>
7.65 (5H, m) , 7.82 (1H, s) , 8.05-8.11 (3H, m) , 9.22 (1H,<br>
d, J = 1.9 Hz), 12.30 (1H, s).<br>
[0437]<br>
tert-Butyl 2-(benzamido)-4-(3-chloro-2-<br>
fluorophenyl)benzoate<br>
1H-NMR (DMSO-d6) 8: 1.57 (9H, s), 7.40 (1H, t, J = 7.9<br>
Hz), 7.43-7.47 (1H, m) , 7.54-7.72 (5H, m) , 7.96-8.01<br>
(2H, m), 8.07 (1H, d, J = 8.3 Hz), 8.72 (1H, s), 11.66<br>
(1H, s).<br>
[0438]<br>
Example 206<br><br>
0.10 g of 2,6-difluorophenylboronic acid, 0.52<br>
g of cesium carbonate, 2.4 mg of palladium acetate and<br>
2.2 mg of 2-dicyclohexylphosphino-2',6'-<br>
dimethoxybiphenyl were added to 2.5 mL of toluene<br>
solution containing 0.20 g of tert-butyl 2-(benzamido)-<br>
4-bromobenzoate at room temperature sequentially, and<br><br>
257<br>
stirred under nitrogen atmosphere at 80C for 1 hour and<br>
10 minutes and then heated to reflux for 1 hour. After<br>
the reaction mixture was cooled to room temperature,<br>
2.4 mg of palladium acetate and 2.2 mg of 2-<br>
dicyclohexylphosphino-2', 6'-dimethoxybiphenyl were<br>
added and the resulting mixture was heated to reflux<br>
under nitrogen atmosphere for 1 hour. After the<br>
reaction mixture was cooled to room temperature, 2.4 mg<br>
of palladium acetate and 2.2 mg of 2-<br>
dicyclohexylphosphino-2',6'-dimethoxybiphenyl were<br>
added and the resulting mixture was heated to reflux<br>
under nitrogen atmosphere for 1 hour. After the<br>
reaction mixture was cooled to room temperature, were<br>
added 2.0 mL of toluene, 0.04 g of 2,6-<br>
difluorophenylboronic acid, 2.4 mg of palladium acetate<br>
and 2.2 mg of 2-dicyclohexylphosphino-2',6'-<br>
dimethoxybiphenyl and the resulting mixture was heated<br>
to reflux under nitrogen atmosphere for 1 hour. A<br>
saturated sodium hydrogen carbonate aqueous solution<br>
and ethyl acetate were added after the reaction mixture<br>
was cooled to room temperature. The organic layer was<br>
separated and dried over anhydrous magnesium sulfate<br>
after washed with a saturated sodium hydrogen carbonate<br>
aqueous solution and a saturated sodium chloride<br>
aqueous solution sequentially, and the solvent was<br>
evaporated under reduced pressure. The obtained residue<br>
was purified with silica gel column chromatography<br>
[PSQ100B (spherical) manufactured by Fuji Silysia<br>
Chemical Ltd., eluent; hexane: ethyl acetate = 20:1] to<br><br>
258<br>
obtain 31 mg of tert-butyl 2-(benzamido)-4-(2,6-<br>
difluorophenyl)benzoate as white solid.<br>
1H-NMR (DMSO-d6) 5: 1.57 (9H, s) , 7.26-7.36 (3H, m) ,<br>
7.53-7.67 (4H, m), 7.95-8.00 (2H, m), 8.07 (1H, d, J =<br>
8.0 Hz), 8.57-8.61 (1H, m) , 11.63 (1H, s).<br>
[0439]<br>
Example 207<br><br>
48 mg of 5-bromobenzothiophene, 40 mg of<br>
sodium hydrogen carbonate, 0.6 mL of ethanol, 0.3 mL of<br>
water and 11 mg of tetrakis(triphenylphosphine)-<br>
palladium(0) were added to 1.6 mL of toluene solution<br>
containing 80 mg of tert-butyl 2-(benzamido)-4-<br>
(4,4,5,5-tetramethyl-l,3,2-dioxaborolan-2-yl)benzoate<br>
at room temperature, and the resulting mixture was<br>
heated to reflux under nitrogen atmosphere for 5 hours.<br>
Ethyl acetate and water were added after the reaction<br>
mixture was cooled to room temperature. The organic<br>
layer was separated and dried over anhydrous magnesium<br>
sulfate after washed with a saturated sodium chloride<br>
aqueous solution, and the solvent was evaporated under<br>
reduced pressure. The obtained residue was purified<br>
with silica gel column chromatography [PSQ100B<br>
(spherical) manufactured by Fuji Silysia Chemical Ltd.,<br>
eluent; hexane: ethyl acetate = 20:1] to obtain 47 mg<br><br>
259<br>
of tert-butyl 2-(benzamido)-4-(benzothiophen-5-<br>
yl)benzoate as white solid.<br>
1H-NMR (CDC13) 8: 1.66 (9H, s) , 7.40-7.44 (2H, m) , 7.50<br>
(1H, d, J= 5.4 Hz), 7.51-7.61 (3H, m), 7.71 (1H, dd, J<br>
= 8.5, 1.7 Hz), 7.96 (1H, d, J = 8.3 Hz), 8.08-8.13 (3H,<br>
m), 8.19 (1H, d, J = 1.5 Hz), 9.34 (1H, d, J = 1.7 Hz),<br>
12.31 (1H, s).<br>
[0440]<br>
Examples 208 to 210<br>
The compounds shown in Table 26 were obtained<br>
in the same manner as in Example 207.<br>
[0441]<br>
[Table 26]<br><br>
[0442]<br>
tert-Butyl 2-(benzamido)-4-(benzofuran-5-yl)benzoate<br>
1H-NMR (CDCI3) 8: 1.66 (9H, s) , 6.84 (1H, dd, J = 2.2,<br>
1.0 Hz), 7.38 (1H, dd, J = 8.3, 2.0 Hz), 7.51-7.61 (4H,<br>
m), 7.64-7.68 (2H, m), 7.96 (1H, d, J = 1.5 Hz), 8.07-<br>
8.12 (3H, m), 9.30 (1H, d, J = 2.0 Hz), 12.29 (1H, s).<br>
[0443]<br>
tert-Butyl 2-(benzamido)-4-(lH-indol-4-yl)benzoate<br><br>
260<br>
1H-NMR (CDCI3) 8: 1.66 (9H, s), 6.93-6.97 (1H, m), 7.24-<br>
7.36 (3H, m), 7.40-7.50 (2H, m), 7.50-7.60 (3H, m),<br>
8.07-8.13 (2H, m), 8.13 (1H, d, J = 8.3 Hz), 8.31 (1H,<br>
s), 9.33 (1H, d, J = 1.5 Hz), 12.24 (1H, s) .<br>
[0444]<br>
tert-Butyl 2-(benzamido)-4-(4-(lH-pyrrol-1-<br>
yl)phenyl)benzoate<br>
1H-NMR (CDCI3) 5: 1.66 (9H, s) , 6.38 (2H, t, J = 2.2 Hz),<br>
7.16 (2H, t, J = 2.2 Hz), 7.35 (1H, dd, J = 8.3, 1.7<br>
Hz), 7.47-7.52 (2H, m) , 7.52-7.61 (3H, m), 7.76-7.82<br>
(2H, m) , 8.07-8.12 (3H, m), 9.29 (1H, d, J = 1.7 Hz),<br>
12.29 (1H, s).<br>
[0445]<br>
Example 211<br><br>
3.0 mL of trifluoroacetic acid solution<br>
containing 40 mg of tert-butyl 2-(benzamido)-4-(4-<br>
nitrophenyl)benzoate was stirred at room temperature<br>
for 1 hour. The solvent was evaporated under reduced<br>
pressure and ethyl acetate and methanol were added to<br>
the obtained residue and a solid substance was<br>
separated by filtration to obtain 15 mg of 2-<br>
(benzamido)-4-(4-nitrophenyl)benzoic acid as white<br>
solid.<br><br>
261<br>
1H-NMR (DMSO-d6) 8: 7.60-7.70 (4H, m) , 7.98-8.04 (4H, m) ,<br>
8.20 (1H, d, J - 8.6 Hz), 8.39 (2H, d, J = 8.5 Hz),<br>
9.16 (1H, s), 12.26-12.32 (1H, broad).<br>
[0446]<br>
Examples 212 to 221<br>
The compounds shown in Table 27 were obtained<br>
in the same manner as in Example 211.<br>
[0447]<br>
[Table 27]<br><br>
[0448]<br>
2-(Benzamido)-4-(4-chlorophenyl)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 7.53 (1H, dd, J = 8.3, 1.8 Hz),<br>
7.59-7.70 (5H, m) , 7.75-7.79 (2H, m) , 7.97-8.01 (2H, m) ,<br>
8.14 (1H, d, J = 8.3 Hz), 9.08 (1H, d, J = 1.8 Hz),<br>
12.28 (1H, s).<br>
[0449]<br>
2-(Benzamido)-4-(3,5-dichlorophenyl)benzoic acid<br><br>
262<br>
1H-NMR (DMSO-de) 5: 7.58-7.70 (4H, m), 7.73 (1H, t, J =<br>
1.8 Hz), 7.77 (2H, d, J = 2.0 Hz), 7.97-8.02 (2H, m),<br>
8.14 (1H, d, J = 8.3 Hz), 9.03 (1H, d, J = 1.7 Hz),<br>
12.24-12.31 (1H, broad).<br>
[0450]<br>
2-(Benzamido)-4-(3,5-dimethyl-4-hydroxyphenyl)benzoic<br>
acid<br>
1H-NMR (DMSO-de) 8: 2.26 (6H, s) , 7.32 (2H, s) , 7.44 (1H,<br>
dd, J = 8.3, 1.8 Hz), 7.58-7.70 (3H, m), 7.96-8.02 (2H,<br>
m) , 8.07 (1H, d, J = 8.3 Hz), 8.60 (1H, s), 9.01 (1H, d,<br>
J= 1.8 Hz), 12.27 (1H, s), 13.60-13.80 (1H, broad).<br>
[0451]<br>
2-(Benzamido)-4-(2-oxoindolin-5-yl)benzoic acid<br>
1H-NMR (DMSO-de) 5: 3.60 (2H, s), 6.97 (1H, d, J = 8.1<br>
Hz), 7.47 (1H, dd, J = 8.5, 1.8 Hz), 7.56-7.70 (5H, m),<br>
7.96-8.02 (2H, m), 8.10 (1H, d, J = 8.5 Hz), 9.06 (1H,<br>
d, J = 1.8 Hz), 10.57 (1H, s), 12.28 (1H, s), 13.60-<br>
13.90 (1H, broad).<br>
[0452]<br>
2-(Benzamido)-4-(3-chloro-2-fluorophenyl)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 7.37-7.44 (2H, m) , 7.56-7.72 (5H, m) ,<br>
7.95-8.00 (2H, m), 8.17 (1H, d, J = 8.3 Hz), 8.97 (1H,<br>
s), 12.22-12.26 (1H, broad).<br>
[0453]<br>
2-(Benzamido)-4-(2,6-difluorophenyl)benzoic acid<br>
1H-NMR (DMSO-de) 8: 7.24-7.35 (3H, m) , 7.52-7.69 (4H, m) ,<br>
7.93-8.00 (2H, m), 8.17 (1H, d, J = 8.3 Hz), 8.86 (1H,<br>
s), 12.24 (1H, s).<br><br>
263<br>
[0454]<br>
2-(Benzamido)-4-(benzothiophen-5-yl)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 7.58-7.71 (5H, m) , 7.74 (1H, dd, J =<br>
8.5, 1.7 Hz), 7.87 (1H, d, J = 5.4 Hz), 7.98-8.04 (2H,<br>
m) , 8.14-8.20 (2H, m), 8.27 (1H, d, J = 1.4 Hz), 9.18<br>
(1H, d, J = 1.7 Hz), 12.31 (1H, s), 13.75-13.95 (1H,<br>
broad).<br>
[0455]<br>
2-(Benzamido)-4-(benzofuran-5-yl)benzoic acid<br>
1H-NMR (DMSO-d6) 5: 7.09 (1H, dd, J = 2.2, 1.0 Hz), 7.56<br>
(1H, dd, J = 8.3, 2.0 Hz), 7.59-7.71 (4H, m) , 7.76 (1H,<br>
d, J = 8.5 Hz), 7.98-8.04 (2H, m), 8.03 (1H, d, J = 1.5<br>
Hz), 8.09 (1H, d, J = 2.2 Hz), 8.15 (1H, d, J = 8.3 Hz),<br>
9.14 (1H, d, J = 2.0 Hz), 12.30 (1H, s), 13.70-13.95<br>
(1H, broad).<br>
[0456]<br>
2-(Benzamido)-4-(lH-indol-4-yl)benzoic acid<br>
1H-NMR (DMSO-de) 5: 6.75-6.79 (1H, m) , 7.21-7.27 (2H, m) ,<br>
7.47-7.54 (2H, m), 7.53 (1H, dd, J = 8.3, 1.8 Hz),<br>
7.58-7.70 (3H, m), 7.98-8.03 (2H, m), 8.17 (1H, d, J =<br>
8.3 Hz), 9.17 (1H, d, J = 1.8 Hz), 11.37 (1H, s), 12.29<br>
(1H, s).<br>
[0457]<br>
2-(Benzamido)-4-(4-(lH-pyrrol-l-yl)phenyl)benzoic acid<br>
1H-NMR   (DMSO-d6)   8:   6.32    (2H,   t,   J =  2.2   Hz),   7.48    (2H,<br>
t,   J =  2.2  Hz),   7.57   (1H,   dd,   J =  8.4,   1.9  Hz),   7.59-<br>
7.71   (3H,   m),   7.74-7.80   (2H,   m),   7.80-7.86   (2H,   m),<br>
7.98-8.03   (2H,   m),   8.15   (1H,   d,   J =  8.4  Hz),   9.12   (1H,<br>
d,   J =  1.9  Hz),   12.30   (1H,   s) .<br><br><br>
44 mg of 3-chlorophenylboronic acid, 4 9 mg of<br>
sodium carbonate and 6 mg of polymer supported<br>
di(acetato)dicyclohexylphenylphosphine palladium(II)<br>
were added to 2.5 mL of N,N-dimethylacetamide solution<br>
containing 70 mg of tert-butyl 2-(benzamido)-4-<br>
bromobenzoate, and stirred at 90C for 15 hours. After<br>
the reaction mixture was cooled to room temperature,<br>
5.7 mg of polymer supported di(acetato)<br>
dicyclohexylphenylphosphine palladium(II) was added and<br>
stirred at 110C for 9 hours and 30 minutes. After the<br>
reaction mixture was cooled to room temperature,<br>
insoluble were removed by filtration and ethyl acetate<br>
and 10% citric acid aqueous solution were added. The<br>
organic layer was separated and dried over anhydrous<br>
magnesium sulfate after washed with 10% citric acid<br>
aqueous solution and a saturated sodium chloride<br>
aqueous solution sequentially, and the solvent was<br>
evaporated under reduced pressure. The obtained residue<br>
was purified with silica gel column chromatography<br>
[Flash Tube 2008 manufactured by Trikonex Company,<br>
eluent; hexane: ethyl acetate = 4:1] to obtain tert-<br>
butyl 2-(benzamido)-4-(3-chlorophenyl)benzoate.<br><br>
265<br>
10 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 2-(benzamido)-4-(3-<br>
chlorophenyl)benzoate and stirred at room temperature<br>
for 1 hour. The solvent was evaporated under reduced<br>
pressure and methanol was added to the obtained residue<br>
and a solid substance was separated by filtration to<br>
obtain 21 mg of 2-(benzamido)-4-(3-chlorophenyl)benzoic<br>
acid as white solid.<br>
1H-NMR (DMSO-d6) 8: 1.52-1.1 A (7H, m) , 7.77 (1H, s) ,<br>
7.97-8.03 (2H, m), 8.14 (1H, d, J = 8.3 Hz), 9.06 (1H,<br>
d, J = 2.0 Hz), 12.27 (1H, s) .<br>
[0459]<br>
Examples 223 to 231<br>
The compounds shown in Table 28 were obtained<br>
in the same manner as in Example 222.<br>
[0460]<br>
[Table 28]<br><br><br>
266<br>
[0461]<br>
2-(Benzamido)-4-(3-fluorophenyl)benzoic acid<br>
1H-NMR (DMSO-d6) 5: 7.27-7.36 (1H, m) , 7.53-7.70 (7H, m) ,<br>
7.96-8.02 (2H, m), 8.14 (1H, d, J = 8.0 Hz), 9.08 (1H,<br>
d, J = 1.7 Hz) , 12.24 (1H, s) .<br>
[0462]<br>
2-(Benzamido)-4-(2,3-difluorophenyl)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 7.34-7.47 (3H, m) , 7.50-7.70 (4H, m) ,<br>
7.95-8.01 (2H, m), 8.17 (1H, d, J = 8.3 Hz), 8.98 (1H,<br>
s), 12.25 (1H, s).<br>
[0463]<br>
2-(Benzamido)-4-(3,5-difluorophenyl)benzoic acid<br>
1H-NMR (DMSO-d6) 5: 7.36 (1H, tt, J = 9.1, 2.2 Hz),<br>
7.43-7.51 (2H, m) , 7.56-7.71 (4H, m), 7.96-8.03 (2H, m) ,<br>
8.14 (1H, d, J = 8.3 Hz), 9.04 (1H, d, J = 1.7 Hz),<br>
12.27 (1H, s) .<br>
[0464]<br>
2-(Benzamido)-4-(2-hydroxyphenyl)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.90-7.02 (2H, m) , 7.20-7.28 (1H, m) ,<br>
7.32 (1H, dd, J = 7.7, 1.6 Hz), 7.40 (1H, dd, J = 8.3,<br>
1.7 Hz), 7.57-7.69 (3H, m), 7.95-8.01 (2H, m), 8.07 (1H,<br>
d, J = 8.3 Hz), 8.96 (1H, d, J = 1.7 Hz), 9.75 (1H, s) ,<br>
12.20-12.45 (1H, broad).<br>
[0465]<br>
2-(Benzamido)-4-(4-isopropoxyphenyl)benzoic acid<br>
1H-NMR (DMSO-de) 8: 1.31 (6H, d, J = 6.1 Hz), 4.65-4.76<br>
(1H, m) , 7.05-7.10 (2H, m), 7.48 (1H, dd, J = 8.3, 1.7<br>
Hz), 7.59-7.70 (5H, m), 7.96-8.02 (2H, m), 8.10 (1H, d,<br>
J = 8.3 Hz), 9.05 (1H, d, J = 1.7 Hz), 12.32 (1H, s) .<br><br>
267<br>
[0466]<br>
2-(Benzamido)-4-(2-phenoxyphenyl)benzoic acid<br>
1H-NMR (DMSO-d6) 5: 6.91-6.97 (2H, m) , 7.02-7.09 (2H, m) ,<br>
7.29-7.50 (5H, m) , 7.54-7.69 (4H, m), 7.93-8.00 (2H, m) ,<br>
8.04 (1H, d, J = 8.2 Hz), 8.99 (1H, d, J = 1.6 Hz),<br>
12.22 (1H, s).<br>
[0467]<br>
2-(Benzamido)-4-(4-(trifluororaethoxy)phenyl)benzoic<br>
acid<br>
1H-NMR (DMSO-de) 8: 7.51-7.57 (3H, m) , 7.58-7.70 (3H, m) ,<br>
7.84-7.89 (2H, m), 7.96-8.02 (2H, m), 8.15 (1H, d, J =<br>
8.3 Hz), 9.08 (1H, d, J = 1.7 Hz), 12.27 (1H, s) ,<br>
13.70-14.05 (1H, broad).<br>
[0468]<br>
2-(Benzamido)-4-(2,3-dimethylphenyl)benzoic acid<br>
1H-NMR (DMSO-de) 8: 2.16 (3H, s) , 2.33 (3H, s) , 7.09 (1H,<br>
d, J = 7.1 Hz), 7.15 (1H, dd, J = 8.1, 1.7 Hz), 7.17-<br>
7.27 (2H, m), 7.57-7.69 (3H, m), 7.94-7.99 (2H, m),<br>
8.11 (1H, d, J = 8.1 Hz), 8.70 (1H, d, J = 1.7 Hz),<br>
12.30 (1H, s).<br>
[0469]<br>
2-(Benzamido)-4-(3-nitrophenyl)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 7.59-7.71 (4H, m) , 7.82-7.88 (1H, m) ,<br>
7.98-8.03 (2H, m), 8.19 (1H, d, J = 8.3 Hz), 8.21 (1H,<br>
ddd, J = 7.8, 1.7, 1.0 Hz), 8.29-8.34 (1H, m), 8.48-<br>
8.50 (1H, m), 9.14 (1H, d, J = 1.9 Hz), 12.27 (1H, s),<br>
13.80-14.15 (1H, broad).<br>
[0470]<br>
Example 232<br><br><br>
42 mg of 3-hydroxymethylphenylboronic acid, 49<br>
mg of sodium carbonate and 6 mg of polymer supported<br>
di(acetato) dicyclohexylphenylphosphine palladium(II)<br>
were added to 2.5 mL of N,N-dimethylacetamide solution<br>
containing 70 mg of tert-butyl 2-(benzamido)-4-<br>
bromobenzoate, and stirred at 90C for 15 hours. After<br>
the reaction mixture was cooled to room temperature, 6<br>
mg of polymer supported di(acetato)<br>
dicyclohexylphenylphosphine palladium(II) was added and<br>
stirred at 110C for 9 hours and 30 minutes. After the<br>
reaction mixture was cooled to room temperature,<br>
insoluble were removed by filtration and ethyl acetate<br>
and 10% citric acid aqueous solution were added. The<br>
organic layer was separated and dried over anhydrous<br>
magnesium sulfate after washed with 10% citric acid<br>
aqueous solution and a saturated sodium chloride<br>
aqueous solution sequentially, and the solvent was<br>
evaporated under reduced pressure. The obtained residue<br>
was purified with silica gel column chromatography<br>
[Flash Tube 2008 manufactured by Trikonex Company,<br>
eluent; hexane: ethyl acetate =4:1] to obtain tert-<br>
butyl 2-(benzamido)-4-(3-(hydroxymethyl)phenyl)benzoate.<br>
10 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 2-(benzamido)-4-(3-<br>
(hydroxymethyl)phenyl)benzoate and stirred at room<br><br>
269<br>
temperature for 1 hour. The solvent was evaporated<br>
under reduced pressure and the obtained residue was<br>
purified with reversed-phase silica gel column<br>
chromatography [eluent; 60-100% acetonitrile /0.1%<br>
trifluoroacetic acid aqueous solution] to obtain 12 mg<br>
of 2-(benzamido)-4-(3-(hydroxymethyl)phenyl)benzoic<br>
acid as white solid.<br>
1H-NMR (DMSO-d6) 8: 4.61 (2H, s), 5.26-5.40 (1H, broad),<br>
7.41 (1H, d, J = 7.6 Hz), 7.47-7.55 (2H, m), 7.58-7.73<br>
(5H, m) , 7.97-8.04 (2H, m), 8.15 (1H, d, J = 8.3 Hz),<br>
9.09 (1H, d, J = 1.7 Hz), 12.33 (1H, s).<br>
[0471]<br>
Examples 233 to 235<br>
[0473]<br>
2-(Benzamido)-4-(2-isopropoxyphenyl)benzoic acid<br>
The compounds shown in Table 29 were obtained<br>
in the same manner as in Example 232.<br>
[0472]<br>
[Table 29]<br><br><br>
270<br>
1H-NMR (DMSO-d6) 8: 1.26 (6H, d, J = 6.1 Hz), 4.59-4.72<br>
(1H, m), 7.05 (1H, t, J = 7.3 Hz), 7.17 (1H, d, J = 8.1<br>
Hz), 7.32-7.41 (3H, m) , 7.57-7.68 (3H, m), 7.95-8.01<br>
(2H, m), 8.07 (1H, d, J = 8.3 Hz), 8.98 (1H, d, J = 1.7<br>
Hz) .<br>
[0474]<br>
2-(Benzamido)-4-(3-(trifluoromethoxy)phenyl)benzoic<br>
acid<br>
1H-NMR (DMSO-d6) 8: 7.48 (1H, d, J - 8.0 Hz), 7.57 (1H,<br>
dd, J = 8.3, 1.9 Hz), 7.59-7.73 (5H, m), 7.79 (1H, d, J<br>
= 7.8 Hz), 7.97-8.03 (2H, m), 8.16 (1H, d, J = 8.3 Hz),<br>
9.08 (1H, d, J = 1.9 Hz), 12.35 (1H, s).<br>
[0475]<br>
2-(Benzamido)-4-(3-methylphenyl)benzoic acid<br>
1H-NMR (DMSO-de) 8: 2.42 (3H, s) , 7.28 (1H, d, J = 7.6<br>
Hz), 7.43 (1H, t, J = 7.6 Hz), 7.49-7.57 (3H, m), 7.59-<br>
7.70 (3H, m), 7.97-8.02 (2H, m), 8.13 (1H, d, J = 8.3<br>
Hz), 9.07 (1H, d, J = 1.7 Hz), 12.29 (1H, s).<br>
[0476]<br>
Example 236<br><br>
60 mg of 4-phenoxyphenylboronic acid, 4 9 mg of<br>
sodium carbonate and 6 mg of polymer supported<br>
di(acetato) dicyclohexylphenylphosphine palladium(II)<br>
were added to 2.5 mL of N,N-dimethylacetamide solution<br><br>
271<br>
containing 70 mg of tert-butyl 2-(benzamido)-4-<br>
bromobenzoate, and stirred at 110C for 24 hours. After<br>
the reaction mixture was cooled to room temperature, 6<br>
mg of polymer supported di(acetato)<br>
dicyclohexylphenylphosphine palladium(II) was added and<br>
stirred at 110C for 24 hours. After the reaction<br>
mixture was cooled to room temperature, insoluble were<br>
removed by filtration and ethyl acetate and 10% citric<br>
acid aqueous solution were added. The organic layer was<br>
separated and dried over anhydrous magnesium sulfate<br>
after washed with 10% citric acid aqueous solution and<br>
a saturated sodium chloride aqueous solution<br>
sequentially, and the solvent was evaporated under<br>
reduced pressure. The obtained residue was purified<br>
with silica gel column chromatography [Flash Tube 2008<br>
manufactured by Trikonex Company, eluent; hexane: ethyl<br>
acetate =4:1] to obtain tert-butyl 2-(benzamido)-4-(4-<br>
phenoxyphenyl)benzoate.<br>
5.0 mL of trifluoroacetic acid was added to<br>
the obtained tert-butyl 2-(benzamido)-4-(4-<br>
phenoxyphenyl)benzoate and stirred at room temperature<br>
for 3 hours. The solvent was evaporated under reduced<br>
pressure, and the obtained residue was purified with<br>
silica gel column chromatography [PSQ100B (spherical)<br>
manufactured by Fuji Silysia Chemical Ltd., eluent;<br>
hexane: ethyl acetate =1:2] to obtain 8.0 mg of 2-<br>
(benzamido)-4-(4-phenoxyphenyl)benzoic acid as white<br>
solid.<br><br>
272<br>
XH-NMR (DMSO-d6) 8: 7.08-7.23 (5H, m) , 7.41-7.48 (2H, m) ,<br>
7.51 (1H, dd, J = 8.3, 1.9 Hz), 7.58-7.70 (3H, m) ,<br>
7.74-7.79 (2H, m), 7.96-8.02 (2H, m), 8.13 (1H, d, J =<br>
8.3 Hz), 9.07 (1H, d, J = 1.9 Hz), 12.30 (1H, s) .<br>
[0477]<br>
Example 237<br><br>
The following compound was obtained in the<br>
same manner as in Example 236.<br>
2-(Benzamido)-4-(4-benzoylphenyl)benzoic acid<br>
XH-NMR (DMSO-d6) 8: 7.57-7.75 (7H, m) , 7.78-7.84 (2H, m) ,<br>
7.89-7.96 (4H, m), 7.98-8.03 (2H, m), 8.19 (1H, d, J =<br>
8.3 Hz), 9.17 (1H, d, J = 1.5 Hz), 12.29 (1H, s).<br>
[0478]<br>
Example 238<br><br>
46 mg of 4-(dimethylamino)phenylboronic acid,<br>
49 mg of sodium carbonate and 5.7 mg of polymer<br>
supported di(acetato)dicyclohexylphenylphosphine<br>
palladium(II) were added to 2.5 mL of N,N-<br>
dimethylacetamide solution containing 70 mg of tert-<br><br>
273<br>
butyl 2-(benzamido)-4-bromobenzoate, and stirred at<br>
110C for 24 hours. After the reaction mixture was<br>
cooled to room temperature 5.7 mg polymer supported<br>
di(acetato)dicyclohexylphenylphosphine palladium(II)<br>
was added and stirred at 110C for 24 hours. After the<br>
reaction mixture was cooled to room temperature,<br>
insoluble were removed by filtration and ethyl acetate<br>
and 10% citric acid aqueous solution were added. The<br>
organic layer was separated and dried over anhydrous<br>
magnesium sulfate after washed with 10% citric acid<br>
aqueous solution and a saturated sodium chloride<br>
aqueous solution sequentially, and the solvent was<br>
evaporated under reduced pressure. The obtained residue<br>
was purified with silica gel column chromatography<br>
[Flash Tube 2008 manufactured by Trikonex Company,<br>
eluent; hexane: ethyl acetate = 4:1] to obtain tert-<br>
butyl 2-(benzamido)-4-(4-(dimethylamino)phenyl)benzoate.<br>
5.0 mL of trifluoroacetic acid was added to<br>
the obtained tert-butyl 2-(benzamido)-4-(4-<br>
(dimethylamino)phenyl)benzoate and stirred at room<br>
temperature for 3 hours. The solvent was evaporated<br>
under reduced pressure, ethyl acetate and water were<br>
added and pH was adjusted to pH 6.5 with a saturated<br>
sodium hydrogen carbonate aqueous solution. The organic<br>
layer was separated and dried over anhydrous magnesium<br>
sulfate after washed with a saturated sodium chloride<br>
aqueous solution, and the solvent was evaporated under<br>
reduced pressure. Methanol was added to the obtained<br>
residue and a solid substance was separated by<br><br>
274<br>
filtration to obtain 3.8 mg of 2-(benzamido)-4-(4-<br>
(dimethylamino)phenyl)benzoic acid as pale yellow solid.<br>
1H-NMR (DMSO-d6) 8: 2.98 (6H, s), 6.83-6.89 (2H, m),<br>
7.45 (1H, dd, J = 8.3, 1.8 Hz), 7.58-7.69 (5H, m) ,<br>
7.97-8.02 (2H, m), 8.06 (1H, d, J = 8.3 Hz), 9.05 (1H,<br>
d, J = 1.8 Hz), 12.32 (1H, s) .<br>
[0479]<br>
Example 239<br><br>
38 mg of 2-methylphenylboronic acid, 49 mg of<br>
sodium carbonate and 6 mg of polymer supported<br>
bis(acetato)triphenylphosphine palladium(II) were added<br>
to 2.5 mL of N,N-dimethylacetamide solution containing<br>
70 mg of tert-butyl 2-(benzamido)-4-bromobenzoate, and<br>
stirred at 110C for 20 hours. After the reaction<br>
mixture was cooled to room temperature, 6 mg of polymer<br>
supported bis(acetato)triphenylphosphine palladium(II)<br>
was added and stirred at 110C for 22 hours. After the<br>
reaction mixture was cooled to room temperature,<br>
insoluble were removed by filtration and ethyl acetate<br>
and 10% citric acid aqueous solution were added. The<br>
organic layer was separated and dried over anhydrous<br>
magnesium sulfate after washed with 10% citric acid<br>
aqueous solution and a saturated sodium chloride<br>
aqueous solution sequentially, and the solvent was<br>
evaporated under reduced pressure. The obtained residue<br><br>
275<br>
was purified with silica gel column chromatography<br>
[Flash Tube 2008 manufactured by Trikonex Company,<br>
eluent; hexane: ethyl acetate =4:1] to obtain tert-<br>
butyl 2-(benzamido)-4-(2-methylphenyl)benzoate.<br>
10 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 2-(benzamido)-4-(2-<br>
methylphenyl)benzoate and stirred at room temperature<br>
for 1 hour. The solvent was evaporated under reduced<br>
pressure and methanol was added to the obtained residue<br>
and a solid substance was separated by filtration to<br>
obtain 14 mg of 2-(benzamido)-4-(2-methylphenyl)benzoic<br>
acid as white solid.<br>
1H-NMR (DMSO-d6) 5: 2.29 (3H, s) , 7.18-7.38 (5H, m) ,<br>
7.57-7.69 (3H, m) , 7.94-8.00 (2H, m), 8.12 (1H, d, J =<br>
8.1 Hz), 8.74 (1H, d, J = 1.4 Hz), 12.27 (1H, s) .<br>
[0480]<br>
Examples 240 to 242<br>
The compounds shown in Table 30 were obtained<br>
in the same manner as in Example 239.<br>
[0481]<br>
[Table 30]<br><br><br>
276<br>
[0482]<br>
2-(Benzamido)-4-(4-methylphenyl)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 2.38 (3H, s), 7.35 (2H, d, J = 8.0<br>
Hz), 7.50 (1H, dd, J = 8.3, 1.9 Hz), 7.58-7.70 (5H, m),<br>
7.96-8.02 (2H, m), 8.12 (1H, d, J = 8.3 Hz), 9.07 (1H,<br>
d, J = 1.9 Hz), 12.33 (1H, s).<br>
[0483]<br>
2-(Benzamido)-4-(3-cyanophenyl)benzoic acid<br>
1H-NMR (DMSO-d6) 5: 7.58-7.70 (4H, m) , 7.76 (1H, t, J =<br>
7.8 Hz), 7.92-7.97 (1H, m) , 7.97-8.02 (2H, m), 8.05-<br>
8.11 (1H, ), 8.16 (1H, d, J = 8.3 Hz), 8.19-8.23 (1H,<br>
in), 9.08 (1H, d, J = 2.0 Hz), 12.28 (1H, s) .<br>
[0484]<br>
2-(Benzamido)-4-(4-cyanophenyl)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 7.56-7.69 (4H, m) , 7.90-8.02 (6H, m) ,<br>
8.16 (1H, d, J = 8.3 Hz), 9.10 (1H, d, J = 2.0 Hz),<br>
12.29 (1H, s).<br>
[0485]<br>
Example 24 3<br><br>
39 mg of 4-hydroxyphenylboronic acid, 4 9 mg of<br>
sodium carbonate and 6 mg of polymer supported<br>
bis(acetato)triphenylphosphine palladium(II) were added<br>
to 2.5 mL of N,N-dimethylacetamide solution containing<br>
70 mg of tert-butyl 2-(benzamido)-4-bromobenzoate, and<br><br>
277<br>
stirred at 110C for 20 hours. After the reaction<br>
mixture was cooled to room temperature, 6 mg of polymer<br>
supported bis(acetato)triphenylphosphine palladium(II)<br>
was added and stirred at 110C for 22 hours. After the<br>
reaction mixture was cooled to room temperature,<br>
insoluble were removed by filtration and ethyl acetate<br>
and 10% citric acid aqueous solution were added. The<br>
organic layer was separated and dried over anhydrous<br>
magnesium sulfate after washed with 10% citric acid<br>
aqueous solution and a saturated sodium chloride<br>
aqueous solution sequentially, and the solvent was<br>
evaporated under reduced pressure. The obtained residue<br>
was purified with silica gel column chromatography<br>
[Flash Tube 2008 manufactured by Trikonex Company,<br>
eluent; hexane: ethyl acetate =2:1] to obtain tert-<br>
butyl 2-(benzamido)-4-(4-hydroxyphenyl)benzoate.<br>
10 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 2-(benzamido)-4-(4-<br>
hydroxyphenyl)benzoate and stirred at room temperature<br>
for 1 hour. The solvent was evaporated under reduced<br>
pressure and the obtained residue was purified with<br>
reversed-phase silica gel column chromatography<br>
[eluent; 55-90% acetonitrile /0.1% trifluoroacetic acid<br>
aqueous solution] to obtain 1.9 mg of 2-(benzamido)-4-<br>
(4-hydroxyphenyl)benzoic acid as white solid.<br>
1H-NMR (DMSO-de) 5: 6.88-6.96 (2H, m), 7.44 (1H, dd, J=<br>
8.3, 1.9 Hz), 7.56-7.69 (5H, m) , 7.96-8.02 (2H, m),<br>
8.08 (1H, d, J = 8.3 Hz), 9.03 (1H, d, J = 1.9 Hz),<br>
9.79 (1H, s), 12.33 (1H, s).<br><br><br>
The following compound was obtained in the<br>
same manner as in Example 243.<br>
2-(Benzamido)-4-(3-hydroxyphenyl)benzoic acid<br>
1H-NMR (DMSO-de) 5: 6.86 (1H, dd, J = 8.1, 1.9 Hz),<br>
7.11-7.19 (2H, m), 7.33 (1H, t, J = 7.9 Hz), 7.47 (1H,<br>
dd, J = 8.1, 1.7 Hz), 7.59-7.70 (3H, m), 7.97-8.02 (2H,<br>
m), 8.13 (1H, d, J = 8.1 Hz), 9.06 (1H, d, J = 1.7 Hz),<br>
9.69 (1H, s), 12.30 (1H, s) .<br>
[0487]<br>
Example 245<br><br>
56 mg of 2-fluorophenylboronic acid, 0.10 g of<br>
sodium hydrogen carbonate, 0.6 mL of ethanol, 0.3 mL of<br>
water and 23 mg of<br>
tetrakis(triphenylphosphine)palladium(0) were added to<br>
2.1 mL of toluene solution containing 0.15 g of tert-<br>
butyl 2-(benzamido)-4-bromobenzoate, and the resulting<br>
mixture was heated to reflux for 2 hours. After the<br>
reaction mixture was cooled to room temperature, 17 mg<br>
of 2-fluorophenylboronic acid and 23 mg of<br><br>
279<br>
tetrakis(triphenylphosphine)palladium(0) were added and<br>
the resulting mixture was heated to reflux for 2 hours.<br>
After the reaction mixture was cooled to room<br>
temperature, toluene and a saturated sodium hydrogen<br>
carbonate aqueous solution were added. The organic<br>
layer was separated and dried over anhydrous magnesium<br>
sulfate after washed with a saturated sodium chloride<br>
aqueous solution, and the solvent was evaporated under<br>
reduced pressure. The obtained residue was purified<br>
with silica gel column chromatography [Flash Tube 2008<br>
manufactured by Trikonex Company, eluent; hexane: ethyl<br>
acetate = 10:1] to obtain tert-butyl 2-(benzamido)-4-<br>
(2-fluorophenyl)benzoate.<br>
10 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 2-(benzamido)-4-(2-<br>
fluorophenyl)benzoate and stirred at room temperature<br>
for 2 hours. The solvent was evaporated under reduced<br>
pressure and toluene was added. The solvent was<br>
evaporated under reduced pressure and diisopropyl ether<br>
was added to the obtained residue and a solid substance<br>
was separated by filtration to obtain 93 mg of 2-<br>
(benzamido)-4-(2-fluorophenyl)benzoic acid as white<br>
solid.<br>
1H-NMR (DMSO-d6) 8: 7.34-7.44 (3H, m) , 7.47-7.55 (1H, m) ,<br>
7.56-7.70 (4H, m) , 7.94-8.01 (2H, m), 8.16 (1H, d, J =<br>
8.3 Hz), 8.96-9.00 (1H, m), 12.27 (1H, s).<br>
[0488]<br>
Examples 246 to 250<br><br>
280<br>
The compounds shown in Table 31 were obtained<br>
in the same manner as in Example 245.<br>
[0489]<br>
[Table 31]<br><br>
[0490]<br>
2-(Benzamido)-4-(3-fluoro-4-methylphenyl)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 2.28-2.34 (3H, m) , 7.42-7.57 (4H, m) ,<br>
7.58-7.70 (3H, m), 7.96-8.02 (2H, m), 8.12 (1H, d, J -<br>
8.3 Hz), 9.06 (1H, d, J = 1.7 Hz), 12.27 (1H, s).<br>
[0491]<br>
2-(Benzamido)-4-(2-chlorophenyl)benzoic acid<br>
1H-NMR (DMSO-d6) 5: 7.29 (1H, dd, J = 8.3, 1.7 Hz),<br>
7.45-7.51 (3H, m) , 7.57-7.69 (4H, m), 7.94-8.00 (2H, m) ,<br>
8.15 (1H, d, J = 8.3 Hz), 8.84 (1H, d, J = 1.7 Hz),<br>
12.28 (1H, s).<br>
[0492]<br>
2-(Benzamido)-4-(3,4-dichlorophenyl)benzoic acid<br>
1H-NMR (DMSO-de) 5: 7.57 (1H, dd, J = 8.3, 1.9 Hz),<br>
7.58-7.70 (3H, m), 7.73 (1H, dd, J = 8.3, 2.2 Hz), 7.81<br><br>
281<br>
(1H, d, J = 8.6 Hz), 7.96-8.01 (3H, m), 8.14 (1H, d, J<br>
= 8.3 Hz), 9.05 (1H, d, J = 1.9 Hz), 12.24 (1H, s) .<br>
[0493]<br>
2-(Benzamido)-4-(5-chloro-2-fluorophenyl)benzoic acid<br>
1H-NMR (DMSO-de) 5: 7.40-7.50 (2H, m) , 7.55-7.70 (5H, m) ,<br>
7.95-8.01 (2H, m), 8.16 (1H, d, J = 8.0 Hz), 8.96 (1H,<br>
s), 12.27 (1H, s).<br>
[0494]<br>
2-(Benzamido)-4-(2,6-dimethylphenyl)benzoic acid<br>
1H-NMR (DMSO-de) 8: 2.03 (6H, s) , 7.02 (1H, dd, J = 8.1,<br>
1.6 Hz), 7.13-7.25 (3H, m), 7.56-7.69 (3H, m), 7.93-<br>
7.99 (2H, m), 8.15 (1H, d, J = 8.1 Hz), 8.53 (1H, d, J<br>
=1.6 Hz), 12.29 (1H, s).<br>
[0495]<br>
Example 251<br><br>
83 mg of 2-chloro-6-fluorophenylboronic acid,<br>
0.10 g of sodium hydrogen carbonate, 0.6 mL of ethanol,<br>
0.3 mL of water and 23 mg of<br>
tetrakis(triphenylphosphine)palladium(O) were added to<br>
2.1 mL of toluene solution containing 0.15 g of tert-<br>
butyl 2-(benzamido)-4-bromobenzoate, and the resulting<br>
mixture was heated to reflux for 2 hours. After the<br>
reaction mixture was cooled to room temperature, 21 mg<br>
of 2-chloro-6-fluorophenylboronic acid and 23 mg<br><br>
282<br>
tetrakis(triphenylphosphine)palladium(O) were added and<br>
the resulting mixture was heated to reflux for 2 hours.<br>
After the reaction mixture was cooled to room<br>
temperature, toluene and a saturated sodium hydrogen<br>
carbonate aqueous solution were added. The organic<br>
layer was separated and dried over anhydrous magnesium<br>
sulfate after washed with saturated sodium chloride<br>
aqueous solution, and the solvent was evaporated under<br>
reduced pressure. The obtained residue was purified<br>
with silica gel column chromatography [Flash Tube 2008<br>
manufactured by Trikonex Company, eluent; hexane: ethyl<br>
acetate = 10:1] to obtain tert-butyl 2-(benzamido)-4-<br>
(2-chloro-6-fluorophenyl)benzoate.<br>
10 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 2-(benzamido)-4-(2-chloro-6-<br>
fluorophenyl)benzoate and stirred at room temperature<br>
for 2 hours. The solvent was evaporated under reduced<br>
pressure and toluene was added. The solvent was<br>
evaporated under reduced pressure and the obtained<br>
residue was purified with reversed-phase silica gel<br>
column chromatography [eluent; 70-100% acetonitrile<br>
/0.1% trifluoroacetic acid aqueous solution] to obtain<br>
5.8 mg of 2-(benzamido)-4-(2-chloro-6-<br>
fluorophenyl)benzoic acid as white solid.<br>
1H-NMR (DMSO-d6) 8: 7.23 (1H, dd, J = 8.3, 1.6 Hz),<br>
7.37-7.45 (1H, m) , 7.49-7.70 (5H, m) , 7.93-7.99 (2H, m) ,<br>
8.17 (1H, d, J = 8.3 Hz), 8.73-8.77 (1H, m) , 12.28 (1H,<br>
s).<br><br><br>
0.15 g of 4-bromo-2-chlorophenol, 0.18 g of<br>
sodium hydrogen carbonate, 0.6 mL of ethanol, 0.3 mL of<br>
water and 42 mg of tetrakis(triphenylphosphine)<br>
palladium(0) were added to 2.1 mL of toluene solution<br>
containing 0.37 g of tert-butyl 2-(benzamido)-4-<br>
(4,4,5,5-tetramethyl-l,3,2-dioxaborolan-2-yl)benzoate<br>
at room temperature, and the resulting mixture was<br>
heated to reflux for 4 hours. Toluene and a saturated<br>
sodium hydrogen carbonate aqueous solution were added<br>
after the reaction mixture was cooled to room<br>
temperature. The organic layer was separated and ethyl<br>
acetate was added after washed with a saturated sodium<br>
chloride aqueous solution and dried over anhydrous<br>
magnesium sulfate, and the solvent was evaporated under<br>
reduced pressure. Hexane was added to the obtained<br>
residue and a solid substance was separated by<br>
filtration to obtain tert-butyl 2-(benzamido)-4-(3-<br>
chloro-4-hydroxyphenyl)benzoate.<br>
10 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 2-(benzamido)-4-(3-chloro-4-<br>
hydroxyphenyl)benzoate and stirred at room temperature<br>
for 2 hours. The solvent was evaporated under reduced<br><br>
284<br>
pressure and toluene was added. The solvent was<br>
evaporated under reduced pressure and diisopropyl ether<br>
was added to the obtained residue and a solid substance<br>
was separated by filtration to obtain 94 mg of 2-<br>
(benzamido)-4-(3-chloro-4-hydroxyphenyl)benzoic acid as<br>
white solid.<br>
1H-NMR (DMSO-d6) 6:	7.13 (1H, d, J = 8.3 Hz), 7.48 (1H,<br>
dd, J = 8.3, 1.7 Hz), 7.56 (1H, dd, J = 8.4, 2.3 Hz),<br>
7.57-7.72 (4H, m) ,	7.96-8.01 (2H, m), 8.09 (1H, d, J =<br>
8.3 Hz), 9.01 (1H,	d, J = 1.7 Hz), 10.50-10.66 (1H,<br>
broad), 12.26 (1H,	s).<br>
[0497]<br>
Example 253<br><br>
0.031 mL of indoline, 0.12 g of cesium<br>
carbonate, 1.7 mg of<br>
tris(dibenzylideneacetone)dipalladium(O), 0.8 mg of<br>
palladium acetate and 4.4 mg of 2-dicyclohexylphosphino<br>
-2',4',6'-triisopropylbiphenyl were added to 1.4 mL of<br>
toluene solution containing 70 mg of tert-butyl 2-<br>
(benzamido)-4-bromobenzoate at room temperature, and<br>
the resulting mixture was heated to reflux under<br>
nitrogen atmosphere for 3 hours. After the reaction<br>
mixture was cooled to room temperature, ethyl acetate<br>
and 10% citric acid aqueous solution were added and<br>
insoluble were removed by filtration. The organic layer<br><br>
285<br>
was separated and dried over anhydrous magnesium<br>
sulfate after washed with a saturated sodium chloride<br>
aqueous solution, and the solvent was evaporated under<br>
reduced pressure. The obtained residue was purified<br>
with silica gel column chromatography [PSQ100B<br>
(spherical) manufactured by Fuji Silysia Chemical Ltd.,<br>
eluent; hexane: ethyl acetate = 10:1] to obtain 77 mg<br>
of tert-butyl 2-(benzamido)-4-(indolin-1-yl)benzoate as<br>
yellow oil.<br>
1H-NMR (CDC13) 8: 1.63 (9H, s) , 3.17 (2H, t, J = 8.4 Hz),<br>
4.10 (2H, t, J = 8.4 Hz), 6.86 (1H, td, J = 7.4, 0.8<br>
Hz), 6.96 (1H, dd, J = 8.9, 2.5 Hz), 7.16-7.24 (2H, m),<br>
7.46-7.57 (4H, m), 7.97 (1H, d, J = 8.9 Hz), 8.06-8.10<br>
(2H, m), 8.81 (1H, d, J = 2.5 Hz), 12.40 (1H, s).<br>
[0498]<br>
Example 254<br><br>
5.0 mL of trifluoroacetic acid solution<br>
containing 75 mg of tert-butyl 2-(benzamido)-4-<br>
(indolin-1-yl)benzoate was stirred at room temperature<br>
for 1 hour and 30 minutes. The solvent was evaporated<br>
under reduced pressure, ethyl acetate and water were<br>
added and pH was adjusted to pH 6.5 with a saturated<br>
sodium hydrogen carbonate aqueous solution. The organic<br>
layer was separated and dried over anhydrous magnesium<br>
sulfate after washed with water and a saturated sodium<br><br>
286<br>
chloride aqueous solution sequentially, and the solvent<br>
was evaporated under reduced pressure. Methanol was<br>
added to the obtained residue and a solid substance was<br>
separated by filtration to obtain 51 mg of 2-<br>
(benzamido)-4-(indolin-1-yl)benzoic acid a yellow solid.<br>
1H-NMR (DMSO-d6) 8: 3.17 (2H, t, J = 8.4 Hz), 4.06 (2H,<br>
t, J = 8.4 Hz), 6.88 (1H, t, J = 7.4 Hz), 6.95 (1H, dd,<br>
J = 9.0, 2.4 Hz), 7.19 (1H, t, J = 7.6 Hz), 7.27 (1H, d,<br>
J = 7.3 Hz), 7.48 (1H, d, J = 8.0 Hz), 7.58-7.69 (3H,<br>
m), 7.96-8.02 (2H, m), 8.02 (1H, d, J = 9.0 Hz), 8.82<br>
(1H, d, J = 2.4 Hz), 12.50 (1H, s), 13.26 (1H, s).<br>
[0499]<br>
Examples 255 to 277<br>
The compounds shown in Table 32 were obtained<br>
in the same manner as in Example 34.<br>
[0500]<br>
[Table 32]<br><br><br>
[0501]<br>
4-Phenethyl-2-(2-(trifluoromethyl)benzamido)benzoic<br>
acid<br>
1H-NMR (DMSO-d6) 8: 2.90-3.02 (4H, m) , 7.13 (1H, dd, J =<br>
8.1, 1.7 Hz), 7.16-7.22 (1H, m) , 7.26-7.32 (4H, m) ,<br>
7.73-7.81 (1H, m) , 7.81-7.86 (2H, m), 7.86-7.97 (2H, m) ,<br>
8.49 (1H, s), 11.62 (1H, s), 13.50-13.70 (1H, broad).<br>
[0502]<br>
4-Phenethyl-2-(2-phenylacetamido)benzoic acid<br>
1H-NMR (DMSO-d6) 6: 2.82-2.94 (4H, m), 3.75 (2H, s) ,<br>
6.99 (1H, dd, J = 8.2, 1.5 Hz), 7.13-7.20 (1H, m) ,<br><br>
288<br>
7.20-7.32 (5H, m) , 7.32-7.42 (4H, m), 7.84 (1H, d, J =<br>
8.2	Hz), 8.44 (1H, d, J = 1.5 Hz), 11.16 (1H, s).<br>
[0503]<br>
2-(2-Methylbenzamido)-4-phenethylbenzoic acid<br>
1H-NMR (DMSO-d6) 8: 2.45 (3H, s), 2.90-3.02 (4H, m),<br>
7.09 (1H, dd, J = 8.3, 1.6 Hz), 7.16-7.23 (1H, m),<br>
7.26-7.37 (6H, m) , 7.40-7.50 (1H, m), 7.59 (1H, d, J =<br>
7.6	Hz), 7.94 (1H, d, J = 8.3 Hz), 8.62 (1H, s), 11.62<br>
(1H, s), 13.45-13.65 (1H, broad).<br>
[0504]<br>
2-(3-Methylbenzamido)-4-phenethylbenzoic acid<br>
1H-NMR (DMSO-d6) 8: 2.42 (3H, s) , 2.90-3.02 (4H, m) ,<br>
7.08 (1H, dd, J = 8.1, 1.6 Hz), 7.16-7.22 (1H, m),<br>
7.25-7.32 (4H, m) , 7.44-7.52 (2H, m), 7.73-7.81 (2H, m) ,<br>
7.96 (1H, d, J = 8.1 Hz), 8.67 (1H, d, J = 1.6 Hz),<br>
12.24 (1H, s).<br>
[0505]<br>
2-(4-Methylbenzamido)-4-phenethylbenzoic acid<br>
1H-NMR (DMSO-d6) 8: 2.40 (3H, s), 2.88-3.01 (4H, m),<br>
7.07	(1H, dd, J = 8.1, 1.7 Hz), 7.15-7.22 (1H, m) ,<br>
7.24-7.32 (4H, m), 7.40 (2H, d, J = 8.2 Hz), 7.86 (2H,<br>
d, J = 8.2 Hz), 7.95 (1H, d, J = 8.1 Hz), 8.67 (1H, d,<br>
J == 1.7 Hz) , 12.22 (1H, s) .<br>
[0506]<br>
2-(4-Nitrobenzamido)-4-phenethylbenzoic acid<br>
1H-NMR (DMSO-d6) 8: 2.89-3.04 (4H, m) , 7.09-7.14 (1H, m) ,<br>
7.15-7.22 (1H, m) , 7.25-7.32 (4H, m) , 7.97 (1H, d, J =<br>
8.3	Hz), 8.19 (2H, d, J = 8.8 Hz), 8.44 (2H, d, J = 8.8<br>
Hz), 8.58 (1H, d, J = 1.5 Hz).<br><br>
289<br>
[0507]<br>
2-(3, 4-Dimethylbenzamido)-4-phenethylbenzoic acid<br>
1H-NMR (DMSO-d6) 8: 2.32 (3H, s), 2.32 (3H, s) , 2.90-<br>
3.00 (4H, m), 7.06 (1H, d, J = 8.2 Hz), 7.15-7.20 (1H,<br>
m) , 7.25-7.30 (4H, m), 7.35 (1H, d, J = 7.7 Hz), 7.68<br>
(1H, d, J = 7.7 Hz), 7.74 (1H, s), 7.95 (1H, d, J = 8.2<br>
Hz), 8.68 (1H, s), 12.16-12.20 (1H, broad).<br>
[0508]<br>
2-(2,3-Dimethylbenzamido)-4-phenethylbenzoic acid<br>
1H-NMR (DMSO-d6) 8: 2.30 (6H, s), 2.90-3.00 (4H, m) ,<br>
7.06-7.11 (1H, m) , 7.16-7.38 (8H, m) , 7.93 (1H, d, J =<br>
8.0 Hz), 8.61 (1H, s), 11.50-11.56 (1H, broad).<br>
[0509]<br>
2-(3-Nitrobenzamido)-4-phenethylbenzoic acid<br>
1H-NMR (DMSO-de) 8: 2.90-3.05 (4H, m) , 7.10-7.21 (2H, m) ,<br>
7.26-7.30 (4H, m) , 7.89-7.99 (2H, m), 8.36-8.42 (1H, m) ,<br>
8.47-8.52 (1H, m), 8.58 (1H, d, J = 1.7 Hz), 8.76 (1H,<br>
t, J = 2.0 Hz), 12.36-12.48 (1H, broad).<br>
[0510]<br>
4-Phenethyl-2-(4-(trifluoromethyl)benzamido)benzoic<br>
acid<br>
1H-NMR (DMSO-de) 8: 2.90-3.02 (4H, m), 7.11 (1H, d, J =<br>
8.0 Hz), 7.16-7.21 (1H, m), 7.25-7.31 (4H, m), 7.94-<br>
8.02 (3H, m), 8.15 (2H, d, J = 7.6 Hz), 8.61 (1H, s),<br>
12.28 (1H, s).<br>
[0511]<br>
2-(Benzothiophene-2-carboxamido)-4-phenethylbenzoic<br>
acid<br><br>
290<br>
1H-NMR (DMSO-de) 8: 2.90-3.02 (4H, m) , 7.10 (1H, dd, J =<br>
8.1, 1.2 Hz), 7.17-7.21 (1H, m), 7.25-7.32 (4H, m) ,<br>
7.48-7.55 (2H, m), 7.98 (1H, d, J = 8.1 Hz), 8.06-8.11<br>
(3H, m) , 8.53-8.57 (1H, m) , 12.34 (1H, s) .<br>
[0512]<br>
2-(2-Fluorobenzamido)-4-phenethylbenzoic acid<br>
1H-NMR (DMSO-de) 6: 2.91-3.00 (4H, m), 7.10 (1H, d, J =<br>
8.0 Hz), 7.16-7.21 (1H, m) , 7.25-7.31 (4H, m), 7.38-<br>
7.44 (2H, m), 7.64-7.69 (1H, m), 7.90-7.96 (2H, m),<br>
8.66 (1H, s), 11.94-12.00 (1H, broad), 13.54-13.60 (1H,<br>
broad).<br>
[0513]<br>
2-(3-Fluorobenzamido)-4-phenethylbenzoic acid<br>
1H-NMR (DMSO-de) 5: 2.90-3.00 (4H, m) , 7.10 (1H, dd, J =<br>
8.1, 1.7 Hz), 7.16-7.20 (1H, m) , 7.25-7.31 (4H, m) ,<br>
7.49-7.52 (1H, m) , 7.64-7.73 (2H, m), 7.78-7.81 (1H, m) ,<br>
7.96 (1H, d, J = 8.1 Hz), 8.60-8.62 (1H, m), 12.16-<br>
12.22 (1H, broad), 13.64-13.76 (1H, broad).<br>
[0514]<br>
2-(2,6-Difluorobenzamido)-4-phenethylbenzoic acid<br>
1H-NMR (DMSO-de) 5: 2.90-3.02 (4H, m) , 7.12-7.21 (2H, m) ,<br>
7.26-7.33 (6H, m), 7.61-7.69 (1H, m), 7.94 (1H, d, J =<br>
8.0 Hz), 8.50 (1H, s), 11.74-11.82 (1H, broad).<br>
[0515]<br>
4-Phenethyl-2-(3-(trifluoromethyl)benzamido)benzoic<br>
acid<br>
1H-NMR (DMSO-de) 5: 2.90-3.03 (4H, m) , 7.10-7.13 (1H, m) ,<br>
7.16-7.21 (1H, m) , 7.25-7.31 (4H, m), 7.87 (1H, t, J =<br>
7.9 Hz), 7.96 (1H, d, J = 8.1 Hz), 8.04 (1H, d, J = 7.8<br><br>
291<br>
Hz), 8.24-8.28 (2H, m), 8.60 (1H, s), 12.28-12.34 (1H,<br>
broad).<br>
[0516]<br>
2-(2-Chlorobenzamido)-4-phenethylbenzoic acid<br>
1H-NMR (DMSO-dg) 5: 2.90-3.02 (4H, m) , 7.12 (1H, dd, J =<br>
8.3, 1.5 Hz), 7.16-7.22 (1H, m) , 7.26-7.32 (4H, m) ,<br>
7.48-7.63 (3H, m), 7.71 (1H, dd, J = 7.3, 1.7 Hz), 7.94<br>
(1H, d, J = 8.3 Hz), 8.53-8.59 (1H, m) , 11.62-11.70 (1H,<br>
broad), 13.54-13.62 (1H, broad).<br>
[0517]<br>
2-(3-Chlorobenzamido)-4-phenethylbenzoic acid<br>
1H-NMR (DMSO-de) 8: 2.90-3.02 (4H, m) , 7.10 (1H, dd, J =<br>
8.3, 1.2 Hz), 7.16-7.22 (1H, m), 7.25-7.31 (4H, m),<br>
7.64 (1H, t, J = 7.8 Hz), 1.12-1.15 (1H, m), 7.91 (1H,<br>
d, J = 7.8 Hz), 7.95-7.97 (2H, m) , 8.58-8.61 (1H, m) ,<br>
12.18-12.24 (1H, broad).<br>
[0518]<br>
2-(4-Chlorobenzamido)-4-phenethylbenzoic acid<br>
1H-NMR (DMSO-d6) 8: 2.90-3.01 (4H, m) , 7.09 (1H, dd, J =<br>
8.0, 1.0 Hz), 7.16-7.20 (1H, m) , 7.26-7.32 (4H, m) ,<br>
7.69 (2H, d, J = 8.5 Hz), 7.93-7.98 (3H, m) , 8.61-8.63<br>
(1H, m), 12.17-12.22 (1H, broad).<br>
[0519]<br>
2-(2,4-Bis(trifluoromethyl)benzamido)-4-<br>
phenethylbenzoic acid<br>
1H-NMR (DMSO-de) 8: 2.90-3.02 (4H, m) , 7.14-7.22 (2H, m) ,<br>
7.26-7.30 (4H, m), 7.93 (1H, d, J = 8.0 Hz), 8.09 (1H,<br>
d, J = 8.0 Hz), 8.24 (1H, s), 8.28 (1H, d, J = 8.3 Hz),<br>
8.36-8.39 (1H, m), 11.60-11.64 (1H, broad).<br><br>
292<br>
[0520]<br>
2-(2,4-Dichlorobenzamido)-4-phenethylbenzoic acid<br>
1H-NMR (DMSO-de) 8: 2.90-3.02 (4H, m) , 7.10-7.15 (1H, m) ,<br>
7.16-7.22 (1H, m) , 7.26-7.32 (4H, m), 7.61 (1H, dd, J=<br>
8.4, 2.1 Hz), 7.75 (1H, d, J = 8.3 Hz), 7.81 (1H, d, J<br>
= 2.1 Hz), 7.93 (1H, d, J = 8.3 Hz), 8.50 (1H, s),<br>
11.62-11.68 (1H, broad).<br>
[0521]<br>
4-Phenethyl-2-((E)-3-(pyridin-4-yl)acrylamido)benzoic<br>
acid trifluoroacetate<br>
1H-NMR (DMSO-de) 5: 2.88-3.00 (4H, m), 7.09 (1H, dd, J=<br>
8.1, 1.5 Hz), 7.16-7.21 (1H, m) , 7.23-7.29 (4H, m),<br>
7.32 (1H, d, J = 15.6 Hz), 7.67 (1H, d, J = 15.6 Hz),<br>
7.93 (1H, d, J = 8.1 Hz), 8.00 (2H, d, J = 6.2 Hz),<br>
8.53 (1H, d, J = 1.5 Hz), 8.78 (2H, d, J = 6.2 Hz),<br>
11.48 (1H, s).<br>
[0522]<br>
4-Phenethyl-2-(5-(lH-pyrrol-l-yl)pyridine-3-<br>
carboxamido)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 2.91-3.03 (4H, m) , 6.39 (2H, t, J =<br>
2.2 Hz), 7.13 (1H, dd, J = 8.1, 1.6 Hz), 7.16-7.31 (5H,<br>
m), 7.58 (2H, t, J = 2.2 Hz), 7.97 (1H, d, J = 8.1 Hz),<br>
8.44 (1H, t, J = 2.3 Hz), 8.57 (1H, d, J = 1.6 Hz),<br>
8.96 (1H, d, J = 2.3 Hz), 9.16 (1H, d, J = 2.3 Hz),<br>
12.20 (1H, s).<br>
[0523]<br>
4-Phenethyl-2-(2-(pyrrolidin-1-yl)pyridine-3-<br>
carboxamido)benzoic acid<br><br>
293<br>
1H-NMR (DMSO-d6) 8: 1.80-1.89 (4H, m) , 2.88-3.01 (4H, m) ,<br>
3.32-3.42 (4H, m), 6.72 (1H, dd, J = 7.4, 4.8 Hz), 7.08<br>
(1H, dd, J = 8.2, 1.7 Hz), 7.15-7.22 (1H, m) , 7.24-7.31<br>
(4H, m), 7.78 (1H, dd, J = 7.4, 1.9 Hz), 7.92 (1H, d, J<br>
= 8.2 Hz), 8.22 (1H, dd, J = 4.8, 1.9 Hz), 8.57 (1H, s),<br>
11.58 (1H, s).<br>
[0524]<br>
Example 278<br><br>
2.0 mg of 5% palladium-carbon was added to a<br>
mixed solution of 1.0 mL of methanol and 2.0 mL of<br>
ethyl acetate containing 7.0 mg of 2-(4-<br>
nitrobenzamido)-4-phenethylbenzoic acid and stirred<br>
under hydrogen atmosphere at room temperature for 2<br>
hours. After insoluble were removed by filtration, the<br>
solvent was evaporated under reduced pressure to obtain<br>
4.0 mg of 2-(4-aminobenzamido)-4-phenethylbenzoic acid<br>
as pale yellow solid.<br>
Hi-NMR (DMSO-d6) 8: 2.80-2.96 (4H, m), 5.55-5.91 (2H,<br>
broad), 6.61 (2H, d, J = 8.6 Hz), 6.81 (1H, dd, J = 8.0,<br>
1.6 Hz), 7.15-7.20 (1H, m), 7.24-7.31 (4H, m), 7.74 (2H,<br>
d, J = 8.6 Hz), 7.89 (1H, d, J = 8.0 Hz), 8.61 (1H, d,<br>
J = 1.6 Hz) .<br>
[0525]<br>
Example 27 9<br><br><br>
0.061 mL of pyridine and 0.086 mL of 2,6-<br>
dichlorobenzoyl chloride were added to 3.0 mL of<br>
toluene solution containing 0.15 g of tert-butyl 2-<br>
amino-4-phenethylbenzoate at room temperature<br>
sequentially, and the resulting mixture was heated to<br>
reflux for 8 hours. The reaction mixture was cooled to<br>
room temperature and a saturated sodium hydrogen<br>
carbonate aqueous solution was added. The organic layer<br>
was separated and dried over anhydrous magnesium<br>
sulfate after washed with 10% citric acid aqueous<br>
solution and a saturated sodium chloride aqueous<br>
solution sequentially, and the solvent was evaporated<br>
under reduced pressure. The obtained residue was<br>
purified with silica gel column chromatography [Flash<br>
Tube 2008 manufactured by Trikonex Company, eluent;<br>
hexane: ethyl acetate =4:1] to obtain tert-butyl 2-<br>
(2,6-dichlorobenzamido)-4-phenethylbenzoate.<br>
3.0 mL of trifluoroacetic acid was added to<br>
the obtained tert-butyl 2-(2,6-dichlorobenzamido)-4-<br>
phenethylbenzoate and stirred at room temperature for 1<br>
hour. The solvent was evaporated under reduced pressure<br>
and diisopropyl ether was added to the obtained residue<br>
and a solid substance was separated by filtration to<br><br>
295<br>
obtain 18 mg of 2-(2,6-dichlorobenzamido)-4-<br>
phenethylbenzoic acid as white solid.<br>
1H-NMR (DMSO-de) 5: 2.91-3.02 (4H, m) , 7.15-7.22 (2H, m) ,<br>
7.26-7.30 (4H, m) , 7.53-7.57 (1H, m), 7.61-7.64 (2H, m) ,<br>
7.64 (1H, d, J = 1.7 Hz), 7.94 (1H, d, J = 8.0 Hz),<br>
8.48-8.50 (1H, broad), 11.56-11.62 (1H, broad).<br>
[0526]<br>
Example 280<br><br>
0.090 mL of pyridine and 0.12 mL of 2,6-<br>
dichlorobenzoyl chloride were added to 3.0 mL of<br>
toluene solution containing 0.15 g of tert-butyl 2-<br>
amino-4-phenylbenzoate at room temperature sequentially,<br>
and the resulting mixture was heated to reflux for 4<br>
hours. The reaction mixture was cooled to room<br>
temperature and 0.023 mL of pyridine and 0.040 mL of<br>
2,6-dichlorobenzoyl chloride were added sequentially<br>
and the resulting mixture was heated to reflux for 2<br>
hours. The reaction mixture was cooled to room<br>
temperature and water was added. The organic layer was<br>
separated and dried over anhydrous magnesium sulfate<br>
after washed with a saturated sodium chloride aqueous<br>
solution, and the solvent was evaporated under reduced<br>
pressure. The obtained residue was purified with silica<br>
gel column chromatography [Flash Tube 2008 manufactured<br><br>
296<br>
by Trikonex Company, eluent; hexane: ethyl acetate =<br>
4:1] to obtain tert-butyl 2-(2,6-dichlorobenzamido)-4-<br>
phenylbenzoate.<br>
3.0 mL of trifluoroacetic acid was added to<br>
the obtained tert-butyl 2-(2,6-dichlorobenzamido)-4-<br>
phenylbenzoate and stirred at room temperature for 1<br>
hour. The solvent was evaporated under reduced pressure<br>
and diisopropyl ether was added to the obtained residue<br>
and a solid substance was separated by filtration to<br>
obtain 0.10 g of 2-(2,6-dichlorobenzamido)-4-<br>
phenylbenzoic acid as white solid.<br>
1H-NMR (DMSO-d6) 8: 7.46-7.65 (7H, m) , 7.73 (2H, d, J =<br>
7.8 Hz), 8.12 (1H, d, J = 8.3 Hz), 8.87-8.89 (1H,<br>
broad), 11.62-11.68 (1H, broad), 13.76-13.88 (1H,<br>
broad).<br>
[0527]<br>
Example 281<br><br>
0.084 mL of pyridine and 0.11 mL of 2,6-<br>
dichlorobenzoyl chloride were added to 3.0 mL of<br>
toluene solution containing 0.15 g of tert-butyl 2-<br>
amino-4-phenoxybenzoate at room temperature<br>
sequentially, and the resulting mixture was heated to<br>
reflux for 4 hours. The reaction mixture was cooled to<br>
room temperature and 0.021 mL of pyridine and 0.037 mL<br><br>
297<br>
of 2,6-dichlorobenzoyl chloride were added sequentially<br>
and heated to reflux for 4 hours. The reaction mixture<br>
was cooled to room temperature and water was added. The<br>
organic layer was separated and dried over anhydrous<br>
magnesium sulfate after washed with a saturated sodium<br>
hydrogen carbonate aqueous solution and a saturated<br>
sodium chloride aqueous solution sequentially, and the<br>
solvent was evaporated under reduced pressure. The<br>
obtained residue was purified with silica gel column<br>
chromatography [Flash Tube 2008 manufactured by<br>
Trikonex Company, eluent; hexane: ethyl acetate = 4:1]<br>
to obtain tert-butyl 2-(2,6-dichlorobenzamido)-4-<br>
phenoxybenzoate.<br>
3.0 mL of trifluoroacetic acid was added to<br>
the obtained tert-butyl 2-(2,6-dichlorobenzamido)-4-<br>
phenoxybenzoate and stirred at room temperature for 1<br>
hour. The solvent was evaporated under reduced pressure<br>
and diisopropyl ether was added to the obtained residue<br>
and a solid substance was separated by filtration to<br>
obtain 70 mg of 2-(2,6-dichlorobenzamido)-4-<br>
phenoxybenzoic acid as white solid.<br>
1H-NMR (DMSO-de) 5: 6.79 (1H, dd, J = 8.9, 2.1 Hz),<br>
7.19-7.23 (2H, m) , 7.26-7.32 (1H, m) , 7.48-7.57 (3H, m) ,<br>
7.61-7.65 (2H, m), 8.05 (1H, d, J = 8.9 Hz), 8.24-8.28<br>
(1H, m) .<br>
[0528]<br>
Example 282<br><br><br>
0.063 mL of triethylamine and 0.040 mL of 2-<br>
fluorobenzoyl chloride were added to 3.0 mL of<br>
methylene chloride solution containing 60 mg of tert-<br>
butyl 2-amino-4-phenylbenzoate at room temperature<br>
sequentially and stirred at the same temperature for 1<br>
hour. 0.51 g of aminomethylated polystyrene was added<br>
to the reaction mixture and stirred at room temperature<br>
overnight. A saturated sodium hydrogen carbonate<br>
aqueous solution was added to the reaction mixture, and<br>
the organic layer was separated, and the solvent was<br>
evaporated under reduced pressure. The obtained residue<br>
was purified with silica gel column chromatography<br>
[Flash Tube 2008 manufactured by Trikonex Company,<br>
eluent; hexane: ethyl acetate =4:1] to obtain tert-<br>
butyl 2-(2-fluorobenzamido)-4-phenylbenzoate.<br>
10 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 2-(2-fluorobenzamido)-4-<br>
phenylbenzoate and stirred at room temperature for 2<br>
hours. The solvent was evaporated under reduced<br>
pressure and diisopropyl ether was added to the<br>
obtained residue and a solid substance was separated by<br>
filtration to obtain 61 mg of 2-(2-fluorobenzamido)-4-<br>
phenylbenzoic acid as white solid.<br><br>
299<br>
1H-NMR (DMSO-d6) 8: 7.39-7.50 (3H, m) , 7.52-7.59 (3H, m) ,<br>
7.65-7.76 (3H, m), 7.96 (1H, td, J = 7.8, 1.8 Hz), 8.13<br>
(1H, d, J = 8.3 Hz), 9.07 (1H, d, J = 1.7 Hz), 12.00-<br>
12.10 (1H, broad), 13.65-13.85 (1H, broad).<br>
[0529]<br>
Examples 283 to 319<br>
The compounds shown in Table 33 were obtained<br>
in the same manner as in Example 282.<br>
[0530]<br>
[Table 33]<br><br><br><br>
301<br>
1H-NMR (DMSO-de) 8: 7.44-7.49 (1H, m) , 7.51-7.58 (4H, m) ,<br>
7.65-7.72 (1H, m) , 7.72-7.77 (3H, m) , 7.81-7.85 (1H, m) ,<br>
8.14 (1H, d, J = 8.3 Hz), 9.02 (1H, d, J = 1.7 Hz),<br>
12.25 (1H, s).<br>
[0532]<br>
2-(4-Fluorobenzamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-de) 8: 7.43-7.59 (6H, m) , 7.71-7.77 (2H, m) ,<br>
8.02-8.09 (2H, m), 8.14 (1H, d, J = 8.3 Hz), 9.04 (1H,<br>
d, J = 1.7 Hz), 12.24 (1H, s), 13.75-13.95 (1H, broad).<br>
[0533]<br>
2-(2,4-Difluorobenzamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-de) 8: 7.32 (1H, td, J = 8.4, 2.4 Hz) ,<br>
7.44-7.58 (5H, m), 7.70-7.76 (2H, m), 8.04 (1H, td, J =<br>
8.8, 6.6 Hz), 8.13 (1H, d, J = 8.3 Hz), 9.04 (1H, d, J<br>
= 2.0 Hz), 12.02-12.06 (1H, m), 13.77 (1H, s).<br>
[0534]<br>
2-(2,6-Difluorobenzamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-de) 8: 7.28-7.35 (2H, m) , 7.44-7.50 (1H, m) ,<br>
7.52-7.61 (3H, m) , 7.62-7.78 (3H, m), 8.12 (1H, d, J =<br>
8.3 Hz), 8.90 (1H, s), 11.86 (1H, s), 13.70-13.95 (1H,<br>
broad).<br>
[0535]<br>
2-(2-Methylbenzamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-de) 8: 2.48 (3H, s) , 7.33-7.39 (2H, m) ,<br>
7.43-7.50 (2H, m) , 7.50-7.59 (3H, m), 7.62-7.66 (1H, m) ,<br>
7.71-7.76 (2H, m), 8.11 (1H, d, J = 8.3 Hz), 9.03 (1H,<br>
d, J = 1.7 Hz), 11.69 (1H, s), 13.71 (1H, s) .<br>
[0536]<br>
2-(3-Methylbenzamido)-4-phenylbenzoic acid<br><br>
302<br>
1H-NMR (DMSO-d6) 8: 2.43 (3H, s), 7.44-7.58 (6H, m) ,<br>
7.71-7.83 (4H, m), 8.14 (1H, d, J = 8.0 Hz), 9.09 (1H,<br>
d, J = 1.7 Hz), 12.27 (1H, s) , 13.80-13.95 (1H, broad).<br>
[0537]<br>
2-(4-Methylbenzamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-de) 5: 2.41 (3H, s), 7.40-7.58 (6H, m),<br>
7.72-7.75 (2H, m), 7.89 (2H, d, J = 8.3 Hz), 8.14 (1H,<br>
d, J = 8.3 Hz), 9.09 (1H, d, J = 1.7 Hz), 12.24 (1H, s),<br>
13.75-13.90 (1H, broad).<br>
[0538]<br>
4-Phenyl-2-(2-(trifluoromethyl)benzamido)benzoic acid<br>
1H-NMR (DMSO-de) 8: 7.47 (1H, tt, J = 7.4, 1.5 Hz),<br>
7.52-7.60 (3H, m) , 7.70-7.94 (6H, m) , 8.12 (1H, d, J =<br>
8.3 Hz), 8.88 (1H, s), 11.69 (1H, s), 13.65-13.85 (1H,<br>
broad).<br>
[0539]<br>
4-Phenyl-2-(3-(trifluoromethyl)benzamido)benzoic acid<br>
1H-NMR (DMSO-de) 8: 7.47 (1H, tt, J = 7.3, 1.5 Hz),<br>
7.52-7.58 (3H, m) , 7.72-7.77 (2H, m), 7.86-7.91 (1H, m),<br>
8.05 (1H, d, J = 8.1 Hz), 8.14 (1H, d, J = 8.3 Hz),<br>
8.27-8.32 (2H, m), 9.01 (1H, d, J = 2.0 Hz), 12.38 (1H,<br>
s), 13.80-14.05 (1H, broad).<br>
[0540]<br>
4-Phenyl-2-(4-(trifluoromethyl)benzamido)benzoic acid<br>
1H-NMR (DMSO-de) 8: 7.47 (1H, tt, J = 7.6, 1.5 Hz),<br>
7.52-7.59 (3H, m), 7.72-7.77 (2H, m), 8.01 (2H, d, J =<br>
8.3 Hz), 8.12-8.22 (3H, m), 9.02 (1H, d, J = 1.7 Hz),<br>
12.34 (1H, s).<br><br>
303<br>
[0541]<br>
2-(3,4-Dimethylbenzamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-d6) 8: 2.32 (3H, s) , 2.33 (3H, s) , 7.37 (1H,<br>
d, J = 7.8 Hz), 7.44-7.58 (4H, m), 7.69-7.79 (4H, m),<br>
8.13 (1H, d, J = 8.3 Hz), 9.09 (1H, d, J = 2.0 Hz),<br>
12.25 (1H, s), 13.75-13.95 (1H, broad).<br>
[0542]<br>
2-(2, 3-Dimethylbenzamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-d6) 8: 2.31 (3H, s) , 2.33 (3H, s) , 7.24 (1H,<br>
t, J = 7.6 Hz), 7.34 (1H, d, J = 7.6 Hz), 7.41 (1H, d,<br>
J = 7.6 Hz), 7.44-7.58 (4H, m) , 7.71-7.75 (2H, m), 8.11<br>
(1H, d, J = 8.3 Hz), 9.03 (1H, s) , 11.60 (1H, s) ,<br>
13.60-13.80 (1H, broad).<br>
[0543]<br>
2-(6-Morpholinopyridine-3-carboxamido)-4-phenylbenzoic<br>
acid<br>
1H-NMR (DMSO-d6) 8: 3.60-3.75 (8H, m) , 7.00 (1H, d, J =<br>
9.0 Hz), 7.43-7.58 (4H, m) , 7.70-7.75 (2H, m) , 8.04 (1H,<br>
dd, J = 9.0, 2.5 Hz), 8.12 (1H, d, J = 8.3 Hz), 8.75<br>
(1H, d, J = 2.5 Hz), 9.06 (1H, d, J = 1.7 Hz), 12.08<br>
(1H, s), 13.70-13.90 (1H, broad).<br>
[0544]<br>
2-(Cyclohexanecarboxamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-de) 8: 1.14-1.52 (5H, m) , 1.60-1.71 (1H, m) ,<br>
1.72-1.81 (2H, m) , 1.88-1.99 (2H, m), 2.30-2.39 (1H, m) ,<br>
7.41-7.56 (4H, m), 7.65-7.71 (2H, m), 8.06 (1H, d, J =<br>
8.3 Hz), 8.90 (1H, d, J = 1.7 Hz), 11.28 (1H, s), 13.61<br>
(1H, s) .<br><br>
304<br>
[0545]<br>
4-Phenyl-2-(2-phenylacetamido)benzoic acid<br>
1H-NMR (DMSO-d6) 5: 3.80 (2H, s), 7.26-7.54 (9H, m),<br>
7.64-7.69 (2H, m) , 8.03 (1H, d, J = 8.3 Hz), 8.87 (1H,<br>
d, J = 1.7 Hz), 11.23 (1H, s), 13.55-13.75 (1H, broad).<br>
[0546]<br>
2-(Cinnamamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.94 (1H, d, J = 15.6 Hz), 7.41-7.57<br>
(7H, m), 7.66 (1H, d, J = 15.6 Hz), 7.69-7.78 (4H, m),<br>
8.10 (1H, d, J = 8.3 Hz), 8.98 (1H, d, J = 1.7 Hz),<br>
11.42 (1H, s), 13.55-13.75 (1H, broad).<br>
[0547]<br>
2-(2-Phenoxyacetamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-d6) 8: 4.77 (2H, s) , 7.03 (1H, t, J = 7.3<br>
Hz), 7.09-7.15 (2H, m), 7.33-7.40 (2H, m), 7.43-7.57<br>
(4H, m), 7.67-7.73 (2H, m), 8.10 (1H, d, J = 8.3 Hz),<br>
9.06 (1H, d, J = 1.7 Hz), 12.26 (1H, s) , 13.82 (1H, s) .<br>
[0548]<br>
2-(Furan-2-carboxamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-de) 8: 6.77 (1H, dd, J = 3.5, 1.7 Hz), 7.30<br>
(1H, dd, J = 3.5, 0.6 Hz), 7.44-7.57 (4H, m) , 7.69-7.75<br>
(2H, m), 8.02 (1H, dd, J = 1.7, 0.6 Hz), 8.13 (1H, d, J<br>
= 8.3 Hz), 9.03 (1H, d, J = 2.0 Hz), 12.26 (1H, s),<br>
13.79 (1H, s).<br>
[0549]<br>
4-Phenyl-2-(thiophene-2-carboxamido)benzoic acid<br>
1H-NMR (DMSO-de) 8: 7.30 (1H, dd, J = 5.0, 3.8 Hz),<br>
7.44-7.50 (1H, m) , 7.50-7.58 (3H, m), 7.70-7.76 (2H, m) ,<br>
7.78 (1H, dd, J = 3.8, 1.1 Hz), 7.96 (1H, dd, J = 5.0,<br><br>
305<br>
1.1 Hz), 8.13 (1H, d, J= 8.3 Hz), 8.94 (1H, d, J = 1.7<br>
Hz), 12.23 (1H, s), 13.80-14.00 (1H, broad).<br>
[0550]<br>
2-(Benzo[1,3]dioxole-5-carboxamido)-4-phenylbenzoic<br>
acid<br>
1H-NMR (DMSO-d6) 8: 6.17 (2H, s), 7.13 (1H, d, J = 8.1<br>
Hz), 7.43-7.59 (6H, m), 7.70-7.76 (2H, m), 8.13 (1H, d,<br>
J = 8.3 Hz), 9.05 (1H, d, J = 2.0 Hz), 12.14 (1H, s),<br>
13.70-13.95 (1H, broad).<br>
[0551]<br>
2-(2,3-Dihydrobenzo[1,4]dioxine-6-carboxamido)-4-<br>
phenylbenzoic acid<br>
1H-NMR (DMSO-d6) 8: 4.28-4.39 (4H, m), 7.07 (1H, d, J =<br>
8.3	Hz), 7.43-7.57 (6H, m) , 7.70-7.75 (2H, m) , 8.13 (1H,<br>
d, J = 8.3 Hz), 9.07 (1H, d, J = 1.7 Hz), 12.16 (1H, s),<br>
13.70-13.90 (1H, broad).<br>
[0552]<br>
2-(Benzothiophene-5-carboxamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-d6) 8: 7.45-7.58 (4H, m), 7.65 (1H, d, J =<br>
5.4	Hz), 1.12-1.18 (2H, m), 7.92-7.97 (2H, m), 8.15 (1H,<br>
d, J = 8.3 Hz), 8.25 (1H, d, J = 8.5 Hz), 8.53 (1H, d,<br>
J = 1.5 Hz), 9.11 (1H, d, J = 1.7 Hz), 12.37 (1H, s).<br>
[0553]<br>
2-(l-Methyl-lH-benzotriazole-5-carboxamido)-4-<br>
phenylbenzoic acid<br>
1H-NMR (DMSO-d6) 8: 4.39 (3H, s), 7.45-7.51 (1H, m) ,<br>
7.53-7.59 (3H, m), 7.73-7.78 (2H, m), 8.07 (1H, d, J =<br>
8.8 Hz), 8.16 (2H, d, J = 8.1 Hz), 8.66 (1H, s), 9.07<br>
(1H, d, J = 1.7 Hz), 12.37 (1H, s).<br><br>
306<br>
[0554]<br>
2-(3-Nitrobenzamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-d6) 8: 7.48 (1H, tt, J = 7.3, 1.5 Hz),<br>
7.52-7.61 (3H, m), 7.72-7.78 (2H, m), 7.93 (1H, t, J =<br>
8.0 Hz), 8.15 (1H, d, J = 8.3 Hz), 8.41 (1H, ddd, J =<br>
8.0, 1.5, 1.0 Hz), 8.51 (1H, ddd, J = 8.1, 2.4, 1.0 Hz),<br>
8.78-8.80 (1H, m) , 8.98-9.00 (1H, m) , 12.42 (1H, s).<br>
[0555]<br>
2-(Benzofuran-5-carboxamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-d6) 8: 7.16 (1H, dd, J = 2.2, 1.0 Hz), 7.47<br>
(1H, tt, J = 7.4, 1.5 Hz), 7.50-7.59 (3H, m), 1.12-1.1%<br>
(2H, m), 7.83 (1H, d, J = 8.5 Hz), 7.96 (1H, dd, J =<br>
8.7, 1.7 Hz), 8.12-8.19 (2H, m), 8.33 (1H, d, J = 1.7<br>
Hz), 9.10 (1H, d, J = 1.7 Hz), 12.31 (1H, s).<br>
[0556]<br>
2-(Benzothiazole-2-carboxamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-de) 8: 7.46-7.51 (1H, m) , 7.53-7.79 (7H, m) ,<br>
8.16-8.22 (2H, m) , 8.29-8.32 (1H, m), 9.10 (1H, d, J =<br>
1.7 Hz), 13.04 (1H, s).<br>
[0557]<br>
2-(Benzothiophene-3-carboxamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-de) 8: 7.45-7.61 (6H, m) , 7.73-7.80 (2H, m) ,<br>
8.11-8.18 (2H, m), 8.51-8.55 (1H, m), 8.56 (1H, s),<br>
9.04 (1H, d, J = 2.0 Hz), 12.09 (1H, s) .<br>
[0558]<br>
2-(Benzofuran-2-carboxamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-dg) 8: 7.37-7.48 (1H, m) , 7.48 (1H, tt, J =<br>
7.4, 1.5 Hz), 7.52-7.59 (4H, m), 7.69-7.78 (4H, m),<br><br>
307<br>
7.86 (1H, d, J = 7.8 Hz), 8.16 (1H, d, J = 8.3 Hz),<br>
9.08 (1H, d, J = 1.7 Hz), 12.61 (1H, s) .<br>
[0559]<br>
2-(Benzothiophene-2-carboxamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-de) 6: 7.45-7.59 (6H, m) , 1.11-1.IB (2H, m) ,<br>
8.06-8.18 (4H, m), 8.95 (1H, d, J = 1.5 Hz), 12.43 (1H,<br>
s).<br>
[0560]<br>
4-Phenyl-2-(l-phenyl-lH-pyrazole-5-carboxamido)benzoic<br>
acid<br>
1H-NMR (DMSO-de) 8: 7.09 (1H, d, J = 2.0 Hz), 7.41-7.55<br>
(9H, m), 7.64-7.69 (2H, m), 7.88 (1H, d, J = 2.0 Hz),<br>
8.12 (1H, d, J = 8.3 Hz), 8.77 (1H, d, J = 1.7 Hz),<br>
12.12 (1H, s).<br>
[0561]<br>
2-(2, 2-Diphenylacetamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-de) 8: 5.34 (1H, s), 7.28 (1H, tt, J= 7.2,<br>
1.7 Hz), 7.33-7.54 (13H, m), 7.65-7.71 (2H, m), 8.02<br>
(1H, d, J = 8.3 Hz), 8.92 (1H, d, J = 1.7 Hz), 11.42<br>
(1H, s), 13.50-13.70 (1H, broad).<br>
[0562]<br>
2-(2-Chlorobenzamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-de) 8: 7.44-7.65 (7H, m) , 7.71-7.78 (3H, m) ,<br>
8.12 (1H, d, J = 8.3 Hz), 8.97 (1H, s) , 11.72 (1H, s).<br>
[0563]<br>
2-(3-Chlorobenzamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-de) 8: 7.44-7.50 (1H, m) , 7.52-7.59 (3H, m) ,<br>
7.66 (1H, t, J = 7.9 Hz), 1.11-1.18 (3H, m), 7.92-7.96<br><br>
308<br>
(1H, in), 7.99 (1H, t, J = 1.8 Hz), 8.14 (1H, d, J = 8.0<br>
Hz), 9.00 (1H, d, J = 2.0 Hz), 12.27 (1H, s) .<br>
[0564]<br>
2-(4-Chlorobenzamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-de) 6: 7.47 (1H, tt, J = 7.4, 1.6 Hz),<br>
7.52-7.59 (3H, m) , 7.68-7.77 (4H, m), 7.97-8.02 (2H, m) ,<br>
8.14 (1H, d, J = 8.3 Hz), 9.02-9.04 (1H, m) , 12.25 (1H,<br>
s).<br>
[0565]<br>
2-(2,4-Dichlorobenzamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-de) 8: 7.47 (1H, tt, J = 7.3, 1.5 Hz),<br>
7.52-7.59 (3H, m), 7.63 (1H, dd, J = 8.3, 2.0 Hz),<br>
7.70-7.76 (2H, m), 7.79 (1H, d, J = 8.3 Hz), 7.83 (1H,<br>
d, J = 2.0 Hz), 8.11 (1H, d, J = 8.3 Hz), 8.91 (1H, s),<br>
11.72 (1H, s).<br>
[0566]<br>
4-Phenyl-2-(2,4-bis(trifluoromethyl)benzamido)benzoic<br>
acid<br>
1H-NMR (DMSO-de) 8: 7.47 (1H, tt, J = 7.4, 1.6 Hz),<br>
7.53-7.57 (2H, m), 7.60 (1H, dd, J= 8.3, 1.7 Hz),<br>
7.70-7.76 (2H, m), 8.10-8.15 (2H, m), 8.25 (1H, s),<br>
8.28-8.33 (1H, m), 8.76 (1H, d, J = 1.4 Hz), 11.69 (1H,<br>
s) .<br>
[0567]<br>
4-Phenyl-2-(3-phenylpropanamido)benzoic acid<br>
1H-NMR (DMSO-de) 8: 2.76 (2H, t, J = 7.6 Hz), 2.97 (2H,<br>
t, J = 7.6 Hz), 7.16-7.22 (1H, m), 7.26-7.31 (4H, m) ,<br>
7.42-7.48 (2H, m) , 7.50-7.56 (2H, m) , 7.65-7.71 (2H, m) ,<br><br>
309<br>
8.05 (1H, d, J = 8.3 Hz), 8.85 (1H, d, J = 2.0 Hz),<br>
11.23 (1H, s), 13.55-13.75 (1H, broad).<br>
[0568]<br>
Example 320<br><br>
1.3 mL of methylene chloride, 1.3 JJ.L of N,N-<br>
dimethylformainide and 0.031 mL of oxalyl chloride were<br>
added sequentially to 69 mg of 6-(piperidin-1-<br>
yl)pyridine-3-carboxylic acid at room temperature, and<br>
stirred at the same temperature for 1 hour. The<br>
reaction mixture was added to a mixed solution of 57 mg<br>
of tert-butyl 2-amino-4-phenoxybenzoate, 3.7 mL of<br>
methylene chloride and 0.22 mL of triethylamine and<br>
stirred at room temperature for 2 hours. A saturated<br>
sodium hydrogen carbonate aqueous solution was added to<br>
the reaction mixture, and the organic layer was<br>
separated, and the solvent was evaporated under reduced<br>
pressure. The obtained residue was purified with silica<br>
gel column chromatography [Flash Tube 2008 manufactured<br>
by Trikonex Company, eluent; hexane: ethyl acetate =<br>
8:1] to obtain tert-butyl 4-phenoxy-2-(6-(piperidin-1-<br>
yl)pyridine-3-carboxamido)benzoate.<br>
10 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 4-phenoxy-2-(6-(piperidin-1-<br><br>
310<br>
yl)pyridine-3-carboxamido)benzoate and stirred at room<br>
temperature for 2 hours. The solvent was evaporated<br>
under reduced pressure and water was added and pH was<br>
adjusted to pH 6.5 with a saturated sodium hydrogen<br>
carbonate aqueous solution. A solid substance was<br>
separated by filtration to obtain 23 mg of 4-phenoxy-2-<br>
(6-(piperidin-1-yl)pyridine-3-carboxamido)benzoic acid<br>
as white solid.<br>
1H-NMR (DMSO-de) 5: 1.47-1.70 (6H, m) , 3.62-3.70 (4H, m) ,<br>
6.73 (1H, dd, J = 9.0, 2.6 Hz), 6.93 (1H, d, J = 9.2<br>
Hz), 7.15-7.18 (2H, m) , 7.25-7.30 (1H, m) , 7.45-7.52<br>
(2H, m), 7.91 (1H, dd, J = 9.2, 2.6 Hz), 8.05 (1H, d, J<br>
= 9.0 Hz), 8.38 (1H, d, J = 2.6 Hz), 8.63 (1H, d, J =<br>
2.6 Hz), 12.22 (1H, s).<br>
[0569]<br>
Example 321<br><br>
0.059 mL of triethylamine and 0.037 mL of 2-<br>
fluorobenzoyl chloride were added to 3.0 mL of<br>
methylene chloride solution containing 60 mg of tert-<br>
butyl 2-amino-4-phenoxybenzoate at room temperature<br>
sequentially and stirred at the same temperature for 2<br>
hours. 0.48 g of aminomethylated polystyrene was added<br>
to the reaction mixture and stirred at room temperature<br>
overnight. A saturated sodium hydrogen carbonate<br><br>
311<br>
aqueous solution was added to the reaction mixture, the<br>
organic layer was separated, and the solvent was<br>
evaporated under reduced pressure. The obtained residue<br>
was purified with silica gel column chromatography<br>
[Flash Tube 2008 manufactured by Trikonex Company,<br>
eluent; hexane: ethyl acetate =4:1] to obtain tert-<br>
butyl 2-(2-fluorobenzamido)-4-phenoxybenzoate.<br>
10 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 2-(2-fluorobenzamido)-4-<br>
phenoxybenzoate and stirred at room temperature for 2<br>
hours. The solvent was evaporated under reduced<br>
pressure and diisopropyl ether was added to the<br>
obtained residue and a solid substance was separated by<br>
filtration to obtain 30 mg of 2-(2-fluorobenzamido)-4-<br>
phenoxybenzoic acid as white solid.<br>
1H-NMR (DMSO-de) 8: 6.79 (1H, dd, J = 8.9, 2.5 Hz),<br>
7.16-7.21 (2H, m), 7.25-7.31 (1H, m), 7.35-7.53 (4H, m) ,<br>
7.63-7.69 (1H, m), 7.88 (1H, td, J = 7.8, 1.8 Hz), 8.06<br>
(1H, d, J = 8.9 Hz), 8.41 (1H, d, J = 2.5 Hz), 12.15-<br>
12.19 (1H, broad), 13.50-13.70 (1H, broad).<br>
[0570]<br>
Examples 322 to 344<br>
The compounds shown in Table 34 were obtained<br>
in the same manner as in Example 321.<br>
[0571]<br>
[Table 34]<br><br><br>
[0572]<br>
4-Phenoxy-2-(2-(trifluoromethyl)benzamido)benzole acid<br>
1H-NMR (DMSO-d6) 8: 6.77 (1H, dd, J = 8.8, 2.4 Hz), 7.19<br>
(2H, d, J = 7.8 Hz), 7.28 (1H, t, J = 7.4 Hz), 7.46-<br>
7.53 (2H, m), 7.74-7.87 (3H, m), 7.89 (1H, d, J = 8.1<br>
Hz), 8.04 (1H, d, J = 8.8 Hz), 8.27 (1H, d, J = 2.4 Hz),<br>
11.82 (1H, s), 13.60 (1H, s).<br>
[0573]<br>
4-Phenoxy-2-(4-(trifluoromethyl)benzamido)benzoic acid<br><br>
313<br>
1H-NMR (DMSO-de) 8: 6.80 (1H, dd, J = 8.9, 2.5 Hz),<br>
7.16-7.22 (2H, m) , 7.26-7.32 (1H, m), 7.47-7.53 (2H, m) ,<br>
7.98 (2H, d, J = 8.3 Hz), 8.06-8.14 (3H, m), 8.37 (1H,<br>
d, J = 2.5 Hz), 12.51 (1H, s), 13.65-13.85 (1H, broad).<br>
[0574]<br>
2-(2-Methylbenzamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-d6) 6: 2.42 (3H, s), 6.75 (1H, dd, J = 8.9,<br>
2.7 Hz), 7.16-7.21 (2H, m), 7.25-7.36 (3H, m), 7.41-<br>
7.52	(3H, m), 7.56-7.60 (1H, m), 8.05 (1H, d, J = 8.9<br>
Hz), 8.39 (1H, d, J = 2.7 Hz), 11.82 (1H, s), 13.45-<br>
13.65 (1H, broad).<br>
[0575]<br>
2-(3-Methylbenzamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-d6) 8: 2.40 (3H, s) , 6.77 (1H, dd, J = 8.8,<br>
2.7 Hz), 7.16-7.21 (2H, m) , 7.26-7.31 (1H, m), 7.44-<br>
7.53	(4H, m) , 7.68-7.74 (1H, m), 7.74 (1H, s) , 8.07 (1H,<br>
d, J = 8.8 Hz), 8.41 (1H, d, J = 2.7 Hz), 12.41 (1H, s) ,<br>
13.71 (1H, s).<br>
[0576]<br>
2-(4-Methylbenzamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-d6) 8: 2.39 (3H, s) , 6.76 (1H, dd, J = 8.9,<br>
2.6 Hz), 7.15-7.21 (2H, m), 7.26-7.31 (1H, m), 7.39 (2H,<br>
d, J = 8.2 Hz), 7.46-7.52 (2H, m), 7.82 (2H, d, J = 8.2<br>
Hz), 8.07 (1H, d, J = 8.9 Hz), 8.41 (1H, d, J = 2.6 Hz),<br>
12.38 (1H, s), 13.67 (1H, s).<br>
[0577]<br>
2-(4-Nitrobenzamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.82 (1H, dd, J = 8.9, 2.5 Hz),<br>
7.16-7.21 (2H, m) , 7.26-7.32 (1H, m), 7.46-7.53 (2H, m) ,<br><br>
314<br>
8.09 (1H, d, J - 8.9 Hz), 8.12-8.17 (2H, m), 8.35 (1H,<br>
d, J = 2.5 Hz), 8.40-8.45 (2H, m), 12.53 (1H, s),<br>
13.65-13.90 (1H, broad).<br>
[0578]<br>
2-(3,4-Dimethylbenzamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-d6) 8: 2.30 (6H, s) , 6.75 (1H, dd, J = 8.9,<br>
2.7 Hz), 7.15-7.20 (2H, m) , 7.25-7.31 (1H, m), 7.34 (1H,<br>
d, J = 7.8 Hz), 7.45-7.53 (2H, m), 7.64 (1H, dd, J =<br>
7.8, 1.9 Hz), 7.71 (1H, d, J = 1.9 Hz), 8.06 (1H, d, J<br>
= 8.9 Hz), 8.42 (1H, d, J = 2.7 Hz), 12.38 (1H, s),<br>
13.69 (1H, s).<br>
[0579]<br>
2-(2,3-Dimethylbenzamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-d6) 8: 2.27 (3H, s) , 2.29 (3H, s) , 6.75 (1H,<br>
dd, J = 8.8, 2.6 Hz), 7.16-7.38 (6H, m), 7.46-7.52 (2H,<br>
m), 8.04 (1H, d, J = 8.8 Hz), 8.40 (1H, d, J = 2.6 Hz),<br>
11.73 (1H, s), 13.53 (1H, s).<br>
[0580]<br>
2-(6-Morpholinopyridine-3-carboxamido)-4-phenoxybenzoic<br>
acid<br>
1H-NMR (DMSO-de) 8: 3.57-3.75 (8H, m) , 6.75 (1H, dd, J =<br>
9.0, 2.6 Hz), 6.96 (1H, d, J = 9.0 Hz), 7.13-7.22 (2H,<br>
m), 7.24-7.31 (1H, m), 7.45-7.53 (2H, m), 7.97 (1H, dd,<br>
J = 9.0, 2.4 Hz), 8.05 (1H, d, J = 9.0 Hz), 8.37 (1H, d,<br>
J = 2.6 Hz), 8.67 (1H, d, J = 2.4 Hz), 12.23 (1H, s),<br>
13.64 (1H, s).<br>
[0581]<br>
4-Phenoxy-2-(2-phenylacetamido)benzoic acid<br><br>
315<br>
1H-NMR (DMSO-d6) 5: 3.73 (2H, s), 6.69 (1H, dd, J = 8.8,<br>
2.5 Hz), 7.12 (2H, d, J = 7.6 Hz), 7.22-7.38 (6H, m),<br>
7.43-7.49 (2H, m), 7.96 (1H, d, J = 8.8 Hz), 8.21 (1H,<br>
d, J = 2.5 Hz), 11.35 (1H, s), 13.45 (1H, s).<br>
[0582]<br>
2-(3-Fluorobenzamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.80 (1H, dd, J = 8.8, 2.7 Hz) ,<br>
7.16-7.21 (2H, m) , 7.26-7.31 (1H, m), 7.46-7.55 (3H, m) ,<br>
7.62-7.70 (2H, m) , 7.74-7.78 (1H, m), 8.08 (1H, d, J =<br>
8.8 Hz), 8.35 (1H, d, J = 2.7 Hz), 12.42 (1H, s),<br>
13.60-13.85 (1H, broad).<br>
[0583]<br>
2-(2,6-Difluorobenzamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-d6) 5: 6.81 (1H, dd, J = 8.8, 2.4 Hz), 7.19<br>
(2H, d, J = 7.8 Hz), 7.24-7.34 (3H, m) , 7.46-7.54 (2H,<br>
m), 7.61-7.70 (1H, m), 8.05 (1H, d, J = 8.8 Hz), 8.25-<br>
8.29 (1H, m), 11.99 (1H, s), 13.50-13.80 (1H, broad).<br>
[0584]<br>
4-Phenoxy-2-(3-(trifluoromethyl)benzamido)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.81 (1H, dd, J = 8.8, 2.4 Hz),<br>
7.16-7.21 (2H, m), 7.26-7.32 (1H, m), 7.46-7.53 (2H, m),<br>
7.85 (1H, t, J = 8.0 Hz), 8.03 (1H, d, J = 7.8 Hz),<br>
8.08 (1H, d, J = 8.8 Hz), 8.18-8.24 (2H, m), 8.35 (1H,<br>
d, J = 2.4 Hz), 12.54 (1H, s) .<br>
[0585]<br>
2-(3-Nitrobenzamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.81 (1H, dd, J = 8.8, 2.4 Hz),<br>
7.17-7.21 (2H, m) , 7.26-7.33 (1H, m), 7.46-7.54 (2H, m) ,<br>
7.89 (1H, t, J = 7.9 Hz), 8.08 (1H, d, J = 8.8 Hz),<br><br>
316<br>
8.30-8.37 (2H, m) , 8.46-8.50 (1H, m), 8.71 (1H, s),<br>
12.62 (1H, s), 13.70-14.00 (1H, broad).<br>
[0586]<br>
2-(2-Chlorobenzamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.79 (1H, dd, J = 8.9, 2.4 Hz),<br>
7.16-7.22 (2H, m), 7.26-7.32 (1H, m), 7.46-7.63 (5H, m),<br>
7.69 (1H, dd, J = 7.4, 1.6 Hz), 8.05 (1H, d, J = 8.9<br>
Hz), 8.30-8.34 (1H, m), 11.86 (1H, s), 13.50-13.75 (1H,<br>
broad).<br>
[0587]<br>
2-(3-Chlorobenzamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-de) 8: 6.79 (1H, dd, J = 8.8, 2.4 Hz) ,<br>
7.16-7.21 (2H, m), 7.25-7.31 (1H, m), 7.45-7.53 (2H, m),<br>
7.60-7.65 (1H, m), 7.69-7.76 (1H, m), 7.84-7.95 (2H, m),<br>
8.07 (1H, d, J = 8.8 Hz), 8.34 (1H, d, J = 2.4 Hz),<br>
12.43 (1H, s).<br>
[0588]<br>
2-(4-Chlorobenzamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-de) 8: 6.78 (1H, dd, J = 8.9, 2.6 Hz),<br>
7.16-7.21 (2H, m) , 7.26-7.32 (1H, m), 7.46-7.52 (2H, m) ,<br>
7.64-7.70 (2H, m), 7.88-7.95 (2H, m) , 8.07 (1H, d, J =<br>
8.9 Hz), 8.36 (1H, d, J = 2.6 Hz), 12.42 (1H, s).<br>
[0589]<br>
2-(2,4-Dichlorobenzamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-de) 8: 6.80 (1H, dd, J = 8.8, 2.7 Hz), 7.18<br>
(2H, d, J = 7.8 Hz), 7.28 (1H, t, J = 7.4 Hz), 7.45-<br>
7.53 (2H, m), 7.60 (1H, dd, J = 8.3, 2.2 Hz), 7.74 (1H,<br>
d, J = 8.3 Hz), 7.81 (1H, d, J = 1.9 Hz), 8.05 (1H, d,<br><br>
317<br>
J = 8.8 Hz), 8.26-8.28 (1H, m) , 11.88 (1H, s), 13.45-<br>
13.80 (1H, broad).<br>
[0590]<br>
2-(Benzothiophene-5-carboxamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-d6) 5: 6.78 (1H, dd, J = 8.8, 2.7 Hz),<br>
7.17-7.22 (2H, m) , 7.27-7.32 (1H, m) , 7.47-7.53 (2H, m) ,<br>
7.62 (1H, d, J = 5.4 Hz), 7.87 (1H, dd, J = 8.4, 1.7<br>
Hz), 7.93 (1H, d, J = 5.4 Hz), 8.09 (1H, d, J = 8.8 Hz),<br>
8.22 (1H, d, J = 8.4 Hz), 8.44 (1H, d, J = 2.7 Hz),<br>
8.47 (1H, d, J = 1.7 Hz), 12.52 (1H, s) .<br>
[0591]<br>
2-(Benzothiophene-2-carboxamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-de) 8: 6.80 (1H, dd, J = 8.8, 2.6 Hz),<br>
7.17-7.22 (2H, m) , 7.26-7.32 (1H, m) , 7.46-7.56 (4H, m) ,<br>
8.04-8.12 (4H, m), 8.28 (1H, d, J = 2.6 Hz), 12.57 (1H,<br>
s), 13.65-13.90 (1H, broad).<br>
[0592]<br>
4-Phenoxy-2-(l-phenyl-lH-pyrazole-5-carboxamido)benzoic<br>
acid<br>
1H-NMR (DMSO-d6) 8: 6.73 (1H, dd, J = 8.9, 2.7 Hz), 7.04<br>
(1H, d, J = 2.1 Hz), 7.10-7.15 (2H, m), 7.20-7.25 (1H,<br>
m), 7.40-7.48 (7H, m), 7.86 (1H, d, J = 2.1 Hz), 8.04<br>
(1H, d, J = 8.9 Hz), 8.13 (1H, d, J = 2.7 Hz), 12.22<br>
(1H, s).<br>
[0593]<br>
4-Phenoxy-2-(2,4-bis(trifluoromethyl)benzamido)benzoic<br>
acid<br>
1H-NMR (DMSO-de) 8: 6.80 (1H, dd, J = 8.9, 2.3 Hz), 7.19<br>
(2H, d, J = 7.8 Hz), 7.26-7.31 (1H, m), 7.45-7.53 (2H,<br><br>
318<br>
m), 8.05 (1H, d, J = 8.9 Hz), 8.09 (1H, d, J = 7.9 Hz),<br>
8.19 (1H, d, J = 2.3 Hz), 8.23 (1H, s), 8.27 (1, d, J =<br>
7.9 Hz), 11.86 (1H, s).<br>
[0594]<br>
4-Phenoxy-2-(3-phenylpropanamido)benzoic acid<br>
1H-NMR (DMSO-de) 5: 2.69 (2H, t, J = 7.7 Hz) , 2.90 (2H,<br>
t, J = 7.7 Hz), 6.69 (1H, dd, J = 8.9, 2.5 Hz), 7.11-<br>
7.21 (3H, m), 7.21-7.31 (5H, m) , 7.43-7.50 (2H, m) ,<br>
7.98 (1H, d, J = 8.9 Hz), 8.21 (1H, d, J = 2.5 Hz),<br>
11.36 (1H, s), 13.40-13.60 (1H, broad).<br>
[0595]<br>
Example 345<br><br>
1.3 mL of methylene chloride, 1.3 ^L of N,N-<br>
dimethylformamide and 0.031 mL of oxalyl chloride were<br>
added to 69 mg of 3,4-dimethoxycinnamic acid at room<br>
temperature sequentially and stirred at the same<br>
temperature for 1 hour. The reaction mixture was added<br>
to a mixed solution of 54 mg of tert-butyl 2-amino-4-<br>
phenylbenzoate, 3.7 mL of methylene chloride and 0.22<br>
mL of triethylamine and stirred at room temperature for<br>
2 hours. A saturated sodium hydrogen carbonate aqueous<br>
solution was added to the reaction mixture, and the<br>
organic layer was separated, and the solvent was<br><br>
319<br>
evaporated under reduced pressure. The obtained residue<br>
was purified with silica gel column chromatography<br>
[Flash Tube 2008 manufactured by Trikonex Company,<br>
eluent; hexane: ethyl acetate =4:1] to obtain (E)-<br>
tert-butyl 2-(3-(3,4-dimethoxyphenyl)acrylamido)-4-<br>
phenylbenzoate.<br>
10 mL of trifluoroacetic acid was added to<br>
obtain (E)-tert-butyl 2- (3-(3,4-<br>
dimethoxyphenyl)acrylamido)-4-phenylbenzoate and<br>
stirred at room temperature for 2 hours. The solvent<br>
was evaporated under reduced pressure, diisopropyl<br>
ether was added to the obtained residue, and a solid<br>
substances was separated by filtration to obtain 20 mg<br>
of (E)-2-(3-(3,4-dimethoxyphenyl)acrylamido)-4-<br>
phenylbenzoic acid as white solid.<br>
1H-NMR (DMSO-d6) 6: 3.81 (3H, s) , 3.85 (3H, s) , 6.84 (1H,<br>
d, J = 15.5 Hz), 7.01 (1H, d, J = 8.3 Hz), 7.26 (1H, dd,<br>
J = 8.4, 1.7 Hz), 7.40 (1H, d, J = 1.5 Hz), 7.43-7.57<br>
(4H, m), 7.59 (1H, d, J = 15.5 Hz), 7.71 (2H, d, J =<br>
7.8 Hz), 8.09 (1H, d, J = 8.4 Hz), 9.00 (1H, d, J = 1.7<br>
Hz), 11.37 (1H, s), 13.50-13.75 (1H, broad).<br>
[0596]<br>
Examples 346 to 367<br>
The compounds shown in Table 35 were obtained<br>
in the same manner as in Example 345.<br>
[0597]<br>
[Table 35]<br><br><br>
[0598]<br>
4-Phenyl-2-((E)-3-(pyridin-4-yl)acrylamido)benzoic acid<br>
trifluoroacetate<br>
1H-NMR (DMSO-de) 6: 7.40 (1H, d, J = 15.6 Hz), 7.47 (1H,<br>
tt, J = 7.3, 1.5 Hz), 7.51-7.58 (3H, m), 7.68-7.75 (3H,<br>
m), 8.07 (2H, d, J = 6.1 Hz), 8.11 (1H, d, J = 8.3 Hz),<br>
8.82 (2H, d, J = 6.1 Hz), 8.96 (1H, d, J = 1.7 Hz),<br>
11.56 (1H, s).<br>
[0599]<br>
2-(3-Methylpyridine-2-carboxamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-de) 8: 2.71 (3H, s) , 7.44-7.61 (5H, m) ,<br>
7.72-7.77 (2H, m), 7.85-7.88 (1H, m), 8.12 (1H, d, J =<br><br>
321<br>
8.0 Hz), 8.56-8.59 (1H, m), 9.20 (1H, d, J = 1.7 Hz),<br>
13.09 (1H, s), 13.45-13.70 (1H, broad).<br>
[0600]<br>
4-Phenyl-2-(3-phenylpropiolamido)benzoic acid<br>
1H-NMR (DMSO-d6) 5: 6.56-6.70 (1H, m) , 7.21 (1H, d, J =<br>
7.8 Hz), 7.27-7.32 (2H, m) , 7.34-7.41 (3H, m), 7.61-<br>
7.70 (3H, m), 7.88-7.92 (2H, m), 8.42 (1H, d, J = 7.8<br>
Hz) .<br>
[0601]<br>
4-Phenyl-2-(6-phenylpyrimidine-4-carboxamido)benzoic<br>
acid<br>
1H-NMR (DMSO-d6) 8: 7.45-7.50 (1H, m) , 7.54-7.66 (6H, m) ,<br>
7.74-7.79 (2H, m), 8.17 (1H, d, J = 8.3 Hz), 8.30-8.38<br>
(2H, m), 8.67 (1H, d, J = 1.2 Hz), 9.24 (1H, d, J = 1.7<br>
Hz), 9.49 (1H, d, J = 1.2 Hz), 13.24 (1H, s) .<br>
[0602]<br>
4-Phenyl-2-(5-phenyl-lH-pyrazole-4-carboxamido)benzoic<br>
acid<br>
1H-NMR (DMSO-d6) 8: 7.38-7.55 (8H, m), 7.67-7.75 (4H, m),<br>
8.08 (1H, d, J = 8.3 Hz), 8.95 (1H, d, J = 1.4 Hz),<br>
11.65-11.80 (1H, broad), 12.82-12.90 (1H, broad).<br>
[0603]<br>
4-Phenyl-2-(3-phenyl-lH-pyrazole-5-carboxamido)benzoic<br>
acid<br>
1H-NMR (DMSO-de) 8: 7.25 (1H, s), 7.38-7.59 (7H, m),<br>
7.71-7.77 (2H, m) , 7.83-7.89 (2H, m), 8.13 (1H, d, J =<br>
8.0 Hz), 9.17 (1H, s), 12.45 (1H, s), 14.01 (1H, s) .<br><br>
322<br>
[0604]<br>
4-Phenyl-2-(3-phenylisoxazole-5-carboxamido)benzoic<br>
acid<br>
1H-NMR (DMSO-d6) 8: 7.45-7.51 (1H, m), 7.53-7.63 (7H, m),<br>
7.74 (2H, d, J = 7.8 Hz), 7.98-8.05 (2H, m), 8.16 (1H,<br>
d, J = 8.3 Hz), 9.05 (1H, d, J = 1.7 Hz), 12.56 (1H, s),<br>
13.75-14.10 (1H, broad).<br>
[0605]<br>
2-(3-Acetoxybenzamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-d6) 6: 2.33 (3H, s), 7.43-7.50 (2H, m),<br>
7.51-7.59 (3H, m), 7.67 (1H, t, J = 7.9 Hz), 7.70-7.77<br>
(3H, m) , 7.85-7.90 (1H, m), 8.14 (1H, d, J = 8.3 Hz),<br>
9.03 (1H, d, J = 1.7 Hz), 12.27 (1H, s), 13.75-14.05<br>
(1H, broad).<br>
[0606]<br>
2-(4-Acetoxybenzamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-de) 6: 2.33 (3H, s) , 7.36-7.42 (2H, m) ,<br>
7.47 (1H, tt, J = 7.3, 1.5 Hz), 7.51-7.59 (3H, m) ,<br>
7.71-7.77 (2H, m), 8.00-8.06 (2H, m), 8.14 (1H, d, J =<br>
8.3 Hz), 9.06 (1H, d, J = 2.0 Hz), 12.25 (1H, s),<br>
13.75-13.95 (1H, broad).<br>
[0607]<br>
2-((E)-3-(4-Acetoxyphenyl)acrylamido)-4-phenylbenzoic<br>
acid<br>
1H-NMR (DMSO-de) 8: 2.29 (3H, s) , 6.92 (1H, d, J = 15.7<br>
Hz), 7.21 (2H, d, J = 8.7 Hz), 7.43-7.58 (4H, m), 7.66<br>
(1H, d, J = 15.7 Hz), 7.68-7.75 (2H, m), 7.81 (2H, d, J<br>
= 8.7 Hz), 8.10 (1H, d, J = 8.3 Hz), 8.98 (1H, d, J =<br>
1.7 Hz), 11.43 (1H, s), 13.50-13.80 (1H, broad).<br><br>
323<br>
[0608]<br>
2-((E)-3-(3-Methoxyphenyl)acrylamido)-4-phenylbenzoic<br>
acid<br>
1H-NMR (DMSO-d6) 8: 3.82 (3H, s) , 6.96 (1H, d, J = 15.6<br>
Hz), 6.97-7.04 (1H, m) , 7.28-7.39 (3H, m) , 7.43-7.58<br>
(4H, m), 7.62 (1H, d, J = 15.6 Hz), 7.71 (2H, d, J =<br>
8.0 Hz), 8.09 (1H, d, J = 8.3 Hz), 8.97 (1H, d, J = 1.7<br>
Hz), 11.45 (1H, s) .<br>
[0609]<br>
2-((E)-3-(4-Chlorophenyl)acrylamido)-4-phenylbenzoic<br>
acid<br>
1H-NMR (DMSO-d6) 8: 6.98 (1H, d, J = 15.7 Hz), 7.46 (1H,<br>
tt, J = 7.3, 1.5 Hz), 7.48-7.57 (5H, m), 7.64 (1H, d, J<br>
= 15.7 Hz), 7.69-7.74 (2H, m), 7.77-7.83 (2H, m), 8.10<br>
(1H, d, J = 8.3 Hz), 8.98 (1H, d, J = 2.0 Hz), 11.43<br>
(1H, s), 13.55-13.80 (1H, broad).<br>
[0610]<br>
2-((E)-3-(3-Chlorophenyl)acrylamido)-4-phenylbenzoic<br>
acid<br>
1H-NMR (DMSO-d6) 8: 7.08 (1H, d, J = 15.6 Hz), 7.43-7.57<br>
(6H, m), 7.63 (1H, d, J = 15.6 Hz), 7.69-7.75 (3H, m) ,<br>
7.92 (1H, s), 8.10 (1H, d, J = 8.0 Hz), 8.98 (1H, d, J<br>
= 2.0 Hz), 11.42 (1H, s), 13.55-13.85 (1H, broad).<br>
[0611]<br>
2-((E)-3-(3,4-Dichlorophenyl)acrylamido)-4-<br>
phenylbenzoic acid<br>
1H-NMR (DMSO-d6) 8: 7.12 (1H, d, J = 15.6 Hz), 7.46 (1H,<br>
tt, J = 7.3, 1.5 Hz), 7.48-7.57 (3H, m), 7.63 (1H, d, J<br>
= 15.6 Hz), 7.68-7.7.4 (3H, m) , 7.77 (1H, dd, J = 8.5,<br><br>
324<br>
2.0 Hz), 8.10 (1H, d, J = 8.3 Hz), 8.14 (1H, d, J = 2.0<br>
Hz), 8.99 (1H, d, J = 1.7 Hz), 11.43 (1H, s), 13.55-<br>
13.80 (1H, broad).<br>
[0612]<br>
2-((E)-3-(Benzo[1,3]dioxol-5-yl)acrylamido)-4-<br>
phenylbenzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.10 (2H, s) , 6.81 (1H, d, J = 15.6<br>
Hz), 6.98 (1H, d, J = 8.1 Hz), 7.21 (1H, dd, J = 8.1,<br>
1.7 Hz), 7.43-7.51 (3H, m) , 7.51-7.61 (3H, m), 7.68-<br>
7.74 (2H, m), 8.09 (1H, d, J = 8.1 Hz), 9.00 (1H, d, J<br>
= 1.9 Hz), 11.37 (1H, s), 13.55-13.75 (1H, broad).<br>
[0613]<br>
4-Phenyl-2-((E)-3-(thiophen-2-yl)acrylamido)benzoic<br>
acid<br>
1H-NMR (DMSO-d6) 8: 6.60 (1H, d, J = 15.4 Hz), 7.17 (1H,<br>
dd, J = 5.1, 3.6 Hz), 7.43-7.58 (5H, m) , 7.68-7.74 (3H,<br>
m) , 7.80 (1H, d, J = 15.4 Hz), 8.08 (1H, d, J = 8.3 Hz),<br>
8.90 (1H, d, J = 1.7 Hz), 11.30 (1H, s) .<br>
[0614]<br>
2-(4-Morpholinobenzamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-de) 8: 3.27-3.31 (4H, m) , 3.74-3.77 (4H, m) ,<br>
7.10 (2H, d, J = 9.0 Hz), 7.43-7.51 (2H, m) , 7.51-7.58<br>
(2H, m), 7.71-7.76 (2H, m), 7.86 (2H, d, J = 9.0 Hz),<br>
8.12 (1H, d, J = 8.3 Hz), 9.12 (1H, d, J = 1.7 Hz),<br>
12.16 (1H, s).<br>
[0615]<br>
2-(2-(4-Nitrophenyl)acetamido)-4-phenylbenzoic acid<br><br>
325<br>
1H-NMR (DMSO-d6) 8: 4.03 (2H, s), 7.42-7.54 (4H, m),<br>
7.64-7.71 (4H, m), 8.04 (1H, d, J = 8.3 Hz), 8.22-8.27<br>
(2H, m), 8.82 (1H, d, J = 1.7 Hz), 11.18 (1H, s).<br>
[0616]<br>
2-((E)-3-(3-Nitrophenyl)acrylamido)-4-phenylbenzoic<br>
acid<br>
1H-NMR (DMSO-de) 8: 7.23 (1H, d, J = 15.9 Hz), 7.43-7.58<br>
(4H, m), 7.69-7.81 (4H, m), 8.10 (1H, d, J = 8.3 Hz),<br>
8.20-8.28 (2H, m), 8.63 (1H, t, J = 1.8 Hz), 8.98 (1H,<br>
d, J = 1.7 Hz), 11.52 (1H, s) .<br>
[0617]<br>
2-((E)-3-(4-Nitrophenyl)acrylamido)-4-phenylbenzoic<br>
acid<br>
1H-NMR (DMSO-dg) 8: 7.20 (1H, d, J = 15.6 Hz), 7.46 (1H,<br>
tt, J = 7.3, 1.6 Hz), 7.50-7.57 (3H, m), 7.69-7.79 (3H,<br>
m), 8.02-8.07 (2H, m), 8.10 (1H, d, J = 8.3 Hz), 8.26-<br>
8.32 (2H, m), 8.97 (1H, d, J = 1.7 Hz), 11.50 (1H, s) .<br>
[0618]<br>
4-Phenyl-2-(4-phenylbutanamido)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 1.91-2.01 (2H, m) , 2.44 (2H, t, J =<br>
7.3 Hz), 2.66 (2H, t, J = 7.7 Hz), 7.15-7.33 (5H, m) ,<br>
7.42-7.48 (2H, m) , 7.49-7.56 (2H, m), 7.66-7.71 (2H, m) ,<br>
8.06 (1H, d, J = 8.3 Hz), 8.86 (1H, d, J = 1.9 Hz),<br>
11.22 (1H, s), 13.55-13.75 (1H, broad).<br>
[0619]<br>
4-Phenyl-2-((E)-4-phenyl-3-butenamido)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 3.40 (2H, dd, J = 7.3, 1.2 Hz), 6.45<br>
(1H, dt, J = 15.9, 7.3 Hz), 6.68 (1H, d, J = 15.9 Hz),<br>
7.25 (1H, tt, J = 7.3, 1.5 Hz), 7.32-7.37 (2H, m),<br><br>
326<br>
7.41-7.55 (6H, m), 7.65-7.71 (2H, m), 8.05 (1H, d, J =<br>
8.3 Hz), 8.89 (1H, d, J 2.0 Hz), 11.28 (1H, s).<br>
[0620]<br>
Example 368<br><br>
1.3 niL of methylene chloride, 1.3 |4.L of N,N-<br>
dimethylformamide and 0.031 mL of oxalyl chloride were<br>
sequentially added to 69 mg of 6-(piperidin-1-<br>
yl)pyridine-3-carboxylic acid at room temperature, and<br>
stirred at the same temperature for 1 hour. The<br>
reaction mixture was added to a mixed solution of 54 mg<br>
of tert-butyl 2-amino-4-phenylbenzoate, 3.7 mL of<br>
methylene chloride and 0.22 mL of triethylamine and<br>
stirred at room temperature for 2 hours. A saturated<br>
sodium hydrogen carbonate aqueous solution was added to<br>
the reaction mixture, and the organic layer was<br>
separated, and the solvent was evaporated under reduced<br>
pressure. The obtained residue was purified with silica<br>
gel column chromatography [Flash Tube 2008 manufactured<br>
by Trikonex Company, eluent; hexane: ethyl acetate =<br>
4:1] to obtain tert-butyl 4-phenyl-2-(6-(piperidin-1-<br>
yl)pyridine-3-carboxamido)benzoate.<br>
10 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 4-phenyl-2-(6-(piperidin-1-<br><br>
327<br>
yl)pyridine-3-carboxamido)benzoate and stirred at room<br>
temperature for 2 hours. The solvent was evaporated<br>
under reduced pressure and water was added and pH was<br>
adjusted to pH 6.5 with a saturated sodium hydrogen<br>
carbonate aqueous solution. A solid substance was<br>
separated by filtration to obtain 56 mg of 4-phenyl-2-<br>
(6-(piperidin-1-yl)pyridine-3-carboxamido)benzoic acid<br>
as white solid.<br>
1H-NMR (DMSO-d6) 8: 1.50-1.70 (6H, m) , 3.65-3.72 (4H, m) ,<br>
6.99 (1H, d, J = 9.3 Hz), 7.43-7.58 (4H, m) , 7.70-7.76<br>
(2H, m), 7.99 (1H, dd, J = 9.3, 2.6 Hz), 8.12 (1H, d, J<br>
= 8.3 Hz), 8.70 (1H, d, J - 2.6 Hz), 9.07 (1H, d, J =<br>
1.7 Hz), 12.05 (1H, s).<br>
[0621]<br>
Example 369<br><br>
1.3 mL of methylene chloride, 1.3 JAL of N,N-<br>
dimethylformamide and 0.031 mL of oxalyl chloride were<br>
added to 69 mg of 3,4-dimethoxycinnamic acid at room<br>
temperature sequentially and stirred at the same<br>
temperature for 1 hour. The reaction mixture was added<br>
to a mixed solution of 57 mg of tert-butyl 2-amino-4-<br>
phenoxybenzoate, 3.7 mL of methylene chloride and 0.22<br>
mL of triethylamine and stirred at room temperature for<br><br>
328<br>
2 hours. A saturated sodium hydrogen carbonate aqueous<br>
solution was added to the reaction mixture, and the<br>
organic layer was separated, and the solvent was<br>
evaporated under reduced pressure. The obtained residue<br>
was purified with silica gel column chromatography<br>
[Flash Tube 2008 manufactured by Trikonex Company,<br>
eluent; hexane: ethyl acetate =4:1] to obtain tert-<br>
butyl 2-((E)-3-(3,4-dimethoxyphenyl)acrylamido)-4-<br>
phenoxybenzoate.<br>
10 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 2-( (E)-3-(3,4-<br>
dimethoxyphenyl)acrylamido)-4-phenoxybenzoate and<br>
stirred at room temperature for 2 hours. The solvent<br>
was evaporated under reduced pressure, and diisopropyl<br>
ether was add to the obtained residue, and a solid<br>
substance was separated by filtration to obtain 13 mg<br>
of (E)-2-(3-(3,4-dimethoxyphenyl)acrylamido)-4-<br>
phenoxybenzoic acid as white solid.<br>
1H-NMR (DMSO-de) 8: 3.80 (3H, s), 3.83 (3H, s) , 6.69-<br>
6.81 (2H, m), 6.99 (1H, d, J = 8.5 Hz), 7.14-7.20 (2H,<br>
m), 7.22-7.31 (2H, m), 7.38 (1H, s), 7.45-7.51 (2H, m),<br>
7.54 (1H, d, J = 15.6 Hz), 8.03 (1H, d, J = 8.8 Hz),<br>
8.38 (1H, d, J = 2.4 Hz), 11.50 (1H, s), 13.40-13.60<br>
(1H, broad).<br>
[0622]<br>
Examples 370 to 387<br>
The compounds shown in Table 36 were obtained<br>
in the same manner as in Example 369.<br><br><br>
[0624]<br>
4-Phenoxy-2-((E)-3-(pyridin-4-yl)acrylamido)benzoic<br>
acid trifluoroacetate<br>
1H-NMR (DMSO-de) 8: 6.78 (1H, dd, J = 8.8, 2.6 Hz),<br>
7.15-7.20 (2H, m) , 7.23-7.32 (2H, m) , 7.45-7.53 (2H, m) ,<br>
7.65 (1H, d, J = 15.6 Hz), 7.94 (2H, d, J = 6.4 Hz),<br>
8.05 (1H, d, J = 8.8 Hz), 8.34 (1H, d, J = 2.6 Hz),<br>
8.75 (2H, d, J = 5.1 Hz), 11.68 (1H, s) .<br>
[0625]<br>
4-Phenoxy-2-(5-(thiophen-2-yl)pyridine-3-<br>
carboxamido)benzoic acid<br><br>
330<br>
1H-NMR (DMSO-de) 8: 6.83 (1H, dd, J = 8.8, 2.6 Hz),<br>
7.17-7.23 (2H, m), 7.25 (1H, dd, J= 5.1, 3.7 Hz),<br>
7.27-7.33 (1H, m), 7.47-7.54 (2H, m), 7.75 (1H, dd, J=<br>
5.1, 1.1 Hz), 7.78 (1H, dd, J = 3.7, 1.1 Hz), 8.09 (1H,<br>
d, J = 8.8 Hz), 8.34 (1H, d, J = 2.6 Hz), 8.43 (1H, t,<br>
J = 2.2 Hz), 8.98 (1H, d, J = 2.2 Hz), 9.14 (1H, d, J =<br>
2.2 Hz), 12.51 (1H, s).<br>
[0626]<br>
4-Phenoxy-2-(6-phenylpyrimidine-4-carboxamido)benzoic<br>
acid<br>
1H-NMR (DMSO-d6) 8: 6.85 (1H, dd, J = 8.8, 2.4 Hz),<br>
7.19-7.25 (2H, m), 7.31 (1H, t, J = 7.5 Hz), 7.48-7.55<br>
(2H, m), 7.57-7.64 (3H, m), 8.10 (1H, d, J = 8.8 Hz),<br>
8.33 (2H, dd, J = 8.0, 1.7 Hz), 8.52 (1H, d, J = 2.4<br>
Hz), 8.60 (1H, d, J = 1.2 Hz), 9.45 (1H, d, J = 1.2 Hz),<br>
13.33 (1H, s), 13.35-13.75 (1H, broad).<br>
[0627]<br>
4-Phenoxy-2-(5-phenyl-lH-pyrazole-4-carboxamido)benzoic<br>
acid<br>
1H-NMR (DMSO-d6) 8: 6.68 (1H, dd, J = 8.8, 2.7 Hz),<br>
7.12-7.17 (2H, m), 7.24 (1H, t, J = 7.4 Hz), 7.32-7.52<br>
(6H, m), 7.64-7.70 (2H, m), 8.00 (1H, d, J = 8.8 Hz),<br>
8.29 (1H, d, J = 2.7 Hz), 11.65-12.00 (1H, broad),<br>
13.35-13.75 (2H, broad).<br>
[0628]<br>
4-Phenoxy-2-(3-phenyl-lH-pyrazole-5-carboxamido)benzoic<br>
acid<br>
1H-NMR (DMSO-d6) 8: 6.74 (1H, dd, J = 8.9, 2.6 Hz) ,<br>
7.16-7.24 (3H, m) , 7.28 (1H, t, J = 7.4 Hz), 7.40 (1H,<br><br>
331<br>
t, J = 7.3 Hz), 7.45-7.53 (4H, m), 7.82 (2H, d, J = 7.6<br>
Hz), 8.05 (1H, d, J = 8.9 Hz), 8.48-8.49 (1H, m), 12.52<br>
(1H, s), 13.30-13.55 (1H, broad), 13.98 (1H, s) .<br>
[0629]<br>
4-Phenoxy-2-(3-phenylisoxazole-5-carboxamido)benzoic<br>
acid<br>
1H-NMR (DMSO-de) 5: 6.82 (1H, dd, J = 8.9, 2.6 Hz),<br>
7.18-7.23 (2H, m) , 7.27-7.33 (1H, m) , 7.47-7.62 (6H, m) ,<br>
7.94-8.02 (2H, m), 8.08 (1H, d, J = 8.9 Hz), 8.38 (1H,<br>
d, J = 2.6 Hz), 12.66 (1H, s).<br>
[0630]<br>
2-(3-Acetoxybenzamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-de) 8: 2.31 (3H, s), 6.78 (1H, dd, J = 8.9,<br>
2.7 Hz), 7.15-7.22 (2H, m), 7.28 (1H, t, J = 7.6 Hz),<br>
7.40-7.45 (1H, m) , 7.46-7.53 (2H, m), 7.61-7.68 (2H, m) ,<br>
7.79-7.81 (1H, m), 8.07 (1H, d, J = 8.9 Hz), 8.37 (1H,<br>
d, J = 2.7 Hz), 12.43 (1H, s), 13.65-13.85 (1H, broad).<br>
[0631]<br>
2-(2-Hydroxybenzamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-de) 6: 6.75 (1H, ddd, J = 8.8, 2.5, 0.9 Hz),<br>
6.92-7.02 (2H, m), 7.14-7.19 (2H, m), 7.23-7.29 (1H, m) ,<br>
7.39-7.51 (3H, m), 7.80 (1H, d, J = 7.6 Hz), 8.04 (1H,<br>
dd, J = 8.8, 0.9 Hz), 8.41 (1H, dd, J = 2.5, 0.9 Hz),<br>
11.31 (1H, s), 12.42 (1H, s).<br>
[0632]<br>
2-(4-Acetoxybenzamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-d6) 8: 2.31 (3H, s), 6.78 (1H, dd, J = 8.9,<br>
2.5 Hz), 7.15-7.21 (2H, m), 7.26-7.31 (1H, m), 7.33-<br>
7.39 (2H, m), 7.46-7.53 (2H, m), 7.93-7.99 (2H, m),<br><br>
332<br>
8.07 (1H, d, J = 8.9 Hz), 8.39 (1H, d, J = 2.5 Hz),<br>
12.39 (1H, s), 13.60-13.80 (1H, broad).<br>
[0633]<br>
2-((E)-3-(3-Methoxyphenyl)acrylamido)-4-phenoxybenzoic<br>
acid<br>
1H-NMR (DMSO-d6) 8: 3.81 (3H, s) , 6.74 (1H, dd, J = 8.8,<br>
2.6 Hz), 6.88 (1H, d, J = 15.6 Hz), 6.99 (1H, dd, J =<br>
8.0, 1.5 Hz), 7.15-7.20 (2H, m), 7.25-7.38 (4H, m),<br>
7.45-7.52 (2H, m), 7.57 (1H, d, J = 15.6 Hz), 8.03 (1H,<br>
d, J = 8.8 Hz), 8.35 (1H, d, J = 2.6 Hz), 11.56 (1H, s),<br>
13.40-13.60 (1H, broad).<br>
[0634]<br>
2-((E) -3-(4-Chlorophenyl)acrylamido)-4-phenoxybenzoic<br>
acid<br>
1H-NMR (DMSO-d6) 8: 6.74 (1H, dd, J = 8.9, 2.6 Hz), 6.89<br>
(1H, d, J = 15.6 Hz), 7.15-7.20 (2H, m), 7.28 (1H, t, J<br>
= 7.4 Hz), 7.45-7.52 (4H, m), 7.60 (1H, d, J = 15.6 Hz),<br>
7.76-7.79 (2H, m), 8.03 (1H, d, J = 8.9 Hz), 8.35 (1H,<br>
d, J = 2.6 Hz), 11.57 (1H, s), 13.40-13.65 (1H, broad).<br>
[0635]<br>
2-((E)-3-(3-Chlorophenyl)acrylamido)-4-phenoxybenzoic<br>
acid<br>
1H-NMR (DMSO-de) 8: 6.75 (1H, dd, J = 8.9, 2.5 Hz), 6.99<br>
(1H, d, J = 15.6 Hz), 7.14-7.20 (2H, m), 7.28 (1H, t, J<br>
= 7.4 Hz), 7.45-7.52 (4H, m) , 7.59 (1H, d, J = 15.6 Hz),<br>
7.66-7.73 (1H, m), 7.90 (1H, s), 8.04 (1H, d, J = 8.9<br>
Hz), 8.35 (1H, d, J = 2.5 Hz), 11.59 (1H, s).<br><br>
333<br>
[0636]<br>
2-((E)-3-(3,4-Dichlorophenyl)acrylamido)-4-<br>
phenoxybenzoic acid<br>
1H-NMR (DMSO-de) 6: 6.75 (1H, dd, J = 9.0, 2.7 Hz), 7.04<br>
(1H, d, J = 15.6 Hz), 7.15-7.21 (2H, m) , 7.28 (1H, t, J<br>
= 7.4 Hz), 7.45-7.53 (2H, m), 7.58 (1H, d, J = 15.6 Hz),<br>
7.69 (1H, d, J = 8.6 Hz), 7.75 (1H, dd, J = 8.6, 2.0<br>
Hz), 8.03 (1H, d, J = 9.0 Hz), 8.12 (1H, d, J = 2.0 Hz),<br>
8.35	(1H, d, J = 2.7 Hz), 11.60 (1H, s) .<br>
[0637]<br>
2-((E)-3-(Benzo[1,3]dioxol-5-yl)acrylamido)-4-<br>
phenoxybenzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.08 (2H, s) , 6.68-6.77 (2H, m) ,<br>
6.96 (1H, d, J = 8.0 Hz), 7.14-7.22 (3H, m), 7.25-7.31<br>
(1H, m), 7.43-7.55 (4H, m), 8.02 (1H, d, J = 9.0 Hz),<br>
8.36	(1H, d, J = 2.7 Hz), 11.50 (1H, s).<br>
[0638]<br>
4-Phenoxy-2-((E)-3-(thiophen-2-yl)acrylamido)benzoic<br>
acid<br>
1H-NMR (DMSO-de) 8: 6.49 (1H, d, J = 15.4 Hz), 6.73 (1H,<br>
dd, J = 9.0, 2.5 Hz), 7.13-7.19 (3H, m), 7.25-7.30 (1H,<br>
m), 7.44-7.54 (3H, m), 7.71 (1H, d, J = 5.1 Hz), 7.75<br>
(1H, d, J = 15.4 Hz), 8.02 (1H, d, J = 9.0 Hz), 8.30<br>
(1H, d, J = 2.5 Hz), 11.50 (1H, s).<br>
[0639]<br>
2-(4-Morpholinobenzamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-de) 8: 3.28 (4H, t, J = 4.9 Hz), 3.74 (4H,<br>
t, J = 4.9 Hz), 6.72 (1H, dd, J = 8.8, 2.4 Hz), 7.07<br>
(2H, d, J = 9.0 Hz), 7.14-7.20 (2H, m) , 7.24-7.32 (1H,<br><br>
334<br>
m) , 7.45-7.52 (2H, m), 7.79 (2H, d, J = 9.0 Hz), 8.05<br>
(1H, d, J = 8.8 Hz), 8.43 (1H, d, J = 2.4 Hz), 12.28<br>
(1H, s), 13.50-13.70 (1H, broad).<br>
[0640]<br>
2-(2-(4-Nitrophenyl)acetamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-de) 5: 3.96 (2H, s) , 6.71 (1H, dd, J= 8.9,<br>
2.5 Hz), 7.09-7.15 (2H, m), 7.24 (1H, t, J = 7.3 Hz),<br>
7.42-7.49 (2H, m), 7.59-7.67 (2H, m), 7.97 (1H, d, J =<br>
8.9 Hz), 8.17 (1H, d, J = 2.5 Hz), 8.18-8.24 (2H, m) ,<br>
11.31 (1H, s), 13.40-13.55 (1H, broad).<br>
[0641]<br>
4-Phenoxy-2-((E)-4-phenyl-3-butenamido)benzoic acid<br>
1H-NMR (DMSO-d6) 6: 3.35 (2H, dd, J = 7.3, 1.0 Hz), 6.41<br>
(1H, dt, J = 15.9, 7.3 Hz), 6.64 (1H, d, J = 15.9 Hz),<br>
6.71 (1H, dd, J = 8.9, 2.6 Hz), 7.11-7.17 (2H, m) ,<br>
7.23-7.29 (2H, m), 7.31-7.37 (2H, m) , 7.43-7.50 (4H, m),<br>
7.99 (1H, d, J = 8.9 Hz), 8.26 (1H, d, J = 2.6 Hz),<br>
11.48 (1H, s), 13.40-13.60 (1H, broad).<br>
[0642]<br>
Example 388<br><br>
0.059 mL of triethylamine and 65 mg of 5-(lH-<br>
pyrrol-l-yl)pyridine-3-carbonyl chloride were added to<br>
5.0 mL of methylene chloride solution containing 60 mg<br>
of tert-butyl 2-amino-4-phenoxybenzoate at room<br><br>
335<br>
temperature sequentially and stirred at the same<br>
temperature for 2 hours.  0.029 mL of triethylamine and<br>
22 mg of 5-(lH-pyrrol-1-yl)pyridine-3-carbonyl chloride<br>
were added to the reaction mixture at room temperature<br>
sequentially and stirred at the same temperature for 1<br>
hour. 0.58 g aminomethylated polystyrene was added to<br>
the reaction mixture and stirred at room temperature<br>
overnight. A saturated sodium hydrogen carbonate<br>
aqueous solution was added to the reaction mixture, the<br>
organic layer was separated, and the solvent was<br>
evaporated under reduced pressure. The obtained residue<br>
was purified with silica gel column chromatography<br>
[Flash Tube 2008 manufactured by Trikonex Company,<br>
eluent; hexane: ethyl acetate =4:1] to obtain tert-<br>
butyl 4-phenoxy-2-(5-(lH-pyrrol-1-yl)pyridine-3-<br>
carboxamido)benzoate.<br>
10 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 4-phenoxy-2-(5-(lH-pyrrol-1-<br>
yl)pyridine-3-carboxamido)benzoate and stirred at room<br>
temperature for 2 hours. The solvent was evaporated<br>
under reduced pressure, ethyl acetate and water were<br>
added and pH was adjusted to pH 7.0 with a saturated<br>
sodium hydrogen carbonate aqueous solution. The organic<br>
layer was separated and the solvent was evaporated<br>
under reduced pressure. Diisopropyl ether was added to<br>
the obtained residue and a solid substance was<br>
separated by filtration to obtain 7.0 mg of 4-phenoxy-<br>
2-(5-(lH-pyrrol-1-yl)pyridine-3-carboxamido)benzoic<br>
acid as white solid.<br><br>
336<br>
1H-NMR (DMSO-de) 8: 6.37 (2H, t, J = 2.2 Hz), 6.84 (1H,<br>
dd, J = 8.9, 2.6 Hz), 7.17-7.22 (2H, m), 7.30 (1H, t, J<br>
= 7.4 Hz), 7.47-7.54 (2H, m), 7.58 (2H, t, J = 2.2 Hz),<br>
8.09 (1H, d, J = 8.9 Hz), 8.32 (1H, d, J = 2.6 Hz),<br>
8.40 (1H, t, J = 2.2 Hz), 8.92 (1H, d, J = 2.2 Hz),<br>
9.15 (1H, d, J = 2.2 Hz), 12.46 (1H, s).<br>
[0643]<br>
Example 389<br><br>
0.25 mL of acetic acid and 4.3 ^L of 2,5-<br>
dimethoxytetrahydrofuran were added sequentially to 10<br>
mg of 2-(3-aminobenzamido)-4-phenylbenzoic acid at room<br>
temperature and stirred at 90C for 5 minutes. Ethyl<br>
acetate and a saturated sodium hydrogen carbonate<br>
aqueous solution were added to the reaction mixture.<br>
The organic layer was separated and dried over<br>
anhydrous magnesium sulfate after washed with a<br>
saturated sodium chloride aqueous solution, and the<br>
solvent was evaporated under reduced pressure to obtain<br>
8.3 mg of 4-phenyl-2-(3-(lH-pyrrol-1-<br>
yl)benzamido)benzoic acid as brown solid.<br>
1H-NMR (DMSO-de) 5: 6.34 (2H, t, J = 2.1 Hz), 7.45-7.51<br>
(3H, m), 7.53-7.59 (3H, m), 7.69 (1H, t, J = 7.9 Hz),<br>
1.13-1.IB (2H, m), 7.82-7.90 (2H, m) , 8.11-8.18 (2H, m) ,<br>
9.08 (1H, d, J = 1.7 Hz), 12.37 (1H, s) .<br><br><br>
0.062 mL of triethylamine and 69 mg of 5-(lH-<br>
pyrrol-1-yl)pyridine-3-carbonyl chloride were added to<br>
5.0 mL of methylene chloride solution containing 60 mg<br>
of tert-butyl 2-amino-4-phenylbenzoate at room<br>
temperature sequentially and stirred at the same<br>
temperature for 2 hours. 0.031 mL of triethylamine and<br>
23 mg of 5-(lH-pyrrol-1-yl)pyridine-3-carbonyl chloride<br>
were added to the reaction mixture at room temperature<br>
sequentially and stirred at the same temperature for 1<br>
hour. 0.62 g of aminomethylated polystyrene was added<br>
to the reaction mixture and stirred at room temperature<br>
overnight. A saturated sodium hydrogen carbonate<br>
aqueous solution was added to the reaction mixture, the<br>
organic layer was separated, and the solvent was<br>
evaporated under reduced pressure. The obtained residue<br>
was purified with silica gel column chromatography<br>
[Flash Tube 2008 manufactured by Trikonex Company,<br>
eluent; hexane: ethyl acetate =4:1] to obtain tert-<br>
butyl 4-phenyl-2-(5-(lH-pyrrol-1-yl)pyridine-3-<br>
carboxamido)benzoate.<br>
10 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 4-phenyl-2-(5-(lH-pyrrol-1-<br><br>
338<br>
yl)pyridine-3-carboxamido)benzoate and stirred at room<br>
temperature for 2 hours. The solvent was evaporated<br>
under reduced pressure, ethyl acetate and water were<br>
added and pH was adjusted to pH 7.0 with a saturated<br>
sodium hydrogen carbonate aqueous solution. The organic<br>
layer was separated and the solvent was evaporated<br>
under reduced pressure. Diisopropyl ether was added to<br>
the obtained residue and a solid substance was<br>
separated by filtration to obtain 23 mg of 4-phenyl-2-<br>
(5-(lH-pyrrol-1-yl)pyridine-3-carboxamido)benzoic acid<br>
as white solid.<br>
1H-NMR (DMSO-d6) 8: 6.39 (2H, t, J = 2.2 Hz), 7.45-7.51<br>
(1H, m) , 7.53-7.61 (5H, m), 7.73-7.77 (2H, m), 8.15 (1H,<br>
d, J = 8.3 Hz), 8.47 (1H, t, J = 2.4 Hz), 8.97-9.02 (2H,<br>
m), 9.17 (1H, d, J = 2.4 Hz), 12.26 (1H, s).<br>
[0645]<br>
Example 391<br><br>
The following compound was obtained in the<br>
same manner as in Example 390.<br>
4-Phenyl-2-(2-(pyrrolidin-1-yl)pyridine-3-<br>
carboxamido)benzoic acid<br>
1H-NMR (DMSO-de) 8: 1.80-1.89 (4H, m) , 3.35-3.44 (4H, m) ,<br>
6.74 (1H, dd, J = 7.4, 4.9 Hz), 7.44-7.58 (4H, m) ,<br><br>
339<br>
7.69-7.74 (2H, m), 7.83 (1H, dd, J = 7.4, 1.8 Hz), 8.10<br>
(1H, d, J = 8.3 Hz), 8.24 (1H, dd, J = 4.9, 1.8 Hz),<br>
9.02 (1H, s), 11.67 (1H, s).<br>
[0646]<br>
Example 392<br><br>
0.056 rtiL of triethylamine and 45 mg of ((E)-2-<br>
phenylvinyl)sulfonyl chloride were added to 3.0 mL of<br>
methylene chloride solution containing 54 mg of tert-<br>
butyl 2-amino-4-phenylbenzoate at room temperature<br>
sequentially and stirred at the same temperature for 1<br>
hour. 0.028 mL of triethylamine and 8.1 mg of ((E)-2-<br>
phenylvinyl)sulfonyl chloride were added to the<br>
reaction mixture at room temperature sequentially and<br>
stirred at the same temperature for 1 hour. A saturated<br>
sodium hydrogen carbonate aqueous solution was added to<br>
the reaction mixture, and the organic layer was<br>
separated, and the solvent was evaporated under reduced<br>
pressure. The obtained residue was purified with silica<br>
gel column chromatography [Flash Tube 2008 manufactured<br>
by Trikonex Company, eluent; hexane: ethyl acetate =<br>
4:1] to obtain tert-butyl 4-phenyl-2-(((E)-2-<br>
phenylvinyl) sulfonamido)benzoate.<br>
10 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 4-phenyl-2-(((E)-2-phenylvinyl)<br><br>
340<br>
sulfonamido)benzoate and stirred at room temperature<br>
for 2 hours. The solvent was evaporated under reduced<br>
pressure and diisopropyl ether was added to the<br>
obtained residue and a solid substance was separated by<br>
filtration to obtain 26 mg of 4-phenyl-2-(((E)-2-<br>
phenylvinyl) sulfonamido)benzoic acid as white solid.<br>
1H-NMR (DMSO-de) 8: 7.39-7.58 (8H, m) , 7.61-7.66 (2H, m) ,<br>
7.73-7.81 (4H, m), 8.05 (1H, d, J = 8.3 Hz), 11.04 (1H,<br>
s) .<br>
[0647]<br>
Examples 393, 394<br>
The compounds shown in Table 37 were obtained<br>
in the same manner as in Example 392.<br>
[0648]<br>
[Table 37]<br><br>
[0649]<br>
2-(Benzylsulfonamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-de) 6: 4.78 (2H, s), 7.23-7.33 (5H, m),<br>
7.41-7.49 (2H, m) , 7.50-7.56 (2H, m) , 7.60-7.65 (2H, m) ,<br>
7.67 (1H, d, J = 1.7 Hz), 8.05 (1H, d, J = 8.3 Hz),<br>
10.75-10.90 (1H, broad).<br>
[0650]<br>
2-(3-Bromobenzamido)-4-phenylbenzoic acid<br><br>
341<br>
1H-NMR (DMSO-d6) 8: 7.44-7.50 (1H, m) , 7.51-7.63 (4H, m) ,<br>
7.70-7.77 (2H, m), 7.85-7.90 (1H, m), 7.95-8.00 (1H, m),<br>
8.10-8.16 (2H, m), 8.99 (1H, d, J = 1.7 Hz), 12.26 (1H,<br>
s), 13.75-14.00 (1H, broad).<br>
[0651]<br>
Example 395<br><br>
0.056 mL of triethylamine and 61 mg of ((E)-2-<br>
phenylvinyl) sulfonyl chloride were added to 5.0 mL of<br>
methylene chloride solution containing 57 mg of tert-<br>
butyl 2-amino-4-phenoxybenzoate at room temperature<br>
sequentially and stirred at the same temperature for 1<br>
hour. A saturated sodium hydrogen carbonate aqueous<br>
solution was added to the reaction mixture, and the<br>
organic layer was separated, and the solvent was<br>
evaporated under reduced pressure. The obtained residue<br>
was purified with silica gel column chromatography<br>
[Flash Tube 2008 manufactured by Trikonex Company,<br>
eluent; hexane: ethyl acetate =4:1] to obtain tert-<br>
butyl 4-phenoxy-2-{((E)-2-phenylvinyl)<br>
sulfonamido)benzoate.<br>
10 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 4-phenoxy-2-(((E)-2-phenylvinyl)<br>
sulfonamido)benzoate and stirred at room temperature<br>
for 2 hours. The solvent was evaporated under reduced<br><br>
342<br>
pressure and diisopropyl ether was added to the<br>
obtained residue and a solid substance was separated by<br>
filtration to obtain 17 mg of 4-phenoxy-2-(((E)-2-<br>
phenylvinyl) sulfonamido)benzoic acid as white solid.<br>
1H-NMR (DMSO-d6) 5: 6.68 (1H, dd, J = 8.8, 2.4 Hz), 6.99<br>
(1H, d, J = 2.4 Hz), 7.04-7.09 (2H, m), 7.23-7.29 (1H,<br>
m), 7.32-7.51 (7H, m), 7.64-7.70 (2H, m), 7.98 (1H, d,<br>
J = 8.8 Hz), 11.16 (1H, s).<br>
[0652]<br>
Example 396<br><br>
2.0 mL of methylene chloride, 3.9 \iL of N,N-<br>
dimethylformamide and 0.094 mL of oxalyl chloride were<br>
added to 206 mg of 4-acetoxycinnamic acid at room<br>
temperature sequentially and stirred at the same<br>
temperature for 1 hour. The reaction mixture was added<br>
to a mixed solution of 8 6 mg of tert-butyl 2-amino-4-<br>
phenoxybenzoate, 3.0 mL of methylene chloride and 0.67<br>
mL of triethylamine and stirred at room temperature for<br>
1 hour. A saturated sodium hydrogen carbonate aqueous<br>
solution was added to the reaction mixture, and the<br>
organic layer was separated, and the solvent was<br>
evaporated under reduced pressure. The obtained residue<br>
was purified with silica gel column chromatography<br>
[Flash Tube 2008 manufactured by Trikonex Company,<br><br>
343<br>
eluent; hexane: ethyl acetate =4:1] to obtain tert-<br>
butyl 2-((E)-3-(4-acetoxyphenyl)acrylamido)-4-<br>
phenoxybenzoate.<br>
10 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 2-((E)-3-(4-<br>
acetoxyphenyl)acrylamido)-4-phenoxybenzoate and stirred<br>
at room temperature for 2 hours. The solvent was<br>
evaporated under reduced pressure and the obtained<br>
residue was purified with reversed-phase silica gel<br>
column chromatography [eluent; 60-100% acetonitrile<br>
/0.1% trifluoroacetic acid aqueous solution] to obtain<br>
34 mg of 2-((E)-3-(4-acetoxyphenyl)acrylamido)-4-<br>
phenoxybenzoic acid as white solid.<br>
1H-NMR (DMSO-d6) 8: 2.28 (3H, s) , 6.74 (1H, dd, J= 8.9,<br>
2.5 Hz), 6.83 (1H, d, J = 15.6 Hz), 7.14-7.23 (4H, m) ,<br>
7.25-7.31 (1H, m) , 7.45-7.52 (2H, m), 7.61 (1H, d, J =<br>
15.6 Hz), 7.76-7.82 (2H, m), 8.03 (1H, d, J = 8.9 Hz),<br>
8.35 (1H, d, J = 2.5 Hz), 11.58 (1H, s), 13.40-13.65<br>
(1H, broad).<br>
[0653]<br>
Example 397<br><br>
2.0 mL of methylene chloride, 3.9 jiL of N,N-<br>
dimethylformamide and 0.094 mL of oxalyl chloride were<br>
added to 180 mg of 2-acetoxybenzoic acid at room<br><br>
344<br>
temperature sequentially and stirred at the same<br>
temperature for 1 hour. The reaction mixture was added<br>
to a mixed solution of 81 mg of tert-butyl 2-amino-4-<br>
phenylbenzoate, 3.0 mL of methylene chloride and 0.67<br>
mL triethylamine, and stirred at room temperature for 1<br>
hour. A saturated sodium hydrogen carbonate aqueous<br>
solution was added to the reaction mixture, and the<br>
organic layer was separated, and the solvent was<br>
evaporated under reduced pressure. The obtained residue<br>
was purified with silica gel column chromatography<br>
[Flash Tube 2008 manufactured by Trikonex Company,<br>
eluent; hexane: ethyl acetate =4:1] to obtain tert-<br>
butyl 2-(2-acetoxybenzamido)-4-phenylbenzoate.<br>
10 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 2-(2-acetoxybenzamido)-4-<br>
phenylbenzoate, and stirred at room temperature for 2<br>
hours. The solvent was evaporated under reduced<br>
pressure and 0.50 mL of methanol, 0.50 mL of<br>
tetrahydrofuran and 6.1 mg of potassium carbonate were<br>
added to the obtained residue sequentially and stirred<br>
at room temperature for 2 hours.  10% citric acid<br>
aqueous solution was added to the reaction mixture and<br>
a solid substance was separated by filtration to obtain<br>
8.2 mg of 2-(2-hydroxybenzamido)-4-phenylbenzoic acid<br>
as white solid.<br>
1H-NMR (DMSO-d6) 5: 6.96-7.05 (2H, m) , 7.42-7.49 (2H, m) ,<br>
7.49-7.58 (3H, m) , 7.71-7.76 (2H, m) , 7.89-7.93 (1H, m),<br>
8.10 (1H, d, J = 8.3 Hz), 9.02 (1H, d, J = 1.7 Hz),<br>
11.46 (1H, s), 12.32 (1H, s) .<br><br><br>
0.50 mL of methanol, 0.50 mL of<br>
tetrahydrofuran and 8.3 mg of potassium carbonate were<br>
added to 15 mg of 2-(3-acetoxybenzamido)-4-<br>
phenylbenzoic acid at room temperature sequentially and<br>
stirred at the same temperature for 2 hours. 10% citric<br>
acid aqueous solution was added to the reaction mixture<br>
and a solid substance was separated by filtration to<br>
obtain 12 mg of 2-(3-hydroxybenzamido)-4-phenylbenzoic<br>
acid as white solid.<br>
1H-NMR (DMSO-d6) 5: 7.00-7.07 (1H, m) , 7.35-7.59 (7H, m) ,<br>
7.73 (2H, d, J = 7.6 Hz), 8.14 (1H, d, J = 8.0 Hz),<br>
9.08 (1H, d, J = 1.4 Hz), 9.92 (1H, s) , 12.22 (1H, s) .<br>
[0655]<br>
Examples 399, 400<br>
The compounds shown in Table 38 were obtained<br>
in the same manner as in Example 398.<br>
[0656]<br>
[Table 38]<br><br><br>
[0657]<br>
2-(4-Hydroxybenzamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-d6) 6: 6.94 (2H, d, J = 8.8 Hz), 7.43-7.51<br>
(2H, m), 7.54 (2H, t, J = 7.6 Hz), 1.10-1.16 (2H, m),<br>
7.85 (2H, d, J = 8.8 Hz), 8.13 (1H, d, J = 8.3 Hz),<br>
9.09 (1H, d, J = 1.7 Hz), 10.29 (1H, s), 12.16 (1H, s).<br>
[0658]<br>
2-((E)-3-(4-Hydroxyphenyl)acrylamido)-4-phenylbenzoic<br>
acid<br>
1H-NMR (DMSO-d6) 8: 6.67 (1H, d, J = 15.6 Hz), 6.82 (2H,<br>
d, J = 8.5 Hz), 7.43-7.50 (2H, m), 7.50-7.62 (5H, m) ,<br>
7.68-7.74 (2H, m), 8.09 (1H, d, J = 8.3 Hz), 9.00 (1H,<br>
d, J = 2.0 Hz), 9.98 (1H, s), 11.37 (1H, s), 13.50-<br>
13.80 (1H, broad).<br>
[0659]<br>
Example 401<br><br><br>
347<br>
0.50 mL of methanol, 0.50 mL of<br>
tetrahydrofuran and 4.2 mg of potassium carbonate were<br>
added sequentially to 8.0 mg of 2-(3-acetoxybenzamido)-<br>
4-phenoxybenzoic acid at room temperature and stirred<br>
at the same temperature for 2 hours. 10% citric acid<br>
aqueous solution was added to the reaction mixture and<br>
a solid substance was separated by filtration to obtain<br>
4.4 mg of 2-(3-hydroxybenzamido)-4-phenoxybenzoic acid<br>
as white solid.<br>
1H-NMR (DMSO-d6) 8: 6.76 (1H, dd, J = 8.8, 2.7 Hz), 7.02<br>
(1H, ddd, J = 7.6, 2.3, 1.5 Hz), 7.15-7.21 (2H, m),<br>
7.25-7.40 (4H, m), 7.46-7.52 (2H, m), 8.07 (1H, d, J =<br>
8.8 Hz), 8.41 (1H, d, J = 2.7 Hz), 9.90 (1H, s), 12.34<br>
(1H, s), 13.55-13.75 (1H, broad).<br>
[0660]<br>
Examples 402, 403<br>
[0662]<br>
2-(4-Hydroxybenzamido)-4-phenoxybenzoic acid<br>
The compounds shown in Table 39 were obtained<br>
in the same manner as in Example 401.<br>
[0661]<br>
[Table 39]<br><br><br>
348<br>
1H-NMR (DMSO-dg) 8: 6.73 (1H, dd, J = 8.8, 2.4 Hz) , 6.91<br>
(2H, d, J = 8.8 Hz), 7.15-7.19 (2H, m), 7.27 (1H, t, J<br>
= 7.4 Hz), 7.45-7.52 (2H, m), 7.78 (2H, d, J = 8.8 Hz),<br>
8.05 (1H, d, J = 8.8 Hz), 8.41 (1H, d, J = 2.4 Hz),<br>
10.28 (1H, s), 12.27 (1H, s) .<br>
[0663]<br>
2-((E)-3-(4-Hydroxyphenyl)acrylamido)-4-phenoxybenzoic<br>
acid<br>
1H-NMR (DMSO-d6) 8: 6.58 (1H, d, J = 15.6 Hz), 6.71 (1H,<br>
dd, J = 8.8, 2.6 Hz), 6.80 (2H, d, J = 8.6 Hz), 7.13-<br>
7.19 (2H, m), 7.24-7.30 (1H, m) , 7.44-7.53 (3H, m) ,<br>
7.56 (2H, d, J = 8.6 Hz), 8.02 (1H, d, J = 8.8 Hz),<br>
8.35 (1H, d, J = 2.6 Hz), 9.97 (1H, s), 11.60 (1H, s).<br>
[0664]<br>
Example 404<br><br>
3.0 mL of methanol, 2.0 mL of ethyl acetate<br>
and 4.0 mg of 5% palladium-carbon were added to 20 mg<br>
of 2-(4-nitrobenzamido)-4-phenoxybenzoic acid at room<br>
temperature and stirred under hydrogen atmosphere at<br>
40C for 8 hours. Insoluble were removed by filtration,<br>
and the solvent was evaporated under reduced pressure<br>
to obtain 20 mg of 2-(4-aminobenzamido)-4-<br>
phenoxybenzoic acid as white solid.<br><br>
349<br>
1H-NMR (DMSO-d6) 8: 6.57-6.65 (3H, m) , 7.07-7.13 (2H, m) ,<br>
7.20 (1H, t, J = 7.4 Hz), 7.41-7.46 (2H, m), 7.67 (2H,<br>
d, J = 8.8 Hz), 8.02 (1H, d, J = 8.6 Hz), 8.39 (1H, d,<br>
J = 2.4 Hz).<br>
[0665]<br>
Example 405<br><br>
2.0 mL of methanol, 2.0 mL of ethyl acetate<br>
and 3.0 mg of 5% palladium-carbon were added to 15 mg<br>
of 2-(3-nitrobenzamido)-4-phenylbenzoic acid at room<br>
temperature and stirred under hydrogen atmosphere at<br>
40C for 2 hours. Insoluble were removed by filtration,<br>
and the solvent was evaporated under reduced pressure<br>
to obtain 5.1 mg of 2-(3-aminobenzamido)-4-<br>
phenylbenzoic acid as white solid.<br>
1H-NMR (DMSO-de) 8: 6.74-6.81 (1H, m) , 7.13-7.22 (3H, m) ,<br>
7.36 (1H, dd, J = 8.1, 1.7 Hz), 7.42 (1H, t, J = 7.3<br>
Hz), 7.49-7.54 (2H, m), 7.66-7.72 (2H, m), 8.10 (1H, d,<br>
J = 8.1 Hz), 9.05 (1H, d, J = 1.7 Hz).<br>
[0666]<br>
Example 406<br><br><br>
350<br>
0.019 mL of lH-pyrrole, 0.12 g of cesium<br>
carbonate, 5.1 mg of<br>
tris(dibenzylideneacetone)dipalladium(O), 1.6 mg of<br>
tri-tert-butylphosphine tetrafluoroborate and 4.4 mg of<br>
2-dicyclohexylphosphino-2',4',6'-triisopropylbiphenyl<br>
were added to 1.4 mL of toluene solution containing 70<br>
mg of tert-butyl 2-(benzamido)-4-bromobenzoate at room<br>
temperature, and the resulting mixture was heated to<br>
reflux under nitrogen atmosphere for 3 hours. After the<br>
reaction mixture was cooled to room temperature, 5.1 mg<br>
of tris(dibenzylideneacetone)dipalladium(O), 1.6 mg of<br>
tri-tert-butylphosphine tetrafluoroborate and 4.4 mg of<br>
2-dicyclohexylphosphino-2',4',6'-triisopropylbiphenyl<br>
were added and the resulting mixture was heated to<br>
reflux under nitrogen atmosphere for 3 hours. After the<br>
reaction mixture was cooled to room temperature, ethyl<br>
acetate and 10% citric acid aqueous solution were added<br>
and insoluble were removed by filtration. The organic<br>
layer was separated and dried over anhydrous magnesium<br>
sulfate after washed with a saturated sodium chloride<br>
aqueous solution, and the solvent was evaporated under<br>
reduced pressure. The obtained residue was purified<br>
with silica gel column chromatography [PSQ100B<br>
(spherical) manufactured by Fuji Silysia Chemical Ltd.,<br>
eluent; hexane: ethyl acetate =10:1] to obtain 60 mg<br>
of tert-butyl 2-(benzamido)-4-(lH-pyrrol-l-yl)benzoate<br>
as white solid.<br>
1H-NMR (CDC13) 5: 1.65 (9H, s) , 6.38 (2H, t, J = 2.2 Hz),<br>
7.12 (1H, dd, J = 8.6, 2.3 Hz), 7.25-7.28 (2H, m) ,<br><br>
351<br>
7.51-7.61 (3H, m) , 8.05-8.10 (3H, m), 9.16 (1H, d, J =<br>
2.3 Hz), 12.36 (1H, s).<br>
[0667]<br>
Example 407<br><br>
33 mg of lH-indole, 0.12 g of cesium carbonate,<br>
5.1 mg of tris(dibenzylideneacetone)dipalladium(O), 1.6<br>
mg of tri-tert-butylphosphine tetrafluoroborate and 4.4<br>
mg of 2-dicyclohexylphosphino-2',4',6'-<br>
triisopropylbiphenyl were added to 1.4 mL of toluene<br>
solution containing 70 mg of tert-butyl 2-(benzamido)-<br>
4-bromobenzoate at room temperature, and the resulting<br>
mixture was heated to reflux under nitrogen atmosphere<br>
for 4 hours. After the reaction mixture was cooled to<br>
room temperature, 33 mg of lH-indole, 79 mg of<br>
tripotassium phosphate, 5.1 mg of<br>
tris(dibenzylideneacetone)dipalladium(O), 1.6 mg of<br>
tri-tert-butylphosphine tetrafluoroborate and 4.4 mg of<br>
2-dicyclohexylphosphino-2',4',6'-triisopropylbiphenyl<br>
were added and the resulting mixture was heated to<br>
reflux under nitrogen atmosphere for 4 hours. After the<br>
reaction mixture was cooled to room temperature, ethyl<br>
acetate and 10% citric acid aqueous solution were added<br>
and insoluble were removed by filtration. The organic<br>
layer was separated and dried over anhydrous magnesium<br><br>
352<br>
sulfate after washed with a saturated sodium chloride<br>
aqueous solution, and the solvent was evaporated under<br>
reduced pressure. The obtained residue was purified<br>
with silica gel column chromatography [PSQ100B<br>
(spherical) manufactured by Fuji Silysia Chemical Ltd.,<br>
eluent; hexane: ethyl acetate =20:1] to obtain 45 mg<br>
of tert-butyl 2-(benzamido)-4-(lH-indol-l-yl)benzoate<br>
as colorless oil.<br>
1H-NMR (CDC13) 5: 1.67 (9H, s) , 6.73 (1H, d, J = 3.4 Hz),<br>
7.18-7.22 (1H, m) , 7.25-7.33 (2H, m), 7.48 (1H, d, J =<br>
3.4 Hz), 7.51-7.62 (3H, m) , 7.66-7.70 (1H, m) , 7.83 (1H,<br>
d, J = 8.3 Hz), 8.06-8.10 (2H, m), 8.17 (1H, d, J = 8.8<br>
Hz), 9.22 (1H, d, J = 2.2 Hz), 12.35 (1H, s).<br>
[0668]<br>
Example 408<br><br>
The following compound was obtained in the<br>
same manner as in Example 200.<br>
tert-Butyl 2-(benzamido)-4-(3, 4-<br>
dimethoxyphenyl)benzoate<br>
1H-NMR (CDCI3) 5: 1.65 (9H, s) , 3.94 (3H, s) , 3.99 (3H,<br>
s), 6.96 (1H, d, J = 8.3 Hz), 7.23 (1H, d, J = 2.2 Hz),<br>
7.28-7.34 (2H, m) , 7.51-7.61 (3H, m) , 8.04-8.11 (3H, m) ,<br>
9.22 (1H, d, J = 2.0 Hz), 12.27 (1H, s).<br><br><br>
0.24 mL of 2.0 mol/L aqueous sodium hydroxide<br>
was added to a mixed solution of 1.0 mL of dioxane and<br>
1.0 mL of methanol containing 58 mg of tert-butyl 2-<br>
(benzamido)-4-(lH-pyrrol-l-yl)benzoate and stirred at<br>
50C for 1 hour and 30 minutes. After the reaction<br>
mixture was cooled to room temperature, water was added<br>
and after pH was adjusted to pH 3.0 with 1.0 mol/L<br>
hydrochloric acid, ethyl acetate was added. The organic<br>
layer was separated and dried over anhydrous magnesium<br>
sulfate after washed with water and a saturated sodium<br>
chloride aqueous solution sequentially, and the solvent<br>
was evaporated under reduced pressure. Diisopropyl<br>
ether were added to the obtained residue and a solid<br>
substance was separated by filtration to obtain 41 mg<br>
of 2-(benzamido)-4-(lH-pyrrol-1-yl)benzoic acid as<br>
white solid.<br>
1H-NMR (DMSO-de) 5: 6.37 (2H, t, J = 2.2 Hz), 7.41-7.47<br>
(3H, m), 7.59-7.71 (3H, m), 7.96-8.02 (2H, m), 8.12 (1H,<br>
d, J = 8.5 Hz), 8.96 (1H, d, J = 2.2 Hz), 12.40 (1H, s).<br>
[0670]<br>
Example 410<br><br><br>
The following compound was obtained in the<br>
same manner as in Example 409.<br>
2-(Benzamido)-4-(lH-indol-1-yl)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.81 (1H, dd, J = 3.4, 0.5 Hz),<br>
7.18-7.24 (1H, m) , 7.28-7.33 (1H, m), 7.47 (1H, dd, J =<br>
8.6, 2.4 Hz), 7.59-7.73 (4H, m), 7.79 (1H, d, J = 3.4<br>
Hz), 7.85 (1H, dd, J = 8.4, 0.6 Hz), 7.98-8.03 (2H, m) ,<br>
8.24 (1H, d, J = 8.6 Hz), 9.09 (1H, d, J = 2.4 Hz),<br>
12.46 (1H, s).<br>
[0671]<br>
Example 411<br><br>
The following compound was obtained in the<br>
same manner as in Example 211.<br>
2-(Benzamido)-4-(3,4-dimethoxyphenyl)benzoic acid<br>
1H-NMR (DMSO-de) 6: 3.83 (3H, s) , 3.87 (3H, s) , 7.12 (1H,<br>
d, J - 9.0 Hz), 7.27-7.32 (2H, m), 7.52 (1H, dd, J =<br>
8.3, 1.8 Hz), 7.58-7.70 (3H, m) , 7.97-8.02 (2H, m) ,<br>
8.10 (1H, d, J = 8.3 Hz), 9.04 (1H, d, J = 1.8 Hz),<br>
12.26 (1H, s).<br><br><br>
55 mg of 2-nitroaniline, 0.17 g of cesium<br>
carbonate, 2.4 mg of<br>
tris(dibenzylideneacetone)dipalladium(O), 1.2 mg of<br>
palladium acetate and 6.3 mg of 2-<br>
dicyclohexylphosphino-2',4',6'-triisopropylbiphenyl<br>
were added to 2.0 mL of toluene solution containing<br>
0.10 g of tert-butyl 2-(benzamido)-4-bromobenzoate at<br>
room temperature, and the resulting mixture was heated<br>
to reflux under nitrogen atmosphere for 4 hours. After<br>
the reaction mixture was cooled to room temperature,<br>
ethyl acetate and 10% citric acid aqueous solution were<br>
added and insoluble were removed by filtration. The<br>
organic layer was separated and dried over anhydrous<br>
magnesium sulfate after washed with a saturated sodium<br>
chloride aqueous solution, and the solvent was<br>
evaporated under reduced pressure. The obtained residue<br>
was purified with silica gel column chromatography<br>
[PSQ100B (spherical) manufactured by Fuji Silysia<br>
Chemical Ltd., eluent; hexane: ethyl acetate =1:1] to<br>
obtain 94 mg of tert-butyl 2-(benzamido)-4-(2-<br>
nitroanilino)benzoate as yellow solid.<br><br>
356<br>
1H-NMR (CDCI3) 6: 1.64 (9H, s), 6.90-6.96 (2H, m), 7.50-<br>
7.60 (4H, m), 7.66 (1H, dd, J = 8.5, 1.2 Hz), 8.02 (1H,<br>
d, J = 8.5 Hz), 8.02-8.08 (2H, m), 8.22 (1H, dd, J =<br>
8.7, 1.6 Hz), 8.94 (1H, d, J = 2.2 Hz), 9.53 (1H, s),<br>
12.33 (1H, s).<br>
[0673]<br>
Example 413<br><br>
10 mg of 5% palladium-carbon was added to a<br>
mixed solution of 4.0 mL of methanol and 8.0 mL of<br>
ethyl acetate containing 50 mg of tert-butyl 2-<br>
(benzamido)-4-(2-nitroanilino)benzoate and stirred<br>
under hydrogen atmosphere at room temperature for 1<br>
hour and 30 minutes. After insoluble were removed by<br>
filtration, the solvent was evaporated under reduced<br>
pressure to obtain 46 mg of tert-butyl 4-(2-<br>
aminoanilino)-2-(benzamido)benzoate as pale yellow<br>
solid.<br>
1H-NMR (CDCI3) 5: 1.59 (9H, s), 3.79 (2H, s), 5.67 (1H,<br>
s), 6.30 (1H, dd, J = 8.8, 2.3 Hz), 6.76-6.85 (2H, m) ,<br>
7.06-7.12 (1H, m) , 7.15-7.18 (1H, m) , 7.49-7.58 (3H, m) ,<br>
7.85 (1H, d, J = 8.8 Hz), 8.03-8.08 (2H, m), 8.41 (1H,<br>
d, J = 2.3 Hz), 12.41 (1H, s).<br>
[0674]<br>
Example 414<br><br><br>
28 mg of formamidine acetate was added to 1.0<br>
mL of ethylene glycol monomethyl ether solution<br>
containing 44 mg of tert-butyl 4-(2-aminoanilino)-2-<br>
(benzamido)benzoate at room temperature and stirred at<br>
80C for 3 hours. After the reaction mixture was cooled<br>
to room temperature, ethyl acetate and water were added.<br>
The organic layer was separated and dried over<br>
anhydrous magnesium sulfate after washed with a<br>
saturated sodium hydrogen carbonate aqueous solution<br>
and a saturated sodium chloride aqueous solution<br>
sequentially, and the solvent was evaporated under<br>
reduced pressure. The obtained residue was purified<br>
with silica gel column chromatography [PSQ100B<br>
(spherical) manufactured by Fuji Silysia Chemical Ltd.,<br>
eluent; hexane: ethyl acetate =1:1] to obtain 36 mg of<br>
tert-butyl 2-(benzamido)-4-(lH-benzimidazol-1-<br>
yl)benzoate as pale yellow oil.<br>
1H-NMR (CDC13) 6: 1.68 (9H, s) , 7.24-7.30 (1H, m) , 7.34-<br>
7.44 (2H, m), 7.53-7.63 (3H, m) , 7.78-7.82 (1H, m) ,<br>
7.87-7.92 (1H, m) , 8.06-8.10 (2H, m), 8.23 (1H, d, J =<br>
8.6 Hz), 8.26 (1H, s), 9.30 (1H, d, J = 2.2 Hz), 12.38<br>
(1H, s).<br>
[0675]<br>
Example 415<br><br><br>
5.0 mL trifluoroacetic acid solution<br>
containing 34 mg of tert-butyl 2-(benzamido)-4-(1H-<br>
benzimidazol-l-yl)benzoate was stirred at room<br>
temperature for 1 hour and 30 minutes. The solvent was<br>
evaporated under reduced pressure and methanol was<br>
added to the obtained residue and a solid substance was<br>
separated by filtration to obtain 24 mg of 2-<br>
(benzamido)-4-(lH-benzimidazol-1-yl)benzoic acid as<br>
white solid.<br>
0.5 mL of trifluoroacetic acid and 0.01 mL of<br>
4.0 mol/L hydrogen chloride/dioxane were added to 1.0<br>
mL suspension containing 15 mg of 2-(benzamido)-4-(1H-<br>
benzimidazol-1-yl)benzoic acid in ethyl acetate<br>
sequentially while ice-cooled and stirred at the same<br>
temperature for 10 minutes. A solid substance was<br>
separated by filtration to obtain 12 mg of 2-<br>
(benzamido)-4-(lH-benzimidazol-1-yl)benzoic acid<br>
hydrochloride as white solid.<br>
1H-NMR (DMSO-d6) 8: 7.46-7.56 (2H, m) , 7.59-7.72 (4H, m) ,<br>
7.87-7.92 (2H, m) , 7.98-8.03 (2H, m), 8.32 (1H, d, J =<br>
8.6 Hz), 9.15 (1H, d, J = 2.2 Hz), 9.16 (1H, s), 12.38<br>
(1H, s).<br>
[0676]<br>
Examples 416 to 425<br><br>
359<br>
The compounds shown in Table 40 were obtained<br>
in the same manner as in Example 251.<br>
[0677]<br>
[Table 401<br><br>
[0678]<br>
2-(Benzamido)-4-(3-chloro-4-fluorophenyl)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 7.52-7.70 (5H, m) , 1.12-1 .IS (1H, m) ,<br>
7.93 (1H, dd, J = 7.1, 2.4 Hz), 7.96-8.02 (2H, m), 8.13<br>
(1H, d, J = 8.3), 9.03 (1H, s), 12.23 (1H, s).<br>
[0679]<br>
2-(Benzamido)-4-(3,4-difluorophenyl)benzoic acid<br>
1H-NMR (DMSO-d6) 5: 7.54 (1H, dd, J= 8.3, 1.7 Hz),<br>
7.56-7.70 (5H, m) , 7.78-7.86 (1H, m) , 7.96-8.05 (2H, m) ,<br>
8.13 (1H, d, J = 8.3 Hz), 9.04 (1H, d, J = 1.7 Hz),<br>
12.22 (1H, s).<br><br>
360<br>
[0680]<br>
2-(Benzamido)-4-(2,5-difluorophenyl)benzoic acid<br>
1H-NMR (DMSO-de) 5: 7.33-7.52 (4H, m) , 7.58-7.70 (3H, m) ,<br>
7.95-8.00 (2H, m), 8.16 (1H, d, J = 8.3 Hz), 8.96-8.99<br>
(1H, m), 12.25 (1H, s).<br>
[0681]<br>
2-(Benzamido)-4-(2,4-dichlorophenyl)benzoic acid<br>
1H-NMR (DMSO-de) 5: 7.28 (1H, dd, J = 8.3, 1.7 Hz), 7.52<br>
(1H, d, J = 8.3 Hz), 7.56-7.70 (4H, m), 7.80 (1H, d, J<br>
= 2.2 Hz), 7.94-8.00 (2H, m), 8.15 (1H, d, J = 8.3 Hz),<br>
8.82 (1H, d, J = 1.7 Hz), 12.27 (1H, s) .<br>
[0682]<br>
2-(Benzamido)-4-(4-fluoro-2-methylphenyl)benzoic acid<br>
1H-NMR (DMSO-de) 8: 2.30 (3H, s) , 7.11-7.25 (3H, m) ,<br>
7.32 (1H, dd, J = 8.5, 6.1 Hz), 7.57-7.69 (3H, m) ,<br>
7.94-7.99 (2H, m), 8.12 (1H, d, J = 8.1 Hz), 8.72 (1H,<br>
d, J = 1.7 Hz).12.26 (1H, s).<br>
[0683]<br>
2-(Benzamido)-4-(2-trifluoromethoxyphenyl)benzoic acid<br>
1H-NMR (DMSO-de) 8: 7.32 (1H, dd, J = 8.1, 1.6 Hz),<br>
7.52-7.69 (7H, m), 7.95-8.00 (2H, m), 8.16 (1H, d, J =<br>
8.1 Hz), 8.91 (1H, d, J = 1.6 Hz), 12.27 (1H, s) .<br>
[0684]<br>
2-(Benzamido)-4-(3,4-dimethylphenyl)benzoic acid<br>
1H-NMR (DMSO-de) 8: 2.29 (3H, s) , 2.33 (3H, s) , 7.29 (1H,<br>
d, J = 7.8 Hz), 7.43-7.53 (3H, m), 7.58-7.70 (3H, m),<br>
7.96-8.02 (2H, m), 8.11 (1H, d, J = 8.3 Hz), 9.06 (1H,<br>
d, J = 1.7 Hz), 12.27 (1H, s).<br><br>
361<br>
[0685]<br>
2-(Benzamido)-4-(3-chloro-4-methoxyphenyl)benzoic acid<br>
1H-NMR (DMSO-de) 8: 3.94 (3H, s) , 7.32 (1H, d, J = 8.7<br>
Hz), 7.52 (1H, dd, J = 8.3, 1.8 Hz), 7.58-7.74 (4H, m),<br>
7.79 (1H, d, J = 2.2 Hz), 7.96-8.02 (2H, m), 8.11 (1H,<br>
d, J = 8.3 Hz), 9.04 (1H, d, J = 1.8 Hz), 12.26 (1H, s),<br>
13.70-13.95 (1H, broad).<br>
[0686]<br>
2-(Benzamido)-4-(2,3-dichlorophenyl)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 7.29 (1H, dd, J = 8.1, 1.7 Hz), 7.45<br>
(1H, dd, J = 7.8, 1.7 Hz), 7.51 (1H, t, J = 7.8 Hz),<br>
7.58-7.69 (3H, m), 7.75 (1H, dd, J = 7.8, 1.7 Hz),<br>
7.94-7.99 (2H, m), 8.15 (1H, d, J = 8.1 Hz), 8.80-8.83<br>
(1H, m) , 12.27 (1H, s) .<br>
[0687]<br>
2-(Benzamido)-4-(2,5-dichlorophenyl)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 7.30 (1H, dd, J = 8.2, 1.6 Hz),<br>
7.54-7.70 (6H, m), 7.94-8.00 (2H, m) , 8.15 (1H, d, J =<br>
8.2 Hz), 8.83 (1H, d, J = 1.6 Hz), 12.25 (1H, s).<br>
[0688]<br>
Example 42 6<br><br>
0.031 mL of 2-chloro-4-iodotoluene, 39 mg of<br>
sodium hydrogen carbonate, 0.6 mL of ethanol, 0.3 mL of<br>
water and 11 mg of<br><br>
362<br>
tetrakis(triphenylphosphine)palladium(0) were added to<br>
1.6 mL of toluene solution containing 79 mg of tert-<br>
butyl 2-(benzamido)-4-(4,4,5,5-tetramethyl-l,3,2-<br>
dioxaborolan-2-yl)benzoate at room temperature, and the<br>
resulting mixture was heated to reflux for 8 hours.<br>
After the reaction mixture was cooled to room<br>
temperature, 11 mg of<br>
tetrakis(triphenylphosphine)palladium(0) was added and<br>
the resulting mixture was heated to reflux for 7 hours.<br>
After the reaction mixture was cooled to room<br>
temperature, ethyl acetate and water were added. The<br>
organic layer was separated and dried over anhydrous<br>
magnesium sulfate after washed with a saturated sodium<br>
chloride aqueous solution, and the solvent was<br>
evaporated under reduced pressure. The obtained residue<br>
was purified with silica gel column chromatography<br>
[PSQ100B (spherical) manufactured by Fuji Silysia<br>
Chemical Ltd., eluent; hexane: ethyl acetate =10:1] to<br>
obtain tert-butyl 2-(benzamido)-4-(3-chloro-4-<br>
methylphenyl)benzoate as white solid.<br>
5.0 mL of trifluoroacetic acid was added to<br>
the obtained tert-butyl 2-(benzamido)-4-(3-chloro-4-<br>
methylphenyl)benzoate and stirred at room temperature<br>
for 2 hours. The solvent was evaporated under reduced<br>
pressure and methanol was added to the obtained residue<br>
and a solid substance was separated by filtration to<br>
obtain 14 mg of 2-(benzamido)-4-(3-chloro-4-<br>
methylphenyl)benzoic acid as white solid.<br><br>
363<br>
1H-NMR (DMSO-d6) 8: 2.40 (3H, s) , 7.50-7.70 (6H, m) ,<br>
7.76 (1H, d, J = 1.7 Hz), 7.97-8.02 (2H, m), 8.13 (1H,<br>
d, J = 8.3 Hz), 9.06 (1H, d, J = 1.7 Hz), 12.26 (1H, s).<br>
[0689]<br>
Examples 427 to 429<br>
The compounds shown in Table 41 were obtained<br>
in the same manner as in Example 252.<br>
[0690]<br>
[Table 41]<br><br>
[0691]<br>
2-(Benzamido)-4-(3-chloro-2-methylphenyl)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 2.29 (3H, s) , 7.20 (1H, dd, J = 8.3,<br>
1.8 Hz), 7.26 (1H, dd, J = 7.7, 1.2 Hz), 7.35 (1H, dd,<br>
J = 7.9, 7.7 Hz), 7.53 (1H, dd, J = 7.9, 1.2 Hz), 7.58-<br>
7.69 (3H, m), 7.94-7.99 (2H, m), 8.13 (1H, d, J = 8.3<br>
Hz), 8.70-8.72 (1H, m) , 12.29 (1H, s).<br>
[0692]<br>
2-(Benzamido)-4-(5-chloro-2-methylphenyl)benzoic acid<br>
1H-NMR   (DMSO-d6)   8:   2.26   (3H,   s),   7.23   (1H,   dd,   J =  8.2,<br>
1.7   Hz),   7.32   (1H,   d,   J =  1.7  Hz),   7.37-7.44   (2H,   m) ,<br><br>
364<br>
7.58-7.70 (3H, m) , 7.94-8.00 (2H, m), 8.13 (1H, d, J =<br>
8.2 Hz), 8.73 (1H, d, J = 1.7 Hz), 12.25 (1H, s).<br>
[0693]<br>
2-(Benzamido)-4-(5-chloro-2-methoxyphenyl)benzoic acid<br>
1H-NMR (DMSO-d6) 5: 3.81 (3H, s), 7.21 (1H, d, J = 8.8<br>
Hz), 7.34 (1H, dd, J = 8.2, 1.7 Hz), 7.38 (1H, d, J =<br>
2.7 Hz), 7.48 (1H, dd, J = 8.8, 2.7 Hz), 7.58-7.69 (3H,<br>
m), 7.95-8.00 (2H, m), 8.09 (1H, d, J = 8.2 Hz), 8.86<br>
(1H, d, J = 1.7 Hz), 12.21 (1H, s).<br>
[0694]<br>
Example 430<br><br>
2.0 mL of methylene chloride, 2.7 ^L of N,N-<br>
dimethylformamide and 0.061 mL of oxalyl chloride were<br>
sequentially added to 0.13 g of 3,5-dichlorobenzoic<br>
acid at room temperature and stirred at the same<br>
temperature for 1 hour. The reaction mixture was added<br>
to a mixed solution of 3.0 mL of methylene chloride and<br>
0.45 mL of triethylamine containing 60 mg of tert-butyl<br>
2-amino-4-phenethylbenzoate at room temperature and<br>
stirred at the same temperature for 1 hour. A saturated<br>
sodium hydrogen carbonate aqueous solution was added to<br>
the reaction mixture, and the organic layer was<br>
separated, and the solvent was evaporated under reduced<br>
pressure. The obtained residue was purified with silica<br><br>
365<br>
gel column chromatography [Flash Tube 2008 manufactured<br>
by Trikonex Company, eluent; hexane: ethyl acetate =<br>
4:1] to obtain tert-butyl 2-(3,5-dichlorobenzamido)-4-<br>
phenethylbenzoate.<br>
10 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 2-(3,5-dichlorobenzamido)-4-<br>
phenethylbenzoate and stirred at room temperature for 2<br>
hours. The solvent was evaporated under reduced<br>
pressure and diisopropyl ether was added to the<br>
obtained residue and a solid substance was separated by<br>
filtration to obtain 62 mg of 2-(3,5-<br>
dichlorobenzamido)-4-phenethylbenzoic acid as white<br>
solid.<br>
1H-NMR (DMSO-d6) 8: 2.89-3.02 (4H, m) , 7.12 (1H, dd, J =<br>
8.0, 1.7 Hz), 7.16-7.21 (1H, m) , 7.24-7.31 (4H, m) ,<br>
7.91-7.97 (4H, m) , 8.48-8.52 (1H, m) , 12.14 (1H, s),<br>
13.65-13.85 (1H, broad).<br>
[0695]<br>
Examples 431 to 439<br>
The compounds shown in Table 42 were obtained<br>
in the same manner as in Example 430.<br>
[0696]<br>
[Table 42]<br><br><br>
[0697]<br>
2-(3,4-Dichlorobenzamido)-4-phenethylbenzoic acid<br>
1H-NMR (DMSO-de) 8: 2.89-3.02 (4H, m) , 7.11 (1H, dd, J =<br>
8.1, 1.5 Hz), 7.16-7.21 (1H, m), 7.24-7.31 (4H, m) ,<br>
7.88-7.91 (2H, m), 7.95 (1H, d, J = 8.1 Hz), 8.13 (1H,<br>
s), 8.54 (1H, d, J = 1.5 Hz), 12.17 (1H, s), 13.60-<br>
13.85 (1H, broad).<br>
[0698]<br>
2-(3,5-Difluorobenzamido)-4-phenethylbenzoic acid<br>
1H-NMR (DMSO-de) 5: 2.88-3.02 (4H, m) , 7.12 (1H, dd, J =<br>
8.1, 1.6 Hz), 7.15-7.21 (1H, m), 7.23-7.32 (4H, m) ,<br>
7.56-7.66 (3H, m), 7.96 (1H, d, J = 8.1 Hz), 8.52 (1H,<br>
d, J = 1.6 Hz), 12.12 (1H, s), 13.60-13.80 (1H, broad).<br>
[0699]<br>
2-(3,4-Difluorobenzamido)-4-phenethylbenzoic acid<br>
1H-NMR   (DMSO-de)   8:   2.88-3.02   (4H,   m) ,   7.10   (1H,   dd,   J =<br>
8.1,   1.7  Hz),   7.16-7.21   (1H,   m),   7.24-7.31   (4H,   m) ,<br>
7.66-7.74    (1H,   m),   7.79-7.85   (1H,   m),   7.91-7.99   (2H,   m),<br><br>
367<br>
8.55 (1H, d, J = 1.7 Hz), 12.12 (1H, s), 13.60-13.80<br>
(1H, broad).<br>
[0700]<br>
2-(3,5-Dimethylbenzamido)-4-phenethylbenzoic acid<br>
1H-NMR (DMSO-d6) 8: 2.37 (6H, s) , 2.88-3.02 (4H, m) ,<br>
7.07 (1H, dd, J = 8.1, 1.5 Hz), 7.16-7.21 (1H, m),<br>
7.24-7.31 (5H, m), 7.57 (2H, s), 7.95 (1H, d, J = 8.1<br>
Hz), 8.66-8.68 (1H, m), 12.19 (1H, s), 13.65-13.80 (1H,<br>
broad).<br>
[0701]<br>
2-(4-Acetoxybenzamido)-4-phenethylbenzoic acid<br>
1H-NMR (DMSO-d6) 5: 2.32 (3H, s) , 2.89-3.02 (4H, m) ,<br>
7.09 (1H, dd, J = 8.3, 1.6 Hz), 7.16-7.21 (1H, m) ,<br>
7.25-7.32 (4H, m), 7.35-7.40 (2H, m), 7.96 (1H, d, J =<br>
8.3 Hz), 7.96-8.03 (2H, m) , 8.63-8.65 (1H, m), 12.17<br>
(1H, s), 13.60-13.75 (1H, broad).<br>
[0702]<br>
4-Phenethyl-2-(6-phenylpyrimidine-4-carboxamido)benzoic<br>
acid<br>
1H-NMR (DMSO-de) 8: 2.92-3.05 (4H, m) , 7.12-7.22 (2H, m) ,<br>
7.25-7.32 (4H, m), 7.58-7.67 (3H, m), 7.99 (1H, d, J =<br>
8.3 Hz), 8.30-8.37 (2H, m), 8.64 (1H, d, J = 1.2 Hz),<br>
8.82 (1H, d, J = 1.5 Hz), 9.47 (1H, d, J = 1.2 Hz),<br>
13.16 (1H, s).<br>
[0703]<br>
4-Phenethyl-2-(3-phenylisoxazole-5-carboxamido)benzoic<br>
acid<br><br>
368<br>
1H-NMR   (DMSO-de)   8:   2.90-3.04    (4H,   m) ,   7.12-7.21    (2H,   m) ,<br>
7.25-7.32    (4H,   m) ,    7.52-7.63    (4H,   m) ,   7.96-8.02    (3H,   m),<br>
8.63   (1H,   d,   J =   1.4   Hz),   12.49   (1H,   s) .<br>
[0704]<br>
4-Phenethyl-2-( (E)-4-phenyl-3-butenaxnido)benzoic  acid<br>
1H-NMR   (DMSO-d6)   8:   2.84-2.97   (4H,   m) ,   3.35-3.38    (2H,   m) ,<br>
6.40-6.50   (1H,   m),   6.66   (1H,   d,   J =  15.8  Hz),   7.01   (1H,<br>
dd,   J =  8.0,   1.6 Hz),   7.14-7.20   (1H,   m) ,   7.21-7.30   (5H,<br>
m),   7.31-7.38   (2H,   m),   7.44-7.50   (2H,   m),   7.87   (1H,   d,<br>
J =  8.0  Hz),   8.49   (1H,   d,   J =  1.6  Hz),   11.29   (1H,   s).<br>
[0705]<br>
2-((E)-2-Methyl-3-phenylacrylamido)-4-phenethylbenzoic<br>
acid<br>
1H-NMR   (DMSO-d6)   8:   2.19   (3H,   d,   J =  1.2  Hz),   2.88-3.01<br>
(4H,   m),   7.05   (1H,   dd,   J=  8.1,   1.5  Hz),   7.16-7.21   (1H,<br>
m) ,   7.24-7.32    (4H,   m) ,   7.35-7.41    (1H,   m) ,   7.43-7.53    (5H,<br>
m),   7.94    (1H,   d,   J  =   8.1   Hz),   8.65   (1H,   s),   11.86   (1H,<br>
s).<br>
[0706]<br>
Examples 440 to 446<br>
The compounds shown in Table 43 were obtained<br>
in the same manner as in Example 369.<br>
[0707]<br>
[Table 43]<br><br><br>
[0708]<br>
2-((E)-3-(4-Nitrophenyl)acrylamido)-4-phenoxybenzoic<br>
acid<br>
1H-NMR (DMSO-d6) 8: 6.77 (1H, ddf J = 8.8, 2.5 Hz), 7.12<br>
(1H, d, J = 15.6 Hz), 7.14-7.21 (2H, m), 7.28 (1H, t, J<br>
= 7.5 Hz), 7.45-7.53 (2H, m) , 7.71 (1H, d, J = 15.6 Hz),<br>
8.00-8.08 (3H, m), 8.26 (2H, d, J = 9.0 Hz), 8.35 (1H,<br>
d, J = 2.6 Hz), 11.66 (1H, s), 13.40-13.65 (1H, broad).<br>
[0709]<br>
2-(3,5-Dichlorobenzamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-d6) 6: 6.81 (1H, dd, J = 8.8, 2.7 Hz),<br>
7.16-7.22 (2H, m), 7.29 (1H, t, J = 7.4 Hz), 7.46-7.53<br>
(2H, m), 7.88 (2H, d, J = 1.8 Hz), 7.94 (1H, t, J = 1.8<br>
Hz), 8.07 (1H, d, J = 8.8 Hz), 8.26 (1H, d, J = 2.7 Hz),<br>
12.43 (1H, s).<br>
[0710]<br>
2-(3,4-Dichlorobenzamido)-4-phenoxybenzoic acid<br><br>
370<br>
1H-NMR (DMSO-d6) S: 6.80 (1H, dd, J = 8.9, 2.5 Hz),<br>
7.15-7.21 (2H, m), 7.26-7.32 (1H, m) , 7.46-7.53 (2H, m) ,<br>
7.84-7.92 (2H, m), 8.07 (1H, d, J = 8.9 Hz), 8.09 (1H,<br>
d, J = 1.7 Hz), 8.30 (1H, d, J = 2.5 Hz), 12.43 (1H, s) .<br>
[0711]<br>
2-(3,5-Difluorobenzamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.81 (1H, dd, J = 8.8, 2.7 Hz),<br>
7.15-7.22 (2H, m), 7.26-7.32 (1H, m), 7.46-7.64 (5H, m) ,<br>
8.07 (1H, d, J = 8.8 Hz), 8.28 (1H, d, J = 2.7 Hz),<br>
12.39 (1H, s).<br>
[0712]<br>
2-(3, 4-Difluorobenzamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.80 (1H, dd, J = 8.9, 2.5 Hz),<br>
7.15-7.22 (2H, m) , 7.25-7.32 (1H, m), 7.45-7.53 (2H, m),<br>
7.65-7.73 (1H, m) , 7.75-7.82 (1H, m) , 7.88-7.94 (1H, m) ,<br>
8.07 (1H, d, J = 8.9 Hz), 8.30 (1H, d, J = 2.5 Hz),<br>
12.37 (1H, s).<br>
[0713]<br>
2-(3,5-Dimethylbenzamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-d6) 8: 2.35 (6H, s) , 6.76 (1H, dd, J = 8.9,<br>
2.4 Hz), 7.16-7.22 (2H, m), 7.26-7.32 (2H, m), 7.45-<br>
7.57 (4H, m), 8.06 (1H, d, J = 8.9 Hz), 8.41 (1H, d, J<br>
= 2.4 Hz), 12.40 (1H, s).<br>
[0714]<br>
2-((E)-2-Methyl-3-phenylacrylamido)-4-phenoxybenzoic<br>
acid<br>
1H-NMR (DMSO-d6) 8: 2.16 (3H, d, J = 1.5 Hz), 6.75 (1H,<br>
dd, J = 8.8, 2.6 Hz), 7.15-7.19 (2H, m), 7.25-7.31 (1H,<br><br>
371<br>
m), 7.34-7.41 (1H, m) , 7.42-7.52 (7H, m), 8.05 (1H, d,<br>
J = 8.8 Hz), 8.38 (1H, d, J = 2.6 Hz), 12.06 (1H, s).<br>
[0715]<br>
Examples 447 to 452<br>
The compounds shown in Table 44 were obtained<br>
in the same manner as in Example 345.<br>
[0716]<br>
[Table 44]<br><br>
[0717]<br>
2-(3,5-Dichlorobenzamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-de) 8: 7.47 (1H, tt, J = 7.3, 1.6 Hz),<br>
7.51-7.59 (3H, m), 7.70-7.75 (2H, m), 7.94 (3H, s) ,<br>
8.12 (1H, d, J = 8.3 Hz), 8.90 (1H, d, J = 1.7 Hz),<br>
12.21 (1H, s).<br>
[0718]<br>
2-(3,4-Dichlorobenzamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-de) 8: 7.44-7.50 (1H, m) , 7.52-7.59 (3H, m) ,<br>
7.70-7.76 (2H, m), 7.89-7.96 (2H, m), 8.13 (1H, d, J =<br><br>
372<br>
8.3 Hz), 8.15-8.19 (1H, m), 8.95 (1H, d, J = 1.7 Hz),<br>
12.23 (1H, s).<br>
[0719]<br>
2-(3,5-Difluorobenzamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-d6) 5: 7.47 (1H, tt, J = 7.2, 1.5 Hz),<br>
7.52-7.67 (6H, m), 7.70-7.77 (2H, m), 8.13 (1H, d, J =<br>
8.3 Hz), 8.93 (1H, d, J = 1.7 Hz), 12.18 (1H, s) .<br>
[0720]<br>
2-(3,4-Difluorobenzamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-d6) 8: 7.44-7.50 (1H, m) , 7.52-7.58 (3H, m) ,<br>
7.67-7.77 (3H, m) , 7.82-7.88 (1H, m) , 7.94-8.02 (1H, m) ,<br>
8.13 (1H, d, J = 8.3 Hz), 8.96 (1H, d, J = 1.7 Hz),<br>
12.19 (1H, s).<br>
[0721]<br>
2-(3, 5-Dimethylbenzamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-d6) 5: 2.38 (6H, s) , 7.30 (1H, s) , 7.44-<br>
7.58 (4H, m), 7.60 (2H, s), 7.70-7.76 (2H, m), 8.13 (1H,<br>
d, J = 8.3 Hz), 9.08 (1H, d, J = 1.7 Hz), 12.26 (1H, s).<br>
[0722]<br>
2-((E) -2-Methyl-3-phenylacrylamido)-4-phenylbenzoic<br>
acid<br>
1H-NMR   (DMSO-de)   5:   2.22   (3H,   d,   J =  1.2  Hz),   7.36-7.41<br>
(1H,   m) ,   7.44-7.58   (9H,   m) ,   7.70-7.74   (2H,   m) ,   8.12   (1H,<br>
d,   J =   8.3   Hz),   9.08    (1H,   d,   J =   1.7   Hz),   11.93    (1H,   s).<br>
[0723]<br>
Example  453<br><br><br>
1.0 mL of methylene chloride, 2.7 jaL of N,N-<br>
dimethylformamide and 0.061 mL of oxalyl chloride were<br>
added to 0.11 g of 2-methoxybenzoic acid at room<br>
temperature sequentially and stirred at the same<br>
temperature for 1 hour. The reaction mixture was added<br>
to a mixed solution of 4.0 mL of methylene chloride and<br>
0.45 mL triethylamine containing 57 mg of tert-butyl 2-<br>
amino-4-phenoxybenzoate and stirred at room temperature<br>
for 1 hour. A saturated sodium hydrogen carbonate<br>
aqueous solution was added to the reaction mixture, and<br>
the organic layer was separated, and the solvent was<br>
evaporated under reduced pressure. The obtained residue<br>
was purified with silica gel column chromatography<br>
[Flash Tube 2008 manufactured by Trikonex Company,<br>
eluent; hexane: ethyl acetate =4:1] to obtain tert-<br>
butyl 2-(2-methoxybenzamido)-4-phenoxybenzoate.<br>
10 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 2-(2-methoxybenzamido)-4-<br>
phenoxybenzoate and stirred at room temperature for 3<br>
minutes. The solvent was evaporated under reduced<br>
pressure and diisopropyl ether was added to the<br>
obtained residue and a solid substance was separated by<br>
filtration to obtain 52 mg of 2-(2-methoxybenzamido)-4-<br>
phenoxybenzoic acid as white solid.<br><br>
374<br>
1H-NMR   (DMSO-d6)   8:   3.99   (3H,   s) ,    6.74    (1H,   dd,   J =   8.9,<br>
2.6  Hz),   7.06-7.12   (1H,   m),   7.14-7.20   (2H,   m),   7.21-<br>
7.29   (2H,   m),   7.44-7.52   (2H,   m) ,   7.55-7.60   (1H,   m) ,<br>
7.91   (1H,   dd,   J =  7.8,   1.7  Hz),   8.04   (1H,   d,   J =  8.9<br>
Hz),   8.55   (1H,   d,   J  =  2.6  Hz),   12.40    (1H,   s),   13.41    (1H,<br>
s).<br>
[0724]<br>
Example 454<br><br>
The following compound was obtained in the<br>
same manner as in Example 453.<br>
2-(3-Methoxybenzamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-de) 5: 3.84 (3H, s), 6.78 (1H, dd, J= 8.8,<br>
2.4 Hz), 7.16-7.24 (3H, m), 7.29 (1H, t, J = 7.3 Hz),<br>
7.43-7.55 (5H, m), 8.07 (1H, d, J = 8.8 Hz), 8.40 (1H,<br>
d, J = 2.4 Hz), 12.40 (1H, s), 13.65-13.85 (1H, broad).<br>
[0725]<br>
Example 455<br><br><br>
375<br>
5.0 mL of methylene chloride, 0.056 mL of<br>
triethylamine and 51 mg of 4-methoxybenzoyl chloride<br>
were added sequentially to 57 mg of tert-butyl 2-amino-<br>
4-phenoxybenzoate at room temperature, and stirred at<br>
the same temperature for 1 hour. A saturated sodium<br>
hydrogen carbonate aqueous solution was added to the<br>
reaction mixture, and the organic layer was separated,<br>
and the solvent was evaporated under reduced pressure.<br>
The obtained residue was purified with silica gel<br>
column chromatography [Flash Tube 2008 manufacture by<br>
Trikonex Company, eluent; hexane: ethyl acetate = 4:1]<br>
to obtain tert-butyl 2-(4-methoxybenzamido)-4-<br>
phenoxybenzoate.<br>
10 mL of trifluoroacetic acid was added to<br>
tert-butyl 2-(4-methoxybenzamido) 4-phenoxybenzoate and<br>
stirred at room temperature for 3 minutes. The solvent<br>
was evaporated under reduced pressure and diisopropyl<br>
ether was added to the obtained residue and a solid<br>
substance was separated by filtration to obtain 55 mg<br>
of 2-(4-methoxybenzamido)-4-phenoxybenzoic acid as<br>
white solid.<br>
1H-NMR (DMSO-d6) 8: 3.85 (3H, s) , 6.75 (1H, dd, J = 9.0,<br>
2.5	Hz), 7.09-7.15 (2H, m) , 7.15-7.21 (2H, m), 7.28 (1H,<br>
t, J = 7.4 Hz), 7.46-7.52 (2H, m), 7.86-7.93 (2H, m) ,<br>
8.06	(1H, d, J = 9.0 Hz), 8.41 (1H, d, J = 2.5 Hz),<br>
12.33 (1H, s), 13.55-13.75 (1H, broad).<br>
[0726]<br>
Example 456<br><br><br>
1.0 mL of methylene chloride, 2.7 fiL of N,N-<br>
dimethylformamide and 0.061 mL of oxalyl chloride were<br>
added to 0.11 g of 2-methoxybenzoic acid at room<br>
temperature sequentially and stirred at the same<br>
temperature for 1 hour. The reaction mixture was added<br>
to a mixed solution of 4.0 mL of methylene chloride and<br>
0.4 5 mL of triethylamine containing 54 mg of tert-butyl<br>
2-amino-4-phenylbenzoate at room temperature and<br>
stirred at the same temperature for 1 hour. A saturated<br>
sodium hydrogen carbonate aqueous solution was added to<br>
the reaction mixture, and the organic layer was<br>
separated, and the solvent was evaporated under reduced<br>
pressure. The obtained residue was purified with silica<br>
gel column chromatography [Flash Tube 2008 manufactured<br>
by Trikonex Company, eluent; hexane: ethyl acetate =<br>
4:1] to obtain tert-butyl 2-(2-methoxybenzamido)-4-<br>
phenylbenzoate.<br>
10 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 2-(2-methoxybenzamido)-4-<br>
phenylbenzoate and stirred at room temperature for 3<br>
minutes. The solvent was evaporated under reduced<br>
pressure and diisopropyl ether was added to the<br>
obtained residue and a solid substance was separated by<br><br>
377<br>
filtration to obtain 65 mg of 2-(2-methoxybenzamido)-4-<br>
phenylbenzoic acid as white solid.<br>
1H-NMR (DMSO-d6) 8: 4.03 (3H, s), 7.10-7.17 (1H, m) ,<br>
7.26 (1H, d, J = 8.3 Hz), 7.43-7.64 (5H, m), 7.70-7.77<br>
(2H, m), 8.02 (1H, dd, J = 7.8, 1.7 Hz), 8.11 (1H, d, J<br>
= 8.3 Hz), 9.19 (1H, d, J = 1.7 Hz), 12.34 (1H, s),<br>
13.59 (1H, s).<br>
[0727]<br>
Example 457<br><br>
The following compound was obtained in the<br>
same manner as in Example 456.<br>
2-(3-Methoxybenzamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-d6) 8: 3.86 (3H, s), 7.22-7.26 (1H, m),<br>
7.44-7.59 (7H, m), 7.72-7.77 (2H, m), 8.14 (1H, d, J =<br>
8.0 Hz), 9.09 (1H, d, J = 1.7 Hz), 12.26 (1H, s),<br>
13.80-14.00 (1H, broad).<br>
[0728]<br>
Examples 458, 459<br>
The compounds shown in Table 45 were obtained<br>
in the same manner as in Example 34.<br>
[0729]<br>
[Table 45]<br><br><br>
[0730]<br>
4-Phenethyl-2-(3-phenylpropanamido)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 2.71 (2H, t, J = 7.7 Hz), 2.84-2.96<br>
(4H, m), 2.94 (2H, t, J = 7.7 Hz), 7.00 (1H, dd, J =<br>
8.2, 1.6 Hz), 7.15-7.31 (10H, m), 7.87 (1H, d, J = 8.2<br>
Hz), 8.43 (1H, d, J = 1.6 Hz), 11.15 (1H, s), 13.45 (1H,<br>
s) .<br>
[0731]<br>
4-Phenethyl-2-(3,5-<br>
bis(trifluoromethyl)benzamido)benzoic acid<br>
1H-NMR (DMSO-de) 8: 2.90-3.04 (4H, m) , 7.14 (1H, dd, J =<br>
8.1, 1.7 Hz), 7.15-7.21 (1H, m), 7.24-7.32 (4H, m) ,<br>
7.96 (1H, d, J = 8.1 Hz), 8.45 (1H, s), 8.49-8.52 (1H,<br>
m), 8.54 (2H, s), 12.32 (1H, s), 13.70-13.90 (1H,<br>
broad).<br>
[0732]<br>
Example 4 60<br><br><br>
379<br>
The following compound was obtained in the<br>
same manner as in Example 282.<br>
4-Phenyl-2-(3,5-bis(trifluoromethyl)benzamido)benzoic<br>
acid<br>
1H-NMR (DMSO-de) 8: 7.45-7.51 (1H, m) , 7.52-7.61 (3H, m) ,<br>
7.71-7.77 (2H, m), 8.13 (1H, d, J = 8.1 Hz), 8.46 (1H,<br>
s), 8.56 (2H, s), 8.91 (1H, d, J = 1.7 Hz), 12.38 (1H,<br>
s) .<br>
[0733]<br>
Example 4 61<br><br>
The following compound was obtained in the<br>
same manner as in Example 321.<br>
4-Phenoxy-2-(3,5-bis(trifluoromethyl)benzamido)benzoic<br>
acid<br>
1H-NMR (DMSO-d6) 8: 6.84 (1H, dd, J = 8.9, 2.6 Hz),<br>
7.17-7.22 (2H, m) , 7.27-7.33 (1H, m) , 7.47-7.54 (2H, m) ,<br>
8.08 (1H, d, J = 8.9 Hz), 8.28 (1H, d, J = 2.6 Hz),<br>
8.44 (1H, s), 8.50 (2H, s), 12.63 (1H, s).<br>
[0734]<br>
Example 462<br><br><br>
The following compound was obtained in the<br>
same manner as in Example 396.<br>
2-((E)-3-(3-Nitrophenyl)acrylamido)-4-phenoxybenzoic<br>
acid<br>
1H-NMR (DMSO-d6) 8: 6.76 (1H, dd, J = 8.9, 2.7 Hz),<br>
7.12-7.22 (3H, m), 7.28 (1H, t, J = 7.4 Hz), 7.46-7.51<br>
(2H, m), 7.68-7.78 (2H, m), 8.04 (1H, d, J = 8.9 Hz),<br>
8.18-8.29 (2H, m), 8.35 (1H, d, J = 2.7 Hz), 8.61 (1H,<br>
s), 11.61 (1H, s).<br>
[0735]<br>
Example 463<br><br>
5.0 mL of methylene chloride, 0.049 mL of<br>
triethylamine and 45 mg of 4-methoxybenzoyl chloride<br>
were added sequentially to 40 mg of methyl 2-amino-4-<br>
phenylbenzoate at room temperature and stirred at the<br>
same temperature for 1 hour. A saturated sodium<br>
hydrogen carbonate aqueous solution was added to the<br>
reaction mixture, and the organic layer was separated,<br>
and the solvent was evaporated under reduced pressure.<br><br>
381<br>
The obtained residue was purified with silica gel<br>
column chromatography [Flash Tube 2008 manufactured by<br>
Trikonex Company, eluent; hexane: ethyl acetate = 4:1]<br>
to obtain methyl 2-(4-methoxybenzamido)-4-<br>
phenylbenzoate.<br>
1.0 mL of 2.0 mol/L aqueous sodium hydroxide<br>
and 3.0 mL of ethanol were added to the obtained methyl<br>
2-(4-methoxybenzamido)-4-phenylbenzoate and stirred at<br>
40C for 2 hours. After the reaction mixture was cooled<br>
to room temperature, 8.0 mL of 0.38 mol/L hydrochloric<br>
acid and 10 mL of ethyl acetate were added. The organic<br>
layer was separated and dried over anhydrous magnesium<br>
sulfate, and the solvent was evaporated under reduced<br>
pressure. The obtained residue was purified with<br>
reversed-phase silica gel column chromatography<br>
[eluent; 55-100% acetonitrile /0.1% trifluoroacetic<br>
acid aqueous solution] to obtain 6.1 mg of 2-(4-<br>
methoxybenzamido)-4-phenylbenzoic acid as white solid.<br>
1H-NMR (DMSO-d6) 8: 3.86 (3H, s) , 7.15 (2H, d, J = 8.8<br>
Hz), 7.44-7.57 (4H, m), 7.73 (2H, d, J = 7.4 Hz), 7.95<br>
(2H, d, J = 8.8 Hz), 8.13 (1H, d, J = 8.3 Hz), 9.09 (1H,<br>
d, J = 1.4 Hz), 12.21 (1H, s), 13.70-13.90 (1H, broad).<br>
[0736]<br>
Example 4 64<br><br><br>
382<br>
2.0 mL of methylene chloride, 2.7 |aL of N,N-<br>
dimethylformamide and 0.061 mL of oxalyl chloride were<br>
sequentially added to 0.13 g of 3-phenyl-lH-pyrazole-5-<br>
carboxylic acid at room temperature and stirred at the<br>
same temperature for 1 hour. The reaction mixture was<br>
added to a mixed solution of 3.0 mL of methylene<br>
chloride and 0.45 mL of triethylamine containing 60 mg<br>
of tert-butyl 2-amino-4-phenethylbenzoate at room<br>
temperature was stirred at the same temperature for 1<br>
hour. A saturated sodium hydrogen carbonate aqueous<br>
solution was added to the reaction mixture, and the<br>
organic layer was separated, and the solvent was<br>
evaporated under reduced pressure. The obtained residue<br>
was purified with silica gel column chromatography<br>
[Flash Tube 2008 manufactured by Trikonex Company,<br>
eluent; hexane: ethyl acetate =4:1] to obtain tert-<br>
butyl 4-phenethyl-2-(3-phenyl-lH-pyrazole-5-<br>
carboxamido)benzoate.<br>
10 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 4-phenethyl-2-(3-phenyl-lH-<br>
pyrazole-5-carboxamido)benzoate and stirred at room<br>
temperature for 2 hours. The solvent was evaporated<br>
under reduced pressure, and the obtained residue was<br>
purified with silica gel column chromatography [Flash<br>
Tube 2008 manufactured by Trikonex Company, eluent;<br>
ethyl acetate] to obtain 2.6 mg of 4-phenethyl-2-(3-<br>
phenyl-lH-pyrazole-5-carboxamido)benzoic acid as white<br>
solid.<br><br>
383<br>
1H-NMR (DMSO-d6) 6: 2.89-3.04 (4H, m) , 7.05 (1H, d, J =<br>
7.7 Hz), 7.15-7.33 (6H, m) , 7.38-7.44 (1H, m), 7.47-<br>
7.53 (2H, m) , 7.84 (2H, d, J = 7.6 Hz), 7.95 (1H, d, J<br>
= 7.7 Hz), 8.74 (1H, s), 12.39 (1H, s), 13.96 (1H, s).<br>
[0737]<br>
Example 465<br><br>
2.0 inL of methylene chloride, 2.7 \iL of N,N-<br>
dimethylformamide and 0.061 mL of oxalyl chloride were<br>
added to 0.13 g of 2-acetoxybenzoic acid at room<br>
temperature sequentially and stirred at the same<br>
temperature for 1 hour. The reaction mixture was added<br>
to a mixed solution of 3.0 mL of methylene chloride and<br>
0.45 mL of triethylamine containing 60 mg of tert-butyl<br>
2-amino-4-phenethylbenzoate at room temperature and<br>
stirred at the same temperature for 1 hour. A saturated<br>
sodium hydrogen carbonate aqueous solution was added to<br>
the reaction mixture, and the organic layer was<br>
separated, and the solvent was evaporated under reduced<br>
pressure. The obtained residue was purified with silica<br>
gel column chromatography [Flash Tube 2008 manufactured<br>
by Trikonex Company, eluent; hexane: ethyl acetate =<br><br>
384<br>
4:1] to obtain tert-butyl 2-(2-acetoxybenzamido)-4-<br>
phenethylbenzoate.<br>
10 mL of trifluoroacetic acid was added to the<br>
obtained tert-butyl 2-(2-acetoxybenzamido)-4-<br>
phenethylbenzoate and stirred at room temperature for 2<br>
hours. The solvent was evaporated under reduced<br>
pressure and 0.50 mL of methanol, 0.50 mL of<br>
tetrahydrofuran and 10 mg of potassium carbonate were<br>
added to the obtained residue sequentially and stirred<br>
at room temperature for 3 hours. After insoluble were<br>
removed by filtration, 3.0 mL of 10% citric acid<br>
aqueous solution was added and a solid substance was<br>
separated by filtration to obtain 11 mg of 2-(2-<br>
hydroxybenzamido)-4-phenethylbenzoic acid as white<br>
solid.<br>
10 mg of potassium carbonate were added to a<br>
mixed solution of 1.0 mL of methanol and 1.0 mL of<br>
1H-NMR (DMSO-d6) 5: 2.88-3.02 (4H, m) , 6.95-7.03 (2H, m) ,<br>
7.07 (1H, dd, J = 8.1, 1.4 Hz), 7.15-7.21 (1H, m) ,<br>
7.24-7.32 (4H, m) , 7.41-7.47 (1H, m), 7.87 (1H, dd, J =<br>
7.9, 1.6 Hz), 7.92 (1H, d, J = 8.1 Hz), 8.59 (1H, d, J<br>
= 1.4 Hz), 11.46 (1H, s), 12.22 (1H, s).<br>
[0738]<br>
Example 4 66<br><br><br>
385<br>
tetrahydrofuran containing 20 mg of 2-(4-<br>
acetoxybenzamido)-4-phenethylbenzoic acid and stirred<br>
at room temperature for 3 hours. After insoluble were<br>
removed by filtration, 3.0 mL of 10% citric acid<br>
aqueous solution was added and a solid substance was<br>
separated by filtration to obtain 15 mg of 2-(4-<br>
hydroxybenzamido)-4-phenethylbenzoic acid as white<br>
solid.<br>
1H-NMR (DMSO-de) 8: 2.88-3.00 (4H, m) , 6.93 (2H, d, J =<br>
8.7 Hz), 7.04 (1H, dd, J = 8.1, 1.6 Hz), 7.15-7.21 (1H,<br>
m) , 7.24-7.32 (4H, m), 7.82 (2H, d, J = 8.7 Hz), 7.94<br>
(1H, d, J = 8.1 Hz), 8.68 (1H, d, J = 1.6 Hz), 10.26<br>
(1H, s), 12.09 (1H, s), 13.50-13.70 (1H, broad).<br>
[0739]<br>
Example 4 67<br><br>
1.3 mg of 10% palladium-carbon was added to a<br>
mixed solution of 1.0 mL of methanol and 1.0 mL of<br>
ethyl acetate containing 10 mg of 4-phenoxy-2-((E)-4-<br>
phenyl-3-butenamido)benzoic acid and stirred under<br>
hydrogen atmosphere at room temperature for 6 hours.<br>
After insoluble were removed by filtration, the solvent<br>
was evaporated under reduced pressure. Hexane and<br>
diisopropyl ether were added to the obtained residue<br>
and a solid substance was separated by filtration to<br><br>
386<br>
obtain 4.6 mg of 4-phenoxy-2-(4-<br>
phenylbutanamido)benzoic acid as white solid.<br>
1H-NMR (DMSO-d6) 8: 1.83-1.94 (2H, m) , 2.28 (2H, t, J =<br>
7.6 Hz), 2.60 (2H, t, J = 7.7 Hz), 6.49-6.57 (1H, m) ,<br>
7.02 (2H, d, J = 7.8 Hz), 7.11-7.31 (6H, m) , 7.35-7.43<br>
(2H, m), 7.95 (1H, d, J = 8.6 Hz), 8.17 (1H, d, J = 2.4<br>
Hz) .<br>
[0740]<br>
Example 468<br><br>
1.0 mg of 10% palladium-carbon was added to a<br>
mixed solution of 0.50 mL of methanol and 0.50 mL ethyl<br>
acetate containing 8.0 mg of 4-phenethyl-2-((E)-4-<br>
phenyl-3-butenamido)benzoic acid and stirred under<br>
hydrogen atmosphere at room temperature for 1 hour and<br>
30 minutes. After insoluble were removed by filtration,<br>
the solvent was evaporated under reduced pressure and<br>
the obtained residue was purified with silica gel<br>
column chromatography [Flash Tube 2008 manufactured by<br>
Trikonex Company, eluent; ethyl acetate] to obtain 4.6<br>
mg of 4-phenethyl-2-(4-phenylbutanamido)benzoic acid as<br>
white solid.<br>
1H-NMR (DMSO-de) 8 (D2O treatment): 1.86-2.02 (2H, m) ,<br>
2.39 (2H, t, J = 7.3 Hz), 2.64 (2H, t, J = 7.6 Hz),<br>
2.85-2.96 (4H, m), 6.56 (1H, s), 7.01 (1H, d, J = 8.2<br><br>
387<br>
Hz), 7.14-7.34 (9H, m), 7.87 (1H, d, J = 8.2 Hz), 8.43<br>
(1H, s) .<br>
[0741]<br>
Example 4 69<br><br>
2.5 mL of methylene chloride, 0.015 mL of N,N-<br>
dimethylformamide and 0.095 mL of oxalyl chloride were<br>
added to 0.17 g of 3-cyanobenzoic acid at room<br>
temperature sequentially and stirred at the same<br>
temperature for 30 minutes. The reaction mixture was<br>
added to a mixed solution of 2.0 mL of methylene<br>
chloride and 0.35 mL of triethylamine containing 0.25 g<br>
of tert-butyl 2-amino-4-phenylbenzoate at room<br>
temperature and stirred at the same temperature for 10<br>
minutes. Ethyl acetate, 1.0 mol/L hydrochloric acid and<br>
tetrahydrofuran were added to the reaction mixture. The<br>
organic layer was separated and dried over anhydrous<br>
magnesium sulfate after washed with a saturated sodium<br>
chloride aqueous solution, and the solvent was<br>
evaporated under reduced pressure. The obtained residue<br>
was purified with silica gel column chromatography<br>
[PSQ100B (spherical) manufactured by Fuji Silysia<br>
Chemical Ltd., eluent; chloroform] to obtain 0.29 g of<br>
tert-butyl 2-(3-cyanobenzamido)-4-phenylbenzoate as<br>
white solid.<br><br>
388<br>
1H-NMR (CDCI3) 8: 1.66 (9H, s) , 7.37-7.44 (2H, m), 7.45-<br>
7.52 (2H, m) , 7.66-7.74 (3H, m), 7.84-7.87 (1H, m) ,<br>
8.10 (1H, d, J = 8.3 Hz), 8.28-8.31 (1H, m), 8.37 (1H,<br>
t, J = 1.5 Hz), 9.19 (1H, d, J = 1.9 Hz), 12.44 (1H, s).<br>
[0742]<br>
Examples 470 to 476<br>
The compounds shown in Table 46 were obtained<br>
in the same manner as in Example 469.<br>
[0743]<br>
[Table 46]<br><br>
[0744]<br>
tert-Butyl 4-phenyl-2-(6-(lH-pyrrol-1-yl)pyridine-3-<br>
carboxamido)benzoate<br>
1H-NMR (CDCI3) 8: 1.66 (9H, s) , 6.41 (2H, t, J = 2.3 Hz),<br>
7.37 (1H, dd, J = 8.5, 2.0 Hz), 7.38-7.50 (4H, m), 7.61<br>
(2H, t, J = 2.3 Hz), 7.70-7.74 (2H, m), 8.10 (1H, d, J<br>
= 8.5 Hz), 8.43 (1H, dd, J = 8.8, 2.4 Hz), 9.15 (1H, d,<br>
J = 2.4 Hz), 9.23 (1H, d, J = 2.0 Hz), 12.44 (1H, s).<br><br>
389<br>
[0745]<br>
tert-Butyl 4-phenyl-2-(2-(lH-pyrrol-l-yl)pyridine-4-<br>
carboxamido)benzoate<br>
1H-NMR (CDC13) 5: 1.68 (9H, s) , 6.40 (2H, t, J = 2.3 Hz),<br>
7.38-7.52 (4H, m), 7.64 (2H, t, J = 2.3 Hz), 7.68 (1H,<br>
dd, J = 5.2, 1.4 Hz), 7.71-7.75 (2H, m), 8.00 (1H, s),<br>
8.12 (1H, d, J = 8.3 Hz), 8.64 (1H, d, J = 5.2 Hz),<br>
9.22 (1H, d, J = 2.0 Hz), 12.59 (1H, s).<br>
[0746]<br>
tert-Butyl 4-phenyl-2-(3-(lH-pyrazol-1-<br>
yl)benzamido)benzoate<br>
1H-NMR (CDCI3) 8: 1.67 (9H, s) , 6.51-6.53 (1H, m) , 7.35-<br>
7.44 (2H, m), 7.45-7.51 (2H, m), 7.62-7.68 (1H, m) ,<br>
7.70-7.78 (3H, m) , 7.94-8.00 (1H, m) , 8.04-8.12 (3H, m) ,<br>
8.36-8.38 (1H, m), 9.25 (1H, d, J = 1.7 Hz), 12.42 (1H,<br>
s).<br>
[0747]<br>
tert-Butyl 2-(biphenyl-4-carboxamido)-4-phenylbenzoate<br>
1H-NMR (CDCI3) 8: 1.67 (9H, s) , 7.36 (1H, dd, J = 8.4,<br>
1.8 Hz), 7.37-7.44 (2H, m) , 7.45-7.53 (4H, m), 7.65-<br>
7.70 (2H, m), 7.72-7.80 (4H, m), 8.10 (1H, d, J = 8.4<br>
Hz), 8.14-8.18 (2H, m), 9.28 (1H, d, J = 1.8 Hz), 12.33<br>
(1H, s).<br>
[0748]<br>
tert-Butyl 2-(3-acetylbenzamido)-4-phenylbenzoate<br>
1H-NMR (CDCI3) 8: 1.66 (9H, s) , 2.72 (3H, s) , 7.36-7.44<br>
(2H, m), 7.45-7.51 (2H, m), 7.67 (1H, t, J = 7.8 Hz),<br>
7.70-7.76 (2H, m), 8.11 (1H, d, J = 8.3 Hz), 8.16-8.22<br><br>
390<br>
(1H, m), 8.25-8.30 (1H, m) , 8.68-8.72 (1H, m) , 9.25 (1H,<br>
d, J = 1.9 Hz), 12.49 (1H, s).<br>
[0749]<br>
tert-Butyl 4-phenyl-2-(3-(lH-tetrazol-1-<br>
yl)benzamido)benzoate<br>
1H-NMR (CDC13) 8: 1.67 (9H, s) , 7.38-7.45 (2H, m) , 7.46-<br>
7.53 (2H, m), 7.70-7.75 (2H, m), 7.81 (1H, t, J = 7.9<br>
Hz), 8.03-8.07 (1H, m), 8.12 (1H, d, J = 8.3 Hz), 8.21-<br>
8.24 (1H, m) , 8.42 (1H, t, J = 1.8 Hz), 9.13 (1H, s) ,<br>
9.22 (1H, d, J = 1.7 Hz), 12.57 (1H, s).<br>
[0750]<br>
tert-Butyl 2-(3-(3,5-dimethyl-lH-pyrazol-l-<br>
yl)benzamido)-4-phenylbenzoate<br>
1H-NMR (CDCI3) 8: 1.65 (9H, s) , 2.32 (3H, s) , 2.46 (3H,<br>
s), 6.05 (1H, s), 7.36 (1H, dd, J = 8.3, 1.9 Hz), 7.36-<br>
7.43 (1H, m), 7.44-7.50 (2H, m), 7.64 (1H, t, J = 7.9<br>
Hz), 7.70-7.74 (2H, m) , 7.74-7.79 (1H, m), 8.02-8.07<br>
(1H, m), 8.09 (1H, d, J = 8.3 Hz), 8.12 (1H, t, J = 1.7<br>
Hz), 9.25 (1H, d, J = 1.7 Hz), 12.40 (1H, s).<br>
[0751]<br>
Example 477<br><br>
To 0.17 g of 3-cyanobenzoic acid were added<br>
2.5 inL of methylene chloride, 0.015 mL of N,N-<br>
dimethylformamide and 0.095 mL of oxalyl chloride at<br><br>
391<br>
room temperature sequentially and stirred at the same<br>
temperature for 30 minutes. The reaction mixture was<br>
added to a mixed solution of 2.0 mL of methylene<br>
chloride and 0.35 mL of triethylamine containing 0.26 g<br>
of tert-butyl 2-amino-4-phenoxybenzoate at room<br>
temperature and stirred at the same temperature for 10<br>
minutes. Ethyl acetate, 1.0 mol/L hydrochloric acid and<br>
tetrahydrofuran were added to the reaction mixture. The<br>
organic layer was separated and dried over anhydrous<br>
magnesium sulfate after washed with a saturated sodium<br>
chloride aqueous solution, and the solvent was<br>
evaporated under reduced pressure. The obtained residue<br>
was purified with silica gel column chromatography<br>
[PSQ100B (spherical) manufactured by Fuji Silysia<br>
Chemical Ltd., eluent; chloroform] to obtain 0.20 g of<br>
tert-butyl 2-(3-cyanobenzamido)-4-phenoxybenzoate as<br>
white solid.<br>
1H-NMR (CDC13) 5: 1.63 (9H, s) , 6.70 (1H, dd, J = 8.9,<br>
2.7 Hz), 7.08-7.13 (2H, m) , 7.18-7.24 (1H, m), 7.38-<br>
7.45 (2H, m), 7.62-7.68 (1H, m), 7.83 (1H, dt, J = 7.6,<br>
1.5 Hz), 8.00 (1H, d, J = 8.9 Hz), 8.21-8.26 (1H, m),<br>
8.31 (1H, t, J = 1.5 Hz), 8.53 (1H, d, J = 2.7 Hz),<br>
12.48 (1H, s).<br>
[0752]<br>
Examples 478 to 484<br>
The compounds shown in Table 47 were obtained<br>
in the same manner as in Example 477.<br>
[0753]<br>
[Table 47]<br><br><br>
[0754]<br>
tert-Butyl 4-phenoxy-2-(6-(lH-pyrrol-1-yl)pyridine-3-<br>
carboxamido)benzoate<br>
1H-NMR (CDCI3) 8: 1.63 (9H, s) , 6.40 (2H, t, J = 2.3 Hz),<br>
6.69 (1H, dd, J = 8.9, 2.5 Hz), 7.08-7.14 (2H, m) ,<br>
7.18-7.24 (1H, m) , 7.38-7.45 (3H, m), 7.59 (2H, t, J =<br>
2.3 Hz), 8.00 (1H, d, J = 8.9 Hz), 8.37 (1H, dd, J =<br>
8.8, 2.4 Hz), 8.56 (1H, d, J = 2.5 Hz), 9.09 (1H, d, J<br>
=2.4 Hz), 12.48 (1H, s).<br>
[0755]<br>
tert-Butyl 4-phenoxy-2-(2-(lH-pyrrol-1-yl)pyridine-4-<br>
carboxamido)benzoate<br>
1H-NMR (CDCI3) 8: 1.64 (9H, s) , 6.39 (2H, t, J = 2.2 Hz),<br>
6.72 (1H, dd, J = 8.9, 2.5 Hz), 7.08-7.14 (2H, m) ,<br>
7.18-7.25 (1H, m), 7.38-7.46 (2H, m) , 7.60-7.64 (3H, m) ,<br>
7.93 (1H, s), 8.01 (1H, d, J = 8.8 Hz), 8.54 (1H, d, J<br>
= 2.5 Hz), 8.60 (1H, d, J = 5.1 Hz), 12.62 (1H, s) .<br><br>
393<br>
[0756]<br>
tert-Butyl 4-phenoxy-2-(2-(lH-pyrrol-1-yl)pyridine-3-<br>
carboxamido)benzoate<br>
1H-NMR (CDC13) 5: 1.49 (9H, s) , 6.22 (2H, t, J = 2.3 Hz),<br>
6.63 (1H, dd, J = 8.9, 2.5 Hz), 7.06-7.14 (2H, m),<br>
7.16-7.24 (3H, m), 7.30 (1H, dd, J = 7.7, 4.9 Hz),<br>
7.37-7.44 (2H, m), 7.88 (1H, d, J = 8.9 Hz), 8.05 (1H,<br>
dd, J = 7.7, 1.8 Hz), 8.51 (1H, d, J = 2.5 Hz), 8.59<br>
(1H, dd, J = 4.9, 1.8 Hz), 11.62 (1H, s).<br>
[0757]<br>
tert-Butyl 4-phenoxy-2-(3-(lH-pyrazol-1-<br>
yl)benzamido)benzoate<br>
1H-NMR (CDCI3) 8: 1.63 (9H, s) , 6.51 (1H, t, J = 2.1 Hz),<br>
6.69 (1H, dd, J = 8.9, 2.4 Hz), 7.09-7.14 (2H, m), 7.21<br>
(1H, t, J = 7.3 Hz), 7.38-7.44 (2H, m), 7.61 (1H, t, J<br>
= 7.9 Hz), 7.75 (1H, d, J = 1.5 Hz), 7.88-7.92 (1H, m) ,<br>
8.00 (1H, d, J = 8.9 Hz), 8.02-8.07 (2H, m) , 8.28-8.31<br>
(1H, m), 8.58 (1H, d, J = 2.4 Hz), 12.45 (1H, s).<br>
[0758]<br>
tert-Butyl 2-(biphenyl-4-carboxamido)-4-phenoxybenzoate<br>
1H-NMR (CDCI3) 8: 1.63 (9H, s) , 6.67 (1H, dd, J = 8.9,<br>
2.5 Hz), 7.08-7.14 (2H, m) , 7.16-7.23 (1H, m), 7.36-<br>
7.52 (5H, m), 7.63-7.68 (2H, m), 7.72-7.78 (2H, m) ,<br>
7.99 (1H, d, J = 8.9 Hz), 8.07-8.13 (2H, m), 8.62 (1H,<br>
d, J = 2.5 Hz), 12.37 (1H, s) .<br>
[0759]<br>
tert-Butyl 2-(3-acetylbenzamido)-4-phenoxybenzoate<br>
1H-NMR (CDCI3) 8: 1.63 (9H, s), 2.70 (3H, s) , 6.69 (1H,<br>
dd, J = 9.0, 2.7 Hz), 7.10-7.15 (2H, m) , 7.18-7.23 (1H,<br><br>
394<br>
m), 7.38-7.45 (2H, m), 7.63 (1H, t, J = 7.8 Hz), 8.00<br>
(1H, d, J = 9.0 Hz), 8.14-8.19 (1H, m) , 8.20-8.24 (1H,<br>
m), 8.57 (1H, d, J = 2.7 Hz), 8.62-8.64 (1H, m), 12.52<br>
(1H, s).<br>
[0760]<br>
tert-Butyl 2-(3-(3,5-dimethyl-lH-pyrazol-l-<br>
yl)benzamido)-4-phenoxybenzoate<br>
1H-NMR (CDC13) 8: 1.61 (9H, s) , 2.31 (3H, s) , 2.44 (3H,<br>
s), 6.03 (1H, s), 6.67 (1H, dd, J = 8.9, 2.5 Hz), 7.08-<br>
7.13 (2H, m), 7.16-7.22 (1H, m), 7.37-7.43 (2H, m) ,<br>
7.60 (1H, t, J = 7.9 Hz), 7.72-7.76 (1H, m), 7.96-8.01<br>
(2H, m), 8.06 (1H, t, J = 1.8 Hz), 8.59 (1H, d, J = 2.5<br>
Hz), 12.43 (1H, s).<br>
[0761]<br>
Example 485<br><br>
0.015 mL of N,N-dimethylformamide was added to<br>
a mixed solution of 2.0 mL of methylene chloride and<br>
0.024 mL of oxalyl chloride containing 47 mg of 6-(lH-<br>
pyrrol-l-yl)pyridine-3-carboxylic acid and stirred at<br>
room temperature for 30 minutes. 74 mg of tert-butyl 2-<br>
amino-4-phenethylbenzoate and 0.090 mL of triethylamine<br>
were added to the reaction mixture at room temperature<br>
sequentially and stirred at the same temperature for 1<br><br>
395<br>
hour and 40 minutes.  1.0 mol/L hydrochloric acid and<br>
ethyl acetate were added to the reaction mixture.  The<br>
organic layer was separated and dried over anhydrous<br>
magnesium sulfate after washed with a saturated sodium<br>
chloride aqueous solution, and the solvent was<br>
evaporated under reduced pressure. The obtained residue<br>
was purified with silica gel column chromatography<br>
[PSQ100B (spherical) manufactured by Fuji Silysia<br>
Chemical Ltd., eluent; chloroform] to obtain 62 mg of<br>
tert-butyl 4-phenethyl-2-(6-(lH-pyrrol-1-yl)pyridine-3-<br>
carboxamido)benzoate as white solid.<br>
1H-NMR (CDC13) 8: 1.63 (9H, s) , 2.90-3.08 (4H, m), 6.41<br>
(2H, t, J = 2.3 Hz), 6.90 (1H, dd, J = 8.1, 1.7 Hz),<br>
7.17-7.32 (5H, m), 7.46 (1H, d, J = 8.7 Hz), 7.60 (2H,<br>
d, J = 2.3 Hz), 7.93 (1H, d, J = 8.1 Hz), 8.41 (1H, dd,<br>
J = 8.7, 2.3 Hz), 8.83 (1H, d, J = 1.7 Hz), 9.13 (1H, d,<br>
J = 2.3 Hz), 12.40 (1H, s).<br>
[0762]<br>
Examples 486 to 488<br>
The compounds shown in Table 48 were obtained<br>
in the same manner as in Example 4 85.<br>
[0763]<br>
[Table 48]<br><br><br>
[0764]<br>
tert-Butyl 4-phenethyl-2-(2-(lH-pyrrol-1-yl)pyridine-4-<br>
carboxamido)benzoate<br>
1H-NMR (CDCI3) 8: 1.64 (9H, s) , 2.94-3.05 (4H, m) , 6.40<br>
(2H, t, J = 2.3 Hz), 6.94 (1H, dd, J = 8.2, 1.7 Hz),<br>
7.18-7.33 (5H, m), 7.63 (2H, t, J = 2.3 Hz), 7.66 (1H,<br>
dd, J = 5.1, 1.5 Hz), 7.94 (1H, d, J = 8.2 Hz), 7.97-<br>
7.99 (1H, m), 8.63 (1H, d, J = 5.1 Hz), 8.81 (1H, d, J<br>
= 1.7 Hz), 12.55 (1H, s).<br>
[0765]<br>
tert-Butyl 2-(biphenyl-3-carboxamido)-4-<br>
phenethylbenzoate<br>
1H-NMR (CDCI3) 6: 1.64 (9H, s) , 2.94-3.06 (4H, m) , 6.89<br>
(1H, dd, J = 8.2, 1.6 Hz), 7.16-7.34 (5H, m) , 7.35-7.43<br>
(1H, m) , 7.45-7.52 (2H, m), 7.61 (1H, t, J = 7.7 Hz),<br>
7.70-7.75 (2H, m), 7.78-7.84 (1H, m), 7.93 (1H, d, J =<br>
8.2 Hz), 8.80-8.05 (1H, m), 8.36 (1H, t, J = 1.7 Hz),<br>
8.88 (1H, d, J = 1.6 Hz), 12.38 (1H, s).<br>
[0766]<br>
tert-Butyl 2-(biphenyl-4-carboxamido)-4-<br>
phenethylbenzoate<br><br>
397<br>
1H-NMR (CDCI3) 5: 1.64 (9H, s), 2.92-3.06 (4H, m) , 6.89<br>
(1H, dd, J = 8.1, 1.6 Hz), 7.16-7.34 (5H, m), 7.37-7.44<br>
(1H, m), 7.45-7.53 (2H, m), 7.64-7.70 (2H, m), 7.74-<br>
7.80 (2H, m), 7.93 (1H, d, J = 8.1 Hz), 8.12-8.17 (2H,<br>
m), 8.89 (1H, d, J = 1.6 Hz), 12.30 (1H, s).<br>
[0767]<br>
Example 48 9<br><br>
0.015 mL of N,N-dimethylformamide was added to<br>
a mixed solution of 2.0 mL of methylene chloride and<br>
0.024 mL of oxalyl chloride containing 47 mg of 4-(lH-<br>
pyrrol-1-yl)benzoic acid and stirred at room<br>
temperature for 30 minutes.  67 mg of tert-butyl 2-<br>
amino-4-phenylbenzoate and 0.090 mL of triethylamine<br>
were added to the reaction mixture at room temperature<br>
sequentially and stirred at the same temperature for 30<br>
minutes. Ethyl acetate and 1.0 mol/L hydrochloric acid<br>
were added to the reaction mixture. The organic layer<br>
was separated and dried over anhydrous magnesium<br>
sulfate after washed with a saturated sodium chloride<br>
aqueous solution, and the solvent was evaporated under<br>
reduced pressure. The obtained residue was purified<br>
with silica gel column chromatography [PSQ100B<br>
(spherical) manufactured by Fuji Silysia Chemical Ltd.,<br><br>
398<br>
eluent; chloroform] to obtain 64 mg of tert-butyl 4-<br>
phenyl-2-(4-(lH-pyrrol-1-yl)benzamido)benzoate as white<br>
solid.<br>
1H-NMR (CDC13) 8: 1.66 (9H, s) , 6.40 (2H, t, J = 2.2 Hz),<br>
7.20 (2H, t, J = 2.2 Hz), 7.35 (1H, dd, J = 8.3, 1.8<br>
Hz), 7.37-7.43 (1H, m), 7.44-7.50 (2H, m), 7.54-7.59<br>
(2H, m), 7.71-7.76 (2H, m), 8.10 (1H, d, J = 8.3 Hz),<br>
8.14-8.18 (2H, m), 9.26 (1H, d, J = 1.8 Hz), 12.33 (1H,<br>
s) .<br>
[0768]<br>
Example 4 90<br><br>
The following compound was obtained in the<br>
same manner as in Example 489.<br>
tert-Butyl 2-(biphenyl-2-carboxamido)-4-phenylbenzoate<br>
1H-NMR (CDCI3) 8: 1.52 (9H, s) , 7.20-7.40 (5H, m) , 7.40-<br>
7.58 (7H, m), 7.64-7.70 (2H, m), 7.74-7.78 (1H, m) ,<br>
7.93 (1H, d, J = 8.3 Hz), 9.10 (1H, s), 11.26 (1H, s).<br>
[0769]<br>
Example 4 91<br><br><br>
399<br>
0.015 mL of N,N-dimethylformamide was added to<br>
a mixed solution of 2.0 mL of methylene chloride and<br>
0.024 mL of oxalyl chloride containing 47 mg of 3-(lH-<br>
pyrrol-1-yl)benzoic acid and stirred at room<br>
temperature for 30 minutes. 71 mg of tert-butyl 2-<br>
amino-4-phenoxybenzoate and 0.090 mL of triethylamine<br>
were added to the reaction mixture at room temperature<br>
sequentially and stirred at the same temperature for 30<br>
minutes. Ethyl acetate and 1.0 mol/L hydrochloric acid<br>
were added to the reaction mixture. The organic layer<br>
was separated and dried over anhydrous magnesium<br>
sulfate after washed with a saturated sodium chloride<br>
aqueous solution, and the solvent was evaporated under<br>
reduced pressure. The obtained residue was purified<br>
with silica gel column chromatography [PSQ100B<br>
(spherical) manufactured by Fuji Silysia Chemical Ltd.,<br>
eluent; hexane: ethyl acetate =40:1] to obtain 31 mg<br>
of tert-butyl 4-phenoxy-2-(3-(lH-pyrrol-1-<br>
yl)benzamido)benzoate as white solid.<br>
1H-NMR (CDC13) 8: 1.63 (9H, s) , 6.38 (2H, t, J = 2.2 Hz),<br>
6.68 (1H, dd, J = 8.9, 2.5 Hz), 7.09-7.14 (2H, m) ,<br>
7.17-7.24 (3H, m), 7.37-7.44 (2H, m), 7.55-7.60 (2H, m) ,<br>
7.84-7.88 (1H, m), 8.00 (1H, d, J = 8.9 Hz), 8.09-8.11<br>
(1H, m), 8.58 (1H, d, J = 2.5 Hz), 12.46 (1H, s).<br>
[0770]<br>
Example 492<br><br><br>
The following compound was obtained in the<br>
same manner as in Example 4 91.<br>
tert-Butyl 2-(biphenyl-2-carboxamido)-4-phenoxybenzoate<br>
1H-NMR (CDCI3) 8: 1.48 (9H, s) , 6.54 (1H, dd, J= 9.0,<br>
2.6 Hz), 7.02-7.08 (2H, m), 7.16 (1H, t, J = 7.4 Hz),<br>
7.21-7.40 (5H, m) , 7.41-7.56 (5H, m) , 7.69-7.73 (1H, m) ,<br>
7.81 (1H, d, J = 9.0 Hz), 8.47-8.52 (1H, broad), 11.23-<br>
11.27 (1H, broad).<br>
[0771]<br>
Example 493<br><br>
4.0 mL of methylene chloride, 0.015 mL of N,N-<br>
dimethylformamide and 0.050 mL of oxalyl chloride were<br>
added to 99 mg of 3-biphenylcarboxylic acid at room<br>
temperature sequentially and stirred at the same<br>
temperature for 20 minutes. 0.16 mL of triethylamine<br>
and 0.12 g of tert-butyl 2-amino-4-phenylbenzoate were<br>
added to the reaction mixture at room temperature<br>
sequentially and stirred at the same temperature for 10<br><br>
401<br>
minutes. Ethyl acetate and 1.0 mol/L hydrochloric acid<br>
were added to the reaction mixture.  The organic layer<br>
was separated and dried over anhydrous magnesium<br>
sulfate after washed with a saturated sodium chloride<br>
aqueous solution, and the solvent was evaporated under<br>
reduced pressure. The obtained residue was purified<br>
with silica gel column chromatography [PSQ100B<br>
(spherical) manufactured by Fuji Silysia Chemical Ltd.,<br>
eluent; chloroform] to obtain 0.14 g of tert-butyl 2-<br>
(biphenyl-3-carboxamido)-4-phenylbenzoate as white<br>
solid.<br>
1H-NMR (CDC13) 5: 1.67 (9H, s) , 7.34-7.43 (3H, m) , 7.45-<br>
7.51 (4H, m), 7.62 (1H, t, J = 7.7 Hz), 7.70-7.76 (4H,<br>
m) , 7.82 (1H, ddd, J = 7.7, 1.8, 1.0 Hz), 8.04 (1H, ddd,<br>
J = 7.8, 1.8, 1.0 Hz), 8.10 (1H, d, J = 8.3 Hz), 8.37-<br>
8.40 (1H, m), 9.28 (1H, d, J = 1.7 Hz), 12.42 (1H, s).<br>
[0772]<br>
Example 494<br><br>
4.0 mL of methylene chloride, 0.015 mL of N,N-<br>
dimethylformamide and 0.050 mL of oxalyl chloride were<br>
added to 99 mg of 3-biphenylcarboxylic acid at room<br>
temperature sequentially and stirred at the same<br>
temperature for 20 minutes. 0.16 mL of triethylamine<br>
and 0.13 g of tert-butyl 2-amino-4-phenoxybenzoate were<br><br>
402<br>
added to the reaction mixture at room temperature<br>
sequentially and stirred at the same temperature for 10<br>
minutes. Ethyl acetate and 1.0 mol/L hydrochloric acid<br>
were added to the reaction mixture. The organic layer<br>
was separated and dried over anhydrous magnesium<br>
sulfate after washed with a saturated sodium chloride<br>
aqueous solution, and the solvent was evaporated under<br>
reduced pressure. The obtained residue was purified<br>
with silica gel column chromatography [PSQ100B<br>
(spherical) manufactured by Fuji Silysia Chemical Ltd.,<br>
eluent; chloroform] to obtain 14 mg of tert-butyl 2-<br>
(biphenyl-3-carboxamido)-4-phenoxybenzoate as white<br>
solid.<br>
1H-NMR (CDC13) 8: 1.63 (9H, s) , 6.68 (1H, dd, J= 8.9,<br>
2.5 Hz), 7.08-7.15 (2H, m), 7.16-7.22 (1H, m), 7.35-<br>
7.52 (5H, m), 7.58 (1H, t, J = 7.7 Hz), 7.68-7.74 (2H,<br>
m), 7.77-7.82 (1H, m) , 7.95-8.04 (2H, m) , 8.30-8.32 (1H,<br>
m), 8.61 (1H, d, J = 2.5 Hz), 12.46 (1H, s).<br>
[0773]<br>
Example 495<br><br>
0.25 mL of acetic acid and 4.1 \iL of 2,5-<br>
dimethoxytetrahydrofuran were added sequentially to 10<br>
mg of 2-(4-aminobenzamido)-4-phenoxybenzoic acid at<br>
room temperature and stirred at 90C for 5 minutes.<br><br>
403<br>
After the reaction mixture was cooled to room<br>
temperature, ethyl acetate and a saturated sodium<br>
hydrogen carbonate aqueous solution were added. The<br>
organic layer was separated and dried over anhydrous<br>
magnesium sulfate after washed with a saturated sodium<br>
chloride aqueous solution, and the solvent was<br>
evaporated under reduced pressure. The obtained residue<br>
was purified with silica gel column chromatography<br>
[PSQ100B (spherical) manufactured by Fuji Silysia<br>
Chemical Ltd., eluent; ethyl acetate] to obtain 3.8 mg<br>
of 4-phenoxy-2-(4-(lH-pyrrol-1-yl)benzamido)benzoic<br>
acid a brown solid.<br>
1H-NMR (DMSO-de) 5: 6.33 (2H, t, J - 2.2 Hz), 6.78 (1H,<br>
dd, J = 8.8, 2.6 Hz), 7.16-7.21 (2H, m), 7.28 (1H, t, J<br>
= 7.4 Hz), 7.46-7.53 (2H, m), 7.53 (2H, t, J = 2.2 Hz),<br>
7.80-7.85 (2H, m) , 7.96-8.01 (2H, m), 8.08 (1H, d, J =<br>
8.8 Hz), 8.41 (1H, d, J = 2.6 Hz), 12.49 (1H, s).<br>
[0774]<br>
Example 496<br><br>
1.0 mL of methylene chloride, 0.010 mL of N,N-<br>
dimethylformamide and 0.064 mL of oxalyl chloride were<br>
added to 0.13 g of 3,4-dimethoxycinnamic acid at room<br>
temperature sequentially and stirred at the same<br>
temperature for 1 hour. The reaction mixture was added<br><br>
404<br>
to a mixed solution of 1.5 mL of methylene chloride and<br>
0.14 mL of triethylamine containing 0.15 g of tert-<br>
butyl 2-amino-4-phenethylbenzoate while ice-cooled and<br>
stirred at room temperature overnight. The solvent was<br>
evaporated under reduced pressure and ethyl acetate and<br>
10% citric acid aqueous solution were added. The<br>
organic layer was separated and dried over anhydrous<br>
magnesium sulfate after washed with 10% citric acid<br>
aqueous solution, a saturated sodium hydrogen carbonate<br>
aqueous solution and a saturated sodium chloride<br>
aqueous solution sequentially, and the solvent was<br>
evaporated under reduced pressure. The obtained residue<br>
was purified with silica gel column chromatography<br>
[PSQ100B (spherical) manufactured by Fuji Silysia<br>
Chemical Ltd., eluent; hexane: ethyl acetate =4:1] to<br>
obtain 0.12 g of tert-butyl 2-( (E)-3-(3,4-<br>
dimethoxyphenyl)acrylamido)-4-phenethylbenzoate as<br>
white solid.<br>
1H-NMR (CDC13) 8: 1.63 (9H, s), 2.94-3.01 (4H, m), 3.93<br>
(3H, s), 3.97 (3H, s), 6.51 (1H, d, J = 15.5 Hz), 6.86<br>
(1H, dd, J = 8.3, 1.3 Hz), 6.89 (1H, d, J = 8.3 Hz),<br>
7.13 (1H, d, J = 1.7 Hz), 7.16-7.32 (6H, m), 7.71 (1H,<br>
d, J = 15.5 Hz), 7.89 (1H, d, J = 8.3 Hz), 8.82 (1H, d,<br>
J = 1.3 Hz), 11.45 (1H, s).<br>
[0775]<br>
Example 4 97<br><br><br>
1.5 mL of methylene chloride, 0.010 mL of N,N-<br>
dimethylformamide and 0.062 mL of oxalyl chloride were<br>
added sequentially to 0.13 g of 6-(piperidin-1-<br>
yl)pyridine-3-carboxylic acid at room temperature and<br>
stirred at the same temperature for 1 hour and 30<br>
minutes. The solvent was evaporated under reduced<br>
pressure, 1.5 mL of methylene chloride was added and,<br>
while ice-cooled, the mixture was added to a mixed<br>
solution of 1.5 mL of methylene chloride and 0.14 mL of<br>
triethylamine containing 0.15 g of tert-butyl 2-amino-<br>
4-phenethylbenzoate and stirred at room temperature<br>
overnight. The solvent was evaporated under reduced<br>
pressure and ethyl acetate and 10% citric acid aqueous<br>
solution were added. The organic layer was separated<br>
and dried over anhydrous magnesium sulfate after washed<br>
with a saturated sodium hydrogen carbonate aqueous<br>
solution and a saturated sodium chloride aqueous<br>
solution sequentially, and the solvent was evaporated<br>
under reduced pressure. Hexane and diisopropyl ether<br>
were added to the obtained residue and a solid<br>
substance was separated by filtration to obtain 0.17 g<br>
of tert-butyl 4-phenethyl-2-(6-(piperidin-1-<br>
yl)pyridine-3-carboxamido)benzoate as white solid.<br><br>
406<br>
1H-NMR (CDCI3) 5: 1.52-1.77 (6H, m), 1.61 (9H, s) , 2.97<br>
(4H, s), 3.66-3.73 (4H, m), 6.70 (1H, d, J = 9.2 Hz),<br>
6.84 (1H, dd, J = 8.2, 1.7 Hz), 7.17-7.31 (5H, m), 7.90<br>
(1H, d, J = 8.2 Hz), 8.10 (1H, dd, J = 9.2, 2.7 Hz),<br>
8.86 (1H, d, J = 1.7 Hz), 8.89 (1H, d, J = 2.7 Hz),<br>
12.11 (1H, s) .<br>
[0776]<br>
Example 498<br><br>
0.5 mL of trifluoroacetic acid was added to<br>
0.5 mL of methylene chloride solution containing 10 mg<br>
of tert-butyl 2-(3-cyanobenzamido)-4-phenoxybenzoate<br>
and stirred at room temperature for 2 hours. The<br>
solvent was evaporated under reduced pressure and<br>
diisopropyl ether was added to the obtained residue and<br>
a solid substance was separated by filtration to obtain<br>
5.0 mg of 2-(3-cyanobenzamido)-4-phenoxybenzoic acid as<br>
white solid.<br>
1H-NMR (DMSO-d6) 8: 6.81 (1H, dd, J = 8.9, 2.6 Hz),<br>
7.16-7.20 (2H, m), 7.29 (1H, t, J = 7.2 Hz), 7.47-7.52<br>
(2H, m), 7.81 (1H, t, J = 7.8 Hz), 8.08 (1H, d, J = 8.9<br>
Hz), 8.12 (1H, d, J = 7.8 Hz), 8.20 (1H, d, J = 8.0 Hz),<br>
8.29 (1H, s), 8.31 (1H, d, J = 2.6 Hz), 12.48 (1H, s).<br>
[0777]<br>
Examples 499 to 507<br><br>
407<br>
The compounds shown in Table 49 were obtained<br>
in the same manner as in Example 498.<br>
[0778]<br>
[Table 49]<br><br>
[0779]<br>
4-Phenoxy-2-(6-(lH-pyrrol-1-yl)pyridine-3-<br>
carboxamido)benzoic acid<br>
1H-NMR (DMSO-de) 5: 6.37 (2H, t, J = 2.3 Hz), 6.81 (1H,<br>
dd, J = 8.9, 2.6 Hz), 7.16-7.22 (2H, m), 7.26-7.32 (1H,<br>
m), 7.46-7.54 (2H, m), 7.78 (2H, t, J = 2.3 Hz), 7.92<br>
(1H, d, J = 8.8 Hz), 8.09 (1H, d, J = 9.0 Hz), 8.30-<br>
8.36 (2H, m), 8.92 (1H, d, J = 2.4 Hz), 12.40 (1H, s).<br>
[0780]<br>
4-Phenoxy-2-(2-(lH-pyrrol-1-yl)pyridine-4-<br>
carboxamido)benzoic acid<br>
Hl-NMR (DMSO-de) 6: 6.35 (2H, t, J = 2.3 Hz), 6.85 (1H,<br>
dd, J= 8.9, 2.7 Hz), 7.16-7.24 (2H, m), 7.26-7.34 (1H,<br>
m), 7.46-7.54 (2H, m), 7.61 (1H, dd, J = 5.1, 1.2 Hz),<br>
7.74 (2H, t, J = 2.3 Hz), 8.05 (1H, s), 8.10 (1H, d, J<br><br>
408<br>
= 8.9 Hz), 8.32 (1H, d, J = 2.7 Hz), 8.66 (1H, d, J =<br>
5.1 Hz), 12.50 (1H, s).<br>
[0781]<br>
4-Phenoxy-2-(2-(lH-pyrrol-1-yl)pyridine-3-<br>
carboxamido)benzoic acid<br>
1H-NMR (DMSO-d6) 5: 6.21 (2H, t, J = 2.2 Hz), 6.75 (1H,<br>
dd, J = 8.9, 2.7 Hz), 7.16-7.22 (4H, m), 7.25-7.30 (1H,<br>
m) , 7.46-7.54 (3H, m), 7.98 (1H, d, J = 8.9 Hz), 8.15-<br>
8.22 (2H, m), 8.64 (1H, dd, J = 4.9, 1.7 Hz), 11.67 (1H,<br>
s) .<br>
[0782]<br>
4-Phenoxy-2-(3-(lH-pyrazol-1-yl)benzamido)benzoic acid<br>
1H-NMR (DMSO-de) 8: 6.60 (1H, dd, J = 2.6, 1.8 Hz), 6.80<br>
(1H, dd, J = 8.9, 2.6 Hz), 7.16-7.23 (2H, m), 1.21-1.32<br>
(1H, m) , 7.46-7.55 (2H, m), 7.71 (1H, t, J = 7.9 Hz),<br>
7.80-7.86 (2H, m) , 8.07-8.13 (2H, m) , 8.41-8.42 (2H, m) ,<br>
8.61 (1H, d, J = 2.4 Hz), 12.53 (1H, s).<br>
[0783]<br>
2-(Biphenyl-3-carboxamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.79 (1H, dd, J = 8.8, 2.1 Hz),<br>
7.17-7.22 (2H, m) , 7.26-7.33 (1H, m), 7.43 (1H, tt, J =<br>
7.4, 1.5 Hz), 7.46-7.55 (4H, m), 7.68 (1H, t, J = 7.8<br>
Hz), 7.72-7.77 (2H, m) , 7.90-7.97 (2H, m), 8.08 (1H, d,<br>
J = 8.8 Hz), 8.19 (1H, t, J = 1.7 Hz), 8.43 (1H, d, J =<br>
2.7 Hz), 12.54 (1H, s).<br>
[0784]<br>
2-(Biphenyl-4-carboxamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-de) 8: 6.78 (1H, dd, J = 8.9, 2.5 Hz),<br>
7.16-7.22 (2H, m) , 7.26-7.32 (1H, m) , 7.41-7.55 (5H, m) ,<br><br>
409<br>
7.75-7.80 (2H, m) , 7.87-7.93 (2H, m) , 7.98-8.04 (2H, m) ,<br>
8.09 (1H, d, J = 8.9 Hz), 8.43 (1H, d, J = 2.5 Hz),<br>
12.48 (1H, s).<br>
[0785]<br>
2-(3-Acetylbenzamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-d6) 8: 2.66 (3H, s), 6.80 (1H, dd, J= 8.9,<br>
2.6 Hz), 7.16-7.22 (2H, m), 7.26-7.32 (1H, m), 7.46-<br>
7.54 (2H, m), 7.75 (1H, t, J = 7.8 Hz), 8.09 (1H, d, J<br>
= 8.9 Hz), 8.15-8.19 (1H, m), 8.20-8.24 (1H, m), 8.40<br>
(1H, d, J = 2.6 Hz), 8.48-8.51 (1H, m) , 12.58 (1H, s) ,<br>
13.60-14.00 (1H, broad).<br>
[0786]<br>
2-(3-(3,5-Dimethyl-lH-pyrazol-l-yl)benzamido)-4-<br>
phenoxybenzoic acid<br>
1H-NMR (DMSO-d6) 8: 2.20 (3H, s) , 2.37 (3H, s) , 6.13 (1H,<br>
s), 6.79 (1H, dd, J = 8.9, 2.5 Hz), 7.17-7.21 (2H, m) ,<br>
7.26-7.32 (1H, m) , 7.46-7.53 (2H, m), 7.70 (1H, t, J =<br>
7.8 Hz), 7.76-7.81 (1H, m) , 7.88-7.93 (1H, m), 7.99 (1H,<br>
t, J = 2.0 Hz), 8.08 (1H, d, J = 8.9 Hz), 8.40 (1H, d,<br>
J = 2.5 Hz), 12.46 (1H, s), 13.50-14.00 (1H, broad).<br>
[0787]<br>
2-(Biphenyl-2-carboxamido)-4-phenoxybenzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.66 (1H, dd, J = 8.8, 2.4 Hz) ,<br>
7.11-7.16 (2H, m), 7.22-7.43 (6H, m) , 7.44-7.55 (4H, m) ,<br>
7.62 (1H, td, J = 7.6, 1.5 Hz), 7.67 (1H, dd, J = 7.6,<br>
1.2 Hz), 7.91 (1H, d, J = 8.8 Hz), 8.22 (1H, s), 11.44<br>
(1H, s), 13.30-13.60 (1H, broad).<br>
[0788]<br>
Example 508<br><br><br>
0.5 mL of trifluoroacetic acid was added to<br>
0.5 mL of methylene chloride solution containing 10 mg<br>
of tert-butyl 2-(3-cyanobenzamido)-4-phenylbenzoate and<br>
stirred at room temperature for 1 hour and 30 minutes.<br>
The solvent was evaporated under reduced pressure and<br>
diisopropyl ether was added to the obtained residue and<br>
a solid substance was separated by filtration to obtain<br>
7.6 mg of 2-(3-cyanobenzamido)-4-phenylbenzoic acid as<br>
white solid.<br>
1H-NMR (DMSO-de) 5: 7.44-7.50 (1H, m) , 7.52-7.60 (3H, m) ,<br>
7.72-7.77 (2H, m), 7.84 (1H, t, J = 7.9 Hz), 8.12-8.18<br>
(2H, m) , 8.25-8.30 (1H, m) , 8.35-8.38 (1H, m) , 8.95 (1H,<br>
d, J = 1.7 Hz) , 12.24 (1H, s) .<br>
[0789]<br>
Examples 509 to 516<br>
The compounds shown in Table 50 were obtained<br>
in the same manner as in Example 508.<br>
[0790]<br>
[Table 50]<br><br><br>
[0791]<br>
4-Phenyl-2-(6-(lH-pyrrol-l-yl)pyridine-3-<br>
carboxamido)benzoic acid<br>
1H-NMR (DMSO-de) 5: 6.38 (2H, t, J = 2.1 Hz), 7.44-7.50<br>
(1H, m), 7.52-7.58 (3H, m), 7.71-7.76 (2H, m) , 7.80 (2H,<br>
t, J = 2.1 Hz), 7.96 (1H, d, J = 8.6 Hz), 8.15 (1H, d,<br>
J = 8.3 Hz), 8.40 (1H, dd, J = 8.6, 2.4 Hz), 8.98-9.02<br>
(2H, m), 12.25 (1H, s).<br>
[0792]<br>
4-Phenyl-2-(2-(lH-pyrrol-1-yl)pyridine-4-<br>
carboxamido)benzoic acid<br>
1H-NMR (DMSO-de) 8: 6.37 (2H, t, J = 2.3 Hz), 7.48 (1H,<br>
tt, J = 7.3, 1.6 Hz), 7.53-7.62 (3H, m), 7.69 (1H, dd,<br>
J = 5.1, 1.4 Hz), 7.74-7.78 (4H, m), 8.13 (1H, s), 8.16<br>
(1H, d, J = 8.3 Hz), 8.69 (1H, dd, J = 5.1, 0.8 Hz),<br>
8.98 (1H, d, J = 1.7 Hz), 12.29 (1H, s).<br>
[0793]<br>
4-Phenyl-2-(3-(lH-pyrazol-l-yl)benzamido)benzoic acid<br><br>
412<br>
1H-NMR (DMSO-dg) 5: 6.62 (1H, dd, J = 2.4, 2.0 Hz),<br>
7.45-7.51 (1H, m) , 7.53-7.60 (3H, m) , 1.12-1 .I'd (3H, m) ,<br>
7.82-7.84 (1H, m) , 7.88-7.94 (1H, m) , 8.10-8.17 (2H, m) ,<br>
8.49 (1H, t, J = 1.8 Hz), 8.63 (1H, d, J = 2.4 Hz),<br>
9.09 (1H, d, J = 1.7 Hz), 12.38 (1H, s).<br>
[0794]<br>
2-(Biphenyl-3-carboxamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-de) 5: 7.42-7.60 (7H, m) , 7.69-7.80 (5H, m) ,<br>
7.94-8.02 (2H, m), 8.15 (1H, d, J = 8.3 Hz), 8.26 (1H,<br>
s), 9.11 (1H, d, J = 1.7 Hz), 12.40 (1H, s).<br>
[0795]<br>
2-(Biphenyl-4-carboxamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-de) 8: 7.42-7.60 (7H, m) , 7.74-7.82 (4H, m) ,<br>
7.90-7.95 (2H, m), 8.06-8.11 (2H, m), 8.16 (1H, d, J =<br>
8.3 Hz), 9.11 (1H, d, J = 1.7 Hz), 12.34 (1H, s) .<br>
[0796]<br>
2-(3-Acetylbenzamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-de) 8: 2.69 (3H, s), 7.45-7.50 (1H, m),<br>
7.52-7.59 (3H, m), 7.72-7.82 (3H, m), 8.15 (1H, d, J =<br>
8.3 Hz), 8.24 (2H, dd, J = 7.8, 1.7 Hz), 8.57 (1H, t, J<br>
= 1.7 Hz), 9.07 (1H, d, J = 2.0 Hz), 12.41 (1H, s) .<br>
[0797]<br>
2-(3-(3,5-Dimethyl-lH-pyrazol-l-yl)benzamido)-4-<br>
phenylbenzoic acid<br>
1H-NMR (DMSO-de) 8: 2.21 (3H, s), 2.39 (3H, d, J = 0.5<br>
Hz), 6.14 (1H, s), 7.47 (1H, tt, J = 7.3, 1.5 Hz),<br>
7.52-7.58 (3H, m) , 7.70-7.77 (3H, m) , 7.79-7.82 (1H, m) ,<br>
7.96-7.99 (1H, m), 8.06-8.07 (1H, m), 8.14 (1H, d, J =<br>
8.3 Hz), 9.05-9.07 (1H, m) , 12.30 (1H, s).<br><br>
413<br>
[0798]<br>
2-(Biphenyl-2-carboxamido)-4-phenylbenzoic acid<br>
1H-NMR (DMSO-de) 8: 7.29 (1H, tt, J = 7.2, 1.7 Hz),<br>
7.34-7.48 (6H, m) , 7.48-7.59 (4H, m) , 7.61-7.70 (3H, m) ,<br>
7.73 (1H, dd, J = 7.6, 1.2 Hz), 7.99 (1H, d, J = 8.3<br>
Hz), 8.85 (1H, s), 11.35 (1H, s), 13.40-13.80 (1H,<br>
broad).<br>
[0799]<br>
Example 517<br><br>
1.0 mL of trifluoroacetic acid was added to<br>
1.0 mL of methylene chloride solution containing 20 mg<br>
of tert-butyl 4-phenethyl-2-(6-(lH-pyrrol-1-<br>
yl)pyridine-3-carboxamido)benzoate and stirred at room<br>
temperature for 1 hour and 30 minutes. The solvent was<br>
evaporated under reduced pressure and diisopropyl ether<br>
was added to the obtained residue and a solid substance<br>
was separated by filtration to obtain 17 mg of 4-<br>
phenethyl-2-(6-(lH-pyrrol-1-yl)pyridine-3-<br>
carboxamido)benzoic acid as white solid.<br>
1H-NMR (DMSO-d6) 8: 2.90-3.02 (4H, m) , 6.38 (2H, t, J =<br>
2.3 Hz), 7.11 (1H, dd, J = 8.3, 1.6 Hz), 7.15-7.24 (1H,<br>
m) , 7.25-7.32 (4H, m), 7.79 (2H, t, J = 2.3 Hz), 7.94<br>
(1H, d, J = 8.7 Hz), 7.97 (1H, d, J = 8.3 Hz), 8.37 (1H,<br><br>
414<br>
dd, J = 8.7, 2.3 Hz), 8.58-8.61 (1H, m), 8.97 (1H, d, J<br>
= 2.3 Hz), 12.15 (1H, s), 13.60-13.80 (1H, broad).<br>
[0800]<br>
Examples 518 to 521<br>
The compounds shown in Table 51 were obtained<br>
in the same manner as in Example 517.<br>
[0801]<br>
[Table 51]<br><br>
[0802]<br>
4-Phenethyl-2-(2-(lH-pyrrol-l-yl)pyridine-4-<br>
carboxamido)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 2.90-3.04 (4H, m) , 6.37 (2H, t, J =<br>
2.3 Hz), 7.12-7.22 (2H, m) , 7.25-7.32 (4H, m), 7.66 (1H,<br>
dd, J = 5.1, 1.5 Hz), 7.74 (2H, t, J = 2.3 Hz), 7.97<br>
(1H, d, J = 8.3 Hz), 8.10 (1H, s), 8.56 (1H, d, J = 1.5<br>
Hz), 8.67 (1H, d, J = 5.1 Hz), 12.21 (1H, s).<br>
[0803]<br>
2-(Biphenyl-3-carboxamido)-4-phenethylbenzoic acid<br>
1H-NMR (DMSO-de) 8: 2.88-3.04 (4H, m) , 7.10 (1H, dd, J =<br>
8.3, 1.5 Hz), 7.15-7.24 (1H, m), 7.24-7.33 (4H, m) ,<br>
7.41-7.46 (1H, m), 7.51-7.55 (2H, m), 7.70 (1H, t, J =<br><br>
415<br>
7.7 Hz), 7.73-7.78 (2H, m), 7.92-8.00 (3H, m), 8.23 (1H,<br>
s), 8.70 (1H, s), 12.31 (1H, s), 13.50-14.00 (1H,<br>
broad).<br>
[0804]<br>
2-(Biphenyl-4-carboxamido)-4-phenethylbenzoic acid<br>
1H-NMR (DMSO-d6) 8: 2.90-3,01 (4H, m), 7.09 (1H, dd, J =<br>
8.1, 1.5 Hz), 7.15-7.25 (1H, m), 7.25-7.30 (4H, m),<br>
7.44 (1H, tt, J = 7.3, 1.4 Hz), 7.49-7.56 (2H, m) ,<br>
7.76-7.80 (2H, m) , 7.88-7.94 (2H, m), 7.97 (1H, d, J =<br>
8.1 Hz), 8.03-8.08 (2H, m), 8.70 (1H, d, J = 1.5 Hz),<br>
12.27 (1H, s).<br>
[0805]<br>
2-((E)-3-(3,4-Dimethoxyphenyl)acrylamido)-4-<br>
phenethylbenzoic acid<br>
1H-NMR (DMSO-d6) 8: 2.89-2.98 (4H, m) , 3.81 (3H, s) ,<br>
3.84 (3H, s), 6.79 (1H, d, J = 15.5 Hz), 7.00 (1H, d, J<br>
= 8.5 Hz), 7.04 (1H, dd, J = 8.3, 1.4 Hz), 7.15-7.20<br>
(1H, m), 7.23-7.30 (5H, m) , 7.38 (1H, d, J = 1.7 Hz),<br>
7.56 (1H, d, J = 15.5 Hz), 7.91 (1H, d, J = 8.3 Hz),<br>
8.58 (1H, d, J = 1.4 Hz), 11.30 (1H, s).<br>
[0806]<br>
1.0 mL of trifluoroacetic acid was added to<br>
1.0 mL of methylene chloride solution containing 20 mg<br>
Example 522<br><br><br>
416<br>
of tert-butyl 4-phenyl-2-(3-(lH-tetrazol-1-<br>
yl)benzamido)benzoate and stirred at room temperature<br>
for 1 hour. The solvent was evaporated under reduced<br>
pressure and ethyl acetate and tetrahydrofuran were<br>
added to the obtained residue and heated to 50C.<br>
Insoluble were removed by filtration at the same<br>
temperature, and the solvent was evaporated under<br>
reduced pressure. Tetrahydrofuran was added to the<br>
obtained residue and a solid substance was separated by<br>
filtration to obtain 5.0 mg of 4-phenyl-2-(3-(1H-<br>
tetrazol-1-yl)benzamido)benzoic acid as white solid.<br>
1H-NMR (DMSO-de) 5: 7.48 (1H, tt, J = 7.3, 1.5 Hz),<br>
7.53-7.60 (3H, m) , 1.12-1.1% (2H, m), 7.92 (1H, t, J =<br>
7.9 Hz), 8.15 (2H, d, J = 8.3 Hz), 8.20-8.24 (1H, m) ,<br>
8.54 (1H, t, J = 1.8 Hz), 9.04 (1H, d, J = 1.7 Hz),<br>
10.23 (1H, s), 12.44 (1H, s).<br>
[0807]<br>
Example 523<br><br>
1.0 mL of methanol and 0.5 mL of 2.0 mol/L<br>
aqueous sodium hydroxide were added to 1.0 mL of<br>
dioxane solution containing 20 mg of tert-butyl 4-<br>
phenyl-2-(4-(lH-pyrrol-1-yl)benzamido)benzoate at room<br>
temperature and stirred at 50C for 30 minutes. Ethyl<br><br>
417<br>
acetate and 1.0 mol/L hydrochloric acid were added<br>
after the reaction mixture was cooled to room<br>
temperature. The organic layer was separated and dried<br>
over anhydrous magnesium sulfate after washed with a<br>
saturated sodium chloride aqueous solution, and the<br>
solvent was evaporated under reduced pressure.<br>
Diisopropyl ether were added to the obtained residue<br>
and a solid substance was separated by filtration to<br>
obtain 15 mg of 4-phenyl-2-(4-(lH-pyrrol-1-<br>
yl)benzamido)benzoic acid as white solid.<br>
1H-NMR (DMSO-d6) 8: 6.34 (2H, t, J = 2.2 Hz), 7.47 (1H,<br>
tt, J = 7.3, 1.5 Hz), 7.50-7.59 (5H, m), 7.72-7.78 (2H,<br>
m) , 7.83-7.88 (2H, m) , 8.03-8.09 (2H, m), 8.15 (1H, d,<br>
J = 8.5 Hz), 9.09 (1H, d, J = 2.0 Hz), 12.33 (1H, s).<br>
[0808]<br>
Example 524<br><br>
1.0 mL of methanol and 0.5 mL of 2.0 mol/L<br>
aqueous sodium hydroxide were added to 1.0 mL of<br>
dioxane solution containing 20 mg of tert-butyl 4-<br>
phenoxy-2-(3-(lH-pyrrol-l-yl)benzamido)benzoate at room<br>
temperature and stirred at 50C for 30 minutes. After<br>
the reaction mixture was cooled to room temperature,<br>
ethyl acetate and 1.0 mol/L hydrochloric acid were<br>
added. The organic layer was separated and dried over<br><br>
418<br>
anhydrous magnesium sulfate after washed with a<br>
saturated sodium chloride aqueous solution, and the<br>
solvent was evaporated under reduced pressure.<br>
Diisopropyl ether were added to the obtained residue<br>
and a solid substance was separated by filtration to<br>
obtain 7.6 mg of 4-phenoxy-2-(3-(lH-pyrrol-1-<br>
yl)benzamido)benzoic acid as white solid.<br>
1H-NMR (DMSO-de) 5: 6.32 (2H, t, J = 2.2 Hz), 6.80 (1H,<br>
dd, J= 8.9, 2.7 Hz), 7.16-7.22 (2H, m), 7.26-7.32 (1H,<br>
m), 7.46 (2H, t, J = 2.2 Hz), 7.47-7.54 (2H, m), 7.66<br>
(1H, t, J = 7.9 Hz), 7.74-7.80 (1H, m), 7.84-7.88 (1H,<br>
m), 8.05 (1H, t, J = 1.8 Hz), 8.09 (1H, d, J = 8.9 Hz),<br>
8.39 (1H, d, J = 2.7 Hz), 12.52 (1H, s).<br>
[0809]<br>
Example 525<br><br>
1.7 mL of trifluoroacetic acid was added to<br>
0.17 g of tert-butyl 4-phenethyl-2-(6-(piperidin-1-<br>
yl)pyridine-3-carboxamido)benzoate and stirred at room<br>
temperature for 3 hours. The solvent was evaporated<br>
under reduced pressure, and hexane and diisopropyl<br>
ether were added to the obtained residue and a solid<br>
substance was separated by filtration. Ethyl acetate<br>
and water were added to the obtained solid substance<br><br>
419<br>
and pH was adjusted to pH 6.8 with a saturated sodium<br>
hydrogen carbonate aqueous solution. A solid substance<br>
was separated by filtration to obtain 65 mg of 4-<br>
phenethyl-2-(6-(piperidin-1-yl)pyridine-3-<br>
carboxamido)benzoic acid as white solid.<br>
1H-NMR (DMSO-d6) 5: 1.51-1.68 (6H, m) , 2.88-2.97 (4H, m) ,<br>
3.62-3.72 (4H, m), 6.94 (1H, d, J = 9.3 Hz), 7.01 (1H,<br>
d, J = 8.1 Hz), 7.16-7.20 (1H, m), 7.25-7.30 (4H, m) ,<br>
7.94 (1H, d, J = 8.0 Hz), 7.94-8.00 (1H, m), 8.65 (1H,<br>
s), 8.69 (1H, d, J = 2.4 Hz), 12.30-12.50 (1H, broad).<br>
[0810]<br>
Example 526<br><br>
29 mg of 3,5-difluorophenol, 79 mg of<br>
tripotassium phosphate, 4.7 mg of 2-(di-tert-<br>
butylphosphino)-2',4',6'-triisopropylbiphenyl and 6.8<br>
mg of tris(dibenzylideneacetone)dipalladium(O) were<br>
added to 1.4 mL of toluene solution containing 70 mg of<br>
tert-butyl 2-(benzamido)-4-bromobenzoate at room<br>
temperature, and the resulting mixture was heated to<br>
reflux under nitrogen atmosphere for 3 hours. After the<br>
reaction mixture was cooled to room temperature, ethyl<br>
acetate and 10% citric acid aqueous solution were added<br>
and insoluble were removed by filtration. The organic<br>
layer was separated and dried over anhydrous magnesium<br>
sulfate after washed with a saturated sodium chloride<br><br>
420<br>
aqueous solution, and the solvent was evaporated under<br>
reduced pressure. The obtained residue was purified<br>
with silica gel column chromatography [PSQ100B<br>
(spherical) manufactured by Fuji Silysia Chemical Ltd.,<br>
eluent; hexane: ethyl acetate =10:1] to obtain 71 mg<br>
of tert-butyl 2-(benzamido)-4-(3,5-<br>
difluorophenoxy)benzoate as colorless oil.<br>
1H-NMR (CDC13) 8: 1.64 (9H, s) , 6.56-6.63 (3H, m) , 6.73<br>
(1H, dd, J = 8.8, 2.4 Hz), 7.50-7.60 (3H, m), 8.01-8.07<br>
(3H, m), 8.70 (1H, d, J = 2.4 Hz), 12.34 (1H, s).<br>
[0811]<br>
Examples 527 to 533<br>
The compounds shown in Table 52 were obtained<br>
in the same manner as in Example 526.<br>
[0812]<br>
[Table 52]<br><br>
[0813]<br>
tert-Butyl 2-(benzamido)-4-(2,3-<br>
dimethylphenoxy)benzoate<br><br>
1H-NMR (CDCI3) 8: 1.61 (9H, s), 2.12 (3H, s), 2.33 (3H,<br>
s), 6.50 (1H, dd, J = 8.9, 2.5 Hz), 6.89 (1H, d, J =<br>
7.8 Hz), 7.04 (1H, d, J = 7.6 Hz), 7.10-7.15 (1H, m) ,<br>
7.48-7.58 (3H, m), 7.94 (1H, d, J = 8.9 Hz), 8.00-8.05<br>
(2H, m), 8.53 (1H, d, J = 2.5 Hz), 12.31 (1H, s).<br>
[0814]<br>
tert-Butyl 2-(benzamido)-4-(3-fluoro-4-<br>
methylphenoxy)benzoate<br>
1H-NMR (CDCI3) 8: 1.62 (9H, s) , 2.26 (3H, d, J = 1.7 Hz),<br>
6.67 (1H, dd, J = 8.9, 2.5 Hz), 6.75-6.83 (2H, m), 7.18<br>
(1H, t, J = 8.5 Hz), 7.48-7.59 (3H, m), 7.99 (1H, d, J<br>
= 8.9 Hz), 7.99-8.05 (2H, m), 8.61 (1H, d, J = 2.5 Hz),<br>
12.32 (1H, s) .<br>
[0815]<br>
tert-Butyl 2-(benzamido)-4-(3-<br>
(trifluoromethoxy)phenoxy)benzoate<br>
1H-NMR (CDCI3) 8: 1.63 (9H, s), 6.69 (1H, dd, J = 8.9,<br>
2.7 Hz), 6.94-6.98 (1H, m), 7.00-7.06 (2H, m), 7.39 (1H,<br>
t, J = 8.3 Hz), 7.49-7.60 (3H, m), 8.00-8.06 (3H, m),<br>
8.67 (1H, d, J = 2.7 Hz), 12.32 (1H, s).<br>
[0816]<br>
tert-Butyl 2-(benzamido)-4-(benzo[1,3]dioxol-5-<br>
yloxy)benzoate<br>
1H-NMR (CDCI3) 8: 1.61 (9H, s) , 6.00 (2H, s) , 6.58 (1H,<br>
dd, J = 8.3, 2.4 Hz), 6.61-6.66 (2H, m), 6.80 (1H, d, J<br>
= 8.3 Hz), 7.48-7.58 (3H, m), 7.97 (1H, d, J = 9.0 Hz),<br>
8.00-8.05 (2H, m), 8.56 (1H, d, J = 2.7 Hz), 12.31 (1H,<br>
s).<br><br>
422<br>
[0817]<br>
tert-Butyl 2-(benzamido)-4-(2,3-<br>
dihydrobenzo[1,4]dioxin-6-yloxy)benzoate<br>
1H-NMR (CDC13) 8: 1.61 (9H, s), 4.27 (4H, s), 6.58-6.67<br>
(3H, m), 6.87 (1H, d, J = 8.8 Hz), 7.48-7.58 (3H, m) ,<br>
7.96 (1H, d, J = 9.0 Hz), 8.00-8.05 (2H, m), 8.57 (1H,<br>
d, J = 2.4 Hz), 12.30 (1H, s).<br>
[0818]<br>
tert-Butyl 2-(benzamido)-4-(benzofuran-5-yloxy)benzoate<br>
1H-NMR (CDCI3) 8: 1.61 (9H, s) , 6.64 (1H, dd, J = 9.0,<br>
2.7 Hz), 6.75 (1H, dd, J = 2.2, 1.0 Hz), 7.07 (1H, dd,<br>
J = 8.8, 2.4 Hz), 7.33 (1H, d, J = 2.4 Hz), 7.47-7.57<br>
(4H, m), 7.66 (1H, d, J = 2.2 Hz), 7.97 (1H, d, J = 9.0<br>
Hz), 7.98-8.04 (2H, m), 8.58 (1H, d, J = 2.7 Hz), 12.31<br>
(1H, s).<br>
[0819]<br>
tert-Butyl 2-(benzamido)-4-(benzothiophen-5-<br>
yloxy)benzoate<br>
1H-NMR (CDCI3) 8: 1.62 (9H, s) , 6.67 (1H, dd, J = 8.9,<br>
2.5 Hz), 7.15 (1H, dd, J = 8.9, 2.1 Hz), 7.27-7.30 (1H,<br>
m), 7.48-7.58 (5H, m), 7.88 (1H, d, J = 8.5 Hz), 7.98<br>
(1H, d, J = 8.8 Hz), 7.99-8.04 (2H, m), 8.63 (1H, d, J<br>
= 2.5 Hz), 12.32 (1H, s).<br>
[0820]<br>
Example 534<br><br><br>
423<br>
6.0 mg of palladium acetate was added to 5 mL<br>
of toluene suspension containing 0.50 g tert-butyl 2-<br>
(benzamido)-4-bromobenzoate, 0.18 mL of 3-methoxyphenol,<br>
17 mg of 2-(di-tert-butylphosphino)-2',4',6'-<br>
triisopropylbiphenyl and 0.57 g of tripotassium<br>
phosphate at room temperature, and the resulting<br>
mixture was heated to reflux under nitrogen atmosphere<br>
for 5 hours. After the reaction mixture was cooled to<br>
room temperature, ethyl acetate and 10% citric acid<br>
aqueous solution were added and insoluble were removed<br>
by filtration. The organic layer was separated and<br>
dried over anhydrous magnesium sulfate after washed<br>
with 10% citric acid aqueous solution and a saturated<br>
sodium chloride aqueous solution sequentially, and the<br>
solvent was evaporated under reduced pressure. The<br>
obtained residue was purified with silica gel column<br>
chromatography [Flash Tube 2008 manufactured by<br>
Trikonex Company, eluent; hexane: ethyl acetate = 6:1]<br>
to obtain 0.32 g of tert-butyl 2-(benzamido)-4-(3-<br>
methoxyphenoxy)benzoate as white solid.<br>
1H-NMR (CDC13) 5: 1.62 (9H, s) , 3.80 (3H, s), 6.64-6.76<br>
(4H, m), 7.28 (1H, t, J = 8.0 Hz), 7.48-7.59 (3H, m) ,<br>
7.98 (1H, d, J = 8.8 Hz), 8.01-8.06 (2H, m), 8.63 (1H,<br>
d, J = 2.7 Hz) , 12.30 (1H, s) .<br>
[0821]<br>
Example 535<br><br><br>
The following compound was obtained in the<br>
same manner as in Example 534.<br>
tert-Butyl 2-(benzamido)-4-(4-methoxyphenoxy)benzoate<br>
1H-NMR (CDC13) 5: 1.61 (9H, s) , 3.82 (3H, s), 6.62 (1H,<br>
dd, J= 9.0, 2.7 Hz), 6.90-6.96 (2H, m) , 7.02-7.08 (2H,<br>
m) , 7.48-7.58 (3H, m), 7.96 (1H, d, J = 9.0 Hz), 7.99-<br>
8.06 (2H, m), 8.54 (1H, d, J = 2.7 Hz), 12.31 (1H, s).<br>
[0822]<br>
Example 536<br><br>
31 mg of 4-nitrophenol was added to 1.0 mL of<br>
toluene suspension containing of 8.9 mg of 60% sodium<br>
hydride at room temperature, and the resulting mixture<br>
was heated to reflux under nitrogen atmosphere for 15<br>
minutes. After the reaction mixture was cooled to room<br>
temperature, 0.5 mL of toluene solution containing 3.8<br>
mg of 2-(di-tert-butylphosphino)-2',41,61-<br>
triisopropylbiphenyl, 1.3 mg of palladium acetate and<br>
56 mg of tert-butyl 2-(benzamido)-4-bromobenzoate were<br>
added and the resulting mixture was heated to reflux<br>
under nitrogen atmosphere for 3 hours. After the<br>
reaction mixture was cooled to room temperature, 1.3 mg<br><br>
425<br>
of tri-tert-butylphosphine tetrafluoroborate and 4.1 mg<br>
of tris(dibenzylideneacetone)dipalladium(O) were added<br>
and the resulting mixture was heated to reflux under<br>
nitrogen atmosphere for 4 hours. After the reaction<br>
mixture was cooled to room temperature, 10% citric acid<br>
aqueous solution and ethyl acetate were added and<br>
insoluble were removed by filtration. The organic layer<br>
was separated and dried over anhydrous magnesium<br>
sulfate after washed with a saturated sodium chloride<br>
aqueous solution, and the solvent was evaporated under<br>
reduced pressure. The obtained residue was purified<br>
with silica gel column chromatography [PSQ100B<br>
(spherical) manufactured by Fuji Silysia Chemical Ltd.,<br>
eluent; hexane: ethyl acetate =10:1] to obtain 18 mg<br>
of tert-butyl 2-(benzamido)-4-(4-nitrophenoxy)benzoate<br>
as white solid.<br>
1H-NMR (CDC13) 6: 1.65 (9H, s) , 6.79 (1H, dd, J= 8.8,<br>
2.4 Hz), 7.12-7.17 (2H, m) , 7.50-7.61 (3H, m), 8.01-<br>
8.06 (2H, m), 8.09 (1H, d, J = 8.8 Hz), 8.23-8.29 (2H,<br>
m), 8.74 (1H, d, J = 2.4 Hz), 12.36 (1H, s).<br>
[0823]<br>
Example 537<br><br>
26 mg of 5-hydroxy-l-methyl-lH-indole, 64 mg<br>
of tripotassium phosphate, 3.8 mg of 2-(di-tert-<br>
butylphosphino)-2',4',6'-triisopropylbiphenyl and 5.5<br><br>
426<br>
mg of tris(dibenzylideneacetone)dipalladium(O) were<br>
added to 1.0 mL of toluene solution containing 50 mg of<br>
methyl 2-(benzamido)-4-bromobenzoate at room<br>
temperature, and the resulting mixture was heated to<br>
reflux under nitrogen atmosphere for 2 hours. After the<br>
reaction mixture was cooled to room temperature, ethyl<br>
acetate and 10% citric acid aqueous solution were added<br>
and insoluble were removed by filtration. The organic<br>
layer was separated and dried over anhydrous magnesium<br>
sulfate after washed with a saturated sodium chloride<br>
aqueous solution, and the solvent was evaporated under<br>
reduced pressure. The obtained residue was purified<br>
with silica gel column chromatography [PSQ100B<br>
(spherical) manufactured by Fuji Silysia Chemical Ltd.,<br>
eluent; hexane: ethyl acetate = 5:1] to obtain 53 mg of<br>
methyl 2-(benzamido)-4-(l-methyl-lH-indol-5-<br>
yloxy)benzoate as pale yellow solid.<br>
1H-NMR (CDC13) 8: 3.83 (3H, s), 3.93 (3H, s) , 6.47 (1H,<br>
dd, J = 3.1, 0.9 Hz), 6.63 (1H, dd, J = 9.0, 2.6 Hz),<br>
7.02 (1H, dd, J = 8.8, 2.2 Hz), 7.10 (1H, d, J = 2.9<br>
Hz), 7.32-7.38 (2H, m) , 7.47-7.57 (3H, m) , 7.97-8.03<br>
(3H, m), 8.58 (1H, d, J = 2.6 Hz), 12.14 (1H, s).<br>
[0824]<br>
Example 538<br><br><br>
427<br>
The following compound was obtained in the<br>
same manner as in Example 537.<br>
Methyl 2-(benzamido)-4-(3-chlorophenoxy)benzoate<br>
1H-NMR (CDC13) 5: 3.96 (3H, s) , 6.70 (1H, dd, J = 9.0,<br>
2.5 Hz), 7.01 (1H, ddd, J = 8.1, 2.1, 0.9 Hz), 7.10 (1H,<br>
t, J = 2.1 Hz), 7.17 (1H, ddd, J = 8.1, 2.1, 0.9 Hz),<br>
7.33 (1H, t, J = 8.1 Hz), 7.48-7.59 (3H, m) , 8.00-8.05<br>
(2H, m), 8.07 (1H, d, J = 9.0 Hz), 8.65 (1H, d, J = 2.5<br>
Hz), 12.17 (1H, s).<br>
[0825]<br>
Example 539<br><br>
5.0 mL of trifluoroacetic acid solution<br>
containing 69 mg of tert-butyl 2-(benzamido)-4-(3,5-<br>
difluorophenoxy)benzoate was stirred at room<br>
temperature for 2 hours. The solvent was evaporated<br>
under reduced pressure and diisopropyl ether was added<br>
to the obtained residue and a solid substance was<br>
separated by filtration to obtain 41 mg of 2-<br>
(benzamido)-4-(3,5-difluorophenoxy)benzoic acid as<br>
white solid.<br>
1H-NMR (DMSO-de) 5: 6.90 (1H, dd, J = 8.8, 2.4 Hz) ,<br>
6.96-7.04 (2H, m), 7.17 (1H, tt, J = 9.4, 2.3 Hz),<br>
7.56-7.69 (3H, m) , 7.91-7.97 (2H, m), 8.12 (1H, d, J =<br>
8.8 Hz), 8.48 (1H, d, J = 2.7 Hz), 12.42 (1H, s).<br><br>
428<br>
[0826]<br>
Examples 540 to 549<br>
The compounds shown in Table 53 were obtained<br>
in the same manner as in Example 539.<br>
[0827]<br>
[Table 53]<br><br>
[0828]<br>
2-(Benzamido)-4-(4-nitrophenoxy)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.98 (1H, dd, J = 8.7, 2.5 Hz),<br>
7.33-7.38 (2H, m), 7.57-7.69 (3H, m), 7.91-7.97 (2H, m),<br>
8.17 (1H, d, J = 8.7 Hz), 8.30-8.36 (2H, m), 8.54 (1H,<br>
d, J = 2.5 Hz), 12.46 (1H, s).<br>
[0829]<br>
2-(Benzamido)-4-(2,3-dimethylphenoxy)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 2.07 (3H, s) , 2.31 (3H, s) , 6.63 (1H,<br>
dd, J = 8.9, 2.7 Hz), 6.94 (1H, d, J = 7.7 Hz), 7.13<br>
(1H, d, J = 7.5 Hz), 7.17-7.22 (1H, m) , 7.55-7.68 (3H,<br>
m), 7.90-7.94 (2H, m), 8.04 (1H, d, J = 8.9 Hz), 8.33<br><br>
429<br>
(1H, d, J = 2.7 Hz), 12.41 (1H, s), 13.50-13.70 (1H,<br>
broad).<br>
[0830]<br>
2-(Benzamido)-4-(3-fluoro-4-methylphenoxy)benzoic acid<br>
1H-NMR (DMSO-de) 8: 2.26 (3H, d, J = 1.7 Hz), 6.79 (1H,<br>
dd, J = 8.9, 2.5 Hz), 6.94 (1H, dd, J = 8.3, 2.2 Hz),<br>
7.07 (1H, dd, J = 10.6, 2.3 Hz), 7.35-7.41 (1H, m) ,<br>
7.56-7.68 (3H, m) , 7.90-7.95 (2H, m), 8.08 (1H, d, J =<br>
8.9 Hz), 8.42 (1H, d, J = 2.5 Hz), 12.42 (1H, s) .<br>
[0831]<br>
2-(Benzamido)-4-(3-methoxyphenoxy)benzoic acid<br>
1H-NMR (DMSO-de) 5: 3.78 (3H, s) , 6.70-6.88 (4H, m) ,<br>
7.38 (1H, t, J = 8.2 Hz), 7.55-7.68 (3H, m) , 7.91-7.95<br>
(2H, m), 8.07 (1H, d, J = 8.8 Hz), 8.43 (1H, d, J = 2.4<br>
Hz), 12.41 (1H, s).<br>
[0832]<br>
2-(Benzamido)-4-(4-methoxyphenoxy)benzoic acid<br>
1H-NMR (DMSO-de) 8: 3.79 (3H, s) , 6.71 (1H, dd, J = 8.9,<br>
2.7 Hz), 7.01-7.06 (2H, m), 7.11-7.17 (2H, m), 7.55-<br>
7.68 (3H, m), 7.89-7.95 (2H, m), 8.05 (1H, d, J = 8.9<br>
Hz), 8.36 (1H, d, J = 2.7 Hz), 12.41 (1H, s).<br>
[0833]<br>
2-(Benzamido)-4-(3-(trifluoromethoxy)phenoxy)benzoic<br>
acid<br>
1H-NMR (DMSO-de) 8: 6.85 (1H, dd, J = 8.8, 2.6 Hz),<br>
7.20-7.31 (3H, m) , 7.56-7.69 (4H, m), 7.90-7.96 (2H, m),<br>
8.11 (1H, d, J = 8.8 Hz), 8.46 (1H, d, J = 2.6 Hz),<br>
12.43 (1H, s).<br><br>
430<br>
[0834]<br>
2-(Benzamido)-4-(benzo[1,3]dioxol-5-yloxy)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.10 (2H, s) , 6.65 (1H, dd, J = 8.3,<br>
2.3 Hz), 6.73 (1H, dd, J = 8.8, 2.7 Hz), 6.87 (1H, d, J<br>
= 2.3 Hz), 6.99 (1H, d, J = 8.3 Hz), 7.56-7.68 (3H, m),<br>
7.90-7.96 (2H, m), 8.05 (1H, d, J = 8.8 Hz), 8.38 (1H,<br>
d, J = 2.7 Hz), 12.42 (1H, s), 13.55-13.75 (1H, broad).<br>
[0835]<br>
2-(Benzamido)-4-(2,3-dihydrobenzo[1, 4]dioxin-6-<br>
yloxy)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 4.25-4.31 (4H, m) , 6.65 (1H, dd, J =<br>
8.7, 2.8 Hz), 6.69-6.74 (2H, m), 6.95 (1H, d, J = 8.5<br>
Hz), 7.56-7.68 (3H, m), 7.90-7.96 (2H, m), 8.05 (1H, d,<br>
J = 8.8 Hz), 8.38 (1H, d, J = 2.7 Hz), 12.42 (1H, s) .<br>
[0836]<br>
2-(Benzamido)-4-(benzofuran-5-yloxy)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.76 (1H, dd, J = 8.9, 2.5 Hz), 7.00<br>
(1H, dd, J = 2.2, 1.0 Hz), 7.15 (1H, dd, J = 8.9, 2.5<br>
Hz), 7.49 (1H, d, J = 2.5 Hz), 7.54-7.67 (3H, m), 7.71<br>
(1H, d, J = 8.9 Hz), 7.88-7.93 (2H, m), 8.06 (1H, d, J<br>
= 8.9 Hz), 8.09 (1H, d, J = 2.2 Hz), 8.39 (1H, d, J =<br>
2.5 Hz), 12.42 (1H, s), 13.50-13.75 (1H, broad).<br>
[0837]<br>
2-(Benzamido)-4-(benzothiophen-5-yloxy)benzoic  acid<br>
1H-NMR   (DMSO-d6)   8:   6.81   (1H,   dd,   J =  8.9,   2.7  Hz),   7.23<br>
(1H,   dd,   J =  8.7,   2.3  Hz),   7.47   (1H,   dd,   J =  5.5,   0.6<br>
Hz),   7.54-7.67   (3H,   m),   7.70   (1H,   d,   J = 2.3  Hz),   7.88<br>
(1H,   d,   J =  5.5  Hz),   7.88-7.93   (2H,   m),   8.08   (1H,   d,   J<br><br>
431<br>
= 8.8 Hz), 8.11 (1H, d, J = 8.5 Hz), 8.42 (1H, d, J =<br>
2.7 Hz), 12.42 (1H, s).<br>
[0838]<br>
Example 550<br><br>
0.094 mL of 2.0 mol/L aqueous sodium hydroxide<br>
was added to a mixed solution of 1.5 mL of dioxane and<br>
1.5 mL of methanol containing 50 mg of methyl 2-<br>
(benzamido)-4-(l-methyl-lH-indol-5-yloxy)benzoate at<br>
room temperature, stirred at 50C for 1 hour, and 0.031<br>
mL of 2.0 mol/L aqueous sodium hydroxide was added at<br>
the same temperature and then stirred at 50C for 30<br>
minutes. After the reaction mixture was cooled to room<br>
temperature, water was added and pH was adjusted to pH<br>
3.5 with 1.0 mol/L hydrochloric acid and ethyl acetate<br>
was added. The organic layer was separated and dried<br>
over anhydrous magnesium sulfate after washed with<br>
water and a saturated sodium chloride aqueous solution<br>
sequentially, and the solvent was evaporated under<br>
reduced pressure. Hexane was added to the obtained<br>
residue and a solid substance was separated by<br>
filtration to obtain 37 mg of 2-(benzamido)-4-(1-<br>
methyl-lH-indol-5-yloxy)benzoic acid as white solid.<br>
1H-NMR (DMSO-d6) 8: 3.84 (3H, s), 6.45 (1H, d, J = 2.9<br>
Hz), 6.71 (1H, dd, J = 8.8, 2.3 Hz), 6.98 (1H, dd, J =<br>
8.8, 2.2 Hz), 7.35 (1H, d, J = 2.2 Hz), 7.42 (1H, d, J<br><br>
432<br>
= 2.9 Hz), 7.51-7.67 (4H, m), 7.87-7.92 (2H, m), 8.03<br>
(1H, d, J = 8.8 Hz), 8.36 (1H, d, J = 2.3 Hz), 12.43<br>
(1H, s), 13.45-13.70 (1H, broad).<br>
[0839]<br>
Example 551<br><br>
0.16 mL of 2.0 mol/L aqueous sodium hydroxide<br>
was added to a mixed solution of 1.0 mL of methanol and<br>
1.0 mL of tetrahydrofuran containing 0.10 g of methyl<br>
2-(benzamido)-4-(3-chlorophenoxy)benzoate while ice-<br>
cooled and stirred at room temperature for 5 hours. The<br>
reaction mixture was added to water and 1.0 mol/L<br>
hydrochloric acid while ice-cooled, and a solid<br>
substance was separated by filtration to obtain 92 mg<br>
of 2-(benzamido)-4-(3-chlorophenoxy)benzoic acid as<br>
white solid.<br>
1H-NMR (DMSO-d6) 8: 6.83 (1H, dd, J = 8.8, 2.4 Hz),<br>
7.15-7.18 (1H, m), 7.29-7.32 (1H, m) , 7.33-7.37 (1H, m) ,<br>
7.51 (1H, t, J = 8.2 Hz), 7.57-7.68 (3H, m), 7.91-7.96<br>
(2H, m), 8.10 (1H, d, J = 8.8 Hz), 8.44 (1H, d, J = 2.4<br>
Hz), 12.42 (1H, s), 13.59-13.92 (1H, broad).<br>
[0840]<br>
Example 552<br><br><br>
433<br>
0.22 g of aluminum chloride was added to 1.0<br>
mL of toluene solution containing 0.10 g of 2-<br>
(benzamido)-4-(3-methoxyphenoxy)benzoic acid at room<br>
temperature and stirred at 80C for 8 hours. After the<br>
reaction mixture was cooled to room temperature, ethyl<br>
acetate and 1.0 mol/L hydrochloric acid were added. The<br>
organic layer was separated and dried over anhydrous<br>
magnesium sulfate after washed with 1.0 mol/L<br>
hydrochloric acid and a saturated sodium chloride<br>
aqueous solution sequentially, and the solvent was<br>
evaporated under reduced pressure. The obtained residue<br>
was purified with silica gel column chromatography<br>
[Flash Tube 2008 manufactured by Trikonex Company,<br>
eluent; hexane: ethyl acetate: acetic acid = 15:10:1]<br>
to obtain 54 mg of 2-(benzamido)-4-(3-<br>
hydroxyphenoxy)benzoic acid as white solid.<br>
1H-NMR (DMSO-d6) 5: 6.52 (1H, t, J = 2.2 Hz), 6.55-6.60<br>
(1H, m), 6.64-6.70 (1H, m), 6.78 (1H, dd, J= 8.9, 2.5<br>
Hz), 7.26 (1H, t, J = 8.0 Hz), 7.54-7.71 (3H, m), 7.89-<br>
7.99 (2H, m), 8.07 (1H, d, J = 8.9 Hz), 8.42 (1H, d, J<br>
= 2.5 Hz), 9.77 (1H, s), 12.43 (1H, s).<br>
The following compound was obtained in the<br>
same manner as in Example 552.<br>
[0841]<br>
Example 553<br><br><br>
434<br>
2-(Benzamido)-4-(4-hydroxyphenoxy)benzoic acid<br>
1H-NMR (DMSO-de) 8: 6.69 (1H, dd, J = 8.8, 2.7 Hz),<br>
6.82-6.88 (2H, m) , 6.97-7.04 (2H, m) , 7.54-7.68 (3H, m) ,<br>
7.90-7.95 (2H, m), 8.03 (1H, d, J = 8.8 Hz), 8.34 (1H,<br>
d, J = 2.7 Hz), 9.51 (1H, s), 12.44 (1H, s).<br>
[0842]<br>
Example 554<br><br>
0.023 mL of p-cresol, 79 mg of tripotassium<br>
phosphate, 2.4 mg of 2-(di-tert-butylphosphino)-<br>
2',4',6'-triisopropylbiphenyl and 0.8 mg of palladium<br>
acetate were added to 1.4 mL of toluene solution<br>
containing 70 mg of tert-butyl 2-(benzamido)-4-<br>
bromobenzoate at room temperature, and the resulting<br>
mixture was heated to reflux under nitrogen atmosphere<br>
for 1 hour. After the reaction mixture was cooled to<br>
room temperature, 4.7 mg of 2-(di-tert-butylphosphino)-<br>
2',4',6'-triisopropylbiphenyl and 1.7 mg of palladium<br>
acetate were added and the resulting mixture was heated<br>
to reflux under nitrogen atmosphere for 6 hours. After<br>
the reaction mixture was cooled to room temperature,<br>
ethyl acetate and 10% citric acid aqueous solution were<br>
added. The organic layer was separated and dried over<br>
anhydrous magnesium sulfate after washed with a<br>
saturated sodium chloride aqueous solution, and the<br>
solvent was evaporated under reduced pressure. The<br><br>
435<br>
obtained residue was purified with silica gel column<br>
chromatography [Flash Tube 2008 manufactured by<br>
Trikonex Company, eluent; hexane: ethyl acetate = 4:1]<br>
to obtain tert-butyl 2-(benzamido)-4-(4-<br>
methylphenoxy)benzoate.<br>
5.0 mL of trifluoroacetic acid was added to<br>
the obtained tert-butyl 2-(benzamido)-4-(4-<br>
methylphenoxy)benzoate and stirred at room temperature<br>
for 3 hours. The solvent was evaporated under reduced<br>
pressure and methanol was added to the obtained residue<br>
and a solid substance was separated by filtration to<br>
obtain 6.2 mg of 2-(benzamido)-4-(4-<br>
methylphenoxy)benzoic acid as white solid.<br>
1H-NMR (DMSO-d6) 8: 2.35 (3H, s) , 6.74 (1H, dd, J= 8.8,<br>
2.6 Hz), 7.05-7.10 (2H, m) , 7.26-7.32 (2H, m), 7.56-<br>
7.68 (3H, m), 7.90-7.95 (2H, m), 8.05 (1H, d, J = 8.8<br>
Hz), 8.39 (1H, d, J = 2.6 Hz), 12.43 (1H, s).<br>
[0843]<br>
Examples 555, 556<br>
The compounds shown in Table 54 were obtained<br>
in the same manner as in Example 554.<br>
[0844]<br>
[Table 54]<br><br><br>
436<br>
[0845]<br>
2-(Benzamido)-4-(2-chlorophenoxy)benzoic acid<br>
1H-NMR (DMSO-de) 5: 6.73 (1H, dd, J = 8.8, 2.5 Hz),<br>
7.33-7.42 (2H, m) , 7.45-7.53 (1H, m) , 7.54-7.72 (4H, m) ,<br>
7.87-7.96 (2H, m) , 8.08 (1H, d, J = 8.8 Hz), 8.36 (1H,<br>
d, J = 2.5 Hz), 12.42 (1H, s), 13.59-13.84 (1H, broad).<br>
[0846]<br>
2-(Benzamido)-4-(4-chlorophenoxy)benzoic acid<br>
1H-NMR (DMSO-d6) 5: 6.81 (1H, dd, J = 8.8, 2.4 Hz),<br>
7.18-7.26 (2H, m) , 7.50-7.69 (5H, m) , 7.88-7.97 (2H, m) ,<br>
8.09 (1H, d, J = 8.8 Hz), 8.42 (1H, d, J = 2.4 Hz),<br>
12.41 (1H, s), 13.60-13.85 (1H, broad).<br>
[0847]<br>
Example 557<br><br>
0.018 mL of 2,4-difluorophenol was added to 1<br>
mL of toluene suspension containing 10 mg of 60% sodium<br>
hydride at room temperature, and the resulting mixture<br>
was heated to reflux under nitrogen atmosphere for 15<br>
minutes. After the reaction mixture was cooled to room<br>
temperature, 0.5 mL of toluene solution containing 4.7<br>
mg of 2-(di-tert-butylphosphino)-2',4',6'-<br>
triisopropylbiphenyl, 1.7 mg of palladium acetate and<br>
70 mg of tert-butyl 2-(benzamido)-4-bromobenzoate was<br>
added and the resulting mixture was heated to reflux<br>
under nitrogen atmosphere for 4 hours. After the<br><br>
437<br>
reaction mixture was cooled to room temperature, 4.5 mg<br>
of 60% sodium hydride, 4.7 mg of 2-(di-tert-<br>
butylphosphino)-2',4',6'-triisopropylbiphenyl and 1.7<br>
mg of palladium acetate were added and the resulting<br>
mixture was heated to reflux under nitrogen atmosphere<br>
for 2 hours. After the reaction mixture was cooled to<br>
room temperature, 0.018 mL of 2,4-difluorophenol, 7.4<br>
mg of 60% sodium hydride, 4.7 mg of 2-(di-tert-<br>
butylphosphino)-2',4',6'-triisopropylbiphenyl and 1.7<br>
mg of palladium acetate were added and the resulting<br>
mixture was heated to reflux under nitrogen atmosphere<br>
for 2 hours. After the reaction mixture was cooled to<br>
room temperature, 1.6 mg of tri-tert-butylphosphine<br>
tetrafluoroborate and 5.1 mg of<br>
tris(dibenzylideneacetone)dipalladium(O) were added,<br>
and the resulting mixture was heated to reflux under<br>
nitrogen atmosphere for 1 hour and 30 minutes. 10%<br>
citric acid aqueous solution and ethyl acetate were<br>
added after the reaction mixture was cooled to room<br>
temperature. The organic layer was separated and dried<br>
over anhydrous magnesium sulfate after washed with a<br>
saturated sodium chloride aqueous solution, and the<br>
solvent was evaporated under reduced pressure. The<br>
obtained residue was purified with silica gel column<br>
chromatography [Flash Tube 2008 manufactured by<br>
Trikonex Company, eluent; hexane: ethyl acetate = 4:1]<br>
to obtain tert-butyl 2-(benzamido)-4-(2,4-<br>
difluorophenoxy)benzoate.<br><br>
438<br>
5.0 mL of trifluoroacetic acid was added to<br>
the obtained tert-butyl 2-(benzamido)-4-(2,4-<br>
difluorophenoxy)benzoate and stirred at room<br>
temperature for 3 hours. The solvent was evaporated<br>
under reduced pressure and diisopropyl ether was added<br>
to the obtained residue and a solid substance was<br>
separated by filtration to obtain 3.8 mg of 2-<br>
(benzamido)-4-(2,4-difluorophenoxy)benzoic acid as pale<br>
yellow solid.<br>
1H-NMR (DMSO-d6) 8: 6.79 (1H, dd, J = 8.8, 2.7 Hz) ,<br>
7.20-7.28 (1H, m), 7.46-7.52 (1H, m) , 7.54-7.68 (4H, m),<br>
7.90-7.95 (2H, m), 8.07 (1H, d, J = 8.8 Hz), 8.38 (1H,<br>
d, J = 2.7 Hz), 12.44 (1H, s) .<br>
[0848]<br>
Example 558<br><br>
52 mg of tert-butyl 5-hydroxy-lH-indole-l-<br>
carboxylate, 79 mg of tripotassium phosphate, 4.7 mg of<br>
2-(di-tert-butylphosphino)-2',4',6'-<br>
triisopropylbiphenyl and 6.8 mg of<br>
tris(dibenzylideneacetone)dipalladium(O) were added to<br>
1.4 mL of toluene solution containing 70 mg of tert-<br>
butyl 2-(benzamido)-4-bromobenzoate at room temperature,<br>
and the resulting mixture was heated to reflux under<br>
nitrogen atmosphere for 2 hours and 30 minutes. After<br>
the reaction mixture was cooled to room temperature,<br><br>
439<br>
ethyl acetate and 10% citric acid aqueous solution were<br>
added and insoluble were removed by filtration.  The<br>
organic layer was separated and dried over anhydrous<br>
magnesium sulfate after washed with a saturated sodium<br>
chloride aqueous solution, and the solvent was<br>
evaporated under reduced pressure. The obtained residue<br>
was purified with silica gel column chromatography<br>
[PSQ100B (spherical) manufactured by Fuji Silysia<br>
Chemical Ltd., eluent; hexane: ethyl acetate = 10:1] to<br>
obtain tert-butyl 5-(3-(benzamido)-4-(tert-<br>
butoxycarbonyl)phenoxy)-lH-indole-1-carboxylate.<br>
1.0 mL of trifluoroacetic acid was added to<br>
4.0 mL of methylene chloride solution containing the<br>
obtained tert-butyl 5-(3-(benzamido)-4-(tert-<br>
butoxycarbonyl)phenoxy)-lH-indole-1-carboxylate while<br>
ice-cooled and stirred at the same temperature for 2<br>
hours and 30 minutes. After the reaction mixture was<br>
warmed to room temperature, ethyl acetate and a<br>
saturated sodium hydrogen carbonate aqueous solution<br>
were added. The aqueous layer was separated and washed<br>
with ethyl acetate after adjusted to pH 6.5 with 6.0<br>
mol/L hydrochloric acid and allowed to stand still for<br>
17 hours. A solid substance was separated by filtration<br>
to obtain 10 mg of 2-(benzamido)-4-(lH-indol-5-<br>
yloxy)benzoic acid as white solid.<br>
1H-NMR (DMSO-d6) 8: 6.41-6.43 (1H, m) , 6.54 (1H, dd, J =<br>
8.6, 2.7 Hz), 6.87 (1H, dd, J = 8.6, 2.3 Hz), 7.25 (1H,<br>
d, J = 2.2 Hz), 7.39-7.41 (1H, m), 7.43 (1H, d, J = 8.5<br><br>
440<br>
Hz), 7.46-7.59 (3H, m) , 7.96-8.04 (3H, m), 8.30 (1H, d,<br>
J = 2.4 Hz), 11.19 (1H, s).<br>
[0849]<br>
Example 559<br><br>
31 mg of 3-nitrophenol, 79 mg of tripotassium<br>
phosphate, 4.7 mg of 2-(di-tert-butylphosphino)-<br>
2',4',6'-triisopropylbiphenyl and 6.8 mg of<br>
tris(dibenzylideneacetone)dipalladium(O) were added to<br>
1.4 mL of toluene solution containing 70 mg of tert-<br>
butyl 2-(benzamido)-4-bromobenzoate at room temperature,<br>
and the resulting mixture was heated to reflux under<br>
nitrogen atmosphere for 2 hours. After the reaction<br>
mixture was cooled to room temperature, 4.7 mg of 2-<br>
(di-tert-butylphosphino)-2',4',6'-triisopropylbiphenyl<br>
and 6.8 mg of tris(dibenzylideneacetone)dipalladium(O)<br>
were added and the resulting mixture was heated to<br>
reflux under nitrogen atmosphere for 1 hour. After the<br>
reaction mixture was cooled to room temperature, ethyl<br>
acetate and 10% citric acid aqueous solution were added<br>
and insoluble were removed by filtration. The organic<br>
layer was separated and dried over anhydrous magnesium<br>
sulfate after washed with a saturated sodium chloride<br>
aqueous solution, and the solvent was evaporated under<br>
reduced pressure. The obtained residue was purified<br>
with silica gel column chromatography [PSQ100B<br><br>
441<br>
(spherical) manufactured by Fuji Silysia Chemical Ltd.,<br>
eluent; hexane: ethyl acetate =10:1] to obtain tert-<br>
butyl 2-(benzamido)-4-(3-nitrophenoxy)benzoate.<br>
5.0 mL of trifluoroacetic acid was added to<br>
the obtained tert-butyl 2-(benzamido)-4-(3-<br>
nitrophenoxy)benzoate and stirred at room temperature<br>
for 3 hours. The solvent was evaporated under reduced<br>
pressure and diisopropyl ether was added to the<br>
obtained residue and a solid substance was separated by<br>
filtration to obtain 34 mg of 2-(benzamido)-4-(3-<br>
nitrophenoxy)benzoic acid as pale yellow solid.<br>
1H-NMR (DMSO-d6) 5: 6.91 (1H, dd, J = 8.8, 2.6 Hz),<br>
7.56-7.71 (4H, m), 7.78 (1H, t, J = 8.2 Hz), 7.90-7.98<br>
(3H, m) , 8.10-8.16 (2H, m), 8.49 (1H, d, J = 2.6 Hz),<br>
12.41 (1H, s).<br>
[0850]<br>
Examples 560 to 570<br>
The compounds shown in Table 55 were obtained<br>
in the same manner as in Example 559.<br>
[0851]<br>
[Table 55]<br><br><br>
[0852]<br>
2-(Benzamido)-4-(4-fluorophenoxy)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.76 (1H, dd, J = 8.9, 2.7 Hz),<br>
7.21-7.28 (2H, m) , 7.29-7.37 (2H, m) , 7.55-7.68 (3H, m) ,<br>
7.90-7.95 (2H, m), 8.07 (1H, d, J = 8.9 Hz), 8.39 (1H,<br>
d, J = 2.7 Hz), 12.41 (1H, s).<br>
[0853]<br>
2-(Benzamido)-4-(4-(trifluoromethoxy)phenoxy)benzoic<br>
acid<br>
1H-NMR (DMSO-de) 8: 6.82 (1H, dd, J = 8.9, 2.7 Hz),<br>
7.28-7.34 (2H, m) , 7.46-7.52 (2H, m), 7.56-7.69 (3H, m) ,<br>
7.90-7.96 (2H, m), 8.10 (1H, d, J = 8.9 Hz), 8.44 (1H,<br>
d, J = 2.7 Hz), 12.41 (1H, s).<br>
[0854]<br>
2-(Benzamido)-4-(2-methylphenoxy)benzoic acid<br>
1H-NMR (DMSO-de) 8: 2.16 (3H, s), 6.67 (1H, dd, J = 8.9,<br>
2.7 Hz), 7.08-7.13 (1H, m), 7.21-7.26 (1H, m), 7.29-<br>
7.34 (1H, m), 7.38-7.41 (1H, m), 7.55-7.68 (3H, m),<br><br>
443<br>
7.89-7.95 (2H, m), 8.05 (1H, d, J = 8.9 Hz), 8.32 (1H,<br>
d, J = 2.7 Hz), 12.41 (1H, s).<br>
[0855]<br>
2-(Benzamido)-4-(3-methylphenoxy)benzoic acid<br>
hi-NMR (DMSO-d6) 8: 2.34 (3H, s), 6.76 (1H, dd, J = 9.0,<br>
2.6 Hz), 6.94-7.02 (2H, m), 7.07-7.12 (1H, m), 7.36 (1H,<br>
dd, J = 8.0, 7.7 Hz), 7.56-7.68 (3H, m), 7.90-7.96 (2H,<br>
m), 8.07 (1H, d, J = 9.0 Hz), 8.41 (1H, d, J = 2.6 Hz),<br>
12.41 (1H, s).<br>
[0856]<br>
2-(Benzamido)-4-(2,6-dimethylphenoxy)benzoic acid<br>
1H-NMR (DMSO-d6) 5: 2.10 (6H, s), 6.58 (1H, dd, J= 9.0,<br>
2.5 Hz), 7.14-7.25 (3H, m) , 7.55-7.68 (3H, m), 7.89-<br>
7.95 (2H, m), 8.04 (1H, d, J = 9.0 Hz), 8.25 (1H, d, J<br>
=2.5 Hz), 12.43 (1H, s).<br>
[0857]<br>
2-(Benzamido)-4-(3-fluorophenoxy)benzoic acid<br>
1H-NMR (DMSO-de) 8: 6.84 (1H, dd, J = 8.8, 2.4 Hz),<br>
7.00-7.05 (1H, m) , 7.08-7.16 (2H, m), 7.48-7.68 (4H, m) ,<br>
7.90-7.96 (2H, m), 8.10 (1H, d, J = 8.8 Hz), 8.45 (1H,<br>
d, J = 2.4 Hz), 12.41 (1H, s).<br>
[0858]<br>
2-(Benzamido)-4-(2-fluorophenoxy)benzoic acid<br>
1H-NMR (DMSO-de) 8: 6.79 (1H, dd, J = 8.8, 2.6 Hz),<br>
7.29-7.51 (4H, m), 7.55-7.69 (3H, m) , 7.89-7.95 (2H, m) ,<br>
8.08 (1H, d, J = 8.8 Hz), 8.39 (1H, d, J = 2.6 Hz),<br>
12.41 (1H, s).<br>
[0859]<br>
2-(Benzamido)-4-(2,6-difluorophenoxy)benzoic acid<br><br>
444<br>
1H-NMR (DMSO-de) 8: 6.85 (1H, dd, J = 9.0, 2.7 Hz),<br>
7.34-7.51 (3H, m) , 7.55-7.68 (3H, m) , 7.89-7.95 (2H, m) ,<br>
8.09 (1H, d, J = 9.0 Hz), 8.42 (1H, d, J = 2.7 Hz),<br>
12.43 (1H, s).<br>
[0860]<br>
2-(Benzamido)-4-(3,4-dimethylphenoxy)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 2.24 (6H, s), 6.72 (1H, dd, J= 8.9,<br>
2.7 Hz), 6.89 (1H, dd, J = 8.1, 2.5 Hz), 6.98 (1H, d, J<br>
= 2.5 Hz), 7.23 (1H, d, J = 8.1 Hz), 7.56-7.68 (3H, m) ,<br>
7.90-7.95 (2H, m), 8.05 (1H, d, J = 8.9 Hz), 8.39 (1H,<br>
d, J = 2.7 Hz), 12.40 (1H, s).<br>
[0861]<br>
2-(Benzamido)-4-(3-(trifluoromethyl)phenoxy)benzoic<br>
acid<br>
1H-NMR (DMSO-dg) 8: 6.85 (1H, dd, J = 9.0, 2.7 Hz),<br>
7.48-7.52 (1H, m), 7.54-7.68 (5H, m), 7.72 (1H, t, J =<br>
7.9 Hz), 7.90-7.95 (2H, m), 8.11 (1H, d, J = 9.0 Hz),<br>
8.46 (1H, d, J = 2.7 Hz), 12.41 (1H, s) .<br>
[0862]<br>
2-(Benzamido)-4-(4-(trifluoromethyl)phenoxy)benzoic<br>
acid<br>
1H-NMR (DMSO-de) 8: 6.90 (1H, dd, J = 8.8, 2.6 Hz),<br>
7.33-7.39 (2H, m) , 7.56-7.69 (3H, m), 7.81-7.88 (2H, m) ,<br>
7.91-7.96 (2H, m), 8.13 (1H, d, J = 8.8 Hz), 8.50 (1H,<br>
d, J = 2.6 Hz), 12.41 (1H, s), 13.70-13.95 (1H, broad).<br>
[0863]<br>
Example 571<br><br><br>
91 mg of 2,4-dichlorophenol was added to 2.1<br>
mL of toluene suspension containing 22 mg of 60% sodium<br>
hydride at room temperature, and the resulting mixture<br>
was heated to reflux under nitrogen atmosphere for 15<br>
minutes. After the reaction mixture was cooled to room<br>
temperature, 70 mg of tert-butyl 2-(benzamido)-4-<br>
bromobenzoate, 4.7 mg of 2-(di-tert-butylphosphino)-<br>
2',4',6'-triisopropylbiphenyl and 6.8 mg of<br>
tris(dibenzylideneacetone)dipalladium(O) were added and<br>
the resulting mixture was heated to reflux under<br>
nitrogen atmosphere for 6 hours. After the reaction<br>
mixture was cooled to room temperature, 61 mg of 2,4-<br>
dichlorophenol, 15 mg of 60% sodium hydride, 4.7 mg of<br>
2-(di-tert-butylphosphino)-2',4',6'-<br>
triisopropylbiphenyl and 6.8 mg of<br>
tris(dibenzylideneacetone)dipalladium(O) were added and<br>
the resulting mixture was heated to reflux under<br>
nitrogen atmosphere for 10 hours. After the reaction<br>
mixture was cooled to room temperature, 10% citric acid<br>
aqueous solution and ethyl acetate were added and<br>
insoluble were removed by filtration. The organic layer<br>
was separated and dried over anhydrous magnesium<br>
sulfate after washed with a saturated sodium chloride<br>
aqueous solution, and the solvent was evaporated under<br><br>
446<br>
reduced pressure. The obtained residue was purified<br>
with silica gel column chromatography [PSQ100B<br>
(spherical) manufactured by Fuji Silysia Chemical Ltd.,<br>
eluent; hexane: ethyl acetate =20:1] to obtain tert-<br>
butyl 2-(benzamido)-4-(2,4-dichlorophenoxy)benzoate.<br>
5.0 mL of trifluoroacetic acid was added to<br>
the obtained tert-butyl 2-(benzamido)-4-(2, 4-<br>
dichlorophenoxy)benzoate and stirred at room<br>
temperature for 2 hours. The solvent was evaporated<br>
under reduced pressure and the obtained residue was<br>
purified with reversed-phase silica gel column<br>
chromatography [eluent; 80-100% acetonitrile /0.1%<br>
trifluoroacetic acid aqueous solution] to obtain 8.7 mg<br>
of 2-(benzamido)-4-(2,4-dichlorophenoxy)benzoic acid as<br>
white solid.<br>
1H-NMR (DMSO-d6) 8: 6.77 (1H, dd, J = 8.8, 2.7 Hz), 7.41<br>
(1H, d, J = 8.8 Hz), 7.53-7.68 (4H, m), 7.88 (1H, d, J<br>
= 2.4 Hz), 7.90-7.95 (2H, m), 8.08 (1H, d, J = 8.8 Hz),<br>
8.36 (1H, d, J = 2.7 Hz), 12.43 (1H, s).<br>
[0864]<br>
Examples 572 to 583<br>
The compounds shown in Table 56 were obtained<br>
in the same manner as in Example 571.<br>
[0865]<br>
[Table 56]<br><br><br>
[0866]<br>
2-(Benzamido)-4-(2,3-difluorophenoxy)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.86 (1H, dd, J = 8.9, 2.7 Hz),<br>
7.20-7.26 (1H, m) , 7.30-7.48 (2H, m), 7.56-7.68 (3H, m) ,<br>
7.90-7.95 (2H, m), 8.10 (1H, d, J = 8.9 Hz), 8.44 (1H,<br>
d, J = 2.7 Hz), 12.41 (1H, s) .<br>
[0867]<br>
2-(Benzamido)-4-(3-chloro-2-fluorophenoxy)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.84 (1H, dd, J = 8.8, 2.7 Hz),<br>
7.32-7.43 (2H, m), 7.53-7.69 (4H, m), 7.90-7.96 (2H, m) ,<br>
8.10 (1H, d, J = 8.8 Hz), 8.43 (1H, d, J = 2.7 Hz),<br>
12.42 (1H, s).<br>
[0868]<br>
2-(Benzamido)-4-(3-chloro-4-fluorophenoxy)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.81 (1H, dd, J = 8.8, 2.7 Hz) ,<br>
7.21-7.28 (1H, m) , 7.52-7.69 (5H, m), 7.90-7.96 (2H, m) ,<br>
8.09 (1H, d, J = 8.8 Hz), 8.42 (1H, d, J = 2.7 Hz),<br>
12.41 (1H, s).<br><br>
448<br>
[0869]<br>
2-(Benzamido)-4-(3,5-dichlorophenoxy)benzoic acid<br>
1H-NMR (DMSO-de) 8: 6.88 (1H, dd, J = 8.8, 2.6 Hz), 7.32<br>
(2H, d, J = 1.9 Hz), 7.52 (1H, t, J = 1.9 Hz), 7.56-<br>
i  7.69 (3H, m), 7.91-7.97 (2H, m), 8.12 (1H, d, J = 8.8<br>
Hz), 8.46 (1H, d, J = 2.6 Hz), 12.42 (1H, s).<br>
[0870]<br>
2-(Benzamido)-4-(4-fluoro-2-methylphenoxy)benzoic acid<br>
1H-NMR (DMSO-de) 5: 2.15 (3H, s) , 6.67 (1H, dd, J = 8.9,<br>
I  2.5 Hz), 7.11-7.20 (2H, m), 7.27-7.31 (1H, m), 7.55-<br>
7.68 (3H, m), 7.89-7.95 (2H, m), 8.05 (1H, d, J = 8.9<br>
Hz), 8.31 (1H, d, J - 2.5 Hz), 12.43 (1H, s).<br>
[0871]<br>
2-(Benzamido)-4-(3,4-difluorophenoxy)benzoic acid<br>
1H-NMR (DMSO-de) 5: 6.81 (1H, dd, J = 8.8, 2.7 Hz),<br>
7.04-7.11 (1H, m) , 7.42-7.48 (1H, m), 7.52-7.69 (4H, m) ,<br>
7.90-7.96 (2H, m), 8.09 (1H, d, J = 8.8 Hz), 8.42 (1H,<br>
d, J = 2.7 Hz), 12.42 (1H, s) .<br>
[0872]<br>
I 2-(Benzamido)-4-(2,5-difluorophenoxy)benzoic acid<br>
1H-NMR (DMSO-de) 8: 6.84 (1H, dd, J = 8.8, 2.7 Hz),<br>
7.21-7.28 (1H, m) , 7.38-7.44 (1H, m) , 7.51-7.69 (4H, m) ,<br>
7.90-7.96 (2H, m), 8.09 (1H, d, J = 8.8 Hz), 8.43 (1H,<br>
d, J = 2.7 Hz), 12.42 (1H, s).<br>
  [0873]<br>
2-(Benzamido)-4-(5-chloro-2-methylphenoxy)benzoic acid<br>
1H-NMR   (DMSO-d6)   8:   2.15   (3H,   s),   6.72   (1H,   dd,   J=  8.9,<br>
2.7  Hz),   7.22   (1H,   d,   J =  2.2  Hz),   7.30   (1H,   dd,   J =<br>
8.3,   2.2  Hz),   7.44   (1H,   d,   J =  8.3  Hz),   7.55-7.68   (3H,<br><br>
449<br>
m), 7.90-7.95 (2H, m), 8.08 (1H, d, J = 8.9 Hz), 8.34<br>
(1H, d, J = 2.7 Hz), 12.42 (1H, s).<br>
[0874]<br>
2-(Benzamido)-4-(3,4-dichlorophenoxy)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.86 (1H, dd, J = 9.0, 2.5 Hz), 7.22<br>
(1H, dd, J= 8.9, 2.7 Hz), 7.54-7.69 (4H, m), 7.74 (1H,<br>
d, J = 8.9 Hz), 7.90-7.96 (2H, m), 8.10 (1H, d, J = 9.0<br>
Hz), 8.45 (1H, d, J = 2.5 Hz), 12.41 (1H, s).<br>
[0875]<br>
2-(Benzamido)-4-(2,3-dichlorophenoxy)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.78 (1H, dd, J = 8.8, 2.6 Hz), 7.36<br>
(1H, dd, J = 8.3, 1.2 Hz), 7.50 (1H, t, J = 8.2 Hz),<br>
7.56-7.69 (4H, m), 7.90-7.96 (2H, m), 8.09 (1H, d, J =<br>
8.8 Hz), 8.38 (1H, d, J = 2.6 Hz), 12.44 (1H, s).<br>
[0876]<br>
2-(Benzamido)-4-(2,5-dichlorophenoxy)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.78 (1H, dd, J = 8.9, 2.7 Hz), 7.46<br>
(1H, dd, J = 8.8, 2.5 Hz), 7.54 (1H, d, J = 2.5 Hz),<br>
7.56-7.69 (3H, m), 7.73 (1H, d, J = 8.8 Hz), 7.90-7.96<br>
(2H, m), 8.09 (1H, d, J = 8.9 Hz), 8.38 (1H, d, J = 2.7<br>
Hz), 12.41 (1H, s).<br>
[0877]<br>
2-(Benzamido)-4-(2,6-dichlorophenoxy)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 6.70 (1H, dd, J = 8.8, 2.7 Hz), 7.46<br>
(1H, t, J = 8.3 Hz), 7.55-7.68 (3H, m), 7.71 (2H, d, J<br>
= 8.3 Hz), 7.89-7.96 (2H, m), 8.08 (1H, d, J = 8.8 Hz),<br>
8.31 (1H, d, J = 2.7 Hz), 12.49 (1H, s).<br><br><br>
8 6 mg of 4-phenylpiperidine, 0.22 g of cesium<br>
carbonate, 2.4 mg of<br>
tris(dibenzylideneacetone)dipalladium(O), 1.2 mg of<br>
palladium acetate and 6.3 mg of 2-<br>
dicyclohexylphosphino-2',4',6'-triisopropylbiphenyl<br>
were added to 3.0 mL of toluene solution containing<br>
0.10 g of tert-butyl 2-(benzamido)-4-bromobenzoate, and<br>
the resulting mixture was heated to reflux for 2 hours.<br>
After the reaction mixture was cooled to room<br>
temperature, 2.4 mg of<br>
tris(dibenzylideneacetone)dipalladium(O), 1.2 mg of<br>
palladium acetate and 6.3 mg of 2-<br>
dicyclohexylphosphino-2',4',6'-triisopropylbiphenyl<br>
were added and the resulting mixture was heated to<br>
reflux for 6 hours. After the reaction mixture was<br>
cooled to room temperature, ethyl acetate and 10%<br>
citric acid aqueous solution were added. The organic<br>
layer was separated and dried over anhydrous magnesium<br>
sulfate after washed with a saturated sodium chloride<br>
aqueous solution, and the solvent was evaporated under<br>
reduced pressure. The obtained residue was purified<br>
with silica gel column chromatography [PSQ100B<br><br>
451<br>
(spherical) manufactured by Fuji Silysia Chemical Ltd.,<br>
eluent; hexane: ethyl acetate = 10:1] to obtain tert-<br>
butyl 2-(benzamido)-4-(4-phenylpiperidin-l-yl)benzoate<br>
as pale yellow solid.<br>
5.0 mL of trifluoroacetic acid was added to<br>
the obtained tert-butyl 2-(benzamido)-4-(4-<br>
phenylpiperidin-1-yl)benzoate and stirred at room<br>
temperature for 3 hours. The solvent was evaporated<br>
under reduced pressure, ethyl acetate and water were<br>
added and pH was adjusted to pH 6.5 with a saturated<br>
sodium hydrogen carbonate aqueous solution. The organic<br>
layer was separated and dried over anhydrous magnesium<br>
sulfate after washed with water and a saturated sodium<br>
chloride aqueous solution sequentially, and the solvent<br>
was evaporated under reduced pressure. Diisopropyl<br>
ether was added to the obtained residue and a solid<br>
substance was separated by filtration to obtain 20 mg<br>
of 2-(benzamido)-4-(4-phenylpiperidin-l-yl)benzoic acid<br>
as white solid.<br>
1H-NMR (DMSO-d6) 8: 1.65-1.78 (2H, m) , 1.86-1.95 (2H, m) ,<br>
2.76-2.87 (1H, m), 2.97-3.08 (2H, m), 4.01-4.11 (2H, m),<br>
6.78 (1H, dd, J = 9.1, 2.5 Hz), 7.17-7.23 (1H, m) ,<br>
7.25-7.34 (4H, m) , 7.56-7.68 (3H, m), 7.88 (1H, d, J =<br>
9.1 Hz), 7.94-7.99 (2H, m), 8.47 (1H, d, J = 2.5 Hz),<br>
12.53 (1H, s).<br>
[0879]<br>
Examples 585 to 588<br>
The compounds shown in Table 57 were obtained<br>
in the same manner as in Example 584.<br><br><br>
[0881]<br>
2-(Benzamido)-4-(1,2,3,4-tetrahydroisoquinolin-2-<br>
yl)benzoic acid<br>
1H-NMR (DMSO-de) 8: 2.95-3.01 (2H, m) , 3.64-3.70 (2H, m) ,<br>
4.58 (2H, s), 6.77 (1H, dd, J = 9.0, 2.6 Hz), 7.18-7.32<br>
(4H, m), 7.57-7.68 (3H, m), 7.90 (1H, d, J = 9.0 Hz),<br>
7.95-8.00 (2H, m), 8.45 (1H, d, J = 2.6 Hz), 12.53 (1H,<br>
s), 12.97 (1H, s) .<br>
[0882]<br>
2-(Benzamido)-4-(4-benzylpiperidin-l-yl)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 1.17-1.31 (2H, m) , 1.62-1.71 (2H, m) ,<br>
1.74-1.88 (1H, m) , 2.50-2.57 (2H, m), 2.82-2.92 (2H, m) ,<br>
3.86-3.96 (2H, m), 6.69 (1H, dd, J = 9.3, 2.5 Hz),<br>
7.16-7.22 (3H, m) , 7.26-7.32 (2H, m), 7.56-7.67 (3H, m) ,<br>
7.84 (1H, d, J = 9.3 Hz), 7.92-7.98 (2H, m) , 8.39 (1H,<br>
d, J = 2.5 Hz), 12.49 (1H, s), 12.94 (1H, s) .<br>
[0883]<br>
2-(Benzamido)-4-(4-benzoylpiperidin-l-yl)benzoic acid<br>
1H-NMR (DMSO-d6) 8: 1.58-1.72 (2H, m) , 1.86-1.95 (2H, m) ,<br>
3.10-3.21 (2H, m) , 3.73-3.83 (1H, m), 3.93-4.03 (2H, m) ,<br><br>
453<br>
6.76 (1H, dd, J = 9.1, 2.4 Hz), 7.53-7.70 (6H, m) , 7.87<br>
(1H, d, J = 9.1 Hz), 7.93-7.98 (2H, m) , 8.01-8.06 (2H,<br>
m), 8.43 (1H, d, J = 2.4 Hz), 12.49 (1H, s), 12.90-<br>
13.15 (1H, broad).<br>
[0884]<br>
2-(benzamido)-4-(4-phenyl-l,2,3,6-tetrahydropyridin-l-<br>
yl)benzoic acid<br>
1H-NMR (DMSO-de) 5: 2.64-2.72 (2H, m) , 3.65-3.71 (2H, m) ,<br>
4.02-4.09 (2H, m), 6.32-6.37 (1H, m), 6.78 (1H, dd, J=<br>
9.1, 2.5 Hz), 7.25-7.32 (1H, m) , 7.35-7.41 (2H, m) ,<br>
7.48-7.53 (2H, m), 7.57-7.68 (3H, m), 7.90 (1H, d, J =<br>
9.1 Hz), 7.95-8.00 (2H, m), 8.47 (1H, d, J = 2.5 Hz),<br>
12.53 (1H, s), 12.90-13.15 (1H, broad).<br>
INDUSTRIAL APPLICABILITY<br>
[0885]<br>
The compounds of general formula [1] of the present<br>
invention or the salts thereof have the inhibitory<br>
activity of MMP-13 production and therefore they are<br>
useful as, for example, therapeutic agents for<br>
rheumatoid arthritis, osteoarthritis, cancer and the<br>
other diseases in which MMP-13 is involved.<br><br>
454<br>
CLAIMS<br>
1.		An anthranilic acid derivative represented by<br>
the general formula:<br>
[Formula 1]<br><br>
wherein, R1 represents a hydrogen atom or a carboxyl<br>
protecting group; R2 represents a phenyl, cycloalkyl or<br>
heterocyclic group which may be optionally substituted;<br>
R3 represents a phenyl, cycloalkyl, cycloalkenyl,<br>
monocyclic heterocyclic or bicyclic heterocyclic group<br>
which may be optionally substituted; X1 represents a<br>
carbonyl group or a sulfonyl group; X2 represents an<br>
alkylene, alkenylene or alkynylene group which may be<br>
optionally substituted or a bond; provided that when X1<br>
is a sulfonyl group and X4 is a bond, X2 represents an<br>
alkylene, alkenylene or alkynylene group which may be<br>
optionally substituted; X3 represents an oxygen atom, a<br>
sulfur atom or a bond; and X4 represents a group<br>
represented by the general formula, -X5-X6- or -X6-X5-,<br>
wherein the bond on the left side of each general<br>
formula is linked to R3; and<br>
X5 represents an oxygen atom, a sulfur atom, an imino<br>
group which may be optionally protected, a sulfinyl<br>
group, a sulfonyl group or a bond; and X6 represents an<br>
alkylene, alkenylene or alkynylene group which may be<br>
optionally substituted or a bond or a salt thereof.<br><br>
455<br>
2.	The anthranilic acid derivative or a salt<br>
thereof according to claim 1 wherein X1 is a carbonyl<br>
group.<br>
3.	The anthranilic acid derivative or a salt<br>
thereof according to claim 1 or 2, wherein R1 represents<br>
a hydrogen atom; R2 represents a phenyl or heterocyclic<br>
group which may be optionally substituted with a group<br>
selected from a halogen atom, a cyano group, a nitro<br>
group, a hydroxyl group which may be optionally<br>
protected, an alkyl group which may be optionally<br>
substituted, an alkenyl group which may be optionally<br>
substituted, an alkynyl group which may be optionally<br>
substituted, an alkoxy group which may be optionally<br>
substituted, an aryl group which may be optionally<br>
substituted, a cyclic amino group which may be<br>
optionally substituted, an aralkyl group which may be<br>
optionally substituted and a heterocyclic group which<br>
may be optionally substituted; R3 represents a phenyl,<br>
monocyclic heterocyclic or bicyclic heterocyclic group<br>
which may be optionally substituted with a group<br>
selected from a halogen atom, a hydroxyl group, an<br>
alkyl group which may be optionally substituted and an<br>
alkoxy group which may be optionally substituted; X2<br>
represents an alkylene group, an alkenylene group, an<br>
alkynylene group or a bond; provided that when X1 is a<br>
sulfonyl group and X4 is a bond, X2 represents an<br>
alkylene group, an alkenylene group or an alkynylene<br>
group; X3 represents an oxygen atom or a bond; and X4<br>
represents the general formula -X6-X5-, wherein the bond<br><br>
456<br>
on the left side of the general formula is linked to R3;<br>
and<br>
X5 represents an oxygen atom, a sulfur atom, an imino<br>
group which may be optionally protected, a sulfinyl<br>
group, a sulfonyl group or a bond; and X6 represents an<br>
alkylene, alkenylene or alkynylene group which may be<br>
optionally substituted or a bond.<br>
4.	The anthranilic acid derivative or a salt<br>
thereof according to claims 1 to 3, wherein R3<br>
represents a phenyl group, a nitrogen-containing<br>
bicyclic heterocyclic group represented by a condensed<br>
or bridged ring containing only 1 to 3 nitrogen atom(s)<br>
as the heteroatom of the said ring, an oxygen-<br>
containing bicyclic heterocyclic group represented by a<br>
condensed or bridged ring containing only oxygen<br>
atom(s) as the heteroatom of the said ring or a sulfur-<br>
containing bicyclic heterocyclic group or represented<br>
by a condensed or bridged ring containing only sulfur<br>
atom(s) as the heteroatom of the said ring; and these<br>
groups may be optionally substituted with a group<br>
selected from a halogen atom, a hydroxyl group, an<br>
alkyl group which may be optionally substituted with a<br>
halogen atom and an alkoxy group which may be<br>
optionally substituted with a halogen atom.<br>
5.	The anthranilic acid derivative or a salt<br>
thereof according to claims 1 to 4, wherein X4<br>
represents the general formula -X6p-X5q-, wherein the<br>
bond on the left side of the general formula is linked<br>
to R3; and X5q represents an oxygen atom, a sulfur atom<br><br>
457<br>
or a bond; and X6p represents an alkylene, alkenylene or<br>
alkynylene group which may be optionally substituted.<br>
6.	The anthranilic acid derivative or salts<br>
thereof according to claims 1 to 4, wherein X4<br>
represents the general formula -X6r-X5s-, wherein the<br>
bond on the left side of the general formula is linked<br>
to R3; and X5s represents an oxygen atom or a bond; and<br>
X6r represents a bond.<br>
7.	A matrix metalloprotease 13 production<br>
inhibitor which comprises the anthranilic acid<br>
derivative or a salt thereof according to claims 1 to 6.<br>
8.	A therapeutic agent for rheumatoid arthritis<br>
which comprises the anthranilic acid derivative or a<br>
salt thereof according to claims 1 to 6.<br><br>
An anthranilic acid derivative represented by<br>
the general formula (X) [wherein R1 represents hydrogen<br>
or a carboxy-protecting group; R2 represents optionally<br>
substituted phenyl, a heterocyclic group, etc.; R3<br>
represents optionally substituted phenyl, a monocyclic<br>
heterocyclic group, etc.; X1 represents carbonyl, etc.;<br>
X2 represents optionally substituted alkylene group, a<br>
bond, etc.; X3 represents oxygen, a bond, etc.; and X4<br>
represents a group represented by the general formula<br>
-X5-X6- or -X6-X5- (wherein X5 means oxygen, a bond,<br>
etc.; and X6 means optionally substituted alkylene, a<br>
bond, etc.)] or a salt of the derivative. The<br>
derivative or salt has the inhibitory activity of MMP-<br>
13 production and is hence useful as a therapeutic<br>
agent for articular rheumatism, osteoarthritis, cancer,<br>
etc.</td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
		<br>
		<div class="pull-left">
			<a href="251576-an-improved-tandoor.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="251578-a-process-for-the-microemulsion-or-emulsion-polymerization.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>251577</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>1796/KOLNP/2007</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>13/2012</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>30-Mar-2012</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>26-Mar-2012</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>21-May-2007</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>TOYAMA CHEMICAL CO., LTD.</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>A CORPORATION ORGANIZED UNDER THE LAWS OF JAPAN, OF 2-5, NISHISHINJUKU 3-CHOME, SHINJUKU-KU TOKYO</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>EIJI HARA</td>
											<td>C/O TOYAMA CHEMICAL CO., LTD. 4-1, SHIMOOKUI 2-CHOME, TOYAMA-SHI, TOYAMA</td>
										</tr>
										<tr>
											<td>2</td>
											<td>HITOSHI AKITSU</td>
											<td>C/O TOYAMA CHEMICAL CO., LTD. 4-1, SHIMOOKUI 2-CHOME, TOYAMA-SHI, TOYAMA</td>
										</tr>
										<tr>
											<td>3</td>
											<td>YUKIE TADA</td>
											<td>C/O TOYAMA CHEMICAL CO., LTD. 4-1, SHIMOOKUI 2-CHOME, TOYAMA-SHI, TOYAMA</td>
										</tr>
										<tr>
											<td>4</td>
											<td>JUNICHI YOKOTANI</td>
											<td>C/O TOYAMA CHEMICAL CO., LTD. 4-1, SHIMOOKUI 2-CHOME, TOYAMA-SHI, TOYAMA</td>
										</tr>
										<tr>
											<td>5</td>
											<td>YOICHI TANIGUCHI</td>
											<td>C/O TOYAMA CHEMICAL CO., LTD. 4-1, SHIMOOKUI 2-CHOME, TOYAMA-SHI, TOYAMA</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>C07C 233/55</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>PCT/JP2005/022367</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td>2005-12-06</td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td>2004-353725</td>
									<td>2004-12-07</td>
								    <td>Japan</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/251577-novel-anthranilic-acid-derivative-or-salt-thereof by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 13:50:40 GMT -->
</html>
